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Abstract 
Herpes simplex type-l (HSV -1) is the prototypical herpesvirus for scientific study. HSV-l 
capsids have an icosahedral structure with capsomers formed by the major capsid protein, 
VP5, linked in groups of three by distinctive structures called triplexes. The aims of the 
work presented in this thesis were to use a variety of mutagenesis techniques to investigate 
the proteins of the HSV-l capsid. 
Triplexes are heterotrimers formed by two proteins in a 1:2 stoichiometry. The single-copy 
protein is called VP19C, and the dimeric protein is VP23. Insertional and deletional 
mutagenesis was carried out on VPI9C and the effects of the mutations on virus growth 
and capsid assembly were examined. Insertional mutagenesis showed that VP 19C can be 
divided into three regions with respect to their ability to tolerate five amino acid insertions, 
with two regions of approximately 100 amino acids at the N- and C- terminal regions of 
the protein being more tolerant of such insertions than a -350 amino acid central region. 
The N -terminal -100 amino acids of the protein, which are particularly insensitive to 
insertional mutagenesis, correspond to a region that is poorly conserved among 
herpesviruses. Some, but not all, severely disabled mutants were compromised in their 
ability to bind VP23 and VP5. 
Analysis of deletional mutants revealed the presence of an unusual nuclear localisation 
signal (NLS) near the N-terminus of VP19C. This was mapped to a 33 amino acid region 
by fusion of specific sequences to a green fluorescent protein (GFP) marker. 
By replacing the endogenous NLS with that from the simian virus 40 (SV 40) large T 
antigen, we were able to show that the first 45 amino acids ofVP19C were not essential for 
assembly of functional capsids and infectious virus particles. However, removing the first 
63 amino acids resulted in the formation of aberrant capsids and prevented virus growth, 
suggesting that the poorly-conserved N-terminal sequences have some as-yet-unidentified 
function. 
In an attempt to locate the N-terminus of VPl9C within the triplex, the structure of B-
capsids was determined for virus expressing a form of VP 19C in which the first 45 amino 
acids were replaced by the SV40 NLS. Surprisingly, the most obvious differences were at 
the tops of the hexons, where additional masses appeared to be present in wild-type 
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caps ids, and at the tops of the pentons, where the mutant capsids contained extra mass. The 
differences were not uniform across capsids, instead forming a gradient with the greatest 
apparent excess of wild-type capsid mass towards the centres of the faces and the greatest 
deficiency at the vertices. This pattern of differences can be explained most simply by a 
change in the overall curvature of the mutant virus capsid, resulting in a more angular 
capsid with flatter faces and more prominent vertices. 
There are many examples of proteins that can be fused to GFP without affecting their 
properties. However in some cases the large size of GFP can interfere with the function 
and fate of recombinant proteins. Although GFP tagging has been carried out successfully 
on the smallest capsid protein, VP26, attempts to tag VP19C with GFP have been 
unsuccessful and the successful tagging of other capsid proteins with GFP has not been 
reported. The labelling of proteins with FIAsH-EDT2 has been suggested as a possible 
alternative to GFP tagging. It has a significant advantage over GFP tagging in that the only 
alteration to the protein sequence that is required is the addition of a short (typically 6-12 
amino acids) motif. The sequence of VP5 was altered to include this motif, and although 
FlAsH-EDT2 was able to label the recombinant protein, levels of background fluorescence 
were such that without improvements this method was not suitable for studying the HSV-l 
capsid. 
VP5 interacts with VP26 at the tips ofhexons and with tegument at the tips of pen tons. Our 
understanding of these interactions has been aided by the resolution of the crystal structure 
of the VP5 upper domain. Since the publication of the crystal structure, computational and 
experimental approaches have been used to identify the particular amino acids involved in 
these interactions. Computational analysis led to eighteen amino acids in the VP5 upper 
domain being suggested as having a role in these interactions. Site-directed mutagenesis 
was carried out on nine of these mutants, and although one mutation prevented the 
production of infectious virus, none of the mutants examined were unable to bind VP26, 
suggesting that the interaction between VP5 and VP26 may involve several points of 
contact. 
Taken together, the results in this thesis have helped to increase our levels of 
understanding of the HSV -1 capsid, and provided new insights into the structure of 
individual proteins within the capsid. 
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1. Introduction 
1.1. Introduction to herpesviruses 
1. 1. 1. Classification of herpesviruses 
Herpesviruses are a large, diverse family with a host range that probably comprises all 
vertebrates and at least one type of invertebrate. In nature, each vertebrate herpesvirus is 
closely associated with a single host species, and the hosts most extensively studied so far 
can be infected by several distinct herpes viruses. It is therefore likely that the 124 
recognised species described as of 2005 (Davison et at., 2005a) represent only a tiny 
proportion of the number in existence. The host-specific occurrence of herpesviruses 
indicates that they have evolved with their hosts over long periods of time and are 
extremely well adapted to them. (Davison, 2002). 
The primary means of identifying members of the herpesvirus family has been according 
to virion structure. The virions are 200-250 nm in diameter and have four distinct layers. 
The dsDNA genome is packaged within an icosahedral shell known as the capsid, which is 
approximately 125 nm in diameter. The capsid is surrounded by an amorphous protein 
layer known as the tegument, which is in tum wrapped in a lipid membrane containing 
several viral glycoproteins. (Roizman and Pellett, 2001; Davison, 2002). 
As well as having a common virion structure, herpesviruses also have some common 
characteristic biological properties. 
• They all encode a large number of proteins and enzymes involved in nucleic acid 
metabolism, and DNA syntheses. 
• Viral DNA replication and capsid assembly occur in the nucleus of the infected 
cell. 
• The production of infectious progeny virus usually results in the destruction of the 
host cell. 
• All herpesviruses studied have the ability to establish latent infection (the dormant 
state for viruses, in which only a small proportion of viral genes are expressed and 
no progeny virus is produced). 
Although herpesviruses share a number of biological properties, they exhibit considerable 
variation, which can be seen in many aspects of herpesvirus biology. Variation occurs in 
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the cell types that the virus can infect in tissue culture, the length of the replication cycle 
and the cell types in which latent infection can be established. 
While classification as herpesviruses has primarily been based on virion structure, various 
additional criteria have been used for classifying herpesviruses into lower taxa, within the 
categories of subfamily, genus and species. The criteria used until recently were mainly 
biological properties - which were largely successful for classification into subfamilies -
and antigenic properties. The majority of currently known herpesviruses infect mammals 
and birds. These herpesviruses can be further classified as Alphaherpesvirinae, 
Betaherpesvirinae and Gammaherpesvirinae. 
1.1.1.1. Alphaherpesvirinae 
Herpesviruses within this subfamily have the ability in infect a wide range of hosts in 
tissue culture under experimental conditions. They have short reproductive cycles «24 
hours), efficiently destroy infected cells and grow rapidly in cell culture. They establish 
latent infection in the ganglia of the sensory nervous system. Alphaherpesvirinae can be 
further classified into four genera: Simplexviruses, which include Herpes Simplex Virus 
type-l and type-2 (HSV-I and HSV-2), Varicelloviruses, which include Varicella-Zoster 
Virus (VZV); Mardiviruses, which include Marek's disease virus-2 and -3 (GaHV-2 and 
GaHV -3); and the Iltoviruses, which include Infectious laryngo-tracheitis virus (ILTV or 
GaHV-1). (Roizman and Pellet, 2001). 
1.1.1.2. Betaherpesvirinae 
Herpesviruses within this subfamily have a restricted host range in tissue culture. They 
have a long reproductive cycle and grow slowly in cell culture conditions. Infected cells 
can become large (cytomegalia), and carrier cultures can be established in which cells 
survive even after being infected. Betaherpesvirinae tend to establish latency in a wide 
range of tissues, for example in secretory glands and the kidneys. Betaherpesvirinae can be 
further divided into four genera: Cytomegaloviruses, which include Human 
cytomegalovirus (HCMV); Muromegaloviruses, which include Murine cytomegaloviruses 
(MHV -1); Roseoloviruses, which include Human herpesviruses type-6 (HHV -6) and type-
7 (HHV -7); and Probosciviruses, which include Elephant Endothelial Herpesvirus (EIHV-
1). (Roizman and Pellet, 2001; McGeoch et al., 2005). 
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1.1.1.3. Gammaherpesvirinae 
Herpesvirses within this subfamily have a very restricted host range in tissue culture, being 
limited to the family or order to which the natural host belongs. Gammaherpesvirinae can 
replicate in lymphoblastoid cells and some also exhibit lytic replication in certain types of 
epithelial and fibroblastic cells. In infections within the natural host, Gammaherpesvirinae 
tend to be specific to B or T lymphocytes. Latent infections are usually established in 
lymphoid tissue. They can be further subdivided into three genera: Lymphocryptoviruses, 
which include Epstein-Barr virus (EBV); Rhadinoviruses, which include Kaposi's Sarcoma 
Herpesvirus (KSHV); and Macaviruses, which include Equine Herpesvirus type-2. 
(Roizman and Pellet, 2001; McGeoch et aI., 2005). 
1.1.1.4. Classification of herpesviruses using DNA sequence 
analysis 
In recent years, classification by biological properties has been superseded by classification 
based on the relationships between DNA and amino acid sequences. Thus, classification is 
based primarily on genetic information such as (i) the structure of the genome, (ii) DNA 
and protein sequence homologies, and (iii) the possession and conservation of certain 
genes, and their arrangements within gene clusters (Roizman and Pellett, 2001; McGeoch 
et al., 1995). However, the original classifications have proved to be remarkably accurate, 
with few viruses requiring to be reclassified. One notable exception has been Marek's 
disease virus-I, the causative agent of tumour-like growths in the lymphoid tissues of 
chickens. This was originally classified as a gammaherpesvirus because of its ability to 
infect lymphoid tissue; however, DNA sequence analysis has shown that it is more akin to 
Alphaherpesvirinae and the virus has been reclassified accordingly (Buckmaster et al., 
1988). 
More sequence information is available for herpesviruses than for any other large DNA 
virus family, and our understanding of the evolution of these viruses is consequently well 
developed. At the time of writing, the complete genome sequences of 39 herpesviruses 
were available (Andrew Davison, personal communication). Comparisons of amino acid 
and DNA sequences have allowed the construction of phylogenetic trees illustrating the 
genetic relationship between herpesviruses, as shown in Figures 1.1 and 1.2. 
Sequence data is now available for several closely related pairs of species, such as HSV-I 
and HSV-2, Equine herpesvirus type-I and type-4 (EHV-I and EHV-4), VZV and Simian 
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Figure 1.1: Lineage map showing the evolutionary divergence of the herpesviruses (not drawn 
to scale). 
Lineage comprises herpesviruses that infect mammalian and avian hosts, and which 
contains the alpha, beta, and gamma herpesvirus subfamilies. Lineage 2 comprises 
herpesviruses that infect fish and amphibians. Lineage 3 comprises herpesviruses that infect 
invertebrate hosts (of which only one example is known at present). A potential fourth lineage 
(broken line) is shown to reflect the similarities in structure, capsid assembly, and DNA 
packaging observed between herpesviridae and dsDNA bacteriophages that suggest that both 
groups are descended from a common ancestral virus. 
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Figure 1.2: Alpha, beta, and gammaherpesvirus phylogenetic tree based on the alignments of 
six sets of homologous proteins. 
Figure provided by Andrew Davison. 
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varicella virus (SVV), and HHV-8 and Rhesus rhadinovirus (RRV). Members of some 
pairs have presumably survived by occupying distinct biological niches within the same 
host. Divergence took place a long time before the present hosts evolved and thus was not 
necessarily caused by host speciation. For example, HSV -1 and HSV -2 are estimated to 
have diverged about eight million years ago (McGeoch et al., 1995), implying that related 
pairs of viruses will also be present in animals that have diverged subsequently (such as 
other higher primates). However, if we consider the cases of VZV and SVV, and HHV-8 
and RRV, we note that these infect different hosts (humans in the former of each pair and 
Old World monkeys in the latter), indicating that divergence may have begun upon host 
speciation. 
1.1.1.5. Fish, amphibian and invertebrate herpesviruses 
Until the last decade, sequence information was available only for mammalian and avian 
herpesviruses. These viruses are clearly related and evolved from a common ancestral 
herpesvirus. In recent years, two other major herpesvirus lineages have been discovered, 
one leading to fish and amphibian herpesviruses, and the other to invertebrate 
herpesviruses, of which only one example, Oyster Herpesvirus (OsHV-l), is known at 
present (Davison, 1992, 1998, 2002; Bernard and Mercier, 1993 ;). If these viruses evolved 
with their hosts, the fish viruses would have diverged about 450 million years ago and the 
invertebrate virus approximately one billion years ago (Kumar and Hedges, 1998; Wray et 
al., 1996). The fish and frog herpesviruses evolved from a common ancestor as they share 
a subset of genes. It is not possible to evaluate the inheritance patterns of OsHV -I genes 
since no related viruses have been identified. This virus is also unusual in that it is not 
restricted (at least in shellfish hatcheries) to a single bivalve species or even a single genus 
(Arzul et al., 2001). 
In contrast to the obvious relationships among viruses within the mammalian/avian or 
fish/amphibian lineages, the extent of divergence between the three lineages is so great that 
it is difficult to be convinced purely from comparisons of amino acid sequence that the 
viruses are derived from a common ancestor. Each lineage has a few functions that are 
Ubiquitous among living organisms, such as DNA polymerase, DNA helicase, or protein 
kinase, but these could have been acquired by independent capture. Genes encoding 
proteins that are confined to herpesviruses are not detectably conserved. However, analysis 
of the Channel Catfish virus (CCV) and OsHV-l has shown that both have a similar capsid 
morphology to HSV -1 (Davison and Davison, 1995; Davison et al., 2005b) and that CCV 
and HSV-l appear to package their DNA in a similar way, by expelling a scaffold protein 
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from a preformed capsid (Davison and Davison, 1995). On balance, therefore, it seems 
likely that the three major lineages evolved from a common ancestor. Support for this 
hypothesis must await the derivation of further information on herpesvirus protein 
structure, at which level distant evolutionary connections are more likely to be visible. 
Structural analysis of herpesvirus capsids will be discussed further in Section 1.4. 
If the relationship between the three lineages is accepted, it implies that the common 
ancestor of all modern herpesviruses existed prior to the evolution of the first vertebrates, 
approximately 400 million years ago and that the morphology of this virus was 
unmistakably that of a herpesvirus (Davison, 2002). Also, the parallels drawn between 
capsid structure and the DNA packaging processes of herpesviruses and some 
bacteriophages suggest that herpesviruses have origins even earlier, before the separation 
of prokaryotic and eukaryotic cell types (Section 1.6). 
1.1.1.6. Herpesviruses that infect humans 
Currently, eight herpesviruses are known to infect humans (Table l.l). Infection is 
widespread in both the developed and underdeveloped world. As with all herpesviruses, 
those that infect humans have the ability to establish latent infection, in which viral DNA is 
maintained as a circular episome within the nuclei of infected cells. The specific cell type 
in which latency is established varies between viruses. However, in all human 
herpesviruses latent infection lasts for the lifespan of the host. During that time the virus 
can sporadically reactivate and enter lytic replication. 
It should be noted that latent infection is asymptomatic, as the virus only expresses a small 
subset of the viral genome, and it is only reactivation that leads to the recurrence of 
physical symptoms. For example, in HSV -I the classical route of infection is through 
mucosal membranes of the mouth and nose, leading to latent infection in the trigeminal 
ganglia. The virus remains invisible to the host in the ganglia until reactivation, which can 
occur after an interval of many years, causing the reappearance of the virus at the site of 
the original infection where it may form characteristic cold sores. Other human 
herpesviruses behave in similar fashions, although reactivation does not always lead to the 
recurrence of the original symptoms. For example in VZV, primary infection (usually in 
children) causes a generalised infection that produces the distinctive skin lesions of 
chicken pox. As with HSV -1, latent infection is established in the ganglia of the sensory 
nervous system. However reactivation is not generalised, being normally restricted to a 
Virus Common Name Subfamily (Genus) Site of GC content Genome Primary Associated Other Associated 
Latenci (%)1.2 Size IlIness3,4.5,6 Illnesses3.4,5,6 
(kb)2.J 
HHV-I Herpes simplex virus type I Alphaherpesvirinae Sensory nerve 68.3 152 Cold sores Genital lesions, 
(HSV-I) (Simp/exvirus) ganglia conjunctivitis, herpetic 
whitlow, keratitias, 
encephalitis 
HHV-2 Herpes simplex virus type 2 Alphaherpesvirinae Sensory nerve 70.4 152 Genital lesions Oral lesions, 
(HSV-2) (Simp/exvirus) ganglia conjunctivitis, herpetic 
whitlow, keratitias, 
encephalitis 
HHV-3 Varicella-zoster virus A Iphaherpesvirinae Sensory nerve 46 125 Chicken pox/fever Reactivation can lead to 
(VZV) (Varicellovirus) ganglia shingles 
HHV-4 Epstein-Barr virus Gammaherpesvirinae B-Iymphocytes 60 172 Glandular fever, Burkitt lymphoma, 
(EBV) (Lymphocryptovirus) mononucleosis nasopharyngeal 
! 
carcinoma 
HHV-5 Human cytomegalovirus Betaherpesvirinae Leukocytes, 57 229 Congenital abnormalities, Immuno-compromised 
(HCMV) ( Cytomegalovirus) endothelial mononucleosis, hepatitis individuals suffer from 
cells gastro-enteritis and 
retinitis 
HHV-6 Exanthem subitum virus Betaherpesvirinae T-lymphocytes 42 160 Infant rash (exanthema Associated with certain 
I 
(Roseolovirus) subitum) malignancies: lymphoma, 
leukaemia. co-factor in 
cervical and oral 
I carcinoma 
I 
HHV-7 HHV-7 Betaherpesvirinae T -lymphocytes 45 145 Febrile illness -
(Roseolovirus) 
HHV-8 Kaposi's sarcoma- Gammaherpesvirinae B-Iymphocytes 54 170 Associated with Kaposi's 
-
associated herpesvirus (Rhadinovirus) sarcoma 
__ (KSHV) 
Table 1.1: Human herpesviruses and their primary and associated illnesses 
(1) Roizman, 1992; (2) Subak-Sharpe and Dargan, 1998); (3) Levy, 1997; (4) Gold and 
Nankervis, 1991; (5) Evans and Niederman, 1991; (6)Nahmiasetal., 1991. 
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region of the skin associated with a single nerve tract (known as a dermatome), where it 
causes a painful rash known as shingles. 
The causes of herpesvirus reactivation are poorly understood, but it often seems to be 
triggered by some form of stimulus, such as mental or physical stress, hormonal changes, 
old age, or exposure to UV radiation. One factor of particular importance is the immune 
state of the host, with particular relevance to individuals infected with the human 
immunodeficiency virus (HIV). Organ transplant patients or patients using 
immunosuppressive drugs are known to be at risk to reactivation of HCMV (Sia and Patel, 
2000). The ability of herpesviruses to remain latent in the host without causing detectable 
symptoms is a survival mechanism that allows the virus to persist in a form invisible to the 
immune system, yet still retain the ability to spread to naive hosts when reactivated. Such a 
strategy requires that the primary infection does not kill the host, and it is not surprising 
that infections of humans are not normally fatal except in unusual circumstances. However, 
this only applies when herpesviruses infect their natural hosts. An example can be 
observed in Cercopithecine herpesvirus-I, an alphaherpesvirus that normally infects 
macaque monkeys. In the natural host, infection is benign, resulting in minor or no 
symptoms. However, in human infection, the result is severe encephalomyelitis, which is 
fatal in approximately 80% of cases. HSV -1 latency is discussed in further detail in Section 
1.3.8. 
1.2. Virion architecture 
The structure and morphology of the virion is conserved across herpesviruses. The virion 
consists of four distinct layers: the DNA genome, the capsid, the tegument, and the 
envelope (Figure 1.3). The structure and composition of each of these layers are discussed 
in the following section. The discussion will concentrate particularly on the HSV -1 virus 
capsid, which is the primary subject of the work described in this thesis. 
1.2.1. The genome 
The HSV -1 (strain 17) genome is a single linear molecule reported as consisting of 152261 
base pairs (bp) of double-stranded DNA (dsDNA), with a GC content of 68.3% (McGeoch 
et al., 1988; Dolan et al., 1998). Comparison between the genome sequences of HSV -1 and 
HSV -2 has resulted in the identification of 74 open reading frames (ORFs) that are 
conserved between the two viruses (McGeoch et a/., 1988; Dolan el a/., 1998). 
Virion Diameter 
= 2000 A 
Envelope 
Tegument 
~~~-- Capsid 
--....... 
D A Genome 
Capsid Diameter = 1250 A 
Figure l.3: Electron micrograph ofa frozen hydrated HSV-l virion. 
The virion consists of four distinct layers: the D A genome, capsid, tegument and envelope. 
Although not directly visible, the D A genome is located within the capsid; the densely 
packaged nature of the D A genome accounting for the electron-dense appearance of the 
capsid. The envelope is vi ible as a thin, electron-den e layer surrounding the virion, while 
the tegument is a less electron-den e layer eparating the envelope and the capsid. 
This figure was reproduced with permission from W. Chiu, Baylor College of Medicine, 
USA. 
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1.2.1.1. Organisation of the genome 
Herpesvirus genomes are linear double-stranded genomes of 125-245 kb (Davison, 2002). 
Their base composition is highly variable, with GC contents ranging from 31 % to 75%. 
Genomes have been classified into seven distinct groups according to their sequence 
arrangement and the presence of terminal or internal repeats (Roizman et al., 1992; 
Davison and McGeoch, 1995). Figure 1.4 shows a schematic representation of the genome 
groups. 
Group 0 genomes have a single unique region with no internal or terminal repeats. Tupaia 
herpesvirus (THV), isolated from the tree shrew, is characteristic of this group (Koch et at., 
1985). Group 1 genomes have a unique long region with direct repeats at each terminus. 
Members of this group include channel catfish virus (CCV), HHV -6 and HHV -7 (Davison, 
1992; Gompels et al., 1995; Nicholas, 1996). Group 2 genomes contain a single unique 
region flanked by multiple copies of a direct repeat at each terminus. Examples of group 2 
genomes include Herpesvirus Saimiri (HVS) and KSHV (Albrecht et al., 1992; Moore et 
al., 1996). Group 3 genomes are similar to group 2, although they contain multiple copies 
of the same repeat sequence internally, in inverted orientation, which result in the genome 
being divided into two unique regions flanked by inverted repeats. The two unique regions 
can invert relative to each other, producing four genetic isomers that are isolated in 
equimolar amounts from infected cells. A virus isolated in rabbits, cottontail herpesvirus, is 
an example of this group (Cebrian et al., 1989). Group 4 genomes contain two unique 
regions flanked by multiple direct repeats at each terminus as well as unrelated internal 
repeats. EBV has this genome structure (Baer et al., 1984). Group 5 genomes have two 
unique regions flanked by inverted repeats. The inverted repeats are not related, but are 
specific to each unique region. VZV belongs to this genome class (Davison and Scott, 
1986). Group 6 genomes are similar to group 5 however they contain an additional 
sequence (the a sequence), which is present as direct repeats at the termini and in inverted 
orientation at the junction between the long and short segments. Additionally, the repeats 
flanking UL are longer than those seen in group 5. The long and short regions are capable 
of inversion and four genomic isomers can be isolated in equimolar amounts from virions. 
HSV-l, HSV-2 and HCMV are all members of this group (Roizman, 1979). 
The organisation of the HSV-l genome is illustrated in Figure 1.5. It is made up of two 
distinct regions - the long region (L) and the short region (S). Each region contains a 
unique sequence (UL and Us) flanked by a pair of inverted repeat sequences known 
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Figure 1.4: Herpesvirus genome organisation 
A schematic representation of the genome structures as defined by Roizman (1992), and 
Davison and McGeoch (1995). Group 0 genomes contain a single unique coding region and 
no repeat units. Group I genomes comprise a single unique region with a single direct repeat 
sequence at each terminus. Group 2 genomes are similar to group I, but contain multiple 
repeats at each terminus. Group 3 genomes have multiple repeats at each terminus and 
internal repeats in the opposite orientation at the junction between the two unique regions. 
Group 4 genomes are similar to group 3, but the internal repeats show no similarity to the 
terminal repeats. Group 5 genomes have inverted repeats surrounding the two unique regions; 
the Us repeats are larger than those flanking the Ul, region. Group 6 genomes are similar to 
group 5, however they also contain a sequence repeats at each terminus and in inverted 
orientation at the LIS junction. Arrows indicate the orientation of the repeats in each case. 

Figure 1.5: Organisation of the HSV-J genome. 
Above: A schematic illustration of the structural organisation of the HSV-I genome. The 
genome is made up of two separate regions; L (long) and S (short), with each domain 
consisting of terminal repeats (TRL and TRs), internal repeats (lRL and IRs), unique sequences 
(UL and US), and the 'a' sequence located at the termini and at the Land S junction. TRtlIRL, 
and TRs/IRs are pairs of inverted repeats, therefore the Land S regions can be inverted 
relative to each other. 
Below: A schematic illustration of the four possible isomers of the HSV-I genome resulting 
from Land S inversion. P (prototype - no inversion of either the L or S region), IL (inversion 
of L), IS (inversion of S), and ILS (inversion of both I and L regions). 
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respectively as long repeats (Rd and short repeats (Rs). Depending on their positions, they 
are known as terminal repeats (TRL and TRs) or internal repeats (IRL and IRs). The 
molecule also contains a terminal redundancy of approximately 400 bp known as the a 
sequence. One or more copies of the a sequence are located internally at the junction of the 
L and S segments, in the opposite orientation to the terminal a sequences (McGeoch et aI., 
1988). The presence of inverted repeats at either side of the ULand Us regions means that 
internal recombination can occur, with the L and S regions being inverted relative to each 
other. This results in the formation of four isomers of the HSV -I genome (Figure 1.5), 
known as P (prototype), IL (inversion of the L region), Is (inversion of the S region) and ILs 
(inversion of both the L and S regions). DNA isolated from cells infected with Wild-type 
HSV -I consists of equimolar concentrations of the four isomers. Viruses in which the 
genomic DNA has been prevented from recombining due to deletion of the internal 
inverted repeats retain their ability to replicate in cell culture, indicating that the ability to 
rearrange the genome is not critical for viability (Roizman and Knipe, 2001). HSV-I ORFs 
are distributed throughout the genome, including the inverted repeats. Each gene is named 
firstly with respect to the region of the genome in which it is located (i.e. UL, Us etc.) and 
secondly by assigning a number relating to the gene order in that region (i.e. UL I is the 
gene closest to the start of UL and UL56 is the gene closest to the end of UL in the P 
orientation). This system gives each gene a unique reference name. For example, the 
capsid shell proteins are encoded by ORFs located in the middle of the UL region and are 
designated ULl8, ULl9, UL35 and UL38. 
1.2.1.2. Packaged state of the genome 
In the herpesvirus virion the genome is found tightly packed inside the icosahedral capsid 
shell, filling all the available space within the capsid (Booy et al., 1991). Together, the 
genome and capsid are referred to as the nucleocapsid. The DNA inside the virions is 
organised in concentric layers with a spacing of 26 A (Figure 1.6) (Zhou et al., 1999), 
which has been likened to the 'spooling' model of DNA packaging proposed for 
bacteriophage T7 (Cerritelli et aI., 1997). This arrangement suggests that the DNA, which 
enters through a unique portal, is wrapped around the inner surface of the capsid shell, 
accumulating one layer at a time until at least ten concentric layers of tightly packed DNA 
have formed. (It should be noted that although the DNA is observed to be closely 
associating with the inner surface of the capsid shell, no icosahedral symmetry has been 
detected in the structure of the packaged DNA, suggesting that no specific DNA-protein 
interactions are involved (Zhou et al., 1999). The validity of this model was confirmed by 
Bhella et al. (2000), who showed that this model of packaging is also applicable to the 
o 100 200 300 400 500 600 650 A 
Figure 1.6: Cross-section through a cryo-EM reconstruction ofa HSV-l capsid. 
This cross-section is viewed along a two-fold axis of symmetry. Concentric shells of density 
(coloured red) are attributable to the genomic D A packaged within the capsid. The spacing 
between layers of D A is 26 A. The resolution of this tructure is 20 A. The figure is 
coloured radially, using the colour scheme shown beneath the virion. Internal structures 
(packaged D A are shown in red, the capsid floor is shown in yellow the triplexes and 
middle domain of the cap omers are shown in green, while the outer domains of the 
capsomer , including the tegument densities associated with the pentons, are shown in blue 
and purple. 
This figure was reproduced from Zhou et ai, (1999). 
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packaged state of HCMV genomic DNA, the only difference being that HCMV genomic 
DNA was found to be packaged at a higher density than that ofHSV-1, with an inter-layer 
spacing of 23 A. The HCMV genome is 35% larger than that of HSV -1. However the 
volume of the HCMV capsid is only 17% greater, giving an explanation of why the HCMV 
genome is packaged at a greater density. 
1.2.2. The capsid 
The HSV-1 capsid is an icosahedral protein shell with a diameter of 125 nm (Wildy el aI., 
1960). Its function is to encase and protect the viral genome and, following infection, to 
deliver the viral genome to the nucleus of the cell. A reconstruction of the HSV -1 capsid 
determined to 8.5 A resolution is shown in Figure 1.7. 
1.2.2.1. Capsid forms found in infected cells 
Three distinct types of capsids have been observed by EM within the nuclei of infected 
cells. The three forms have been classified as A-capsids, B-capsids and C-capsids, and they 
can be separated by gradient centrifugation. The structure of the capsid shell is the same 
for all three forms, but they differ in their internal composition. A-capsids are empty capsid 
shells with no internal structure. B-capsids contain an internal proteinaceous core 
composed of the scaffolding proteins VP21 and VP22a, while C-capsids contain the 
packaged viral genome and lack the protein core of the B-capsid (Gibson and Roizman, 
1972; reviewed in Steven and Spear, 1997). 
It was originally proposed that B-capsids represent the intermediate in the capsid 
assembly/DNA packaging process and that the scaffolding protein within the B-capsid is 
replaced by the viral genome to produce the C-capsid. However, a fourth class of 
intranuclear particle has now been identified - the procapsid, which is now known to be 
the precursor of the other three forms. The procapsid was originally identified in cell-free 
systems but has also been detected in thin sections of infected cells (Newcomb el al., 1996; 
Trus el al., 1996; Rixon and McNab, 1999; Newcomb el a/., 2000). The shell of the 
procapsid is spherical rather than polyhedral as in the A, B and C capsids, and it is believed 
that the process of capsid maturation and angularisation occurs simultaneously with DNA 
packaging (Heymann el al., 2003). If this model is correct then A and B capsids are dead-
end products, and only the C-capsid represents a genuine intermediate in the virion 
assembly process. The procapsid will be discussed further in Section 1.5.1. 
Figure 1.7: Structure of the HSV-l capsid detennined to .5 A resolution. 
The capsid shell has a diameter of 1250 A and a MW of approximately 192 Mda. In thi 
reconstruction it consists of 162 capsomeres: ISO hexons (blue) forming the face and edge 
of the capsid and 12 pentons (red) forming the capsid vertices. Between adjacent capsomeres 
lie the capsid's 320 triplexes (green). The H V-I capsid conforms to T=16 icosahedral 
symmetry. Only icosahedrally-ordered tructures are shown in this reconstruction. on-
icosahedrally-ordered tructures, such as the UL6 portal complex, are not shown. 
This figure wa reproduced from Zhou el ai, (2000). 
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1.2.2.2. Protein composition of HSV-1 capsids 
The HSV -1 B-capsid is composed of seven major and several minor proteins. The major 
proteins of the capsid are summarised in Table 1.2 and as described individually below. 
The structural arrangements of the proteins within the HSV -1 capsid will be discussed in 
Section 1.4. 
VP5 
VP5 (also see Section 1.4.4.1) is encoded by the UL19 ORF (Costa et al., 1984; McGeoch 
et al., 1988) and has a predicted molecular weight (MW) of 149075 Da. This figure 
correlates well with the observed MW of 150-155k Da, which indicates that VP5 does not 
undergo any significant post-translational modification (Gibson and Roizman, 1972; 
Cohen et aI., 1980; Rixon et at., 1990). VP5 is also known as the major capsid protein. It 
forms both the hexon and the penton subunits and comprises approximately 70% by mass 
of the total capsid shell. Thus, it is not surprising that VP5 is essential for capsid formation. 
Weller et al. (1987) identified temperature-sensitive mutants of the ULl9 ORF that prevent 
capsid formation at the non-permissive temperature. Furthermore, Desai et al. (1993) 
constructed a VP5 null mutant, in which the ULl9 ORF was interrupted by the insertion of 
the LacZ gene. This mutant was unable to form capsids unless wild-type VP5 was supplied 
in trans by a complementing cell line. HSV -1 capsid assembly studies using the 
baculovirus expression system have also shown that VP5 is essential for capsid assembly 
(Newcomb et al., 1994; Thomsenetal., 1994; Tatman et al., 1994). 
VP5 forms extensive interactions with the other capsid proteins. It was Nicholson et at. 
(1994) who observed the migration ofVP5 to the nucleus in the presence ofpreVP22a and 
first proposed an interaction between the two proteins. This interaction was later confirmed 
by the yeast two-hybrid system (Desai and Person, 1996). Further investigation of this 
interaction revealed that VP5 binds to the C-terminal 25 amino acids of scaffolding 
proteins pre VP21 and pre VP22a (Kennard et al., 1995; Thomsen et al., 1995; Desai and 
Person, 1996; Hong et al., 1996) and that residues in the N -terminal 100 amino acids of 
VP5 are involved in mediating this interaction (Desai and Person, 1999; Warner et al., 
2001). VP5 has also been shown to interact with VP 19C and VP26 (Nicholson et al., 1994; 
Rixon et al., 1996). Furthermore, an interaction between VP5 and a tegument protein 
(tentatively identified as VPl-3) has been revealed by cryo-EM (Zhou et aI., 1999). 
Gene Protein MW(Da) No. of copies per capsid Location in capsid Presence in A-, B-, and C-
capsids 
ULI8 VP23 34268 630 or 640' Triplexes A,B,C 
ULI9 VP5 149075 955 or 960' Hexons and Pentons A, B,C 
UL26 VP21 39875 100 t Internal scaffold B 
UL26 VP24 26628 100 t Internal scaffold A,B,C 
UL26.5 VP22a 33765 1000 to 1500 t Internal scaffold B 
UL35 VP26 12095 900 Tips of hexons A,B,C 
UL38 VP19c 50260 315 or 320' Triplexes A,B,C 
I 
--
Table 1.2: Summary of the HSV-I major capsid proteins within HSV-I A-, B-, and C-capsids. 
*. The UL6 portal protein complex may replace a single penton subunit. As a result, the actual 
copy number ofVP23, VP19C and VP5 may be reduced (for example, in VP5, 955 copies per 
capsid as opposed to 960 copies). 
t. Approximate numbers 
References: Homa and Brown, 1997; Steven and Spear, 1997 
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Structurally, VP5 is the best characterised of the HSV -1 capsid proteins. Proteolytic 
digestion of VP5 has identified a large fragment believed to represent a discrete domain 
within the protein. The structure of this fragment has been determined using X-ray 
crystallographic techniques and shown to correlate to the outermost portion of VP5, 
referred to as the VP5 upper domain (VP5ud) (Baker et al., 2003). 
VP19C 
VP19C (also see Section 1.4.4.3) is encoded by the UL38 ORF (McGeoch et aI., 1988; 
Rixon et al., 1990). It was originally designated VP 19, but renamed VP 19C in order to 
differentiate it from a 53 kDa glycosylated virion protein with which it co-migrated during 
SDS-PAGE (Heine et al., 1974). It has a predicted MW of 50260 Da - a figure that 
correlates well with the observed MW of 50-54 kDa, indicating that VP19C does not 
undergo any significant post-translational modification (Gibson and Roizman, 1972; 
Cohen et aI., 1980; McGeoch et aI., 1988; Rixon et al., 1990). VP19C forms part of the 
heterotrimeric complex known as the triplex, in which one copy of VP 19C interacts with 
two copies of VP23. VP19C has also been shown to interact with VP5 (Rixon et al., 1996; 
Saad et al., 1999). VP 19C is essential for capsid formation. Person and Desai (1998) 
constructed a null mutant of VP 19C and demonstrated that capsids could not be formed 
unless wild-type VP 19C was supplied in trans by a complementing cell line. HSV -1 capsid 
assembly studies using the baculovirus expression system have also shown that VP 19C is 
essential for capsid assembly (Newcomb et al., 1994; Thomsen et al., 1994; Tatman et al., 
1994). 
VP23 
VP23 (also see Section 1.4.4.3) is encoded by the ULl8 ORF (McGeoch et al., 1988; 
Rixon et al., 1990). It has a predicted MW of 34268 Da; again, this is a figure that 
correlates well with the observed MW of 30-34k Da, indicating that VP23 does not 
undergo any significant post-translational modification (Gibson and Roizman, 1972; 
Cohen et aI., 1980; McGeoch et al., 1988; Rixon et aI., 1990). Together with VP 19C, 
VP23 forms the heterotrimeric triplex. VP23 is essential for capsid formation. Desai et al. 
(1993) constructed a null mutant of VP23 and demonstrated that capsids could not be 
formed unless wild-type VP23 was supplied in trans by a complementing cell line. HSV-l 
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capsid assembly studies using the baculovirus expression system have also shown that 
VP23 is essential for capsid assembly (Newcomb et at., 1994; Thomsen el al., 1994; 
Tatman el al., 1994). Interestingly, although the formation of full-size (125 nm diameter) 
capsids requires the presence of VP23, VP5 and VP 19C expressed in the absence of VP23 
(and the scaffolding protein) interact to form smaller (88 nm diameter) particles with T=7 
icosahedral symmetry (Rixon el al., 1996; Saad et al., 1999). These results suggest that 
VP23 is potentially involved in controlling the dimensions ofthe assembling capsid. 
VP26 
VP26 (also see Section 1.4.4.2) is encoded by the UL35 ORF (McGeoch el al., 1988; 
Davison el al., 1992). It has a predicted MW of 12095 Da. This figure correlates well with 
the observed MW of 12 kDa (Heilman el al., 1979; Cohen et al., 1980; McGeoch et al., 
1988; Rixon et aI., 1990). VP26 is located on the tips of the hexon subunits of the capsid, 
but not on the pentons. It has been shown to be present in A, B, and C-capsids, but not in 
the procapsid (Chi and Wilson, 2000; Newcomb et al., 2000). Studies using the 
baculovirus expression system have shown that VP26 is not essential for capsid assembly 
(Newcomb el aI., 1994; Thomsen et aI., 1994; Tatman et aI., 1994). Furthermore, a VP26 
null mutant (K~26Z), which was made by replacing the UL35 ORF with the LacZ reporter 
gene, was able to replicate in cell culture to the same levels as WT virus (Desai et aI., 
1998). Although VP26 is not essential for capsid assembly, it has been proposed to have a 
role in the production of infectious virus in nervous tissue. Desai el al. (1998) showed that 
when K~26Z was grown in vivo in mouse trigeminal ganglia, the virus yield from infected 
cells was 30-100 fold less than with WT virus. They also showed that K~26Z has reduced 
ability to reactivate from latent infection compared to WT virus. Douglas et al. (2004) 
demonstrated a role for VP26 in the retrograde transport of viral capsids towards the cell 
nucleus. They observed that 2-4 hours after infection, capsids containing VP26 move 
closer to the cell nucleus, while capsids lacking VP26 remained in a random distribution 
and proposed that although VP26 is not essential for virus replication in vitro, it is likely 
that that it is involved in the mediation of retrograde axonal transport in vivo. 
VP21, VP24 and VP22a 
VP21, VP24 and VP22a (also see Section 1.4.4.4) are scaffolding proteins. They are 
encoded by two overlapping in-frame genes: UL26 (which encodes VP21 and VP24) and 
UL26.5 (which encodes VP22a) (Liu and Roizman, 1991a and 1991b; Preston el al., 1992) 
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(Figure 1.8). For proper formation of the HSV -1 capsid, the presence of either UL26 or 
UL26.5 is essential (Preston el al., 1983; Gao el al., 1994; Sheaffer el aI., 2000). However, 
if UL26 is absent, DNA packaging does not take place and infectious virus is not produced 
(Gao et aI., 1994). Production of infectious virus takes place in the absence of UL26.5, 
however this process is inefficient (Matusick-Kumar et al., 1994). The role of the 
scaffolding proteins is to form the internal scaffold - a transient structure that directs the 
correct assembly of the procapsid shell. The scaffold disassociates and is removed from the 
capsid during maturation and DNA packaging (Dasgupta and Wilson, 1999; McClelland et 
al., 2002). During this process the scaffolding proteins undergo proteolytic cleavage, as 
will be discussed further in Section 1.5.1. 
The UL26 ORF initiates at nucleotide 50809 and terminates at nucleotide 52714 
(McGeoch et aI., 1988; Davison et al., 1992), encoding a 62466 Da protein. The N-
terminus of the UL26 protein encodes a serine protease domain (Liu and Roizman, 1993) 
while the the C-terminus encodes an oligomerisation (Desai and Person, 1996; Pelletier et 
al., 1997) and VP5 binding (Hong et aI., 1996; Oien et aI., 1997) domain. The UL26 
protein is incorporated into the assembling capsid as a single polypeptide (Preston et al., 
1983; Kennard et aI., 1995; Thomsen et aI., 1995; Robertson et al., 1996). During capsid 
maturation, the N-terminal protease domain self-cleaves the UL26 protein between amino 
acids A247 and S248 (known as the release site), resulting in the formation of the minor 
capsid proteins VP24 and preVP21, which constitute the N- and C- terminal domains of 
the UL26 protein respectively. Thus, VP24 is 247 amino acids in length while preVP21 is 
387 amino acids in length (Liu and Roizman, 1993). During procapsid maturation, 
preVP21 is cleaved a second time by the VP24 protease, between amino acids A610 and 
S611 (known as the maturation site). This removes the C-terminal 25 amino acids of 
preVP21 to give VP21, which is 362 amino acids in length (Hong et al., 1996; Oien ef aI., 
1997). 
The UL26.5 ORF initiates at nucleotide 51727 (within the UL26 ORF) and like the UL26 
ORF, terminates at nucleotide 52714 (McGeoch et al., 1988), encoding the 40 kDa protein 
pre VP22a. The primary sequence of pre VP22a is identical to that of pre VP21, with the 
exception that preVP21 has an additional 48 amino acids at the N-terminus. Therefore, 
pre VP22a contains the C-terminal 328 amino acids of pre VP21. pre VP22a is incorporated 
into the assembling capsid and is cleaved by VP24 protease during procapsid maturation 
between the same two amino acids as preVP21 (amino acids A610 and S611 of VP21). 
R M 
1 247 610 635 
NI VP24 I lie UL26 VP21 ORF 
M 
307 611 r~5 NI VP22a UL26.5 ORF 
Figure 1.8: Structural organisation of the HSV -I scaffolding genes. 
The scaffolding proteins are encoded by the overlapping UL26 and UL26.5 ORFs. UL26 
encodes the VP24 maturational protease (residues 1-247) and the VP21 minor scaffolding 
protein (residues 248-635). UL26.5 encodes the VP22a major scaffolding protein (residues 
307-635). The R (release) and M (maturation) sites of proteolytic cleavage are indicated. 
Cleavage at the R site results in the release of proteins preVP21 and VP24. Cleavage at the M 
site results in the removal of 25 amino acids from both pre VP21 and pre VP22a to yield to 
mature forms ofVP21 and VP22a respectively. 
29 
Cleavage removes the C-tenninal 25 amino acids from preVP22a to give VP22a, which is 
303 amino acids in length (Hong et al., 1996; Oien et al., 1997). 
Differential regulation of UL26 and UL26.5 transcription results in preVP22a being 
expressed at higher levels than preVP21 and VP24. As a result, VP22a is present at much 
larger quantities in B-capsids than VP21 or VP24 (approximately 1000-1500 copies of 
VP22a per capsid, compared to approximately 100 copies of VP21 and VP24). Hence, 
VP22a is referred to as the major scaffolding protein (Newcomb et al., 1993). VP21 and 
VP22a are released from the capsid during packaging, therefore VP21 and VP22a are 
found only in B-capsids. VP24 is retained within the capsid during procapsid maturation 
and is therefore a component of A, B, and C-capsids as well as mature virions (Gibson and 
Roizman, 1972; Spear and Roizman, 1972; Booy et aI., 1991; Stevenson et al., 1997). 
Minor Capsid Proteins 
A number of proteins have been identified as minor constituents of the HSV -1 capsid. 
These minor capsid proteins are encoded by the ORFs UL6, UL15, ULI7, UL25, UL28, 
and UL33 (Homa and Brown, 1997). They are involved in the cleavage and packaging of 
the viral genome into the newly assembled capsid. The UL6 proteins have been shown to 
fonn the portal through which the viral genome enters and exits the capsid. The portal is 
located at a unique capsid vertex where it probably replaces a penton (Newcomb et al., 
2001 a). It has also been demonstrated that the UL15 and UL28 proteins interact with the 
UL6 protein (White et al., 2003), which leads to the conclusion that the minor capsid 
proteins assemble into a DNA cleavage and packaging complex located at a unique capsid 
vertex. Due to this arrangement, the minor capsid proteins are not arranged on the capsid 
with icosahedral symmetry. As a consequence, the location of these proteins and the 
structure of the DNA cleavage and packaging complex cannot be determined by cryo-EM 
and image reconstruction techniques, since these techniques require the subject material to 
have icosahedral symmetry (for example, Zhou et al., 2000). UL 17 is present in both the 
tegument and the capsid, and as the tegument is not attached to DNA-containing capsids in 
the nucleus (Booy et al., 1991), it is likely that the UL17 protein participating in DNA 
packaging is bound to the capsid (Thurlow et al., 2005). Both UL17 and UL25 appear to 
be present at multiple sites on the capsid, although their precise locations have not been 
determined (Ogasawara et al., 2001; Thurlow et aI., 2006). It has recently been suggested 
that UL25 is located near to the vertices on the external surface of the capsid (Newcomb et 
al., 2006). UL33 is present in A, B, and C capsids, independent of the presence of UL6, 
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ULl5 or UL28, and it has been suggested that it acts as part of the molecular machinery 
that translocates cleaved genomic DNA into the capsid (Beard et aI., 2004). The roles of 
minor capsid proteins in the packaging of the viral genome will be discussed further in 
Section 1.3 .6. 
1.2.3. The tegument 
1.2.3.1. Composition of the tegument 
The tegument is the least-well understood component of the HSV -1 virion. It is an 
amorphous proteinaceous layer located between the capsid and the envelope (Figure 1.3). 
Its exact composition is uncertain, but it is thought to contain at least nineteen proteins 
(Table 1.3). The functions of many of these proteins are poorly understood. Some are 
important for the early stages of infection. The virion host shutoff protein (vhs, the gene 
product of UL41) shuts off host cell protein synthesis (reviewed by Smiley et af., 200 I). 
VPI6 (UL48) acitvates HSV-I immediate-early gene expression (Campbell et af., 1984). 
The presence of these proteins in the tegument means that they can be released rapidly 
upon infection, without the delay that is inevitable when proteins have to be expressed de 
novo from the viral genome. This helps to ensure a rapid and efficient infection of the host 
cell. Other known functions performed by tegument proteins are summarised in Table 1.3. 
The structural arrangement of tegument proteins is poorly understood. L-particles are non-
infectious particles composed solely of envelope and tegument. Their existence shows that 
tegument proteins have an inherent ability to self-associate in the absence of capsids 
(McLauchlan and Rixon, 1992; Rixon et af., 1992; Szilagyi and Berriman, 1994). Virus 
morphogenesis has been shown to proceed in the absence of several tegument proteins, 
such as US3, UL13, UL41, UL46, UL47, and UL49 (reviewed by Mettenleiter, 2002). 
Furthermore, over-expression of the tegument protein VP22 (the gene product of UL49) 
leads to increased amounts of the protein within the tegument, but does not appear to have 
any obvious impact on tegument structure (Leslie et al., 1996). These observations suggest 
unlike the capsid, that the tegument does not have a precisely defined structure and 
exhibits flexibility in its arrangement. In addition, the level of protein synthesis can be a 
controlling factor in levels of incorporation into the tegument, as is the case for VP22 
(Leslie et al., 1996), while del Rio et al. (2005) used Green Fluorescent Protein (GFP) 
tagging to show that even without an increase in protein synthesis, the abundance of VP22 
varies between individual virions. However, the organisation of proteins in the tegument is 
Gene Protein MW Properties and Functions (kDa) 
UL4 - 60 Co localises with UL3. Function not known. 
ULiI gM 17-22 Myristylated, necessary for in envelopment and exocytosis 
ULl3 VP18.5 11 Protein kinase, phosphorylates ICPO, ICP22, VP22, vhs (UL41), gE (US8) etc. 
ULI4 
-
24 Aids in cell to cell spread of virus 
ULI6 
- 40 Associated with the capsid. Required for DNA packaging. 
ULl7 
-
75 Required for DNA packaging. 
UL21 - 58 Phosphoprotein 
UL36 VPI-3 336 Implicated in capsid transport to nucleus, role in initiating tegument 
assembly around capsid 
UL37 - 121 Cytoplasmic phosphoprotein, role in initiating tegument assembly 
around capsid 
UL41 vhs 55 Virion host shutoff protein (vhs) 
UL46 VPIIIJ2 79 Phosphoprotein, modulates activity of UL48 
UL47 VPI3/14 74 Phosphoprotein, modulates activity of UL48 
UL48 VPI6 54 Transactivates IE gene expression 
UL49 VP22 32 Phosphoprotein, secreted and exported to neighbouring cells 
UL51 
- 25 Function not known 
UL56 - - Function not known 
RL2 ICPO 110 IE gene transcription regulator 
RSI ICP4 133 IE gene transcription regulator 
US3 - 53 Protein kinase, phosphorylates ICP22 and UL34, partially inhibits 
apoptosis 
USJO 
- 34 Phosphoprotein, function unknown 
USII 
-
18 RNA binding protein, associates with 60s ribosomal subunit 
Table 1.3: Summary of the HSV-I tegument proteins and their known functions. 
References: Leopardi et al., 1997; Roizman and Knipe, 2001; Mettenleiter, 2002. 
31 
not simply random. Over-expression of the tegument protein UL3 7 did not result in any 
detectable increase in the amount of UL37 protein incorporated into virus particles 
(McLauchlan, 1997). More recently, work using cryo-electron tomography has revealed 
some interesting results regarding the structure and organisation of the tegument 
(Grunewald et aI., 2003). Most notably, the tegument was shown to have an asymmetric 
structure with respect to the capsid. On one side (the proximal pole), the tegument forms a 
very thin layer and the capsid is located in close proximity to the envelope, while on the 
other side of the virion (the distal pole) the capsid and envelope are separated by a thick 
layer of tegument. These results are interesting as they imply that the tegument and capsid 
layers do not move independently of each other, and the structure of the tegument contains 
some degree of organisation. The studies in question did not detect any structural features 
within the tegument other than filamentous structures believed to be actin filaments 
(Grunewald et ai., 2003). Therefore, while the tegument may not possess a single defined 
structure as is the case with the capsid, it does appear to have some level of structural 
organisation, although the exact nature of this organisation remains unclear. 
Although the structure of the tegument as a whole is not well understood, cryo-EM 
examination of intact HSV -I virions has identified regions of icosahedrally ordered 
tegument protein that form extensive interactions with the penton subunits of the capsid 
(Figure 1.9) (Zhou et ai., 1999). Calculations based on these reconstructions estimate that 
this icosahedrally ordered tegument protein has a molecular mass of 170-200 kDa and is 
approximately 200A in length. While the identity of this protein has not been confirmed, 
the most likely candidate is VPI-3 - a tegument protein that is so closely associated with 
the capsid that it was originally identified as a capsid protein (Gibson and Roizman, 1972). 
The function of VP 1-3 is not well understood, but it known to be essential. Studies of a 
temperature-sensitive mutant ofUL36 (the gene that encodes VPI-3), known as IsB7, have 
revealed that at the non-permissive temperature, the release of viral DNA from the capsid 
is blocked (Knipe, el aI., 1981; Batterson et aI., 1983). More recent work has demonstrated 
the presence of a portal in the capsid, which is formed by the UL6 protein. The portal is 
thought to be the location at which HSV -1 genomic DNA enters and exits the capsid, and it 
has been demonstrated that the UL6 portal complex is located at a unique capsid vertex 
(Newcomb et al., 200Ia). While the nature of the interaction between UL6 and VPI-3 
remains unclear, the implication that VPI-3 is involved in DNA exit from the capsid 
makes it appropriate for VP 1-3 to be associated with the portal vertex, however association 
with the portal may not imply association with the other vertices. 
Figure 1.9: Visualisation oficosahedrally ordered tegument proteins associated with the HSV-
1 capsid. The structure of the H V-I B-cap id is shown in grey. Associated tegument proteins 
are highlighted in colour. The dimensions of a single ico ahedral capsid face are outlined by 
the broken yellow line. The resolution of this tructure i 20 A. This figure shows that the 
tegument densities are associated with only the capsid vertice (the pentons), and not with any 
other cap id ubunit (the hexons or trip1exe ). 
This figure was reproduced from Zhou et aI, (1999) . 
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There are arguments against VPI-3 being the tegument protein that is associated with the 
pentons. It has been reported that the virion contains between 120-200 copies of VPl-3 
(Heine et aI, 1974), which is more than the 55-60 copies that would be required if this 
protein bound to the capsid solely at the pentons in a 1: 1 ratio with VP5 as suggested by 
cryo-EM. Furthermore, VPl-3 is known to be a component of L-partic1es, which lack 
capsids (Szilagyi and Cunningham, 1991). Although these observations are not sufficient 
evidence to dismiss VPI-3 as a candidate for the penton-associated protein, they do 
suggest that it does not interact exclusively with the capsid and that it is also a structural 
component of the tegument. 
Icosahedrally ordered tegument proteins have been identified in HCMV and simian 
cytomegalovirus (SCMV) - both Betaherpesvirinae (Trus et al., 1999; Chen et al., 1999). 
The interactions in HCMV and SCMV differ significantly from those observed in HSV -1. 
While tegument/capsid interactions are restricted to pentons in HSV -1, in HCMV and 
SCMV extensive contacts are formed all over the surface of the capsid. In SCMV, two 
distinct species of tegument protein are clearly seen to be binding to the capsid; one to the 
major capsid protein and the other to the triplex. The tegument mass attached to the major 
capsid protein has been estimated at approximately 50-60 kDa, while the mass attached to 
the triplex has been estimated at approximately 100-120 kDa - both values considerably 
lower than the 170-200 kDa mass of the tegument proteins attached to the HSV -I capsid. 
What is striking from these comparisons is that the organisation of the tegument in HS V-I 
is completely different from that observed in both HCMV and SCMV - the proteins have 
different shapes, sizes and binding patterns with respect to the capsid. Trus el al. (1999) 
and Chen et al. (1999) proposed a number of proteins as candidates for the tegument 
proteins that bind to capsids in HCMV and SCMV. These proteins have been identified on 
the basis of the size of the protein and the abundance of the protein within the 
virion/tegument. The most likely candidate for the tegument protein that binds to the major 
capsid protein is the upper matrix protein (UM) (69 kDa, the gene product of UL82), 
which functions as a transactivator of immediate-early gene expression in HCMV (Baldick 
et al., 1997). The candidate proposed for the tegument protein that binds to the triplex is 
the basic phosphoprotein (BPP) (119 kDa), which has been implicated in the transport of 
the capsid in the cytoplasm (Meyer et al., 1997). Neither BPP nor UM have been shown to 
have any counterparts in HSV -1 (Chee et aI., 1990). The conclusion drawn from these 
results is that the structure and function of the HCMV ISCMV capsid-associated tegument 
proteins are entirely different to those of HSV-1. 
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It has also been suggested that SCMV capsids fonn interactions with the high-molecular-
weight protein (HMWP), a 205 kOa protein, which is the homologue of HSV-l VPI-3. 
SOS-Page analysis revealed small amounts of HMWP associated with cytoplasmic B-
capsids isolated from SCMV infected cells (Chen et aI., 2001; Trus et al., 1999). VPI-3 is 
poorly conserved; nevertheless, homologues have been identified in all mammalian and 
avian herpesviruses. These observations indicate an essential and possibly identical role for 
the protein across Alpha, Beta and Gammaherpesvirinae. Since HSV-l VPI-3 has been 
identified as the most likely candidate to be the tegument protein associated with the HSV-
1 capsid, it has been proposed that HMWP binds in a similar manner in SCMV capsids 
(Chen et al., 200 I). Thus, although the bulk of the icosahedrally ordered tegument proteins 
in HCMV and SCMV are likely to be structurally and functionally unrelated to those of 
HSV -1, it is plausible that VP 1-3 homologues bind to capsids and function in a similar 
manner in all three viruses. 
1.2.4. The envelope 
The envelope fonns the outennost boundary of the virion (Figure 1.3), and like the 
tegument, it is a poorly understood layer, proving intractable to structural analysis. It is 
derived from the host cell late in infection. There are at least eleven virally encoded 
glycoproteins in HSV-l (Table 1.4). Although no glycoprotein has been shown to be 
essential for virion assembly, four are essential in the initial infection of the host cell 
(Steven and Spear, 1997). 
The lack of symmetry in the envelope prevents the use of symmetry-based cryo-EM and 
image reconstruction techniques. However, cryo-EM of virions and L-particles has been 
used to give some limited structural infonnation concerning the envelope. The membrane 
has been shown to be spherical and to contain spike-like projections of approximately 15 
nm in length protruding from the surface. These presumably correspond to the 
glycoproteins (Szilagyi and Berriman, 1994). Negative staining has been employed to 
directly visualise the glycoproteins and structures ranging from 80A to 140A in length are 
clearly visible in the membrane. However, these preparations provide no infonnation 
regarding the organisation of the glycoproteins within the undamaged membrane (Stannard 
et al., 1987). 
Gene Protein MW Properties and Functions (kDa) 
ULI gL 40 Forms complex with gH, required for viral penetration and cell fusion 
ULIO gM 60 Phosphorylated, role in acquisition of the viral envelope in the 
cytoplasm (secondary envelopment) 
UL22 gH 115 Forms complex with gL, required for viral penetration and cell fusion 
UL27 g8 120 Forms homooligomers, required for viral penetration and cell fusion 
UL44 gC 120 Responsible for initial attachment to heparin sulphate 
UL53 gK 40 Involved in cell fusion. Potential role in secondary envelopment in the cytoplasm 
US4 gG 60 Required for entry into polarised cells, involved in viral egress 
and cell to cell spread 
US5 gJ 10 Non-essential for viral replication in cultured cells 
US6 gO 60 Required for receptor-binding, viral penetration and cell fusion 
US7 gJ 70 Forms complex with gE, role in acquisition of the viral envelope in the cytoplasm (secondary envelopment) 
Forms complex with gI, role in acquisition ofthe viral envelope 
US8 gE 80 in the cytoplasm (secondary envelopment), involved in cell-to-
cell spread 
Table 1.4: Summary of the HSV -I glycoproteins and their known functions. 
References: Haarr and Skulstad, 1994; Steven and Spear, 1997; Subak-Sharpe and 
Dargan, 1998; Roizman and Knipe, 200 I; Mettenleiter, 2002; Farnsworth, et 
al,2003 
34 
Cryo-electron tomography has been used to provide some interesting results regarding the 
organisation of the envelope glycoproteins (Grunewald et aI., 2003). The envelope was 
shown to contain 650-700 glycoprotein spikes. The glycoprotein spikes ranged in length 
from 100A to 250A and also varied in morphology. Interestingly, the glycoproteins were 
shown to not be randomly distributed, with an accumulation of spikes at the distal pole, 
where the tegument is thickest. This has been proposed to be a result of lipid raft 
involvement in envelope assembly (Grunewald et aI., 2003). 
1.3. Viral replication 
The stages of the HSV -I life cycle, from initial infection to the release of infectious 
progeny virus, are discussed below and summarised schematically in Figure 1.10. 
1.3.1. Virus attachment and entry 
The entry of HSV -I into cells occurs in at least three stages: (i) the attachment of the virion 
to the surface of the cell, (ii) the interaction of gO with one of several cellular receptors, 
and (iii) fusion of the viral envelope and plasma membrane to release the capsid/tegument 
structure into the cytoplasm. Most of the information currently available on this process is 
based on studies of non-polarised cells, in which the membrane proteins interacting with 
envelope proteins are most likely to be randomly distributed. Attachment and entry to 
polarised cells, such as most epithelial cells in the human body, may differ in detail. 
The initial attachment of the virus particle to the cell is mediated by the interaction of 
glycoproteins gC and, to a lesser extent gB, with the glycosaminoglycans (GAGs) on the 
cell surface (WuOunn and Spear, 1989; Shieh et al., 1992). Interestingly, although gC 
confers the greatest efficiency for attachment, it is not essential for either entry or viral 
replication (Heine et al., 1974). In cases where gC is absent, binding to GAG is mediated 
by glycoprotein gB. The preferential GAG for this interaction is heparin sulphate. 
Nevertheless, cells devoid of heparin sulphate but expressing other GAGs such as 
chondroitin sulphate can also be infected (Banfield et al., 1995). 
The second stage of viral attachment involves the interaction of gO with one of several 
cell-surface receptors. There are three classes of cell-surface molecule that are known to 
serve as receptors for HSV -I attachment: (i) herpesvirus entry mediator (HVEM or HveA), 
which is a member of the tumour necrosis factor receptor family (Montgomery el at., 
HSV-1 
virion 
! 
5. 
Cytoplasm 
~ 
Nucleus 
10· 0 
/VV\./vVv 
00 
\ 7. \ 
/XXXXXX:xX:x:;O 
6. 
\ 
/)OO()OO<)OOOOO 
~
c ) 
--. ~ 
J 9c. 
9b\ 
~. 
13. JifJf?A:\. 
'1J1J 
/15. 
trans- Goigi 
network 
Figure 1.10: Overview of the HSV -I lytic cycle 
(1) Virions attach to the cell surface via specific interactions between viral glycoproteins (g8 
and gC) and the extracellular matrix. (2) Interaction of gO with cellular receptors initiates 
fusion of the cellular and viral membranes and the releases the capsid and tegument proteins 
into the cytoplasm. (3) Tegument proteins are either retained in the cytoplasm, where they 
influence host cell responses, or are transported to the nucleus where they are involved in the 
initiation of viral gene expression. (4) The nucleocapsid is transported to the nucleus via 
microtubules, and (5, 6) docks at the nuclear pore, where the viral genome is released into the 
nucleus. (7) HSV-I gene expression is activated by the VPI6 tegument protein. Viral genes 
are expressed in a tightly-regulated cascade. (8) Following transcription, viral mRNAs are 
exported to the cytoplasm for translation on cellular ribosomes. Virally-encoded proteins are 
targeted to the appropriate sites within the infected cell; (9a) some IE proteins, and those 
involved in DNA replication or capsid assembly are required within the nucleus. (9b) Other 
proteins, such as tegument proteins, remain in the cytoplasm. (9c) Viral glycoproteins enter 
the Golgi where they undergo post-translational modification. (10) Capsid proteins assemble 
in the nucleus, forming procapsids. (11) DNA replication initially takes place by the theta 
mode of replication, but soon changes to a rolling-circle mode of replication. The vast 
majority of progeny genomes form concatameric molecules. (12) These are cleaved to form 
monomeric unit-length genomes and are packaged into the procapsid. During packaging the 
procapsid undergoes extensive structural remodelling to form a mature polyhedral capsid. 
(13) DNA-containing capsids exit the nucleus by budding into the perinuclear space and then 
into the cytoplasm. Tegument assembly takes place in the cytoplasm, and is initiated by the 
interaction of tegument protein VP \-3 with the penton subunits of the capsid. (14, 15) 
Tegumented capsids acquire an envelope by budding into the trans-golgi network. This 
process involves the interaction of the tegument proteins with the cytoplasmic tails of viral 
glycoproteins gO, gE/gI, and gM. (16) Progeny virions are released from the infected cell at 
the membrane by exocytosis. 
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1996), (ii) nectin-l (HveC) or nectin-2 (HveB), two members of the Immunoglobulin 
superfamily (Geraghty et al., 1998; Warner et aI., 1998), and (iii) specific sites in heparin 
sulphate generated by certain isoforms of 3-0-sulphotransferases (Shukla et al., 1999). 
Anyone of these cell surface molecules can bind to gO to mediate viral entry, with HSV-I 
and HSV -2 having different receptor preferences. For example, HVEM and nectin-I are 
excellent entry receptors for both HSV-I and HSV-2, nectin-2 is more effective for HSV-2 
than for HSV -I and 3-0-sulphated heparin sulphate is probably more effective for HSV-I 
than for HSV -2. (Roizman and Knipe, 2001; reviewed by Spear and Longnecker, 2003). 
Viruses lacking gD are unable to interact with cell-surface receptors, therefore gO is 
essential for the entry of virus into cells (Johnson and Ligas, 1988). 
The final stage of HSV -1 entry is the fusion of the viral envelope with the cellular 
membrane. This process requires the involvement of glycoproteins gO, gB, and the 
heterodimer gH-gL in a manner yet to be clarified (reviewed by Campadelli-Fiume et aI., 
2000). Bender et al. (2003) showed that cholesterol-rich lipid rafts may be involved in the 
fusion event through an interaction with glycoprotein gB. It has also been demonstrated 
that as an alternative to fusing directly with the cellular membrane, a second pathway for 
HSV -I entry exists, in which after binding to the cell surface, the virus particle is taken 
into the cell via endocytosis and membrane fusion occurs in a pH-dependent manner 
(Nicola et a/. , 2003). The significance of these findings is uncertain, but it has been 
suggested that HSV -1 may use different methods of cell entry depending on the cell type 
that it is infecting. 
1.3.2. Transport to the cell nucleus 
Following fusion of the viral envelope with the cellular membrane, the HSV -1 capsid and 
tegument proteins are released into the cytoplasm of the host cell. Since viral ONA 
replication occurs in the nucleus of the infected cell, the capsid has to be transported 
through the cytoplasm to the nucleus. High concentrations of protein along with the 
presence of the cytoskeleton and organelles can cause molecular crowding in the 
cytoplasm, which effectively restricts free diffusion of molecules larger than 50 kDa 
(Luby-Phelps, 2000). This indicates that virions are transported by active processes. It has 
been shown that the HSV -1 capsid is transported through the cytoplasm by an active 
process involving the microtubule network of the cell. In the presence of microtubule 
depolymerising agents such as clochicine, vinblastine or nocodazole, there was a 
significant reduction in the concentration of capsids observed at the nuclear rim, with the 
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majority remaining scattered throughout the cytosol (Sodeik et a/., 1997). A more detailed 
study of this process has shown that HSV -1 is transported by interaction with dynein (a 
minus end-directed microtubule motor protein) and dynactin (a co-factor of dynein) 
(Dohner et al., 2002). The HSV -1 proteins that are responsible for mediating this reaction 
are currently unknown but are likely to involve outer capsid or inner tegument proteins. An 
interaction between the dynein intermediate chain (DIC) and UL34 has been reported (Ye 
et at., 2000), however the UL34 protein is absent from mature virions in HSV -1 (Reynolds 
et al., 2002) and PRY (Klupp et a/. , 2000). 
Recent work by Douglas et al. (2004) demonstrated an interaction between VP26 and 
dyenin light chains RP3 and Tctex!' This interaction was first identified using the yeast 
two-hybrid method. Subsequently, Glutathione S-transferase pull-down assays confirmed 
the binding of VP26 to RP3, Tctexl and intact cytoplasmic dyne in complexes. 
Furthermore, they observed that 2-4 hours after infection, micro-injected capsids 
containing VP26 had moved closer to the cell nucleus while capsids lacking VP26 
remained in a random distribution, prompting authors to conclude that VP26 mediates the 
binding of incoming HSV -1 capsids to cytoplasmic dynein during cellular infection, 
through interactions with the dynein light chain. 
Other potential candidates for the microtubule binding protein are US 11, UL25 and VP22 
(Elliott and O'Hare, 1998; Kaelin et al., 2000; Diefenbach et al., 2002). Of these, the 
minor capsid protein UL25 is possibly the best candidate since it is known that UL25 is 
closely associated with the capsid and also that it remains with the capsid until it reaches 
the nucleus (Kaelin et a/., 2000). The large tegument protein VP 1-3 is another potential 
candidate. Although it has not been demonstrated that VPI-3 interacts with microtubules, it 
has been shown that VP 1-3 is very tightly associated with the pentons of the capsid (Zhou 
et al., 1999). Sodeik et at. (1997) showed that the interaction with microtubules appeared 
to involve the pentons, correlating with the observed localisation ofVPI-3. 
Following transport through the cytoplasm, the capsid docks at the nuclear pore complexes 
(NPCs), possibly through an interaction between importin P of the NPC and an HSV-l 
tegument protein such as VPI-3 (Ojala et al., 2000). Following binding to the NPC, the 
viral DNA is released from the capsid and injected into the nucleus where it localises 
adjacent to nuclear ND 1 0 domains and circularises (Maul et al., 1996). Recent evidence 
indicates that although viral genomes can associate with pre-existing ND I 0 domains, 
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structures resembling ND 10 domains form de novo and associate with viral genome 
complexes during the initial stages of infection (Everett and Murray, 2005). 
1.3.3. Disruption of host cell protein synthesis 
The HSV -1 virion contains a number of regulatory proteins that prime the newly-infected 
cell to support efficient virus replication. These proteins are located in the tegument, and 
are delivered to the cytoplasm after fusion with the host cell plasma membrane. Among 
these proteins is the virion host shutoff protein (vhs), which triggers the rapid shutoff of 
host cell protein synthesis by accelerating the rate of degradation of both cellular and viral 
mRNAs in a non-specific manner (Kwong and Frenkel, 1987; Oroskar and Read, 1987; 
Elgadi et al., 1999). However, although viral mRNA is degraded, its rate of synthesis is 
greater than the rate ofvhs-mediated degradation (Kwong et at., 1988; Elgadi et at., 1999). 
It has been shown that vhs interacts with the cellular translation initiation factor eIF4H, 
which presumably serves to target vhs to mRNA molecules (Feng et at., 2001), and also 
that vhs possesses nuclease activity, and therefore degrades mRNAs directly rather than 
targeting them for cellular-mediated degradation (Everly et al., 2002). 
The vhs protein is not essential for viral replication, since mutants lacking the UL41 ORF 
are viable. However, mutants lacking functional vhs show a marked reduction in virus 
growth in cell culture (Read and Frenkel, 1983; Read et at., 1993), and wild-type virus 
rapidly outgrows vhs mutants in mixed infections (Kwong et a/. , 1988). 
Three lines of evidence demonstrate that the vhs protein is necessary and sufficient for 
virion-induced host shutoff. Read and Frenkel (1983) isolated viable HSV mutants 
deficient in virion-induced shutoff, and one of these mutants (vhsl) was subsequently 
mapped to the UL41 ORF (Kwong et a/., 1988; McGeoch et al., 1988). The ORF encoding 
vhs was confirmed by targeted disruptions of the UL41 gene, which produced a vhs-
deficient phenotype (Fenwick and Everett, 1990b). Secondly, viral recombinants in which 
the HSV -1 UL41 gene was replaced with the corresponding gene of HSV -2 display the 
more robust shutoff phenotype characteristic of HSV-2 (Fenwick and Everett, 1990a). 
Thirdly, vhs is sufficient to block reporter gene expression when it is expressed as the only 
HSV-1 protein in transiently transfected mammalian cells (Jones et at., 1995; Pak et at., 
1995). 
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It should be noted that vhs is not the only mechanism employed by HSV-I in the control of 
host cell protein synthesis. The IE protein ICP27 inhibits the splicing of cellular pre-
mRNAs by disrupting spliceosomes and redistributing cellular small-nuclear 
ribonuc1eoproteins (snRNPs) (Phelan et al., 1993; Hardy and Sandri-Goldin, 1994; Sandri-
Goldin et aI., 1995; Bryant et al., 2001). Since the majority of HSV -I genes are intron-less 
and do not require splicing, this is an effective mechanism for reducing host cell protein 
synthesis. Four HSV-l genes contain introns and therefore require splicing prior to 
translation. Three of these genes are IE genes (ICPO, ICP22, and ICP47), which are 
transcribed and processed before ICP27 can effectively inhibit the splicing of pre-mRNAs. 
Late in infection, ICP27 is localised to replication compartments. At this stage it may no 
longer repress RNA splicing, allowing ULl5 RNA to be spliced (Roizman and Knipe, 
2001). ULl5 is the fourth HSV -1 gene that contains introns and is expressed late in 
infection. 
Another mechanism by which HSV-I might disrupt host cell protein synthesis is through 
the action of ICP22 and the ULl3 protein kinase. These proteins have been shown to 
phosphorylate cellular RNA polymerase II (Rice et al., 1995; Long et al., 1999), although 
it is uncertain how this affects protein synthesis since this enzyme is also required for 
transcription of the viral genome. 
1.3.4. HSV-1 gene expression 
Transcription of viral DNA takes place in the nucleus. The host RNA polymerase II is 
responsible for the transcription of all viral DNA during infection (Alwine et al., 1974; 
Costanzo et al., 1977). The resulting mRNAs are then transported into the cytoplasm for 
translation on cellular ribosomes. During productive infection, 74 HSV -1 genes are 
expressed in a highly regulated cascade fashion (Honess and Roizman, 1974; Roizman and 
Knipe, 2001). 
Very soon after infection (within two to four hours), the viral immediate-early (a or IE) 
genes are expressed (Roizman and Knipe, 200 I). Five such genes have been identified 
encoding ICP4 (RS1), ICPO (RL2), ICP27 (UL54), ICP22 (US1), and ICP47 (USI2). 
Expression of these genes is controlled by the action of VP 16, a virion trans-activator 
protein. VP 16, encoded by the UL48 gene, forms a complex with cellular proteins and 
mediates IE gene expression through a common regulatory element found in the promoters 
of each of the IE proteins (often designated as T AA TGARA T - the best conserved portion 
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of the consensus sequence involved). Activation of the HSV -1 IE genes is initiated by the 
fonnation of a multi-protein complex containing the virion protein VP 16, and two host cell 
proteins: oct-I (octamer DNA-binding protein) and HCF (Host Cell Factor). The complex 
binds to TAATGARAT elements present in each IE gene promoter (Weir et al., 2001). As 
IE gene expression is mediated by pre-existing viral and cellular proteins, it does not 
require de novo protein synthesis, thus allowing IE genes to be activated rapidly after 
infection. The function of the IE genes is primarily to serve as transactivators of E and L 
gene expression. However, as discussed in the previous section, ICP27 and ICP22 are also 
involved in the shutoff of host cell protein synthesis. 
The second set of HSV -I genes to be expressed are the early genes W or E). These genes 
require the presence of functional IE protein ICP4 (Watson and Clements, 1980), but not 
the onset of viral DNA synthesis, and their expression peaks five to seven hours after 
infection (Honess and Roizman, 1974). Many early proteins promote viral DNA 
replication, and the expression of late genes is then stimulated. Two general groups of 
early proteins have been identified. The PI genes are expressed shortly after the onset of 
synthesis of a proteins. Examples include UL29, which encodes ICP8 - the single-
stranded DNA binding protein, and UL39, which encodes ICP6 - the large subunit of 
ribonuclotide reductase (Huszar and Bacchetti, 1981). The P2 genes are expressed with 
more delay after a protein expression, and are exemplified by UL23, which encodes 
thymidine kinase. Some p genes require ICP27 for their expression (Samaniego et af., 
1995; McGregor et al., 1996; Uprichard and Knipe, 1996), and this may correlate with the 
later kinetics that are characteristic of P2 genes (Roizman and Knipe, 200 I). 
The final class of viral genes to be expressed are the late (y or L) genes. The L genes 
primarily encode the structural proteins of the virion, such as the capsid proteins (UL 19, 
UL18 etc), the scaffolding proteins (UL26 and UL26.5), the viral glycoproteins (gB, gD 
etc), and the proteins of the tegument (vhs, VPI6 etc) Roizman and Knipe, 2001; Weir, 
2001). Expression of L genes begins concurrently with the initiation of DNA replication 
(Weir, 2001). They can be sub-divided into leaky-late (yl) and true-late (y2) genes. True-
late genes, such as UL38 and UL25, are those that require DNA replication for any 
significant expression of the protein, while leaky-late genes, such as ULI 9 and ULI 8) can 
be expressed in the absence of DNA replication (Roizman and Knipe, 2001). L gene 
expression peaks eight to ten hours after infection, then continues for the remainder of the 
lytic replication cycle (Harris-Hamilton and Bachenheimer, 1985). 
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1.3.5. Viral DNA replication 
Viral DNA replication commences shortly after early gene expreSSIOn, and the viral 
genome and several early gene products localise within the nucleus at specific sites known 
as prereplicative sites, located near NO 1 0 structures (lshov and Maul, 1996; Uprichard and 
Knipe, 1996, Sourvinos and Everett, 2002; Everett and Murray, 2005). Seven viral proteins 
are required for viral DNA replication. These are (i) the viral DNA polymerase (encoded 
by UL30) and (ii) its accessory protein or processivity factor (UL42), (iii) an origin-
binding protein (UL9), (iv) the single-stranded DNA-binding protein (UL29), and (v)-(vii) 
a helicase-primase complex of three proteins (UL5, UL8 and UL52) (Boehmer and 
Lehman, 1997; Lehman and Boehmer, 1999; Roizman and Knipe, 2001). A number of host 
cell proteins that are involved in DNA replication, such as topoisomerase II and DNA 
ligase, are also likely to be involved in the replication of the viral genome (Roizman and 
Knipe, 2001). 
A model for HSV-I DNA replication has been proposed, in which initiation occurs at one 
of three cis-acting (ori) elements located within the HSV -1 genome. UL9, the origin-
binding protein binds to one of these elements and begins to unwind the DNA. UL9 then 
recruits ICP8, the single-stranded DNA-binding protein, which binds to the unwound 
single-stranded DNA. UL9 and ICP8 then recruit the five remaining viral DNA replication 
proteins to the replication forks. The helicase-primase proteins and the viral polymerase 
complex assemble at each replication fork. It has been suggested that replication is initiated 
by a bi-directional, theta mode of replication. However, there is a rapid switch by an 
unknown mechanism to a rolling-circle mode of replication. UL9 is not necessary for 
rolling-circle replication, which is not origin-dependent. Due to this rapid change to 
rolling-circle replication, the majority of progeny viral genomes are in the form of long 
head-to-tail concatamers, which are cleaved into monomeric molecules during packaging 
(reviewed by Boehmer and Lehman, 1997; Roizman and Knipe, 2001). 
1.3.6. DNA packaging 
Following DNA replication, individual viral genomes are cleaved from concatamers, and 
each is packaged into a preformed capsid (Homa and Brown, 1997). This step involves 
extensive interactions between the capsid, DNA and the packaging machinery. Genetic 
analyses have identified a total of seven HSV -I-encoded proteins, i.e. the products of 
genes UL6, UL15, UL17. UL25, UL28, UL32 and UL33, which are demonstrated to be 
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necessary for DNA packaging (Table 1.5). When cells are infected with HSV -I mutants 
lacking the function of any of these seven genes, capsid formation and DNA replication 
occur normally, but no packaging takes place (Weller, 1995; Homa and Brown, 1997; 
Newcomb et al., 2001a). 
The portal forms the channel through which genomic DNA enters HSV -I capsids 
(Newcomb et aI., 2001a). It is composed ofa dodecamer ofUL6 molecules, which form a 
ring-like structure (Figure 1.11) found at a single vertex in the icosahedron, replacing one 
of the pentons (Trus et al., 2004). Recent studies have demonstrated that portal containing 
capsids only form if the portal is present at the outset of assembly, indicating that the portal 
is incorporated into the capsid at the initiation of assembly. If portals are not present, 
assembly is initiated in another, as yet undefined way (Newcomb et aI., 2005). 
The UL15 and UL28 proteins have been shown to interact with each other (Yu and Weller, 
1998; Krosky et ai, 1998; Koslowski et aI., 1999; Abbotts et al., 2000). UL15 has been 
shown to share limited sequence homology with the ATPase subunit of the bacteriophage 
T4 terminase (Davison, 1992), and there is evidence that the resulting complex may be 
analogous to the terminase of double-stranded DNA bacteriophage. This enzyme usually 
consists of two subunits, binds to specific sequences in the bacteriophage genome and acts 
as a molecular motor, delivering the DNA through the portal complex. The terminase 
initiates the translocation of DNA into the capsid by cleaving replicated concatameric viral 
DNA at a specific site, and provides energy for the packaging process through the 
hydrolysis of ATP. It terminates the process by a second cleavage event (Fujisawa and 
Morita, 1997; Catalano et aI., 2000). 
Further evidence that supports the role of UL 15IUL28 as the HSV -1 terminase comes from 
a demonstration that both UL 15 and UL28 interact with the UL6 portal protein (White et 
al., 2003) - an interaction that would be expected if UL15 and UL28 were to function as 
the HSV -1 terminase. The UL33 protein has also been shown to form a complex with 
ULl5 and UL28 in infected cells, and has been proposed as a third subunit of the HSV-l 
terminase (Beard et aI., 2002). 
While procapsids contain the UL 15 and UL28 proteins, the levels of both decrease during 
capsid maturation. In contrast, the amount of UL25 protein present was seen to increase 
during maturation (McNab et aI., 1998; Sheaffer et al., 2001). Levels of the UL6 protein 
are similar in procapsids, B-capsids and C-capsids (Patel and Maclean, 1995; Sheaffer et 
MW Present in 
Gene Properties and Functions 
(kDa) mature virion 
UL6 74 Yes 
Portal protein; forms the channel through which the DNA 
enters the capsid. 
Putative terminase subunit, interacts with UL28, UL33 and 
ULI5 81 No the UL6 portal protein. 
Homologous to bacteriophage T4 terminase subunit gp 15 
ULI7 77 Yes No function assigned to date 
UL25 62.5 Yes 
Proposed to have a role in sealing the capsid following 
completion of DNA packaging. 
UL28 85.5 
Putative terminase subunit, interacts with UL 15, UL33 and 
No 
the UL6 portal protein 
UL32 64 No No function assigned to date 
UL33 19 No Putative terminase subunit, interacts with UL 15 and UL28 
Table 1.5: Summary of the HSV-I DNA packaging proteins and their known functions. 
Figure 1.11: Various views ofa 3D reconstruction of the HSV-1 portal at 16 A resolution. 
The portal comprises twelve copies of UL6. It has an axial channel, peripheral flange-like 
domains, and its dimensions are compatible with those of the vertex ite. cale bar = 50 A. 
This figure was reproduced from Trus et al., 2004. 
42 
al., 2001). UL 17 is found in procapsids, B-capsids and C-capsids, with increased levels 
found in C-capsids, suggesting that it may have a second function after the DNA has been 
packaged (Goshima et al., 2000; Thurlow et al., 2005). Only UL6, ULl7 and UL25 are 
present in significant amounts in the C-capsid and mature virion. The remaining DNA 
packaging proteins are only transiently associated with the capsid and appear to 
disassociate on completion of their function. In null mutants of UL6 and ULl7, DNA 
packaging does not take place. In UL25 null mutants a low level of viral DNA replication 
is observed, but most of the packaged DNA is not full length. Because of this it has been 
suggested that the UL25 protein is required at a later stage in DNA packaging than either 
UL6 or ULl7 (NcNab et al., 1998; Hodge, 2001). The UL25 protein has been observed in 
greater amounts in C-capsids than in B-capsids or the procapsid (Sheaffer et aI., 2001; 
Thurlow et aI., 2005), implicating it in a post-packing/scaffold-loss role. It has been 
suggested as potentially having a role in anchoring the DNA within the capsid following 
packaging, and in sealing the portal channel (Ogasawara et aI., 2001) - a function 
analogous to the 'head completion' proteins of bacteriophages such as P22 (Strauss and 
King, 1984). 
Another protein that plays an important role in DNA cleavage and packaging is UL 12, 
which encodes an alkaline exonuclease. The growth of a ULl2 null mutant virus is 
severely impaired, with yields of progeny virus that are 0.1-1 % of wild-type virus yields. 
Viruses lacking ULl2 have been shown to form capsids containing DNA, but these capsids 
are not transported to the cytoplasm (Shao et al., 1993). The role that has been proposed 
for the UL 12 alkaline nucleus is in processing branched forms of concatameric genomic 
DNA molecules that arise during HSV-l replication, presumably by recombination 
between repeat sequences in the viral genome (Zhang et al., 1994; Martinez et al., 1996a; 
Goldstein and Weller, 1998). A second protein that is translated from the ULl2 ORF is 
ULl2.S. It shares the 3' terminus with ULl2 alkaline nuclease and uses an internal 
methionine codon of ULl2 to initiate translation. ULl2.5 is unable to compensate for the 
absence of full-length ULl2, it is not essential for viral growth in culture, it does not 
associate with viral capsids, and it is unlikely to play an important role in lytic infection 
(Martinez et aI., 1996b; Martinez et aI., 2002). 
The mechanism by which viral DNA enters the capsid is currently not well defined. 
Cleavage of concatameric DNA molecules into unit length monomeric genomes is unable 
to take place in the absence of capsid assembly, indicating that that processes of DNA 
cleavage and packaging are linked (Desai et al., 1993). A model has been proposed in 
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which the packaging proteins assemble on the capsid at the unique portal vertex 
(Newcomb et ai" 2001a), The 'a' sequence found in the concatameric genomic DNA 
contains the signals that are required for cleavage and encapsidation, and the packaging 
proteins bind to these sequences (Mocarski and Roizman, 1982; Spaete and Frenkel, 1982; 
Stow et a/., 1983; Varmuza and Smiley, 1985;), It is believed that the packaging signal at 
one end of a unit-length genome is taken into the capsid and packaging continues until the 
packaging signal at the other end of the genome is reached, A cleavage event then takes 
place, presumably mediated by the ULl5IUL28IUL33 terminase, yielding a monomeric 
DNA molecule, Amplicon vectors are 4-5 kb plasmids, which contain only the HSV-I 
origin of replication and minimal DNA cleavage/packaging signals, yet contain all the 
information necessary to direct packaging of the plasmid into HSV -I capsids (Spaete and 
Frenkel, 1982; Hodge and Stow, 200 I), These vectors have provided an insight into the 
mechanisms involved in DNA packaging, as they show that although there appears to be 
no lower limit in the amount of DNA that will be encapsidated, DNA molecules that are 
significantly longer than the HSV -1 genome cannot be packaged, presumably because they 
simply will not fit into the capsid. It appears that UL25 has a role in ensuring that the 
complete HSV -1 genome is packaged. In a UL25 null mutant virus (KUL25NS), viral 
DNA was synthesised, but only A and B capsids were present in infected cell nuclei and 
the replicated KUL25NS DNA was susceptible to DNase (McNab et ai" 1998). However, 
unlike previously examined HSV -I packaging mutants, both unit-length KUL25NS 
genomes and terminal genomic DNA fragments were detected in infected cells (McNab el 
ai" 1998). These observations suggest that the absence of UL25 may have resulted in an 
abortive packaging process in which viral DNA was only transiently associated with the 
capsid, and that the role of UL25 in packaging was to retain DNA in capsids. Subsequent 
work by Stow (2001) highlighted the presence ofa DNase resistant KUL25NS DNA at low 
levels (in contrast to the earlier findings), demonstrated the ability of KUL25NS to 
package genomes of less than approximately 100 kbp, and also showed that the L-terminus 
of the HSV -I genome is packaged first, with packaging subsequently proceeding towards 
the S terminus. 
A limitation of the methods of cryo-EM and image reconstruction used with viruses is the 
requirement that the subject material must possess icosahedral symmetry. While the bulk 
of the HSV -I capsid is icosahedrally symmetric, there are features of it that are not, 
namely the scaffold, the DNA genome, the bulk of the tegument and envelope, UL6, 
ULl5, UL28, UL33 portal/terminase complex. As a result, these structures are not visible 
in current cryo-EM reconstructions. However, the technique of electron tomography has 
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elucidated three-dimensional structural information for structures in the HSV -I virion that 
do not possess icosahedral symmetry (Grunewald et aI., 2003). More recently, single 
particle cryo-EM was used to determine the structure of epsilonl5, a dsDNA bacteriophage 
that infects Salmonella anatum. Using this technique, non-icosahedral components could 
be seen clustering at one of the twelve capsid vertices (Jiang et aI., 2006). The application 
of these techniques to studies of the portal complex could be used in the future to produce 
further information on the structures that comprise it. 
1.3.7. Acquisition of tegument and egress from the host cell 
Once DNA packaging has been completed, the capsid leaves the nucleus and acquires the 
tegument and envelope prior to exiting the host cell by the exocytic pathway. 
The first stage of this process is the exit of the capsid from the nucleus. This is achieved by 
the budding of the capsid at the inner leaflet of the nuclear membrane (Vlazny et al., 
1982). This is known as primary envelopment, and results in the capsid and envelope 
derived from the inner leaflet being released into the perinuclear space. UL31 and UL34 
have both been shown to be involved in this process. These proteins, homologues of which 
are present in members of all three mammal and avian herpesvirus subfamilies, encode a 
nuclear phosphoprotein and a C-terminally anchored membrane protein respectively 
(Purves et aI., 1992; Klupp et al., 2000). UL31 and UL34 have been shown to interact 
(Reynolds et al., 2001; Fuchs et aI, 2002a) and form a complex in the inner and outer 
leaflets of the nuclear membrane. The insoluble lamina underlying the inner nuclear 
membrane presents a barrier to herpesvirus envelopment. However, it appears that 
herpesviruses are able to modify the nuclear lamina to allow access to primary 
envelopment sites at the inner nuclear membrane. In murine cytomegalovirus (MCMV), 
M50/p38 and M50/p35 (the MCMV homologues of UL31 and UL34 respectively) recruit 
protein kinase C to phosphorylate and possibly disassemble the nuclear lamina (Muranyi et 
al., 2002). If UL31 or UL34 are deleted, there is a drastic impairment of primary 
envelopment, with capsids being effectively trapped in the nucleus (Chang et a/. , 1997; 
Klupp et al., 2000; Roller et al., 2000; Reynolds et al., 2001; Fuchs et al., 2002a). 
Historically, the fate of DNA-containing capsids following entry into the perinuclear space 
was a source of controversy. In the lumenal model, it was proposed that perinuclear virions 
contain their full complement oftegument and envelope proteins, which are never lost, and 
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that the envelope glycoproteins are modified in situ in the envelope of the mature virion 
during transit through the cell. The virions then leave the cell via the cellular secretory 
pathway (Enquist et al., 1999). Recent research using several approaches has indicated that 
this model is incorrect. Immunoelectron microscopy has been used to demonstrate 
differences in composition between perinuclear and mature virions. Although UL31 and 
UL34 are present in the virions within the perinuclear space, they are not components of 
cytoplasmic or extracellular virions (Klupp et aI., 2000). In other work, a mutant strain of 
HSV-l that encoded a form of gD modified to contain an endoplasmic reticulum retention 
signal was constructed (Whiteley et al., 1999; Skepper et al., 2001). Immuno-EM was used 
to examine cells that had been infected with either wild-type HSV -lor the mutant strain of 
HSV -I that encoded the ER-retained form of gD. The results showed that in cells infected 
with wild-type virus, gD was found in both perinuclear and mature extracellular virions. In 
contrast, when cells were infected with the mutant virus, although the inner and outer 
nuclear leaflets of the nuclear membrane and perinuclear virions were shown to contain 
gD, no gD was observed in extracellular virions. These results suggest that the envelope of 
the perinuclear virions has been lost during virion assembly (Skepper et al., 2001). Further 
evidence against the lumenal model comes from observations indicating that late in 
infection, tegument proteins accumulate in the cytoplasm of infected cells (Elliott and 
O'Hare, 1999; Sanchez et al., 2000; Kopp et al., 2002). This would suggest that virion 
assembly occurs in the cytoplasm rather than the nucleus. Moreover, studies have indicated 
that the lipid composition of virion membranes is more similar to that of cytoplasmic 
membranes than nuclear membranes (van Genderen, 1994). However, it should be noted 
that the host cell undergoes extensive biological changes during infection, and these 
changes may account for the differences in lipid composition observed. 
In a departure from the established model, Leuzinger et aI., (2005) recently suggested a 
third mechanism to account for the fate of DNA-containing capsids. Their observations 
implied the existence of at least two different pathways of herpesvirus envelopment. One 
pathway is in accordance with the previously discounted lumenal model. In the second 
pathway capsids escape the nucleus through dilated nuclear pores and are wrapped by 
Golgi membranes. This hypothesis has been controversial, and the observations reported 
have since been challenged (Mettenleiter and Minson, 2006). 
A number of proteins have been identified as having a potential role in the exit of capsids 
from the perinuclear space. These are gK (Foster and Kousoulas, 1999), UL20 (Baines et 
aI., 1991), UL48 (Mossman et al., 2000), and US3 (Wagenaar et al., 1995; Klupp et aI., 
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2001). Mutants in these proteins are unable to exit the perinuclear space efficiently, 
resulting in an accumulation of perinuclear virions. Of these proteins, only UL48 is 
essential for virus replication. However, this is likely to reflect the importance of the 
protein in the initiation of viral gene expression, rather than its involvement in egress from 
the perinuclear space. These observations suggest that egress is not dependent on one 
protein, although the mechanisms by which these proteins act in egress are not well 
understood. 
Tegumentation of the capsid takes place predominantly in the cytoplasm of the host cell. 
Sanchez et al. (2000) identified large accumulations of tegument proteins that may be sites 
of virion assembly in the cytoplasm. The tegument contains approximately twenty proteins 
(Homa and Brown, 1997; Mettenleiter, 2002; Mettenleiter, 2004). In addition to the 
tegument proteins that are associated with the capsid (Chen et al., 1999; Trus et at., 1999; 
Zhou et al., 1999), several tegument proteins are known to form interactions with other 
tegument proteins (for example Read et al., 1993; Elliott et al., 1995; Vittone et al., 2005). 
Tegument assembly probably begins with an interaction between the UL36 protein (VPI-
3) and the capsid. VPI-3 appears to interact with VP5 at the pentons, and to form the 
innermost layer of tegument. The next stage of tegument formation is the addition of 
UL37, which has been identified as an interaction partner for UL36 in HCMV and PRY 
(Klupp et al., 2001). Support for this model comes from the observation that in HSV -1 null 
mutants of either UL36 or UL37, virion morphogenesis is completely blocked, capsids 
accumulate in the cytoplasm and no infectious progeny virions arise (Desai, 2000; Desai et 
at., 2001). Similar observations have been made for null mutants of the PRY homologues 
ofUL36 (Fuchs et al., 2004) and UL37 (Klupp et al., 2001). The more distal parts of the 
tegument are less well defined. A number of gene products represent tegument 
constituents, but as yet, many have not been assigned a function in virus maturation. 
The final stage in virion assembly is the acquisition of the envelope and the exit of progeny 
virus from host cells. Tegumented capsids become enveloped by budding into membrane-
bound vesicles of the trans-golgi network (TGN) - this is where viral glycoproteins are 
acquired (Mettenleiter et al., 2004). Viral glycoproteins are translated on ribosomes on the 
endoplasmic reticulum. From these ribosomes, they enter the cellular secretory pathway 
and undergo post-translational modification. As a result, the glycoproteins are already 
present in TGN vesicles prior to secondary envelopment. It has been hypothesised that to 
mediate envelopment, viral glycoproteins have to interact with tegument components via 
their cytosolic tails (Brack et al., 2000; Fuchs et al., 2002b; Farnsworth et aI., 2003). 
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Glycoproteins gD, gE, gH, gI, and gM have all been proposed as candidates for this 
process (Farnsworth et a/.,2003; Gross et a/., 2003). While gE, gI and gM are not 
individually essential, if all three are deleted there is a significant reduction in the yield of 
progeny virus and an accumulation of unenveloped but tegumented capsids in the 
cytoplasm - a result which indicates a degree of redundancy in tegument/envelope 
interactions (Brack et a/., 1999). Later work has confirmed that the cytoplasmic tails of the 
glycoproteins are responsible for mediating this phenotype (Brack et a/., 2000). The yeast 
two-hybrid system was used to detect interactions between the tegument protein UL49 and 
the tails of glycoproteins gE and gM (Fuchs et aI., 2002b). (UL49 is not required for virus 
formation, which indicates that there must be additional redundancies on the part of 
tegument proteins.) In more recent work, Chi et a/. (2005) used a glutathione S-transferase 
fusion protein binding assay was used to show that UL49 bound specifically to the gD tail. 
They also showed that HSV -I capsids bound to the gD tail, suggesting that the UL49 
protein may act as a linker, mediating the interaction of the capsid with gO. A similar 
interaction has been proposed for the tegument protein ULlI (Kopp et a/.,2003). ULlI has 
been proposed as being involved in directing herpesvirus tegument proteins to the 
envelopment site. Interestingly, in HSV-l and PRY, ULll does not appear to be essential 
for the production of progeny virus, since deletion mutants only moderately impair viral 
replication (MacLean et a/., 1992; Kopp et a/. ,2003). Nevertheless, a similar deletion 
mutant in HCMV blocked replication (Silva et a/., 2003). A further glycoprotein/tegument 
interaction has been observed to take place between the cytoplasmic tail of gH and VP16 
(Gross et a/., 2003). When VPl6 is deleted, cytoplasmic capsids fail to envelope 
(Mossman et a/., 2000), suggesting that VP16 might be involved in sequestering 
membrane proteins at the site of envelope formation. However, its interactions with 
glycoproteins may exhibit a degree of redundancy as it is also able to interact with gB and 
gD (Zhu and Courtney, 1994). Overall, the results suggest a model for secondary 
envelopment that involves the recruitment of tegumented capsids to membranes of TGN 
vesicles by interactions between glycoproteins gE, gI, gD, gH and gM and tegument 
proteins ULll, UL48, and UL49. 
1.3.8. Latency 
One of the defining characteristics of herpesviruses is their ability to establish potentially 
life-long latent infection in the host organism. Latent infection in herpesviruses can be 
viewed as having three distinct phases: establishment, maintenance, and reactivation. 
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During initial infection, HSV -1 virions infect nerve endings of the sensory nervous system 
that are located in the mucosal epithelium. They are then transported to the neuronal cell 
body, where the DNA enters the nucleus and is able to persist in an episomal state for the 
lifetime of the host. Periodic reactivation of HSV -1 can occur, leading to lytic infections in 
the same dermatomal distribution as the initial infection (reviewed by Jones, 2003). During 
latency the only abundant viral RNAs are the latency associated transcripts (LATs) 
(Stevens et a/., 1987), although very low levels of lytic gene RNAs have been detected by 
reverse transcription PCR techniques (Kramer and Coen, 1995; Chen Hua et aI., 2002). 
The location of the LA Ts in the HSV -1 genome is shown in Figure 1.12. The LA T region 
encodes multiple transcripts, including the 8.3 kb primary transcript and two stable introns 
of 2.0 kb and 1.5 kb (Farrell e/ al., 1991), which are predominantly localised to the 
neuronal nucleus and are transcribed antisense and partially complementary to the coding 
sequence for ICPO. 
Since the LATs are the only gene products transcribed during latency, it would seem 
reasonable to assume that they must have some role in the establishment, maintenance or 
reactivation from latency. However, their true role has been the subject of conflicting 
reports and currently remains unidentified. The observations that LA Ts are transcribed 
antisense and complementary to ICPO, and that ICPO is a powerful transactivator of IE 
genes has led to the suggestion that the LA Ts themselves function to repress IE gene 
expression by preventing or reducing the expression of ICPO. This was supported by 
evidence that the 2 kb LA T could inhibit the transactivation of the HSV -1 tk gene 
promoter by ICPO (Farrell e/ al., 1991). In addition, mutant viruses unable to make the 2 kb 
LAT have an increased accumulation of ICPO RNA (Arthur et aI., 1998). Furthermore, 
LA Ts can suppress IE gene expression in a neuronal cell line (Mador et aI., 1998). This 
theory would therefore predict that a virus lacking both copies of LA T would be unable to 
repress ICPO expression and therefore reactivate from latency with enhanced efficiency. 
Interestingly, the opposite appears to be true, with observations demonstrating that LAT 
negative mutants are impaired for reactivation in vivo (Leib e/ al., 1989; Hill e/ aI., 1990; 
Pemg et al., 1994; Bloom et al., 1996). However, whether this impaired reactivation is 
simply a downstream effect of a reduced efficiency in latency establishment is debatable 
(Thomson and Sawtell, 1997). 
TATA 
I 
LAPJ LAP2 
Primary LAT (8.3 kbp) --~~~-----------+. 
Major LAT (2 kbp) 
1.5 kbp LAT 
Figure 1.12: The genetic organisation of the LAT region. 
The LA T region is located on the long repeat regions of the genome, and is therefore present 
in two copies. The primary LA T is an unstable 8.3 kbp transcript. The major species are the 2 
kbp and 1.5 kbp LATs, which may be smaller spliced introns from the primary LAT. LATs 
are transcribed antisense and at least partially complementary to the gene encoding ICPO. The 
two latency-associated promoters, LAP1 and LAP2, are indicated. 
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1.4. Capsid structure 
1.4.1. Principles of capsid structure 
1.4.1.1. Quasi-equivalence 
Crick and Watson (1956) first realised that viral genomes did not possess enough genetic 
information to encode a single protein coat molecule that could surround the viral genome. 
They suggested that virion coats would have to be made up of symmetric arrays of one or a 
small number of proteins, and that these symmetric arrays would have specific bonding 
properties, allowing them to make specific intersubunit contacts that would be repeated 
exactly throughout the particle. In helical viruses such as tobacco mosaic virus (TMV), the 
helical coat protein fulfils this prediction - each subunit in the TMV capsid particle 
interacts with its neighbouring protein in essentially the same way. The exceptions are 
those subunits at the ends of the virus particle, for which there are unsatisfied bonding 
capabilities (Crick and Watson, 1956; Namba et al., 1989; reviewed by Casjens, 1997). 
The situation is more complex in so-called spherical viruses with closed protein shells. 
Although in theory capsid shells could be tetrahedral, cubic, octahedral, dodecahedral, or 
icosahedral (the five kinds of cubic symmetry), only examples of icosahedral symmetry 
have been found. Crick and Watson (1956) proposed that in order to construct a virus 
particle using repeating units of a single polypeptide, in which each subunit interacts 
identically with its neighbours, the virus particle would have to be made up of exactly 60 
subunits. This hypothesis holds true for some very small icosahedral virus particles such as 
the parvoviruses. Parvoviruses typically consist of a linear 5 kb single-stranded DNA 
genome surrounded by an icosahedral capsid shell made up of 60 copies of a single 
polypeptide unit. However, the hypothesis does not account for the many icosahedral 
viruses that are made up of considerably more than 60 identical subunits, such as HSV-l 
(Casjens, 1997). 
The contradiction between the large size of many icosahedral viruses and the requirements 
for identical interaction led Caspar and Klug (1962) to promote a theory that appears to 
reconcile these differences. Caspar and Klug suggested that all icosahedral viruses have 
rings of five subunits that interact around each of the 12 fivefold rotationally symmetric 
icosahedral vertices (5 x 12 = 60). For viruses in which more than 60 subunits are used, the 
extra subunits are systematically inserted between the pentamers as rings of six subunits 
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(hexamers). A combination of pentamers and hexamers is required to form a closed 
icosahedral shell. A repeating pattern of hexamers can form a flat plane, but this is not the 
case with pentamers, since removing one subunit from a hexamer causes it to adopt a 
convex shape. Hence, in capsids, pentamers form the comers while hexamers form the 
faces. The addition of extra hexamer subunits would allow the size of the icosahedron to be 
increased without disrupting the basic geometry of the capsid shell. Thus, the simplest 
virus capsids consist of an icosahedron composed solely of 12 pentamers at the capsid 
vertices (60 subunits). The smallest capsid shells composed of both hexamers and 
pentamers consist of 12 pentamers at the capsid vertices and 20 hexamers on the faces of 
the capsid (180 subunits). An icosahedral capsid constructed using 60 subunits is referred 
to as a T=l icosahedron. Likewise, a capsid constructed using 180 subunits is a T=3 
icosahedron. The multiples of 60 subunits could be any member of the infinite series T= 1, 
3,4, 7, ... , (T= h2 + hk + k2, where h is the number of moves in one direction and k is the 
number of moves in a second direction from one pentamer to the next on the surface 
lattice) corresponding to 60, 180, 240, 420, ... , subunits respectively (Caspar and K1ug, 
1962; Johnson and Speir, 1997). A consequence of this theory is that subunit proteins 
interact with their neighbours in slightly different ways, depending on their location within 
the capsid. Therefore, icosahedral shells that contain hexamers have 'quasi-equivalent' 
geometry: the morphology of the proteins and protein interactions formed in their 
construction is almost the same, but not identical, to what it would be in a capsid composed 
of just 60 subunits (reviewed by Casjens, 1997). 
The models proposed by Crick and Watson (1956) and Caspar and Klug (1962) are purely 
mathematical attempts to describe means by which proteins can interact to form large 
icosahedral viruses. However, experimental analysis of virus particles has revealed that 
some viruses do not conform to these models, and that in some cases they diverge greatly. 
The polyomavirus capsid is composed of 360 subunits of the major capsid protein. 
According to the models described above, this would suggest that the capsid is made up of 
62 cap somers (12 pentamers and 50 hexamers) arranged on a T=6 lattice - an impossible 
configuration. In reality, the polyomavirus capsid is made up of 72 capsomers, which are 
all pentamers of the major capsid protein. The 72 capsomers conform to T=7 icosahedral 
symmetry, with each hexavalent capsid being constructed from five copies of the major 
capsid protein (reviewed by Dokland, 2000). Another example of divergence from the 
models mentioned above can be seen in adenovirus capsids. The adenovirus capsid has 252 
capsomers that are arranged with T=25 symmetry (reviewed by Johnson and Speir, 1997). 
Quasi-equivalence would imply the presence of 1500 structural subunits (12 pentamers and 
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240 hexamers). However, in adenovirus capsids the hexons and pentons are constructed 
from two different types of protein. The twelve vertices are pentamers of the penton base 
protein, while the 240 'hexamers' are trimers of the major capsid protein. Thus, 
adenoviruses deviate from quasi-equivalence in two major ways. 
1.4.1.2. Quasi-equivalence in the HSV-1 capsid 
Unusually for such a large virus, the HSV-I capsid conforms closely to Casper and Klug's 
quasi-equivalence model. Until recently, it was thought that the capsid was constructed 
using 960 copies of VP5 arranged as 12 pentamers (pentons) and 60 hexamers (hexons), 
with the pentons and hexons being made up of five or six copies of VP5 respectively. It is 
now generally accepted that one vertex is occupied by the portal complex, although it is 
not yet certain whether this replaces or is present in addition to a penton. Apart from this, 
the structural arrangement of the HSV -I capsid corresponds closely to T= 16 icosahedral 
symmetry, although the differences in structure between penton and hexon subunits and 
slight differences among hex on subunits (He et al., 200 I) are not consistent with precise 
quasi-equivalence. 
In contrast to the capsomers, the triplexes diverge significantly from quasi-equivalence. 
Triplexes occur in positions of three-fold symmetry between adjacent capsomers and form 
interactions with the middle and floor domains of the surrounding capsomers. Cryo-EM 
has been used to demonstrate that the interactions between adjacent capsomers are not 
uniform, with T a-T f (Figure 1.13) having slightly different degrees of interaction with 
adjacent capsomers. The most striking differences are observed when one compares Ta to 
triplexes T b-Te (Zhou et al., 1994; Zhou et al., 1998). This variation can also be detected 
biochemically, possibly reflecting differences in bonding interfaces. Peripentonal triplexes 
(T a and T c) more readily disassociate from capsids treated with GuHCl than triplexes 
surrounding adjacent hexons (Newcomb et al., 1993). The triplex is a heterotrimer 
composed of two copies of VP23 and one copy of VP 19C. It is therefore, by definition, an 
asymmetric structure. As a result, it has been difficult to determine how the triplex 
occupies a three-fold symmetrical position within the icosahedral capsid. The floor of the 
capsid, which interacts with each triplex, exhibits precise three-fold radial symmetry. This 
paradox may be resolvable through the observation that the base of the triplex appears to 
form a pseudotrimer with VP 19C and the two VP23s forming symmetrical connections 
with the three identical VP5 floor domains (Zhou et al., 2000). Above the floor, the 
arrangement of the upper regions of the triplex proteins is markedly asymmetric (Figure 
1.14). 
Figure 1.13: Schematic representation of the relative locations of the various structural 
components of the HSV-l capsid. The quasi-equivalent subunits of pen tons and hexons in one 
of the asymmetric units are labelled 1-16. The quasi-equivalent triplexes in the asymmetric 
unit are labelled Ta-Tf. Lines indicate the interactions between triplexes and their 
neighbouring capsomeric subunits. 
This figure was reproduced from Zhou el ai, (1994). 
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Figure 1.14: Structure of the triplex at 8.5 A resolution. 
A. A single triplex subunit at 8.5 A resolution. VPI9C is shown in pale green. The two VP23s 
are shown in turquoise and bottle-green. The capsid floor (blue) is formed by domains of 
VP5. The structure shown was obtained by averaging the structural data from the four 
triplexes, T b, Tc, T d, and Te, as labelled in Figure LIS. B. The same triplex subunit rotated by 
1800 around the 3-fold axis of symmetry. The molecules have been separated to highlight the 
structural arrangement of the component proteins. C. Images i-iv represent horizontal cross-
sections through the triplex structure at the positions indicated by broken lines in figure A. (i) 
Cross-section through the capsid floor. (ii) Cross-section through the base of the triplex where 
it makes contact with the capsid floor. The densities attributed to VPI9C (blue ellipse) and 
VP23s (black ellipse) are indicated. The arrangement of the three protein densities 
approximates the three-fold radial symmetry of the capsid floor (image (i), orange lines). (iii) 
The two copies of VP23 form a flattened ring (grey ellipse) that now exhibits two-fold radial 
symmetry (orange line), with densities corresponding to VPI9C on either side. (iv) The top of 
the triplex: a completely asymmetric structure composed almost entirely of VP 19C. 
This figure was reproduced from Zhou et ai, (2000). 
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1.4.2. Overview of capsid structure 
The HSV -1 capsid has been the subject of intense study, and its structure and composition 
are relatively well characterised compared to other virion compartments (Steven and Spear, 
1997). It consists of a protein shell, which has T=16 icosahedral symmetry. Three 
distinctive structural elements, designated pentons, hexons, and triplexes, make up the bulk 
of this shell. 150 hexons form the faces and edges of the icosahedron, while the vertices are 
formed by the pentons. Hexons and pentons are made up of five and six copies of the 
major capsid protein, VP5 (Section 1.2.2.2), respectively. Six copies of VP26 (Section 
1.2.2.2) occupy the outer surface of each hexon. Three separate classes of hexons are 
formed: P (peripentonal), E (edge), and C (central), each of which has a slightly different 
morphology as a result of differences in quasi-equivalent environments in the icosahedral 
capsid face (Steven et aI., 1986; Schrag et a/. , 1989; Steven and Spear, 1997; He el al., 
2001). The locations of the three forms ofhexons are shown in Figure 1.15, and discussed 
further in Section 1.4.3. The triplexes, characteristic features of herpesvirus capsids, are 
heterotrimers made up of VP19C and VP23 (Section 1.2.2.2) in ap2 organisation, which in 
HSV -1 is formed by a single molecule of VP 19C (a-subunit) and two copies of VP23 (~­
subunit). They occupy the 3-fold positions between the hexons and pentons. The 
icosahedral geometry of the capsid largely determines the numbers of each component, but 
the precise numbers of pen tons and triplexes is uncertain. This is because one of the twelve 
vertices is believed to be the location of a portal complex through which the genome enters 
and exits the capsid (Newcomb et al., 2001a). It seems probable that the portal replaces 
one of the pentons leaving eleven occupying the remaining icosahedral vertices. Similarly, 
for the triplex, there are 320 local 3-fold positions in the capsid, including five surrounding 
each vertex. However, the relationship between the triplexes and the portal is unknown, 
making it unclear whether triplexes are present at the five positions surrounding the portal. 
Early work to identify the structure of the capsid involved the EM analysis of negatively-
stained specimens (Wildy et a/., 1960; Furlong, 1978). These studies demonstrated that the 
capsid is icosahedral in shape and is made up of 162 capsomers, thus producing a structure 
that has icosahedral symmetry of triangulation class T= 16. More recent studies have 
employed the techniques of cryo-EM and image reconstruction to generate three-
dimensional structures of the HSV -1 capsid. This approach was first described by Schrag 
et al. (1989), who determined the structure of the capsid to a resolution of 40A. Advances 
Figure l.15: The asymmetric unit of the HSV- l capsid. 
An enlarged view of the HSV -1 capsid at 8.5 A resolution. The structural components of the 
asymmetric unit are indicated : the penton (labelled Pn), the three types of hex on (P, E and C), 
and the six types of triplex (Ta to Tf). The image is radially colour-coded. Inner structures 
(the capsid floor) are blue and outer tructures (capsomeres and triplexes) are green and 
yellow. The icosahedral five-fold, three-fold and two-fold axes of ymmetry, which define th 
asymmetric unit, are indicated a 5, 3 and 2 respectively. 
This figure was reproduced from Zhou et ai, (2000). 
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in the technology used to produce these images have resulted in a gradual refinement of the 
generated structures, and to date the HSV -I capsid has been determined to a resolution of 
8.sA (Zhou e/ at., 2000). 
The capsid shell is approximately IsoA thick. Capsomers are held together by their 
innermost portions. These are packed closely together to form the floor of the capsid, 
which is approximately 35A thick. Each capsomer has a chimney-like protrusion that rises 
approximately 100A outward from the floor, and is traversed by an axial channel of non-
uniform diameter. On the outer surface of the floor lie the triplexes. (Steven and Spear, 
1997). 
At the current resolution of 8.sA (Figure 1.7) (Zhou e/ al., 2000), a-helixes are the only 
distinguishable secondary structural feature (Baker et al., 2003). However, our 
understanding of the structure of part of the HSV -1 capsid has been greatly increased 
following the publication of the crystal structure of a portion of the HSV -I major capsid 
protein (Figure 1.16) (Bowman e/ aI., 2003). HSV-I capsid proteins have generally been 
intractable to analysis by x-ray crystallographic techniques, but partial trypsin digestion 
isolated a 65 kDa fragment of VPS that was soluble and crystallised. The structure of this 
fragment was solved to a resolution of2.9A. The fragment represented a central 604 amino 
acids of the protein sequence (residues 451-1054), and using a combination of x-ray 
crystallographic, EM and biochemical information it was identified as the upper domain of 
VP5 (VP5ud). Fitting the VP5ud into the 8.sA cryo-EM reconstruction ofthe capsid (Zhou 
e/ al., 2000) revealed details of the interactions between regions of VP5 within hexons and 
pentons. These results will be discussed fully in Section 1.4.4.1. 
1.4.3. The asymmetric unit 
An asymmetric unit is the smallest portion of a structure to which symmetry can be applied 
to generate one full unit. In the context of the HSV -1 capsid, this is all the information 
required to build an icosahedral capsid shell. Each of the twenty triangular faces of the 
icosahedron consists of three asymmetric units, each of which is made up of one fifth of a 
penton, one P-hexon, one C-hexon, one half of an E-hexon, one each of triplexes Ta - Te, 
and one third of triplex TdFigure US; Zhou et aI., 1994). Thus, in the structural analysis 
of HSV -1 capsids it is standard practice to simplify the analysis by assuming that the 
/, ~lyprOline 
loop 
Figure 1.16: A ribbon representation of the crystal structure of the upper domain of VP5 
(residues 451-1054). 
The secondary structural elements in the structure are coloured: a-helices are shown in red, ~­
strands are shown in blue, and loops are shown in green. Key elements are labelled in the 
structure. 
Reproduced from Bowman et aI., 2003 . 
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capsid is fonned from 60 identical asymmetric units. The classifications of different types 
of hex on and triplex are described in more detail in the following sections. 
1.4.4. Structural composition of the capsid 
The seven proteins that make up the HSV -I capsid have been known for some time: VP5, 
VP 19C, VP21, VP22a, VP23, VP24, and VP26 (Section 1.2.2.2). Historically, two main 
approaches have been used to detennine the structural organisation of these proteins, 
namely antibody labelling (Vernon et al., 1981; Rixon et aI., 1988; Trus et aI., 1992) and 
the systematic depletion of component proteins from purified capsids (Newcomb and 
Brown, 1989; Newcomb and Brown, 1991; Newcomb et al., 1993). Newcomb and Brown 
(1989) used argon ion (Ar) plasma etching to show that when purified B-capsids are 
exposed to low doses of ion plasma, VP5, VPI9C, and VP23 more readily disassociate 
from the capsid than VP21, VP24 and, VP22a. They concluded that VP5, VP19C and 
VP23 are more likely to be present on the outer surface of the capsid, and that VP21, VP24 
and VP22a are more likely to be internal components, requiring longer periods of exposure 
to disassociate. More recently, techniques such as cryo-EM and image reconstruction have 
made more detailed analysis of the organisation of the component proteins possible, 
culminating in the resolution of the 8.5A structure (Zhou et aI., 2000) - currently the best 
available. A complete structural description requires atomic resolution, however at present 
this is only possible through X-ray crystallography. 
1.4.4.1. Hexons and pentons are respectively hexamers and 
pentamers of VP5 
It was Gibson and Roizman (1972) who originally proposed that VP5 is a major 
component of the HSV -1 capsid shell. This proposal was based on SDS-P AGE studies of 
capsids, which showed that VP5 comprised approximately 70% of capsid mass. 
Subsequently, Trus et al., (1992) used cryo-EM to show that antibodies raised against VP5 
bound only to the hexons, while an antibody raised against purified B-capsids bound only 
to the pentons. They concluded that the differences in antibody binding were likely to have 
been caused by differences in confonnation for VP5 in hexons and pentons. Pentons in 
HSV-l B-capsids treated with either guanidine hydrochloride (GuHCl) or 6M urea were 
shown to dissociate from the capsid. SDS-PAGE analysis of the material that had been 
removed con finned that the pentons were composed of VP5, and that hexons and pentons 
were hexamers and pentamers of VP5 (Newcomb and Brown, 1993). 
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More recently, detailed information on the structure of hexons and pentons has been 
obtained from cryo-EM and X-ray crystallography experiments (such as Zhou et af., 2000; 
Baker et af., 2003; Bowman et af., 2003). Hexons and pentons are both cylindrical and of 
similar size and dimensions. Hexons are 170A in diameter and 140A high, while pentons 
are 145A in diameter and have a height of 140A (Steven et af., 1986; Schrag et af., 1989; 
Zhou et af., 1994). Analysis of the crystal structure of the VP5ud shows that the protein 
folds in a broadly similar manner in hexons and pentons (Bowman et aI., 2003). However, 
it is interesting to note that previous studies identified antibodies that bind to distinct 
conformational epitopes at the tops of either hexons or pentons (Trus et al., 1992). This 
observation implies that each type of capsomer also contains distinctive features, which 
could explain the specific interactions formed by hexons and pentons (Wingfield et al., 
1997). 
The five copies of VP5 found in the penton are less closely associated than those in the 
hex on, and are 'twisted' relative to each other (Figure 1.17), resulting in the penton 
channel being larger than that found in the hexon. These differences in arrangement have 
been proposed (Bowman et al., 2003; Chen et al., 2001) to account for VP26 only binding 
to the hexon (Trus et al., 1995; Zhou et aI., 1995) and the tegument only binding to the 
penton (Zhou et al., 1999) (Figure 1.17). Differential binding in hexons and pentons is not 
restricted to the tops of VP5. Scaffolding protein has been shown to interact with the floor 
domains of hexons, but not pentons (Zhou et al., 1998b). 
1.4.4.2. VP26 is located at the tips of the hexons but not the 
pentons 
Newcomb and Brown (1991) originally proposed that VP26 was either associated with 
capsid vertices or formed the triplexes. They demonstrated that VP26 could be readily 
detached from purified capsids in the presence of either urea or GuHCI. Subsequent cryo-
EM analysis of VP26 depleted and VP26 re-associated capsids revealed that VP26 is 
specifically located at the tips of hexons (Booy et a/. , 1994). Studies using recombinant 
capsids have shown that six copies of VP26 bind to each hexon, forming a star-shaped ring 
at the hexon tip (Zhou et al., 1995; Wingfield et af., 1997). VP26 is absent from the 
equivalent position in pentons (Zhou et al., 1995). It has been proposed that this is due to 
different interactions between neighbouring VP5s in hexons and pentons, as discussed in 
Section 1.4.4.1. This theory has been supported by the observation that VP26 does not bind 

Figure 1.17: Structural comparisons of the hexon and penton (viewed from above). 
A. Ribbon representation of the VP5ud 2.9 A crystal structures as seen from above in the 
hexon (C-hexon). Alpha helices are shown as red cylinders, beta sheets as blue arrows, and 
looped regions are shown as green lines. B. Ribbon representation of the VP5ud structures in 
the penton as seen from above (same colour scheme as A). VP5 subunits in the penton are 
twisted in comparison to their organisation in the hexon. C. Space-filled representation of the 
VP5ud structures in the hexon (C-hexon) as seen from above. D. Space-filled representation 
of the VP5ud structures in the penton as seen from above. The penton channel has a wider 
diameter than that of the hexon. The structures in images C and D are coloured coded to 
reflect the electrostatic charges of the amino acids in each structure. Acidic residues are 
coloured red, basic residues are coloured blue and uncharged amino acids are coloured 
pink/grey. As a consequence of the differences in structural arrangements, the hexon channel 
is much more acidic than the penton channel. E. Space-filled representation of two hexon 
VP5ud subunits bound to the VP26 small capsid protein (blue-grey semi-transparent 
structure). F. Space-filled representation of two penton VP5ud subunits bound to the VPl-3 
tegument protein (blue-grey semi-transparent structure). 
Figure reproduced from Bowman et ai, 2003 
56 
to the procapsid, where the conformation of VP5s in hexons greatly differs from that in 
mature capsids (Chi and Wilson, 2000; Newcomb et al., 2000). 
1.4.4.3. Triplexes are heterotrimers of VP19C and VP23 
Triplexes (Figure 1.14) were originally identified as a component of the HSV -1 capsid by 
negative stain EM analysis. They were shown to connect adjacent capsomers (Vernon et 
al., 1974), Early cryo-EM work showed triplexes as V-shaped masses located on the 3-fold 
axes of symmetry and connecting adjacent capsomers (Schrag et aI., 1989; Baker et aI., 
1990; Booy et aI., 1991). 2M GuHCI treatment of capsids removed the triplexes that 
surround the penton (Ta and Tc) (Newcomb et aI., 1993). Quantitative analysis of the 
proteins associated with the removal of these triplexes suggested that the triplexes were 
heterotrimers made up of one copy of VP19C and two copies of VP23. More recently, 
high-resolution cryo-EM has been used to show that contrary to earlier hypotheses, most 
triplexes are asymmetrical rather than Y -shaped (Zhou et al., 1994; Zhou et al., 1998b). 
For descriptive purposes, the triplex is separated into an upper, diamond-shaped portion 
comprising the 'head' and 'tail' regions, and a lower portion consisting of two 'legs'. The 
head and tail form connections with adjoining VP5 molecules, and the legs interact with 
the capsid floor. Studies of recombinant particles that lack VP23 have allowed the 
positions of each component to be determined (Saad et aI., 1999). These studies proposed 
that the two copies of VP23 form the legs, while VP 19C forms the head and the tail of the 
triplex (Zhou et aI., 2000), although more recent work has cast doubt on this interpretation 
(Section 5.4). 
A total of six different types of triplex (T a-T f) contribute to a single asymmetric unit, with a 
total of 16 triplexes making up each icosahedral face (Figure l.l3) (Zhou et al., 1994). 
Each type of triplex has a slightly different morphology by virtue of differences in the 
quasi-equivalent environments in the icosahedral capsid face. Ta-Te are asymmetric, but T f, 
which is located at the global three-fold axis, appears to be symmetrical in computer 
reconstructions, although this is believed to be an artefact of the reconstruction process. 
The locations and interactions between the triplexes and their adjacent cap somers varies 
according to the position of the triplex within the capsid. 
1.4.4.4. Structure of the internal scaffold 
It was originally proposed that the major scaffolding protein, VP22a, was only present in 
B-capsids (Gibson and Roizman, 1972). This observation was later supported by Rixon et 
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al. (1988) who used immunogold labelling to demonstrate that VP22a is a component of 
empty capsids but not present in full capsids or mature virions, and suggested that VP22a 
is transiently associated with capsids at an early stage of assembly and is lost during DNA 
packaging. Ar+ etching of purified B-capsids revealed that VP22a, VP21, and VP24 were 
all relatively well protected from erosion by low-intensity plasma, and it was concluded 
that they must form the internal components of the capsid (Newcomb and Brown, 1989). 
Subsequently, cryo-EM was used to compare A and B capsids. Additional protein masses 
were observed in B-capsids and it was suggested that these correlated to the presence of 
internal core proteins (Baker et al., 1990). It is now known that the major internal scaffold 
component is VP22a, which is present in over 1000 copies in each capsid (VP21 and VP24 
are both present in approximately 100 copies per capsid) (Newcomb et at., 1993). The 
scaffold exists in two forms within the interior of capsids. In large cored capsids, the C-
terminal 25 amino acids of pre VP22a and/or pre VP21 have not been cleaved by the VP24 
protease, while in small cored capsids this cleavage event has taken place. Large cored 
capsids can be made by omitting UL26, which encodes VP21 and VP24 (Tatman et al., 
1994; Thomsen et al., 1994). Within the UL26 gene, temperature sensitive mutants that are 
defective in the processing of UL26 into VP21 and VP24, such as Is 120 I, also produced 
large cored capsids at the non-permissive temperature. If the temperature was altered to 
become permissive, UL26 is processed correctly and small cored capsids are produced 
(Preston el al., 1983). Gao et al. (1994) demonstrated that virus lacking UL26 was unable 
to grow on Vero cells, and that although the mutant virus produced capsids, the assembly 
of VP5 into hexons is altered, suggesting that the protease is required for the formation of 
functional capsid structures. 
The interaction between preVP22a and VP5 has been shown to occur through the C-
terminal 25 amino acids of VP22a, indicating that these residues are essential for capsid 
formation (Kennard et al., 1995; Matusick-Kumar et al., 1995; Hong et al., 1996). These 
residues are thought to interact with the N-terminal of VP5 (Desai and Person, 1999; 
Warner et al., 2000; Warner et al., 2001). Cryo-EM analysis has revealed that most of the 
scaffold mass possesses no icosahedral symmetry, although some regions do appear to be 
icosahedrally arranged, forming rod-like densities that protrude from the capsid shell into 
the interior of capsids and are approximately 40A in length. These densities appear to be 
located beneath triplexes Tb, Te, and Te. Furthermore, it has been shown that interactions 
between the capsid and scaffold only take place with VP5s in hexons. These masses are 
thought to represent the positions at which the C-terminal of the scaffold interacts with the 
capsid shell (Zhou et aI., 1995; Zhou el al., 1998b). 
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Through studies using the baculovirus system, it has been shown that pre VP21 can 
substitute for pre VP22a in the formation of capsids, although capsids are assembled at a 
greatly decreased efficiency and larger numbers of aberrant shells are formed, as compared 
to UL26.5 mediated assembly (Newcomb et al., 1993; Thomsen et aI., 1994; Tatman et a/., 
1994). Subsequently, it was demonstrated that in capsid assembly in the absence of 
UL26.5, there was no compensatory increase in the incorporation of VP21 and VP24 into 
the capsid (Sheaffer et al., 2000). This led researchers to conclude that assembly could 
occur (albeit less efficiently) on a minimal scaffold of preVP2 1. 
The mature forms of VP21 and VP22a are released from the capsid. It was proposed that in 
the procapsid, the onset of DNA packaging results in pH changes that result in the reversal 
of the self-interaction of the scaffold proteins, and that monomeric VP21 and VP22a are 
then able to leave the capsid through its numerous channels and pores, possibly by 
displacement when DNA enters (McClelland et al., 2002). It is now accepted that the B-
capsid is an abortive product resulting from failure in DNA packaging. This means that in 
B-capsids there would be no pH change and hence no disassociation (McClelland et a/., 
2002). While VP21 and VP22a are removed from the capsid, VP24 is retained (Gibson and 
Roizman, 1972; Spear and Roizman, 1972; Booy e/ a/., 1991; Stevenson e/ af., 1997). It 
has been proposed that this retention is mediated by retention signals carried by the 
protein, and that VP24 may have additional functions within the capsid, although these 
functions are as yet unknown (Rixon 1993; Sheaffer et al., 2000). 
1.5. Capsid assembly 
Although the structure of the HSV -1 capsid has been under investigation for several 
decades, studies on the mechanisms by which it undergoes assembly began comparatively 
recently. Our understanding of the events and processes leading to capsid assembly has 
been aided by the introduction of insect cell-based protein expression systems. These have 
made it possible to develop in vitro capsid assembly systems and have revealed details of 
the mechanisms involved in the assembly of the capsid. A proposed model for HSV-l 
capsid assembly is shown in Figure 1.18. 
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Figure 1.18: The main events in the HSV -I virus assembly pathway showing the relationship 
between capsid assembly, maturation and DNA packaging. Copies of VP5 are depicted as 
open boxes, triplexes as crescents, and scaffolding proteins as triangles. Capsid assembly 
appears to be initiated at the UL6 portal complex. The release of the scaffold and the closure 
of the portal complex are poorly understood, and therefore they may differ in detail from the 
mechanisms shown. 
Figure reproduced from Rixon and Chiu, (2003). 
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1.5.1. Nuclear assembly of HSV-1 capsids 
A characteristic feature of all herpesviruses is that DNA replication, capsid assembly and 
DNA packaging all occur inside the nucleus. Hence, HSV -I capsid proteins translated in 
the cytoplasm must be transported to the nucleus. Nicholson et al. (1994) and Rixon et al. 
(1996) showed how the major structural components of the capsid go to the nucleus. 
VP19C and preVP22a are able to locate to the nucleus independently, which indicates that 
these proteins each contain a nuclear localisation signal (NLS), while VP5, VP23, and 
VP26 are not capable of independent nuclear localisation. PreVP22a associates with VP5, 
while VP19C associates with VP5 and VP23. In each case, the association results in the 
localisation of the proteins to the nucleus. VP26 does not localise to the nucleus when co-
expressed with either VP 19C or pre VP22a alone, but nuclear localisation is observed when 
VP26 is co-expressed with VP5 and either VP19C or preVP22a. This result led the authors 
to conclude that VP26 binds directly to VP5, and the subsequent interaction of VP5 with 
VPI9C or preVP22a results in VP26 nuclear localisation. 
Some of the interactions involved in the nuclear localisation of capsid proteins have been 
confirmed by the yeast two-hybrid system. Using this system, Desai and Person (\996) 
detected interactions between VP\9C and VP23, and between VP5 and VP22a. However, 
they did not detect the known interaction between VP5 and VPI9C. 
Detailed analysis of capsid protein nuclear localisation using confocal microscopy has 
revealed that capsid assembly takes place at defined foci in the nucleus, in close proximity 
to DNA replication compartments (Ward et aI., 1996; de Bruyn Kops et aI., 1998). 
1.5.1.1. HSV-1 capsid assembly analysis within insect cells 
The development of the baculovirus expression system has been significant in studies of 
protein interactions within the HSV -1 capsid (Bishop, 1992). Baculoviruses naturally 
infect arthropods, and they can be recombinantly manipulated to express single or multiple 
genes of interest within cultured insect cells. One of the most commonly used insect ceJl 
lines is that of Spodoptera Jrugiperda (SF). High levels of protein expression are achieved 
when SF ceJls are infected with recombinant baculoviruses that express gene(s) of interest 
under the strong late polyhedron promoter. 
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Tatman et al. (1994) and Thomsen et al. (1994) used the baculovirus expression system to 
identify the proteins involved in the assembly of capsids. Capsid particles that resemble 
wild-type B-capsids were produced by infecting insect cell lines with a panel of 
baculoviruses expressing six capsid protein genes: ULl9 (VP5), ULl8 (VP23), UL38 
(VPI9C), UL35 (VP26), UL26 (VP21NP24), and UL26.5 (preVP22a). The omission of 
UL35 has little effect on capsid production, indicating that it is not required for capsid 
formation. However, capsid formation is prevented ifULl9, ULI8, or UL38 is omitted. 
These studies also showed that neither of the scaffold protein genes, UL26 or UL26.5 is a 
sine qua non for capsid formation. Expression of either UL26 or UL26.5 is sufficient to 
serve as a scaffold for capsid formation. In the absence of UL26, large numbers of capsids 
form. The only apparent difference between these capsids and wild-type B-capsids is that 
they have larger scaffolds. By contrast, in the absence of UL26.5, the number of capsids 
produced decreases significantly. Moreover, large numbers of incomplete caps ids are 
present; indicating that capsid formation in the absence of UL26.5 is inefficient. If both 
UL26 and UL26.5 are omitted, incomplete and distorted capsid shells form. If UL26.5 is 
expressed in the absence of other capsid proteins, large numbers of core-like structures 
form, indicating that pre VP22a can self-assemble in the absence of other capsid proteins 
(Preston et at., 1994). 
The use ofbaculovirus expression systems has allowed the minimal requirements for HSV-
1 capsid assembly (namely ULl8, ULl9, UL38, and either UL26 or UL26.5) to be 
identified. It should be emphasised that the HSV -1 capsid does contain additional proteins, 
such as the DNA packaging proteins UL6 and UL25. Nevertheless, the results described 
above demonstrate that although these proteins are essential for replication in mammalian 
cells, they are not required for the actual assembly of the capsids. 
1.5.1.2. In vitro HSV-1 capsid assembly and procapsid formation 
Recombinant expression of capsid proteins using the baculovirus expression system has 
led to the development of an in vitro-based capsid assembly model. In vitro studies have a 
significant advantage over cell-based analyses, in that they make it possible to study the 
assembly of the HSV -1 capsid under much more clearly defined experimental conditions. 
It was Newcomb et al. (1994) who showed that capsids were able to form from a mixture 
of lysed SF cell extracts that had been individually infected with viruses expressing VP5. 
VPI9C. VP23. and preVP22a. The lysed cell extracts were incubated overnight at 28°C, 
and subsequent EM analysis revealed that the resulting capsids were similar to wild-type 
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capsids in terms of size and morphology (T=16), and in the presentation of specific surface 
epitopes to monoclonal antibodies. The group went on to identify a series of intermediate 
capsid structures by the immunoprecipitation of complexes from in vitro assembly-
competent reaction mixtures, with subsequent EM analysis (Newcomb et al., 1996). Partial 
capsids, closed spherical particles (designated procapsids since they resemble the proheads 
formed in the capsid assembly pathways of dsDNA bacteriophages), and mature 
polyhedral capsids were identified after 1 minute, 90 minutes and 8 hours respectively of 
combined extract incubation. It was suggested that partial capsids are the precursors to 
procapsids - since they are rarely seen in reactions after 90 minutes of incubation. 
When EM was carried out on procapsids (Newcomb et al., 1996) they were seen to be 
highly uniform in morphology. They consist of a round closed outer shell with identifiable 
capsomer protrusions (composed of VP5) surrounding a scaffold core. The continued 
incubation of purified procapsids results in the production of mature angularised 
icosahedral particles. This led the authors to conclude that procapsids were the HSV-l 
capsid assembly intermediate. Interestingly, partial capsids and procapsids disintegrated at 
2°C, while angularised particles resembling those of mature B-capsids remained stable. 
The cold-sensitivity of partial capsids and procapsids is consistent with that seen in tailed 
bacteriophages that assemble through procapsid intermediates, such as T4 phage (Steven el 
al., 1976). 
Confirmation that the procapsid was an intermediate in the HSV-l capsid assembly 
pathway came from work done by Rixon and McNab (1999). Cells were infected with a 
strain of HSV -1 that encodes a temperature-sensitive UL26 protease (Is 120 1) (Preston el 
al., 1983). Cells infected with Is 1201 at the non-permissive temperature formed capsids 
that were cold-sensitive and which disassembled at O°C in a similar manner to procapsids 
formed in vitro (Newcomb et ai., 1996). The lesion encoded by ts1201 affects the ability of 
UL26 protease to cleave the scaffolding proteins at the maturation site. As a result, at the 
non-permissive temperature, the scaffolding proteins remain uncleaved and connected to 
VP5. This defect is reversible. When ts1201 cells infected at the non-permissive 
temperature were incubated at the permissive temperature, the UL26 protease became 
activated and was able to cleave the scaffolding protein. Moreover, the capsids were able 
to undergo structural remodelling which allowed them to form mature, cold-stable 
polyhedral capsids (Preston et al., 1983; Addison el al., 1990; Rixon and McNab, 1999). 
As well as confirming the procapsid as an intermediate in the capsid assembly pathway, 
these observations implicated the protease as having a role in capsid maturation. 
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Current evidence suggests that capsid proteins are added to the growing procapsid shell as 
small preformed protein complexes rather than as individual proteins. This hypothesis was 
originally proposed by Trus et al. (1996). It was based on experiments showing that the 
nuclear localisation of HSV -1 capsid proteins requires that the capsids and scaffolding 
proteins interact in the cytoplasm prior to transport to the nucleus (Nicholson et at., 1994; 
Rixon et al., 1996). Subsequent experiments supported this model. Spencer et a/. (1998) 
demonstrated that VP23 and VPI9C initially interact to form heterotrimeric triplexes, 
before being incorporated into the assembling procapsid shell. Newcomb e/ al. (1999) 
demonstrated that VP5 and pre VP22a interacted in vitro, forming complexes consisting of 
one or two copies ofVP5 and up to six copies ofpreVP22a. On the basis of these results it 
was possible to add detail to the proposed model for procapsid assembly: VP5 and the 
scaffolding protein (pre VP22a or UL26 protease) interact in the cytoplasm, forming small 
complexes. These complexes are transported to the nucleus, where they interact with 
preformed triplex subunits. Individual VP5/scaffoiding protein complexes are cross-linked 
by the triplexes to form partial capsids. These are then extended by the addition of further 
complexes until a spherical procapsid is formed (Newcomb et al., 1999). The importance 
of the interaction between the scaffolding protein and VP5 was further highlighted with the 
identification of hydrophobic residues in the N-terminus ofVP5 that, when mutated, result 
in VP5 no longer being able to interact with the scaffold protein. These mutations also 
prevented the closure of capsid shells (Walters et al., 2003). Recently, Newcomb et al., 
(2005) demonstrated the importance of the portal in initiating the assembly of the 
procapsid (as discussed in Section 1.3.6), thereby adding further detail to our 
understanding of capsid assembly mechanisms. 
Saad et al. (1999) infected insect cells with baculoviruses expressing only VP 19C and 
VP5, and observed the formation of spherical particals. These were smaller than those 
observed in wild-type HSV-I, with a diameter of 880A and T=7 icosahedral symmetry. 
This would suggest that the formation of closed spherical structures with icosahedral 
symmetry does not require the presence of scaffolding proteins, and instead that it is an 
inherent property of capsid proteins. More recently, Newcomb et al. (2001 b) examined 
cell-free assembly systems in which the concentration of preVP22a was varied while 
concentrations of VP5, VP19C and VP23 remained constant. They observed that below a 
threshold concentration of preVP22a the capsids produced were smaller. They suggested 
that they had T=9 icosahedral symmetry, although this was not confirmed by 
reconstruction, indicating that the scaffolding protein concentration affects the structure of 
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nascent procapsids with a minimum amount required for the assembly of procapsids with 
the standard radius of curvature and scaffolding protein content. When scaffolding proteins 
are expressed in the absence of other capsid proteins, they self-assemble into ~600 A 
diameter structures (Newcomb and Brown, 1991; Preston et aI., 1994; Tatman et al., 1994; 
Kennard et al., 1995). This suggests that scaffolding proteins have a role in preventing 
capsid proteins from forming smaller structures and in ensuring that they assemble into a 
shell of the correct size (Thuman-Commike et al., 1999). It is interesting to note that if 
VP5, VPI9C, and VP23 are co-expressed in the absence of scaffolding protein, no 880 A 
particles are seen, although partial and distorted capsid shells are formed. This observation 
suggests that VP23 may modulate the interaction between VP19C and VP5. If this 
hypothesis is correct, one might conclude that VP23 could be considered to be an external 
scaffolding protein, acting in conjunction with the internal scaffold to form 1250 A 
capsids. External scaffolding proteins have been described in other viruses, such as the 
ssONA virus phiX174 (Ookland et aI., 1974). However as VP23 remains an integral part 
of the capsid in mature virions, in cannot be classed as a scaffolding protein. 
1.5.1.3. The structure of the procapsid 
The structure of the HSV-l procapsid has been determined using cryo-EM and image 
reconstruction techniques (Trus et al., 1996; Newcomb et aI., 1999; Newcomb et al., 2000; 
Heymann et al., 2003). These studies have demonstrated that although the procapsid is an 
icosahedral shell with T=16 symmetry, there are a large number of visible differences 
between it and a mature HSV-l capsid. The procapsid is more open and porous, with 
relatively little contact between neighbouring VP5 subunits in pentons and hexons other 
than at their bases. Furthermore, individual capsomers have no direct contact with the 
capsomers that surround them, and are held in place principally by the triplexes, indicating 
that the development of the capsid floor occurs at the stage of capsid maturation rather than 
initial assembly. The consequence of the loose association between the components of the 
procapsid is an increased fragility compared to the mature capsids - an observation that is 
reflected in the instability and resulting disassembly of procapsids at low temperatures 
(Newcomb et aI., 1996; Newcomb et aI., 2000). Several divergences from mature capsids 
have been noted in the hexons of procapsids. They do not exhibit six-fold symmetry. but 
form distorted oval (in the case of E- and P-hexons) and triangular shapes (C-hexons); 
moreover, the trans-hexon channel - a small circular opening in the mature capsid - is 
considerably wider in the procapsid. The triplexes appear more trimeric than those of 
mature capsids and VP26 does not bind to the tops of hexons in procapsids, presumably as 
a result of the difference in hexon structure (Chi and Wilson, 2000; Newcomb et al., 2000). 
64 
1.5.1.4. Maturation of the procapsid 
The successful end product of procapsid maturation is the C-capsid: a mature capsid that 
has lost its internal scaffold, successfully packaged the DNA genome and undergone 
structural remodelling. The completion of these processes involves a number of different 
structural and molecular events. It has been proposed that these events are triggered by the 
activation of UL26 protease and the subsequent cleavage of scaffolding protein, and that 
they take place either simultaneously or in rapid succession during maturation (Gao e/ al., 
1994; Church and Wilson, 1997; Rixon and McNab, 1999; Newcomb et al., 2000). 
Sheaffer et al. (2000) demonstrated that in HSV-l, DNA packaging proteins interact with 
the procapsid - which is evidence that DNA packaging takes place, or is at least initiated in 
the procapsid state. It has also been shown that DNA packaging and the loss of the scaffold 
are linked (Dasgupta and Wilson, 1999), with DNA entry into the procapsid probably 
being the trigger for the disassociation of the internal scaffold following cleavage 
(McClelland et a/. , 2002). 
Although the successful result of procapsid maturation is the C-capsid, it is not an entirely 
efficient process. Cells also contain A-capsids (empty shells) and B-capsids (which retain a 
core composed of scaffold proteins). Both A- and B-capsids are abortive products, 
although angularisation takes places in A-, B-, and C-capsids. It has been suggested 
(McClelland et al. 2002) that the procapsid represents an unstable configuration for capsid 
shell proteins, and that it is only the interaction between VPS and the scaffold that 
maintains the procapsid form. Thus, cleavage of the scaffolding protein renders the 
procapsid unstable, and as a result, the capsid proteins spontaneously rearrange themselves 
into a more stable configuration: the polyhedral capsid. 
1.6. The capsid in virus evolution 
All known herpesviruses share a characteristic four-component virion architecture, 
comprising a DNA core, capsid, tegument, and envelope. Our knowledge of herpesvirus 
capsid structures has been extended by the advent of cryo-EM. By this means, capsids have 
been defined to resolutions as high as 8.sA in the case of HSV -1 (Zhou et aI., 2000). 
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1.6.1. Three-dimensional reconstructions of herpesvirus 
capsids 
Three-dimensional reconstructions for a number of alpha, beta, and gammaherpesviruses 
have now been generated: HSV -1 (Zhou et aI., 2000), HCMV (Butcher et aI., 1998; Chen 
et aI., 1999), SCMV (Trus et al., 1999), HHV -8 (Wu el al., 2000; Trus et al., 2001), 
Equine herpesvirus 1 (Baker et al., 1990), and Rhesus monkey rhadinovirus (Yu et al., 
2003). The appearances of hexons and pentons are similar in each case, with both 
structures being composed of the same protein and extending approximately 10 nm 
outwards from the capsid floor. A 3-D reconstruction has also been determined for CCV 
(Booy et aI., 1996), and although it represents a different class of herpesviruses (Section 
1.1.1.5), the size and arrangement of the hexons and pentons in CCV is strongly suggestive 
of a similar pattern to that seen in alpha, beta, and gammaherpesviruses. More recently, a 
3-D reconstruction of OsHV-l has been carried out (Davison et al., 2005b). Unlike other 
3-D reconstructions of herpesvirus capsids, in OsHV -1 large voids are visible at the 
pentagonal vertices. However, this is thought to be due to the loss of pentons during 
preparation of the sample, so to date there is no data available concerning the penton 
structure of OsHV -1 (Davison et aI., 2005b). 
All alpha, beta, and gammaherpesviruses examined by 3-D reconstruction contain 
triplexes, each consisting of two copies of one protein and one copy of a second protein. It 
is not known whether capsids from the fish and bivalve herpesviruses families are 
organised in this way, although CCV capsids contain suitably-sized candidate proteins with 
appropriate stoichiometries (Booy et al., 1996; McGeoch et aI., in submission). 
Although the information from CCV and OsHV -1 is less detailed, it is clear that the 
capsids of all herpesviruses studied display a common set of structural features. The 3-D 
structures that have been obtained provide evidence that all three families have a common 
evolutionary origin with respect to capsid architecture, and thus that they possess related 
sets of capsid proteins. The actual amino acid sequences of the respective proteins have, 
for the most part, diverged to the extent that there is no detectable homology between the 
three herpesvirus families. However, one protein provides an interesting exception to this 
observation, containing sequence features indicative of common descent, namely the 
ATPase subunit of terminase. This protein has a role in DNA packaging and thus interacts 
directly with the nascent capsid (McGeoch et a/. , in submission). The presence of the 
conserved terminase has not been considered definitive evidence for a common origin of 
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the three disparate herpesviruses because the same relationship is seen with the ATPase 
subunit of bacteriophage T4 terminase, suggesting possible early horizontal exchange with 
a T 4-like tailed bacteriophage (Davison et aI., 2002). However, recent evidence suggests 
that it might in fact be indicative of a wider evolutionary relationship that would 
encompass both herpesviruses and tailed bacteriophages. 
1.6.2. Similarities between virus families 
Historically, although similarities had been observed in the coat proteins of small 
icosahedral viruses, the viral 'universe' was often viewed and studied as a collection of 
unrelated families. However, the discovery that P3, the major coat protein of the 
bacteriophage PROI, has a very similar structural fold to that of hexon, the major coat 
protein of human adenovirus (Benson et al., 1999; Benson et al., 2002) altered the way in 
which the evolution of viruses was viewed. 
PRO 1 P3 and the adenovirus hexon are both trimeric molecules containing two jelly rolls 
(also known as p-barrels) per subunit, and both produce a pseudohexagonal base in the 
trimer. The adenovirus hexon is much larger than P3: there are 951 amino acids in 
adenovirus type 5, compared with 394 in P3. However, most of the additional residues in 
hexon form loops above the jelly rolls that lead to extensive, entangled towers (Figure 
1.19). The similarity between PROI P3 and adenovirus hexon is the most striking of many 
structural similarities between PROt and adenovirus virions, which include virion 
architecture, vertex recognition spikes, and genomes with inverted terminal repeats and 
terminal proteins. These observations suggest that the two viruses are evolutionarily related 
(Benson et aI., 1999). The implication of this is that if an evolutionary relationship can be 
detected between viruses that infect two very different hosts who diverged billions of years 
ago, many other viruses that were previously thought to have arisen independently may in 
reality have originated from a common predecessor. 
The relationship has now been extended, with more examples of viruses from families that 
were previously thought to be unrelated containing capsid proteins that exhibit similar 
folding patterns. The capsid of paramecium bursaria chlorella virus 1 (PBCY -I), an algal 
phycodnavirus, is composed of trimers of the Yp54 coat protein. This protein has been 
shown to contain two jelly rolls arranged similarly to adenovirus hexon and PROI P3 
(Nandhagopal et al., 2002). Recently, a similar arrangement was also described for the coat 
protein of sulfolobus turreted icosahedral virus (STIY), a virus that infects the 
A 
P3 - V1 Domain P3 - V2 Domain 
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P3 hexon 
Figure 1.19: Comparison of the P3 and adenovirus hexon. 
Schematic organisation of the two jelly rolls in P3 and adenovirus type 2 hexon. Adenovirus 
hexon is larger than P3, however most of the additional residues form loops, leading to 
extensive entagled towers in the trimer. A. The locations of a-helices and loops are similar. 
The numbers of residues between the ~ strands are indicated. Arrows and black boxes indicate 
~ strands and a-helices respectively. B. Ribbon diagrams of P3 and hexon highlighting the 
jelly rolls (green and blue). 
Figure reproduced from Benson et al. (1999). 
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hyperthermophilic archeon Sulfolobus sulfataricus (Rice et aI., 2004). The similar 
organisation of the capsid proteins from viruses that infect eukaryotes, bacteria and archaea 
suggests long-range evolutionary relationships between viruses from all three domains of 
life. It is possible that this similarity is a result of horizontal gene transfer between all three 
domains, however this would be unprecedented, and must have happened long enough ago 
for all sequence resemblance to have disappeared. If STIV, PBCV -1, PRO 1 and 
adenovirus all evolved from a common ancestor, then that ancestor presumably must have 
existed prior to the divergence of eukaryotes, bacteria and archaea: more than three billion 
years ago. The striking similarity in the proteins of these viruses suggests that this is the 
case (Rice et al., 2004). 
1.6.3. Similarities between herpesviruses and dsDNA 
bacteriophages 
There is a growing body of evidence that demonstrates a possible evolutionary relationship 
between herpesviruses and tailed dsONA bacteriophages, such as T4, P22 and A. The 
hypothesis that these diverse viruses are related was originally based on parallels in capsid 
assembly pathways (Casjens and King, 1975; Steven and Spear, 1997). The likelihood of 
such a relationship existing was strengthened by analyses of HSV-l portal complexes. 
However, until recently, no detailed evidence from protein structural comparisons between 
herpesviruses and tailed bacteriophages was available. However, the improvement in 
resolution of capsid reconstructions during recent years for both herpesviruses and tailed 
bacteriophages has progressed to the point that it has been possible to compare the capsids 
of HSV -1 and certain tailed bacteriophages. Such comparisons have revealed some 
previously unsuspected similarities. 
1.6.3.1. Parallels in capsid assembly 
Capsid assembly in tailed bacteriophage can be compared to that in herpesviruses. For 
example, a mature capsid of P22, a dsONA bacteriophage that infects the bacterium 
Salmonella tryphimurium (Hendrix and Garcea, 1994; King and Chiu, 1997), consists of 
420 copies of the coat protein gpS. It comprises 60 hexamers and 12 pentamers, and it is 
arranged in T=7 icosahedral symmetry. 
Assembly of the P22 capsid involves the interaction of gpS with a scaffolding protein to 
form a spherical capsid intermediate. A maturation process then follows, which involves 
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extensive structural remodelling, the loss of the internal scaffold, and the packaging of 
viral DNA. The procapsid normally initiates around a portal complex made up of twelve 
copies of gp 1. Recent studies have demonstrated that the HSV -1 procapsid also initiates 
around a portal complex (Section 1.3.6). The P22 procapsid grows by sequential addition 
of gp5 subunits around an internal core of 300 copies of the scaffolding protein. Following 
assembly, minor proteins such as gp16, gp20 and gp7 attach to the capsid. These proteins 
are required for the injection of DNA into a new host following attachment. However, as in 
HSV -1, these proteins, along with the portal complex, are nonessential for capsid assembly 
in vitro. 
The P22 procapsid is spherical. In striking similarity to the HSV -1 procapsid, P22 
capsomers appear skewed, but become more regularly hexagonal upon maturation, while 
holes that are present at the six-fold axes of the P22 procapsid are absent in the mature 
capsid. During maturation, the most extensive conformational changes take place at the 
trimer clusters. In another parallel with HSV -1, these three-fold symmetrical axes have 
been shown to be the positions at which the scaffold binds to the inner surface of the 
capsid shell. The observation that the site of scaffold binding is also that of considerable 
conformational rearrangement implicates the scaffold in both the assembly of P22 capsids, 
and also in the maturation of the capsid during DNA packaging. 
1.6.3.2. Parallels in portallterminase complexes 
In HSV -1 and some dsDNA bateriophages, the replicated viral genome is a concatameric 
DNA molecule, which is cleaved into a unit length genome and packaged into a preformed 
capsid. This process involves two separate protein complexes: the portal (the channel 
through which viral DNA enters the capsid), and the terminase (an enzyme complex which 
recognises the viral genome and cleaves it into monomers). 
In HSV-1, the portal is composed of twelve UL6 molecules, which form a ring-like 
structure found at a single vertex in the icosahedron as discussed in Section 1.3.6. Similar 
organisation is seen at the portals of tailed bacteriophages such as A, which also contain a 
unique vertex composed of a dodecameric ring of twelve copies of the gpB protein, 
through which the DNA enters the capsid (Bazinet and King, 1985; Valpuesta and 
Carrascosa, 1994). 
In bacteriophage A, the terminase consists oftwo subunits: gpA and gpNul. These subunits 
interact through the N-terminal48 amino acids of gpA, and the C-terminal 91 amino acids 
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of gpNul. The N-terminus of gpNul binds specifically to the Iv DNA packaging signal 
(cos). The gpA C-terminus is involved in procapsid binding, and in endonuclease and 
helicase activities (reviewed by Catalano, 2000). 
It has been hypothesised that Iv terminase mediates DNA cleavage by gpNu I binding to the 
cos sequence in conjunction with a host cell protein known as integration host factor (IHF). 
GpNul then recruits gpA, which binds as a dimer to either side of the cos sequence, and its 
endonuclease activity results in symmetrical cleavage at the cos site. The two members of 
the gpA dimer then separate, causing the DNA strands to separate, effectively cleaving the 
DNA at the cos site. The result of these actions is a complex known as complex I, a stable 
intermediate in the DNA packaging process in which the mature left end of the viral 
genome is tightly bound by the terminase complex. This complex then interacts with the 
pre-assembled procapsid at the portal complex to form complex II. The viral genome is 
then driven into the procapsid in an ATP-dependent manner. As this takes place, gpNuI 
'scans' the incoming viral genome until a second cos sequence is reached. This cos 
sequence is then cleaved by the gpA endonuclease, resulting in the reconstitution of 
complex I on the newly-formed end of the concatameric DNA, which can then interact 
with another procapsid (reviewed by Catalano, 2000). 
In HSV-I, UL6 forms the portal channel, and the DNA packaging proteins UL15, UL28, 
and UL33 have been proposed as subunits of the terminase enzyme (Davison, 1992; Beard 
et al., 2003; White et al., 2003). It appears likely that all herpesviruses package their 
genomes in a similar fashion. However, while the Iv terminase is known to contain two 
subunits, the composition of the terminase has not been determined in herpesviruses so it is 
not possible to determine how many components it contains. 
1.6.3.3. Parallels in capsid structure 
It was previously thought that T= 16 capsid architecture was unique to herpesviruses. 
However this arrangement has now also been observed in the bacteriophage SPO 1. 
Furthermore, the SPO 1 capsid has been suggested to contain heterotrimeric triplexes at 
positions of threefold symmetry (Duda et al., 2006). 
The secondary structure of HSV -1 VP5 has been compared to gp5, the capsid shell protein 
of the lambdoid bacteriophage HK97 (Baker et al., 2005). Although gp5 is much smaller 
(282 amino acids compared with 1374 in VP5), it has very similar dimensions to the floor 
domain of VP5, and when comparison is confined to this domain (i.e. excluding the middle 
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and upper domains of VP5), the overall shapes of the two proteins and the dispositions of 
their secondary structural elements appear strikingly similar (Figure 1.20). Capsids from 
several more bacteriophages have now been analysed at sufficient resolution to reveal 
secondary structural features, and in each case, despite limited sequence similarity, a fold 
pattern similar to HK97 gp5 has been observed (Wikoff et aI., 2000; Jiang et al., 2003; 
Fokine et al., 2004; Morais et aI., 2005). No herpesvirus capsid structure other than that of 
HSV-l is known in sufficient detail to carry out similar analyses, but the general 
uniformity of herpesvirus capsid structures makes it very likely that the floor domain fold 
in VP5 is maintained throughout herpesviruses. 
Taken together these findings indicate that the entire capsid packaging machinery is of 
ancient origin, and that it has been passed down to herpesviruses and tailed bacteriophages 
from a common progenitor. This helps to explain why tailed bacteriophages have provided 
such useful models in examining herpesvirus capsid assembly. 
1.7. Experimental aims 
The aim of the work presented in this thesis was to add to the current understanding of the 
proteins that make up the HSV -1 capsid and the interactions that take place between them. 
Insertional and deletional mutagenesis was carried out on the triplex protein VP 19C in 
order to identify regions that were important for its function. The results of this work 
identified the N-terminal region of the protein as a particular region of interest, and led to 
attempts to map the nuclear localisation signal that this region contained, and attempts to 
identify the effect that removing amino acids from this region of the protein has on overall 
capsid morphology. 
The remaining work aimed to further characterise the major capsid protein, VP5. The 
possibility of fluorescently labelling VP5 by amending the protein sequence to include a 
six amino acid motifwas investigated. Amino acids in VP5 that were proposed to be 
responsible for interaction with VP26 were examined by producing a panel of VP5 mutants 
containing single amino acid substitutions. These particular topics are introduced in more 
detail at the beginning of the relevant results chapters (chapters 3, 4, 6, and 7). 
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Figure 1.20: The econdary structural elements of HSV -1 VP5 and HK97 gp5 and their 
molecular interactions in capsid . (a) The VP5 floor domain (turquoise), viewed from outside 
the cap id. The structure has been predicted to contain two long a-helices (red; 0'1 and 0'2) 
adjacent to a large (3 heet (yellow; (31) in the floor domain, as well as a second (3 sheet 
(yellow, (32), and evera] smaller helices flanking 0'1 and 0'2. (b) HK97 gp5 shown in the 
same view reveals a similar structural motif. (c) Alignment of secondary tructural elements 
demonstrates a clear match between the floor domain of VP5 and gp5. (d) Arrangement of 
gp5 subunits around a local three-fold axi (denoted with a black triangle) in the HK97 
capsid, as viewed from inside the cap id. (e) Organisation of the HSV-l capsid floor as hown 
in the same view as (d). Individual VP5 subunit floor domains are shown, with the long 0'-
helice (0'1 and 0'2) and associated (3 sheets «(31 and (32) annotated in one subunit. 
Figure reproduced from Baker et ai. , 2005. 
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2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals 
The chemicals and reagents used for EM analysis were purchased from either Agar Aids or 
T AAB laboratories. All other chemicals and reagents were purchased from either Sigma-
Aldrich or BDH Chemicals UK, unless otherwise stated below or in subsequent sections. 
Chemical 
Acetic Acid 
Ammonium Persulphate 
Butanol 
Chloroform 
DMSO (dimethyl sulphoxide) 
DNTPs 
ECl 
Ethanol (ultra pure) 
Glacial Acetic Acid 
Hydrochloric Acid 
Methanol 
Nitro-Cellulose Membrane 
Rainbow Markers 
S.O.c. 
Sodium Chloride 
Tris-HCl 
2.1.2. Oligonucleotides 
Supplier 
Rhone-Poulenc Ltd 
Biorad 
Prolabo 
Prolabo 
Koch-Light Laboratories Ltd 
Pharmacia 
Amersham Biosciences 
Fisher Scientific 
Prolabo 
Rhone-Poulenc Ltd 
Prolabo 
Hybond 
Amersham Biosciences 
Invitrogen 
Prolabo 
Roche 
All oligonucleotides were supplied by either Sigma-Genosys or TAG Newcastle. 
2.1.3. Enzymes 
All restriction enzymes and DNA modifying enzymes were supplied by Amersham 
Biosciences, Fermentas life Sciences, New England Biolabs or Sigma-Aldrich. 
2.1.4. Cel/lines 
Baby hamster kidney-21 Cl3 (BHK-21) cells: A fibroblastic cell line originally 
derived from the kidney of a baby hamster (MacPherson and Stoker, 1962). 
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Rabbit skin cells expressing UL19 (ULI9RSC): Rabbit skin cells are a fibroblastic cell 
line originally derived from the skin of a rabbit (Baines and Roizmann, 1991). In 
ULl9RSCs, rabbit skin cells have been modified to constitutively express the HSV-I 
major capsid protein VP5. Supplied by Dr. V. Preston. 
Rabbit skin cells expressing UL38 (UL38RSC): As above, but modified to 
constitutively express the HSV -1 major capsid protein VPI9C. (Thurlow e/ al., 2005). 
Spodop/era jrugiperda 21 (SF21): Insect cells derived from ovarian tissue (Vaughn et 
aI., 1977). 
Human bone osteosarcoma epithelial cells (U20S): Cultivated from the bone tissue of a 
human female suffering from osteosarcoma (Ponten and Saksela, 1967). Supplied by Dr C. 
Boutell. 
2.1.5. Tissue culture medium 
All tissue culture media and media supplements were obtained from Invitrogen. The 
growth media and the supplement requirements for each of the cell lines used were as 
follows: 
BHK-21 cells: BHK-21 medium (Glasgow Modified Eagles Medium) supplemented with 
10% tryptose phosphate broth and 10% newborn calf serum. 
RSCULl9, RSCUL38 and U20S cells: Dulbeccos Modified Eagles Medium supplemented 
with 10% foetal calf serum and 1 % non-essential amino acids. 
Sf21 cells: TC 1 00 medium supplemented with 5% foetal calf serum. 
Optimem: A commercially available growth medium that has a reduced serum content 
compared with other growth media; this medium was used during liposome transfections. 
Overlay medium: BHK-21 medium (Glasgow Modified Eagles Medium) supplemented 
with 10% tryptose phosphate broth, 10% newborn calf serum, 2% L-glutamine, 0.26% 
sodium bicarbonate, 1 % penicillin/streptomycin and 1.125% carboxymethyicellulose. 
2.1.6. Viruses 
Wild-type HSV -1: strain 17 syn+, originally described by Brown e/ aI., 1973. 
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vf138YFP: Constructed by removing nucleotide sequences 84522 to 85982 in the HSV-I 
strain 17 genome and replacing them with the yellow fluorescent protein ORF (Thurlow et 
al.2005). 
KSI1Z: A mutated strain of HSV -1 in which the UL 19 ORF has been disrupted by insertion 
of the LacZ gene (Desai et al., 1993). 
AcUL38: Baculovirus AcPAK6 vector expressing full-length VPI9C. (Tatman et ai, 
1994). 
AcUL19: Baculovirus AcPAK6 vector expressing full-length VP5. (Tatman et al.,1994). 
AcUL26.5: Baculovirus AcPAK6 vector expressing full-length preVP22a. (Tatman et ai, 
1994). 
AcAB3.12: Baculovirus AcPAK6 vector expressing full-length VP23, VP26, and the 
UL26 protease: Made by cloning the ORFs into the triple expression transfer plasmid 
pAcAB3 (BD Biosciences, Pharmingen) and recombining them into AcPAK6 (Bishop, 
1992). 
Recombinant baculoviruses expressing modified VP 19C proteins were produced using the 
BAC-TO-BAC Baculovirus Expression System (Invitrogen) following the manufacturer's 
protocol (Section 2.2.7). 
2.1.7. Bacterial culture medium 
L-broth (LB) 
L-broth agar (LB agar) 
LB/LB agar + antibiotic 
10 gil NaCI, 10 gil Bacto ™ peptone, S gil 
Bacto ™ yeast extract 
L-broth with 1.5% (w/v) Bacto ™ agar 
LB I LB agar supplemented with: 
Ampicillin at 100 f.lg/ml and/or kanamycin 
at 25 f.lglml 
(Unless alternative concentrations stated) 
LB agar plates for BAC-TO-BAC LB agar supplemented with: 
Baculovirus Expression Systems (Gibco) 50 flg/ml kanamycin 
7 flg/ml gentamycin 
10 f.lg/ml tetracycline 
100 f.lg/ml Bluo-gal 
40 flg/ml IPTG 
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2.1.8. Bacterial strains 
DH5u: A strain of E. coli containing the endA and recA mutations (Invitrogen). The endA 
mutation eliminates endonuclease I activity, preventing degradation of plasmid DNA 
within the bacterial cell, thereby improving the quality of DNA preparations. The recA 
mutation reduces homologous recombination between plasmid DNAs, thereby increasing 
the stability of the plasmid within the bacterial cell. 
GM48: A strain of E. coli that lacks both dam and dcm methylase activity, thereby 
producing plasmid DNA that is un-methylated at both dam and dcm recognition sites 
(Marinus, 1973). This strain is used to prepare plasmid DNA for situations where digestion 
with a methylation-sensitive restriction enzyme is required. 
Note: Both of the above strains used were grown from our own glycerol stocks and were 
made competent for transformation using the method described in Section 2.2.3.3. 
E. coli DHI0B: Commercially available transformation competent bacterial cells 
(Invitrogen), used in situations where increased efficiency of transformation is required. 
2.1.9. Plasmids 
pGEM-T Easy: Commercially available plasmid (Prom ega) used to directly clone PCR 
products into a plasmid vector. pGEM-T Easy has been linearised and has 3'-terminal 
thymidine nucleotides added. As taq polymerase adds a single adenine to the 3' end of 
PCR products, they can be directly cloned into pGEM-T Easy without further enzymatic 
manipulation (Figure 2.1). 
pF ASTBAC 1: Commercially available plasmid (Invitrogen) containing a baculovirus-
specific promoter (the polyhedrin promoter from Autographa calif arnica 
nucleopolyhedrovirus) for expression of proteins in insect cells (Figure 2.1). 
pFBpCI (Roger Everett, unpublished) was made by inserting a BgllII EcoRI fragment 
containing the human cytomegalovirus (HCMV) promoter/enhancer from pCI-neo 
(Promega) into BamHII EcoRI digested pF ASTBAC HTa (Invitrogen) (Figure 2.1). 
B. 
pGEM - T EASY 
3023 bp 
pFastbac1 
4776 bp 
~OMI - 657 - G'GGCC C 
Apal - 661 - G GGCC'C -
Zral - 665 - GAC'GTC 
AatU - 667 - G ACGT'C 
Sphl - 673 - G -CATG'C 
Ncol - 684 - c'CATG G 
Styl - 684 - C'CwwG G 
Sacll - 696 - CC GC'GG 
EcoR! - 699 - G'AAlT C 
Spel - 719 - A'CTAG T 
EcoR! - 725 - G'AATI C 
B.spMI - 732 - ACCTGCnnnn'nnnn_ 
L-J="- Sb/I - 743 - CC TGCA'GG 
PstI - 743 - C TGCA'G 
Sail - 745 - GfTCGA C 
Accl - 746 - GT'mk AC 
Hincll - 747 - GTy'rAC 
NdeI - 752 - CA'TA TG 
EcoICR! - 762 - GAG'CTC 
Sacl - 764 - G AGCT'C 
MId - 769 - A 'CGCG T 
BslXI - 773 - CCAn Mnn'nTGG 
BfrBI - 780 - ATG'CAT 
Nsil - 782 - A TGCA'T 
BamHI - 1107 - G'GATC_C 
RsrII -1114 - CG'GwC_CG 
BssHII - 1122 - G'CGCG _ C 
EcoRl - 1129 - G'AATI_C 
StuI - 1139 - AGG'CCT 
SaII - 1145 - G'TCGA _ C 
HeoICR! - 1153 - GAG'CT 
SacI - 1155 - G _AG T' 
;;e:;:::--- Spel - 11S7 - A'CTAG_T 
~--- Noil - 1l65 - CC'CCCC_GC 
BstBI - 1174 - IT'CG_AA 
)(bal - 1179 - T'CTAG_ 
Pst! - 1191 - C_TGC 'G 
XhoI - 1194 - C'Tca _G 
SphI - 1204 - G_CATG'C 
Acc6SI - 1206- G'GTA _C 
KpnI -1210 - G GT C' 
HindUI -1212 - A'AGCT_T 
pFastbac pC1 
5950 bp 
Nhel -1391- G'CTAG_C 
Bmtl -1395 - G_CTAG'C 
EcoRI -1402 - G'AATT C 
Stul - 1412 - AGG'CCT 
SaIl - 1418 - G'TCGA C 
~ __ NotI - 1438 - GC'GGCC GC 
BstBI -1447 - TT'CG AA 
Xbal - 1452 - T'CTAG A 
Sphl - 1477 - G_CATG'C 
Acc6SI -1479 - G'GTAC C 
Kpnl-1483- G_GTAC'C 
Figure 2.1: A. pGEM-T Easy. B. pFASTBACl. C. pFASTBAC pCl. 
Multiple cloning site are hown for each plasrrtid. 
PBS complete 
PBSA + 6.8 mM CaCL2, 4.9 mM MgCh. 
PBSAIT 
PBSA, 0.05% Tween-20. 
Phenol/chloroform (1 : 1) 
Mixed phenol/chloroform (1 :1) saturated with 10 mM Tris (pH 8.0). 
Alkaline Lysis Solution 1 
25 mM Tris (pH 8.0), 10 mM EDTA, 50 mM glucose. 
Alkaline Lysis Solution 2 
0.2M NaOH, 1% SDS 
Alkaline Lysis Solution 3 
150 mM NaCI, 15mM trisodium citrate (pH 7.5) 
lOx Loading Buffer 
40% (w/v) sucrose, 250 mM EDTA, 0.75% (w/v) bromophenol blue. 
TBE 
90 mM Tris (PH 8.0), 90 mM boric acid, 1 mM EDT A 
TAE 
40 mM Tris (PH 7.5),20 mM glacial acetic acid, 1 mM EDTA pH 8.0 
TBS 
20 mM Tris-HCl (PH 7.5), 500 mM NaCI 
Trypsin 
0.25% (w/v) trypsin (Sigma-Aldrich) dissolved in TBS 
Tryptose Phosphate Broth 
10% (w/v) tryptose phosphate (Difco) dissolved in PBSA. 
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Versene 
600 mM EDT A dissolved in PBS A containing 0.0002% phenol red. 
Antibody Solution A 
PBS complete, 5% newborn calf serum, 0.05% Tween-20 
Acid washing 
Wash solution: 0.14 M NaCI 
Acid solution: 0.14 M NaCI, 0.1 M glycine, pH 3. 
Formaldehyde Fix 
PBSA, 2% sucrose, 2% formaldehyde 
2x Cell Lysis Buffer (for packaging assay) 
10 mM Tris-HCI (pH7.5), 1 mM EDTA, 0.6% SDS 
Resuspension Buffer (for packaging assay) 
1 mM Tris-HCI (pH 7.5),10 mM KCI, 1.5 mM MgCh 
Resolving Gel Buffer 
0.75 M Tris-HCI (pH 8.0),1% SDS 
Stacking Gel Buffer 
0.125 M Tris-HCl (pH 6.7), 0.1 % SOS 
3x SOS PAGE Sample Buffer 
Stacking gel buffer: 25% SOS:p mercaptoethanol:glycerol (10:8:5:10) 
Tank Buffer 
50 mM Tris, 50 mM glycine, 0.1 % SOS 
Oestain 
Methanol:H20:acetic acid (50:880:70) 
Coomassie Brilliant Blue Stain 
0.2% Coomassie Brilliant Blue R250 in Oestain 
Towbin Buffer 
40 mM Tris, 50 mM glycine, 20% methanol, 0.4% SOS 
Blocking Buffer 
PBSAlT, 5% Marvel milk powder 
Reticulocyte Standard Buffer (RSB) 
10 mM Tris-HCI (pH 7.5), 10 mM KCI, 1.5 mM MgC}z 
2.1.12. Commercial kits 
QIAprep 8 Miniprep Kit Qiagen Ltd 
Sephaglas BandPrep Kit Amersham Pharmacia Biotech Inc 
pGEM-T Easy Vector System I Promega 
Expand High Fidelity PCR System Roche 
FIAsHTM-EDT2 Labeling Kit Panvera 
Mutation Generation System Finnzymes 
2.1.13. Miscellaneous reagents 
Ampicillin 
Gene Pulser ® cuvettes, 0.1 cm electrode 
100 bp ladder, Lipofectamine reagent, 
Plus ™ reagent. 
1 Kb ladder, lambda DNA-Bst E II digest 
Beecham Research Laboratories Ltd 
Biorad 
Invitrogen 
New England Biolabs 
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2.2. Methods 
2.2.1. Gel electrophoresis 
2.2.1.1. Analytical agarose gel electrophoresis of DNA 
1 % agarose/TBE gels were prepared by mixing the agarose in 1 x TBE and heating the 
solution in a microwave oven until the agarose had completely dissolved. The solution was 
allowed to cool to approximately 500e before ethidium bromide was added to a 
concentration of 0.5~g/ml. When the gel had set it was submerged in I x TBE buffer 
containing 0.5 ~g/ml ethidium bromide. DNA samples were mixed at a ratio of 10: 1 with 
lOx loading buffer, before being loaded on to the gel alongside appropriate size markers 
and electrophoresed at 100 V for 30-40 minutes. The DNA was examined and 
photographed under short-wave UV transillumination. 
2.2.1.2. Preparative agarose gel electrophoresis of DNA 
1 % agarose gels were prepared using the procedure described above (analytical gel 
electrophoresis), except that TAE was used in place ofTBE. DNA samples were mixed at 
a ratio of 10: I with lOx loading buffer, before being loaded on to the gel alongside 
appropriate size markers and eletrophoresed at 60 V for 60-90 minutes. If very small DNA 
fragments were to be purified, the length of time that the gel was electrophoresed was 
reduced. The gel was examined under long-wave UV transillumination and the desired 
DNA fragments were cut from the gel using a sterile scalpel. Gel slices were transferred to 
a 1.5 ml microfuge tube and stored at -20°C until required for purification (Section 
2.2.2.4). 
2.2.1.3. Polyacrylamide gel electrophoresis of DNA 
5% acrylamide/TBE gels were prepared by mixing 3.5 ml 30% acrylamide-bis (Bio-Rad), 
2 ml lOx TBE, 14.3 ml H20, 20~1 TEMED (Sigma-Aldrich), and 200 III 10% ammonium 
persulphate. The mixture was immediately poured between the glass plates of a Biorad 
Mini-Protean II electrophoresis apparatus and a comb was inserted into the top of the gel. 
Once set, the samples to be analysed were mixed with lOx loading buffer at a ratio of 10: 1 
and loaded on to the gel. All the samples were run alongside the 100 bp ladder. The gel 
was electrophoresed in Ix TBE at 100 V for 20-30 minutes until the bromophenol blue dye 
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front had reached the bottom of the gel. However, if very small DNA fragments were 
being analysed, electrophoresis was stopped before the dye front reached the bottom of the 
gel. The gel was stained by submerging it for 30 minutes in a solution of Ix TBE 
containing 0.5~g Iml ethidium bromide. The gel was then examined by short-wave UV 
transillumination and photographed. 
2.2.2. DNA cloning and manipulation 
2.2.2.1. Polymerase chain reaction 
Each PCR reaction was set up in a thin-walled 0.2 ml PCR tube (Applied Biosystems) 
using the enzyme and buffer from the Expand™ High Fidelity PCR system. A typical PCR 
reaction mixture contained the following ingredients: 
Template DNA (50-IOOng) I ~l 
Forward primer (lOOpmol!~l) 0.5 ~l 
Reverse primer (l OOpmol/~I) 0.5 ~l 
5x PCR buffer 5 ~l 
2mMdNTP mix 2 ~l 
Tag expand (1.7 units) 0.5 ~l 
H2O 41.5 ~I 
The reaction's components were mixed by flicking the tube, taking care not to introduce 
air bubbles. PCR reactions were performed using an Applied Biosystems GeneAmp 9700 
thermocycler running the following PCR profile: 
Step 1: I cycle 
Step 2: 35 cycles 
Step 3: Constant temperature 4°C 
96°C for 4 minutes 
55°C for 2 minutes 
nOc for 3 minutes 
96°C for I minute 
55°C for 2 minutes 
nOc for 3 minutes 
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To detennine whether the peR reaction was successful,S ).11 of the reaction was mixed 
with 0.5 ).11 lOx loading dye and analysed by agarose gel electrophoresis. A frequent 
drawback of this method is the presence of unwanted minor bands. Thus a comparision of 
the DNA profile of the peR reaction with DNA size markers is essential to identify the 
desired product. If required, the remainder of the peR reaction was mixed with 4.5 ).11 lOx 
loading dye and run on a preparative agarose gel. The desired band was then extracted and 
purified. 
2.2.2.2. Restriction enzyme digestion 
Analytical digests 
0.2-0.5 Ilg of plasmid DNA was digested in a 20 ).11 reaction containing the appropriate 
restriction buffer, 2 Ilg BSA (if recommended) and 10 units of the desired restriction 
enzyme. The mixture was incubated at the recommended temperature for 60 minutes. 
In the case of double digests, the buffer and temperature requirements for the two 
restriction enzymes were taken into consideration. If the enzymes functioned well under 
the same conditions, both could be added to the same reaction. However, if they had 
incompatible requirements the restriction digest had to be carried out in two sequential 
reactions. In this case, the DNA was digested with the first enzyme for 60 minutes in a 
20).11 reaction, under the conditions optimal for that enzyme. After 60 minutes, the reaction 
mixture was modified by adding the second enzyme, 3 ).11 of the appropriate restriction 
buffer for that enzyme, and the volume of the reaction was increased to 30 Ill. The DNA 
was then digested for a further 60 minutes under the new conditions. All restriction digests 
were confinned by analytical gel electrophoresis. 
Preparative digests 
The same basic principles as those used in analytical digests apply. The differences were 
that typically, 1-3 ).1g of plasmid DNA and 20 units of restriction enzyme were used in the 
reaction. In addition, to confinn that the digest was successful, aliquots of the reaction 
were examined by analytical gel electrophoresis before the remainder of the reaction was 
purified using a preparative agarose gel. 
2.2.2.3. De-phosphorylation of digested DNA 
To reduce self-ligation, the digested vector DNA was treated with calf intestinal 
phosphotase (eIP), since de-phosphorylation of the ends of the vector DNA renders them 
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unable to self-ligate. The CIP digestion was performed after restriction digestion by adding 
10 units (l ~I) of CIP directly to the digest reaction and incubating for a further 30-4S 
minutes at 37°C. CIP is functional in all restriction buffers. 
2.2.2.4. Purifying DNA fragments from a gel slice 
Purification of DNA fragments from agarose/T AE gel slices was performed using the 
Sephaglas ™ BandPrep Kit in accordance with the standard protocols supplied. The yield 
and puity of the purified fragment could be determined by running a small fraction 
(typically 10%) on an analytical agarose gel. 
2.2.2.5. DNA ligation 
Standard ligation 
Purified insert and vector DNA pre-digested with compatible restriction enzymes were 
mixed at an approximate 3: I molar ratio in a 20 ~l reaction containing 1 unit of T4 DNA 
ligase and Ix T4 ligase buffer. The reaction components were mixed by flicking the tube 
and incubated overnight at ISoC. Following overnight incubation, the ligation reaction was 
stored at -20°C until required. 
Ligation of oligonucleotides 
Complementary nucleotides (O.S ~g of each) in 20 ~I of H20 were heated for two minutes 
at 100°C, then transferred to a 37°C waterbath and allowed to cool for two minutes. S ~I of 
5x T4 ligase buffer was added, after which the reaction was returned to the 37°C waterbath 
and incubated for a further 20 minutes. At this point, one unit of T4 ligase and I ~g of 
appropriately digested and de-phosphorylated vector DNA were added. The reaction 
mixture was transferred to a ISoC waterbath and incubated overnight. 
Ligation of peR products 
1 ~I of gel-purified PCR product was ligated into the pGEM-T Easy vector in accordance 
with the standard ligation protocols supplied. The identity of the cloned PCR product was 
confirmed by DNA sequencing and restriction digestion. 
2.2.2.6. Small-scale plasmid DNA preparation ('miniprep') 
1.5 ml of a bacterial culture (Section 2.2.3.1) was transferred to a I.S ml microfuge tube 
and pelleted by centrifugation at 13 000 rpm for one minute in a bench-top microfuge. The 
supernatant was discarded and the pellet was processed using the QIAprep 8 Miniprep Kit 
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in accordance with the standard protocols supplied. The only deviation from this protocol 
was an increase in the elution volume from 100 III to 150 Ill, which allowed improved 
recovery of the purified plasmid. The vacuum manifold used was a Qiagen QIA vac 6S, 
used with a KNF vacuum pump (model number N022AN.18). Following purification, the 
miniprep DNA was analysed by restriction digestion and agarose gel electrophoresis. 
In situations where the DNA under preparation was to be used for further cloning steps 
other than analysis or sequencing (such as in the production of intermediate plasmids 
during the process of creating random insertional mutants), the preparation was carried out 
using an alkaline lysis miniprep. Cells were pelleted as described above. The pellet was 
then resuspended in 100 III of ice-cold alkaline lysis solution 1 (Materials) and incubated 
on ice for five minutes. 200 III of freshly prepared alkaline lysis solution 2 (Materials) was 
added and mixing was carried out by inverting the mirofuge tube six or seven times. 150 III 
of ice-cold alkaline lysis solution 3 (Materials) was then added. Mixing was again carried 
out by inversion and the mixture was incubated on ice for five minutes. The resulting white 
precipitate, consisting of cell debris, was pelleted by centrifugation at 13 000 rpm for five 
minutes at RT in a microfuge. The supernatant was transferred to another 1.5 ml reaction 
tube and the DNA was recovered by phenol/chloroform extraction and ethanol 
precipitation (Section 2.2.2.7). The DNA pellets were typically resuspended in 50 III of 
dH20 containing 10 Ilg/ml of RNaseA. 
2.2.2.7. Phenol/chloroform extraction and ethanol precipitation of 
DNA 
If the volume of the original DNA solution was less than 200 Ill, the volume was brought 
up to 200 III by the addition of distilled H20. An equal volume of phenol/chloroform (1: 1) 
was added to the DNA solution and briefly vortexed before being centrifuged at 13 000 
rpm for five minutes at RT. The upper (aqueous) phase was then removed. If the aqueous 
phase appeared cloudy then the phenol/chloroform extraction was repeated until the 
aqueous phase appeared clear. The DNA was precipitated by the addition of a 1110 volume 
of 3 M sodium acetate and two volumes of 100% ethanol. The mixture was inverted 
several times and incubated for at least 30 minutes at -20°C. Precipitated DNA was 
pelleted by centrifugation at 13 000 rpm for five minutes at RT in a microfuge. The DNA 
pellets were washed in 200 III of 70% ethanol to remove excess salts and the DNA was 
pelleted by centrifugation at 13,000 rpm for two minutes at RT in a microfuge. The DNA 
pellets were then either dried for ten minutes in an Eppendorf Concentrator 5301 or 
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allowed to air dry before being resuspended in the appropriate volume of d H20 containing 
10 !!g/ml RnaseA and stored at -20°C until required. 
2.2.2.8. Oligonucleotides 
All the oligonucleotides ordered from commercial sources were supplied as a Iyophilised 
powder. This was resuspended in a volume of H20 that would provide a final 
oligonucleotide concentration of 100 pmoles/!!I, vortexed vigorously, then incubated 
briefly at 37°C to ensure that all the material had dissolved. 
2.2.2.9. DNA sequencing 
All sequencing was carried out by either the Molecular Biology Support Unit at Glasgow 
University, or by Claire Addison at the MRC Virology Unit, Glasgow. The quality of the 
sequence data was confirmed by analysis of the chromatogram using a sequence viewing 
program called Chromas. This was obtained via the Internet from the URL: 
http://www.technelysium.com.au. 
2.2.3. Bacterial methods 
2.2.3.1. Bacterial culture 
(i) Large scale cultures 
A 10ml starter culture was set up by inoculating 10mi of LB broth + antibiotic with a 
single isolated colony from a LB agar plate or from a glycerol stock (Section 2.2.3.5) and 
incubating overnight at 37°C in an orbital shaker at approximately 200 rpm. The following 
day, 100 ml of LB broth + antibiotic was inoculated with the 10 ml starter culture and 
grown overnight as before. Plasmid DNA was prepared as described above. 
(ii) Miniprep cultures 
2.5 ml of LB + antibiotic was inoculated with a single isolated colony from a LB agar plate 
and incubated overnight at 37°C in an orbital shaker at 200 rpm. On the following day, the 
culture was harvested to make DNA as described above (Section 2.2.2.6). 
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2.2.3.2. Preparation of electrocompetent E. Coli cells 
E. coli cells were recovered from a -70°C glycerol stock, placed in a 10ml starter culture of 
unsupplemented LB (containing no antibiotics) and grown overnight. On the following 
day, the starter culture was used to inoculate 100 ml of unsupplemented LB and again 
grown overnight. 50 ml of this culture was used to inoculate 1 litre of unsupplemented LB 
and grown until the culture reached an 00600 of 0.5-0.6. 
The culture was transferred to six pre-chilled 250 ml Falcon tubes (each containing 
approximately 160 ml of culture) and incubated on ice for at least 30 minutes. The cells 
were pelleted by centrifugation at 3500 rpm for 15 minutes at O°C using a Sorvall SLA-
1500 rotor. The supernatant was discarded and each of the six pellets was resuspended in 
160 ml of ice-cold, sterile H20. 
The cells were pelleted again as before and the supernatants discarded. The six pellets were 
resuspended in a total of 500 ml of ice-cold, sterile H20 and combined to give -160 ml in 
each of three 250 ml Falcon tubes. The cells were pelleted again as before and the 
supernatants discarded. The three pellets were pooled and resuspended in a total volume of 
40 ml ice-cold, sterile 10% glycerol, transferred to a pre-chilled 50 ml SS34 tube and 
centrifuged at 5800 rpm for 15 minutes at O°C using the Sorvall SS34 rotor. The 
supernatant was discarded and the pellet resuspended in 2 ml ice-cold, sterile 10% (v/v) 
glycerol. The competent cells were aliquoted into pre-chilled sterile 1.5 ml microfuge tubes 
(40 ~l per aliquot) and stored at -70°C until required. 
2.2.3.3. Transformation of E. coli by electroporation 
The transformation efficiency of electro-competent E. coli cells is reduced with repeated 
freeze-thaw cycles. For this reason, only as many vials as required for each experiment 
were removed from the -70°C freezer and kept on dry ice. The cells were thawed on ice 
immediately prior to use. 
5-10 ng of plasmid DNA, or 1 ~l of a ligation reaction was transferred to a Gene Pulser 
cuvette (Biorad). 25 III of electro-competent cells (Section 2.2.3.2) were then added to the 
cuvette and mixed with the plasmid DNA or ligation reaction by pipetting up and down. 
The cuvette was placed in a Hybaid Cell Shock, and the apparatus set to 1800 V and 
activated. The electroporated cells were resuspended in 1 ml of S.O.C. medium, tranferred 
to a 15 ml Falcon tube and incubated for 1 hour at 37°C in an orbital shaker. 50-200 III 
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aliquots of the transformation reaction were plated out on to LB agar plates containing the 
appropriate antibiotic and incubated overnight at 37°C. 
2.2.3.4. Making glycerol stocks 
1 ml of bacterial culture was transferred to a 1.5 ml microfuge tube. The cells were pelleted 
by centrifugation at 13 000 rpm for 1 minute and the supernatant discarded. The cell pellet 
was then resuspended in 250 J.lI 2% Bacto ™ peptone (Difco) and 250 J.ll 80% glycerol, 
vortexed thoroughly, labelled, and stored at -70°C. 
2.2.3.5. Recovering cells from glycerol stocks 
The culture to be recovered was removed from the -70°C freezer and kept on dry ice. 
U sing a sterile toothpick, a small amount of the frozen glycerol stock was used to inoculate 
a 10 ml starter culture as described above (Section 2.2.3.1). 
2.2.4. Cell culture methods 
2.2.4.1. Mammalian cell culture 
(i) Passage 
BHK-21 cells were passaged routinely every 3-4 days in 850 cm2 roller bottles. The cells 
were seeded at 2xl07 cellibottle in 100 ml ofBHK-21 medium (Section 2.1.5), gassed with 
CO2 to 5%, and rotated slowly at 37°C. To harvest the confluent monolayers, the growth 
medium was removed, the cells were rinsed twice, briefly, in 20 ml oftypsin/versene (1:4) 
and incubated at 37°C until the cells had detached. The cells were resuspended in 20 ml of 
BHK-21 medium. The cell density was measured by placing a diluted aliquot of the cell 
suspension on to a haemocytometer (Neubauer) and counting the cells under an inverted 
light microscope (Olympus). The typical yield from an 850 cm2 roller bottle was 20 ml of 
cell suspension at approximately 1 x 1 07 cells/ml. Cells in suspension remained viable for 
up to one week at 4°C. 
Rabbit skin cells and U20S cells were passaged in 150 cm2 flasks. The procedure was 
essentially the same as for BHK-21 cells except that they were grown in Dulbeccos 
medium (Section 2.1.5). 
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(ii) Freezing and storage 
Cells grown in a 150 cm2 flask were harvested by trypsinisation as described above 
(Section 2.2.4.1 i). After removal from the flask, the cells were pelleted by centrifugation at 
1000 rpm for 10 minutes using a Sorvall RT7 centrifuge. The growth medium was 
discarded and the cells were resuspended in 3 ml of 'freezing medium', i.e. 40% 
appropriate growth medium (minus calf serum), 40% calf serum, and 20% glycerol. The 
medium was aliquoted into 3 screw cap cryo-vials, placed in a polystyrene container, and 
stored at -70°C overnight before transfer to liquid nitrogen for long-term storage. 
(iii) Recovery of frozen stocks 
One vial of cells was thawed quickly in a water bath at 37°C and recovered into alSO cm2 
flask containing the appropriate growth medium and incubated at 37°C. The medium was 
changed the following day and, when confluent, the cells were passaged in the normal way 
(Section 2.2.4.1 i). 
2.2.4.2. 8f21 cell culture 
Sf21 cells were passaged every 3-4 days in 150 cm2 tissue culture flasks containing 50 ml 
of TC 1 00/5 medium. The cells were removed from the flask by the addition of 10 ml of 
TCI00/5 medium and gentle tapping of the flask. Cell clumps were broken up by pipetting 
the medium up and down. Confluent flasks were typically passaged using a 1:4 split. 
Where appropriate, cell densities were calculated using a Nebauer counting chamber. Cells 
were counted using an inverted light microscope (Olympus). 
(i) Freezing and storage ofSf21 cells 
Sf21 cells were grown in 150 cm2 flasks at 28°C until confluent. They were then harvested 
in 10 ml of TC 1 00/5 medium and the cell suspension transferred to a 15 ml Falcon tube. 
Cells were pelleted by centrifugation at 1500 rpm for five minutes in a Sorvall RT7 
centrifuge. The supernatant was removed and the cells were resuspended in 2 ml 
TC I 00/10. An equal volume of ice-cold freezing mix (80% TC 100/1 0, 20% DMSO) was 
added. The cell suspension was ali quoted into cryogenic vials (1 ml/vial) before being 
frozen overnight at -70°C. Frozen cells were then transferred to liquid nitrogen for long-
term storage. 
(ii) Recovery of Sf21 cells 
Aliquots of Sf21 cells removed from liquid nitrogen were thawed quickly in a water bath at 
37°C before being resuspended in a small volume of TC100/5 (approximately 5 ml). The 
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cell suspension was then transferred to a 15 ml Falcon tube and cells were pelleted by 
centrifugation at 1000 rpm for five minutes in a Sorvall RT7 centrifuge. The supernatant 
was discarded and the cell pellet was resuspended in TC 100/5, which was used to seed to a 
medium flask (200 ml volume). The flask was incubated at 28°C until the cells had firmly 
attached to the solid substrate. The medium was then replaced with fresh TC 1 00/5. Once 
the monolayer had reached confluency, the cells were passaged into a large flask and 
cultured in the normal way. 
2.2.4.3. Liposome transfection of mammalian cells 
The procedure was carried out as described in the protocols supplied with the 
lipofectamine reagent (Invitrogen). Cells were set up in 24 well plates (Nunc) at a density 
of lxl05 cells/well and incubated overnight at 37°C. On the following day, the DNA to be 
transfected was diluted in Optimem. For transfection with a single plasmid, 0.5 Ilg of DNA 
was required and for double and triple transfections, 0.25 Ilg of each plasmid was used. In 
each case, the DNA was diluted to a final volume of 21 III with Optimem. 4 Jll of Plus 
reagent was added to the diluted DNAlOptimem, then the solution was mixed and 
incubated at room temperature for 15 minutes. During this incubation, lipofectamine 
reagent was diluted 1 in 25 with Optimem. 25 III of diluted lipofectamine was added to 
each DNA sample and mixed. The sample was then incubated for a further 15 minutes at 
room temperature. During the incubation, the cells to be transfected were washed twice 
with unsupplemented growth medium and then overlaid with 200 JlI of the same medium. 
The transfection mix (50 Ill) was added to the cells and the cells were incubated at 37°C. 
At three hours post-transfection, the medium was removed and 1 ml of supplemented 
growth medium was added to each well. The cells were then incubated at 37°C. The cells 
were now ready for processing as required, either for virus yield or immunofluorescence. 
In transfections carried out in 40 mm plates (Nunc), cells were transfected in a similar 
fashion to that described above, with the modification that they were set up at a density of 
106 cells/plate, and the volumes and concentrations of the reagents used during 
transfections were increased fourfold. 
If the cells were to be processed for immunofluorescence (Section 2.2.4.5) or Green 
Fluorescent Protein fluorescence (Section 2.2.4.6), they were grown on 13 mm covers lips 
placed at the bottom of the wells of the 24 well plate. This allows the cell sheet to be easily 
removed and manipulated. However, if the cells were to be harvested for titration 
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following superinfection (Sections 2.2.4.4 and 2.2.4.7), no coverslips were required and the 
cells were grown directly in the base of the well. 
2.2.4.4. Superinfection of mammalian cells with HSV-1 and acid 
washing 
(i) Superinfection with HSV-l 
The cells to be infected were transfected using the procedure described above (Section 
2.2.4.1) At five hours after transfection the growth medium was removed from the wells 
and the cells washed with supplemented growth medium. 
For BHK-21 cells, virus to be infected was added to the cells at a titre of 2 pfu per cell in a 
total volume of 100 ~l. The cells were incubated in the presence of the virus for one hour at 
37De. 
(ii) Acid washing 
After one hour of absorption, the medium containing the virus was removed and the cells 
were washed twice in I ml of wash solution (Section 2.1.11). The wash solution was 
removed and replaced with 0.5 ml of acid solution (Section 2.1.11). After 30 seconds the 
acid solution was removed and I ml of PBS complete (Section 2.1.11) added to the cells to 
neutralise the acid. It was important not to incubate the cells for longer than 60 seconds as 
they are adversely affected by low pH. Therefore, if a large number of samples were to be 
processed they were typically dealt with in batches of four or five at a time. When all cells 
had been treated, the PBS complete was replaced by Iml of supplemented growth medium 
and the cells were incubated for 18-24 hours at 37°C. 
2.2.4.5. Immunofluorescence 
Following transfection (Section 2.2.4.3) and overnight incubation at 37°e, the growth 
medium was removed, the cells were washed twice in I ml PBS complete. They were then 
fixed and stored in I ml methanol at -20De for at least 30 minutes. When required, the 
methanol was removed from the well and the cells were washed twice with I ml of PBS 
complete. The cells were rehydrated by adding 1 ml of antibody solution A (Section 
2.1.11) to the well and incubating at room temperature for 10-15 minutes. During this 
incubation the primary antibody (Section 2.1.10) was diluted in antibody solution A and 
stored on ice until required. 
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Following rehydration, the coverslips were removed from the wells and drained. They 
were then placed upside-down in a 20 fll drop of diluted antibody, which had previously 
been placed on a surface such as the lid of a 24 well plate (NUNC). To prevent the 
coverslips from drying out, they were incubated in a humidified chamber. After 45 
minutes, the coverslips were drained, inverted, and washed in antibody solution A for five 
minutes. To ensure that all traces of primary antibody were removed, the wash step was 
repeated three times. The secondary antibody (Section 2.1.10) was diluted in antibody 
solution A and 20 III was added to the upside-down coverslip. The coverslips were 
incubated for a further 45 minutes, again using a humidified chamber, then drained and 
washed four times in antibody solution A (five minutes per wash) and once in H20 for ten 
seconds. They were then drained thoroughly and mounted onto microscope slides using 
Mowiol mounting medium (Harco) containing 2.5% DABCO (Sigma). The covers lips 
were then examined on a Zeiss LSM 510 confocal microscope. 
2.2.4.6. Green fluorescent protein fluorescence 
Following transfection (Section 2.2.4.3) and overnight incubation at 37°C, the growth 
medium was removed. The cells were then washed in I ml PBS complete, fixed with 
formaldehyde fix (Section 2.l.l1), and incubated at 4°C for at least 30 minutes. When 
required, the formaldehyde fix was removed and cells were washed twice in 1 ml PBS 
complete and once in H20. They were then drained thoroughly, mounted on microscope 
slides and examined as described for immunofluorescence (Section 2.2.4.5). 
2.2.4.7. Determination of virus titre 
Mammalian cells were set up in 40 mm plates at a density of 1 x 1 06 cells in 2 ml of 
appropriate growth medium. They were incubated overnight at 37°C until they were 
approximately 80% confluent. The virus sample to be assayed was prepared by making a 
series of tenfold serial dilutions in PBS plus Newborn Calf Serum. For assaying high-titre 
virus stock, dilutions were made to the order of 1 x 10'9, but for complementation studies the 
amount of virus in the samples was considerably lower. In the latter cases, dilutions to the 
order of 1 x 1 0'3 or 1 x 1 0-4 were appropriate. 
The growth medium was removed from the cells and 100 fll of diluted virus solution was 
added. The cells were incubated at 37°C with periodic shaking. After 1 hour the virus 
inoculum was removed and replaced with 3 ml of overlay medium containing 1.125% 
carboxymethylcellulose (Section 2.1.5). The cells were incubated for two days at 37°C 
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until virus plaques became visible. The overlay medium was then removed and replaced 
with 3 ml of Geimsa stain. After 2-3 hours the stain was removed. The cell sheets were 
then washed in copious amounts of water and allowed to dry. The plaques were counted 
using a dissection microscope and the virus titre was calculated. 
2.2.5. Electron microscopy 
2.2.5.1. Preparation of samples for electron microscopy 
To prepare cells for thin sectioning, the culture medium was removed and replaced with 
0.5ml of complete PBS. The cells were harvested using a disposable cell scraper (Becton 
Dickinson), transferred to a BEEM capsule (T AAB), and pelleted by centrifugation at 1000 
rpm for 5 minutes using a Beckman microfuge 12, which has a vertical rotor to ensure the 
formation of a compact and symmetrical cell pellet. 
The supernatant was discarded and the cell pellet was fixed by overnight incubation at 4°C 
in 500,..1 of 2.5% glutaraldehyde in complete PBS. The fixed pellets were rinsed twice with 
complete PBS and incubated at room temperature for I hour in I % osmium tetroxide 
(T AAB). The pellet was again rinsed twice in complete PBS, then dehydrated through a 
graded alcohol series comprising sequential incubations in 30, 50, 70, 90, and 100% 
ethanol. Following dehydration, the ethanol was carefully removed and replaced by newly 
prepared Epon 812 resin (TAAB). The capsules were left overnight with their lids open to 
allow residual ethanol to evaporate. The cell pellets were then drained and fresh resin was 
added. The samples were left overnight before being labelled and placed in an embedding 
oven at 65°C for two days in order to harden. 
2.2.5.2. Analysis of ultra-thin sections by transmission electron 
microscopy 
Embedded samples were sectioned using a Leica Ultracut E and mounted on to 400 mesh 
uncoated copper grids (Agar Aids). The cell sections were stained by immersing them in a 
saturated solution of uranyl acetate (BDH) in 90% ethanol for one hour. They were then 
washed by immersion (3 x 10 minutes) in water, before being stained with lead citrate for 
one minute, and given further washes (3 x 10 minutes) in water. After this they were dried 
and examined using a JEOL 100S electron microscope. 
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2.2.5.3. Analysis of purified proteins 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein samples were resolved using a 10% polyacrylamide gel, prepared in Ix resolving 
gel buffer (see Materials), polymerised by the addition of 150 111 of APS and 15 111 of 
TEMED, and poured within a vertical mini gel plate system (Bio-Rad). Until the 
acrylamide became polymerised, it was overlaid with butanol, which produces a consistent 
upper boundary in the resolving gel. The butanol was removed following polymerisation, 
and the resolving gel was overlaid with a 5% polyacrylamide stacking gel. The stacking 
gel was prepared in Ix stacking gel buffer (see Materials) and polymerised by the addition 
of75 111 of APS and 5111 ofTEMED. 
Protein samples were prepared in SDS PAGE sample buffer (Materials) and heated at 
100DC for approximately two minutes prior to loading. Gels were typically electrophoresed 
at 150 V until the dye had reached the bottom of the resolving gel. If protein standards 
were required, 3 111 of Rainbow™ markers (Amersham) were analysed next to the protein 
samples for comparison. 
Gels that were not going to be used for Western blotting were fixed and stained using 
Coomassie Brilliant Blue stain solution (Materials) for 10-20 minutes before being 
transferred into a de stain solution (Materials) in order to remove excess background 
staining. Gels were photographed using a digital camera and images were processed using 
Photoshop 3.1 software (Adobe). 
2.2.6. Semi-dry western blot analysis 
2.2.6.1. Protein transfer 
The transfer of proteins to a nitro-cellulose membrane was carried out by semi-dry transfer. 
SDS-PAGE (Section 2.2.5.3) was carried out. The stacking gel was removed from the 
resolving gel which was soaked in Towbin buffer (Materials) for approximately ten 
minutes, as was a nitro-cellulose membrane (Hybond). The nitro-cellulose membrane was 
placed on a stack of three pieces of 3 mm Whatman paper, which had been cut to the 
appropriate size, and soaked briefly in Towbin buffer. The resolving gel was then placed 
on to the nitro-cellulose membrane, and an additional stack of three pieces of 3 mm 
Whatman paper (also soaked briefly in Towbin buffer) was placed on top of the resolving 
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gel. The transfer of proteins on to the nitro-cellulose membrane was carried out using a 
2117 Multiphor II Electrophoresis Unit (Pharmacia), typically at 40 rnA, for at least two 
hours. 
2.2.6.2. Detection of proteins 
When the transfer was complete, non-specific binding sites on the nitro-cellulose 
membrane were blocked by immersing the membrane in 50 ml of 2.5% Marvel milk 
powder in PBS-To Incubation was carried out at RT for a minimum of one hour on an 
orbital shaker. The blocked membrane was then washed (3 x 15 minutes) in approximately 
50 ml of PBS-T. The membrane was subsequently probed at room temperature in 10 ml of 
PBS-T containing the appropriately diluted primary antibody, for a minimum of one hour 
on an orbital shaker. The membrane was then washed as described above, before the 
addition of the secondary antibody, protein-A peroxidase, which was diluted I: 1000 in 
PBS-T. The membrane was incubated at room temperature in approximately 10 ml of 
diluted secondary antibody for a minimum of one hour on an orbital shaker. The 
membrane was then washed again as described above. Immuno-detection was carried out 
using ECL (Amersham) in accordance with the manufacturer's intructions. Kodak XS-I 
film was used for the visualisation of immuno-complexes. 
2.2.7. Construction of recombinant baculoviruses 
L-broth agar plates containing kanamycin, gentamycin, tetracycline, BIuo-gal and IPTG 
were prepared as described in Section 2.1.7. DHIOBac cells (Gibco) were transformed as 
previously described, with DNA containing pFASTBAC (Section 2.1.9) modified to 
contain the gene of interest. Plates were incubated overnight at 37°C. Colonies containing 
bacmids into which the modified pF ASTBAC had inserted could be identified by their 
white colour (as opposed to the blue colour observed when the lacZ gene of the bacmid 
had not been interrupted by the insertion ofpFASTBAC.) Four white colonies were picked 
and streaked out on L-broth agar plates identical to those described above, in order to 
confirm that the colonies selected were indeed white in colour. (Blue colour in colonies 
can take time to form, resulting in the possibility of false-positive samples). A single 
colony was picked from each of the plates used in this second round of growth, and 
inoculated into 2 ml of L-broth containing kanamycin, gentamycin and tetracycline. The 
colony was then grown overnight at 37°C on an orbital shaker. On the following day, an 
alkaline lysis miniprep (Section 2.2.2.6) was carried out on each of the samples. 
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2.2.7.1. Transfection of 5f21 cells with recombinant bacmid DNA 
Sf21 cells were set up in 40mm plates as previously described (Section 2.2.4.2). On the 
following day, transfections were set up in a similar fashion to that described for BHK-21 
cells in Section 2.2.4.3, with the modification that the incubations were carried out at 28°C 
and the BHK-21 medium was replaced with TCIOOl5 medium. Virus was harvested from 
cell culture medium 72 hours after transfection. The supernatant was transferred to a sterile 
1.5 ml reaction vial. Any cells that were carried over were pelleted by centrifugation at 13 
000 rpm for two minutes in a microfuge. The supernatant was transferred to a fresh 1.5 ml 
cryo-vial, frozen on dry ice and stored at -70°C until required. 
2.2.7.2. Production of low-titre baculovirus stocks 
Sf21 cells in TC 10015 media were seeded in small tissue culture flasks (200 ml) and grown 
at 28°C until the monolayer reached a confluency of 50%. The media was removed, then 
500~1 medium containing baculovirus, harvested as described in Section 2.2.7.1 was 
inoculated on to the cells and allowed to absorb for one hour at 28°C. 10ml of fresh 
TClOOl5 medium was added to the cells, which were then incubated for 4-5 days at 28°C. 
The medium was then transferred to a fresh 15 ml Falcon tube, aliquotted, and stored at -
70°C until required. Baculovirus DNA was made from 500 ~I of this supernatant, and PCR 
was carried out to confirm the presence of the desired inserts. 5 ml of this supernatant was 
used to infect a 50% confluent monolayer of Sf21 cells in ISO cm2 flasks (as described 
above). After absorption, 50 ml of TC 1 0015 medium was added to the cells. These were 
subsequently incubated for 4-5 days at 28°C, after which the supernatant was harvested and 
stored at -70°C. The flask harvest was then titrated as described in Section 2.2.7.4. 
2.2.7.3. Production of high-titre baculovirus stocks 
High-titre stocks of recombinant baculoviruses were grown in roller bottles containing 
Sf21 cells at a density of 5x105 cellslml (typically 300 ml per bottle). Cells were infected at 
a m.o.i. of 0.1 pfulml and cultured for five days at 28°C. Cultures were transferred to 250 
ml Falcon tubes and the cells were pelleted by centrifugation at 3000 rpm for five minutes 
in a Sorvall RT7 centrifuge. The supernatant was transferred to a 500 ml Sorvall Swan-
Neck centrifuge bottle and baculovirus was pelleted by centrifugation at 12 000 rpm for 
two hours at 4°C in a Sorvall SLA-3000 rotor. Virus pellets were resuspended in TC 1 0015 
medium, transferred to sterile 1.5 ml cryo-vials and stored at -70°C until required. 
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2.2.7.4. Baculovirus titration 
High-titre stocks of baculovirus were titrated using the method described by Brown and 
Faulkner (1997). Sf21 cells were seeded on 40mm plates at a density of 1 x 1 06 cells per 
plate and grown overnight at 28°C to generate a 70-80% confluent monolayer. Serial 
tenfold dilutions of the virus were performed in TC 1 00/5 medium. The medium was 
removed from the cells, then 100 III of diluted virus, from 10.5 to 10.9, was added to each 
40mm plate and allowed to absorb for one hour at 28°C, with occasional rocking to prevent 
the cell monolayer from drying out. Following absorption, 1 ml of overlay was added. The 
overlay was a 1:1 mixture of TClOO/5 and 3% LTG agarose (SeaPlaque), which had 
previously been melted and incubated at 45°C to prevent the overlay from setting. Once the 
overlay medium had set (approximately ten minutes), 1.5 ml of TCIOO/5 was added and 
the plates were incubated for a further 4-5 days at 28°C. The medium was removed and 1.5 
ml of neutral red stain (0.4% neutral chloride mixed 1:50 with TClOO/5) was added on top 
of the agar. The plates were then incubated for a further five hours at 28°C. The stain was 
removed and the plates were inverted on to tissue paper and allowed to air dry overnight at 
RT. Plaques were counted and the virus titre was calculated. 
2.2.8. FlAsH labelling 
BHK-21 cells in which FlAsH labelling was to be carried out were set up and transfected 
as previously described (Section 2.2.4.3) in 24 well plates. At three hours post-transfection, 
Iml of growth medium (Section 2.1.5) was added to each well and the cells were incubated 
at 37°C overnight. 
25 mM EDT was prepared by mixing 2.1 III 1,2-ethanedithiol (EDT) with 1 ml of DMSO. 
This was freshly prepared each time the procedure was carried out. I III of25mM EDT was 
added to 2 III of 1 11M FlAsH (Panvera), and incubated at room temperature for 5-10 
minutes to ensure that all FlAsH was in FIAsH-EDT2 form. The cells were washed three 
times with PBS complete supplemented with 1 g/litre D+ glucose. 
1.88111 ofFIAsH-EDT2 (from the 5-10 minute incubation described in the paragraph above) 
was added to 2.5 ml of PBS/glucose. PBS/glucose was removed from the cells and 
replaced with 250 III PBS/glucoseIFIAsHIEDT. The cells were then incubated at 37°C for 
one hour. Washing solution was prepared by mixing 36 III of British Anti-Lewisite in 1 ml 
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DMSO, and then transferring 50 III of this solution to 50 ml of PBS/glucose. Following 
incubation, the labelling solution was removed, and the cells were given two rinses and 
three ten minute washes in washing solution. The cells were then overlayed with 4% 
formaldehyde, incubated at 4°C for at least 30 minutes, and processed for viewing on a 
confocal microscope, as previously described. 
If the cells were also to be probed with a VP5 antibody, this was carried out as previously 
described (Section 2.2.4.5). 
2.2.9. Transient DNA packaging assay 
Packaging assays were carried out as described by Hodge and Stow (2001). BHK-21 cells 
were seeded on 40 mm plates at a density of 1 x I 06 cells per plate and grown overnight at 
37°C, in order to generate a 70-80% confluent monolayer. The cells were transfected with 
DNA using the lipofectamine transfection method as described in Section 2.2.4.3. Three 
hours after transfection, the medium was removed and replaced with 800 III of 
supplemented BHK-21 growth medium. Five hours after transfection, cells were infected 
at a multiplicity of 5 pfu/cell with an appropriate virus. 
Incubation was continued for 16 hours at 37°C. The medium was then removed, the cells 
were resuspended in 2.3 ml TBS and divided into two equal samples, which were used to 
prepare total cellular and DNase-resistant (encapsidated) DNA. The cells from both 
samples were pelleted and resuspended in 184 III of reticulocyte standard buffer (RSB) 
containing 0.5% NP-40. An equal volume of packaging assay cell lysis buffer (Materials) 
containing 1 mg/ml protease was added. In the case of the total cellular DNA, this was 
done immediately. In the case of the encapsidated DNA, the sample was first incubated in 
the presence of 200 Ilg of DNase IIml, with occasional mixing, for 20 minutes at 37°C. 
After the addition of protease, all the samples were incubated for one hour at 37°C, 
extracted sequentially with phenol and chloroform, and precipitated with ethanol. The 
nucleic acids were redissolved in H20 containing 10 Ilg /ml of RNaseA. 
Following digestion with DpnI, the digested DNA was fractionated by agarose gel 
electrophoresis and transferred to a Hybond-N membrane (Amersham). Replicated (DpnI-
resistant) plasmid DNA was detected by hybridisation to a 32P-labelled probe prepared 
from the vector pAT153. Phosphoimages of Southern blots were acquired using a Biorad 
Personal Molecular Imager FX. 
CHAPTER 3 
USING INSERTIONAL MUTAGENESIS TO STUDY 
VP19C 
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3. Using insertional mutagenesis to study VP19C 
3.1. Introduction 
Transposons are mobile genetic elements that were originally discovered in maize 
(McClintock, 1949). Since then they have become useful tools for genetic analysis of a 
variety of organisms (Berg and Berg, 1995; Kaiser et al., 1995). Bacteriophage Mu, which 
uses DNA transposition to replicate its genome, is one of the best-characterised mobile 
genetic elements, and the first for which an in vitro transposition reaction was established 
(Mizuuchi, 1983). Subsequently, the bacteriophage Mu transposition reaction has been 
modified for use as a tool in genetic and molecular analysis (Happa et al., 1999). In 
principle, any DNA sequence inserted between the ends of the Mu DNA can be used as a 
transposon. 
The Mutation Generation System (Finnzymes) was based on the transposition machinery 
of Bacteriophage Mu (Figure 3.1). Using this system, it is possible to construct a library of 
15 bp insertional mutations for the gene of interest, and this library can subsequently be 
used to carry out a functional analysis of the protein encoded by the gene. One 
transposition reaction can generate thousands of mutants with, in theory, random coverage 
throughout the gene. The insert sequences produced are short (five amino acids). Due to 
the sequence of the nucleotides inserted it is not possible for a stop codon to be introduced 
(as described in Figure 3.2), and as 15 nucleotides are introduced, the reading frame does 
not change and the amino acids downstream of the insertion site are not altered. 
Furthermore, the nucleotides inserted include a Noll restriction enzyme recognition 
sequence (GCGGCCGC). This can be used to estimate the position of the insertion within 
the gene of interest. Thereafter, the precise position can be identified by sequencing the 
gene. 
In all the work described in this thesis, the transposon inserted during the Mutation 
Generation System transposition reaction (designated as the Entranceposon) is 1139 bp in 
length and contains a gene that codes for kanamycin resistance. This gene is flanked by 50 
bp inverted terminal repeat sequences, which act as a recognition sequence for the 
transposase enzyme. The distal end of each terminal repeat sequence is straddled by a Noll 
restriction enzyme recognition sequence, therefore cleavage with Noll removes the 
intervening transposon sequences (Figure 3.1). Based on this arrangement for the 
Entranceposon, there are certain prerequisites for any target DNA that the transposition 
A. Tarl:etDNA Entranceposon Transposition Complex B. Not.! Noil 
o c.,,?C) 000 
c. 
-
-
Figure 3.1: The Mutation Generation System 
The Mutation Generation System is designed for the rapid construction of libraries of 
insertional mutants. The system employs the transposition machinery of the bacteriophage 
Mu to generate a pool of 15 bp insertional mutants . A. The transpo ition reaction is catalysed 
by MuA transposase. B. The entranceposon i randomly inserted into the target D A. C. The 
plasmid D A is digested with NotI , and the central portion of the entrancepo on is removed . 
D. NotI digested plasmids are then self-ligated, resulting in a 15 bp insertion in the target 
plasmid. The location of the insertion can be estimated by carrying out a series of re triction 
digests, and confirmed by D A sequencing. E. If the 15 bp insertion is in an ORF, it is 
translated into five extra amino acid in the encoded protein. 
Figure adapted from manufacturer ' Internet site (http://www.finnzymes.fil) . 
Frame 1: 
5 ' N12 345 TGC GGC CGC A12 345 NNN 3 ' 
X X Cys Gly Arg lIe X X 
Met 
Thr 
Asn 
Lys 
Ser 
Arg 
Frame 2: 
5' NN1 234 5TG CGG CCG CAl 234 5 NN 3 ' 
X X Leu Arg Pro His X X 
Met GIn 
val 
Frame 3: 
5 ' NNN 123 45T GCG GCC GCA 123 45 N 3 ' 
X X X* Ala Ala Ala X X 
X = Any amino acid 
X* = Any amino acid except GIn , Glu , Lys , Met , Trp 
Figure 3.2: Tran lation of the 15 bp insertions 
The amino acid patterns possible in mutant proteins following in ertional mutagenesis. 
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reaction is to be performed on: namely that the target DNA should not itself contain any 
NotI restriction sites, and that it should not have a gene for kanamycin resistance. 
The aim of the work described in this chapter was to use the mutation generation system to 
examine the triplex protein VPl9C and identify regions of the protein that are important 
for its correct function. 
3.2. Construction of insertional mutants 
A previously constructed plasmid, pBJ382 (Tatman et aI., 1994), contains the UL38 open 
reading frame within a plasmid construct that also contains a gene encoding for ampicillin 
resistance. Furthermore, pBJ382 does not contain any Not I restriction sites, thus making it 
a suitable target for the Mutation Generation System. Following mutagenesis, mutated 
UL38 open reading frames can be transferred to a plasmid containing suitable promoter 
and enhancer sequences, and then analysed. A further advantage of using pBJ382 as the 
target DNA for mutagenesis is its small size - 4169 bp. Since the UL38 ORF is 1395 bp, 
approximately 33% of the mutant plasmids obtained by means of the transposition reaction 
should have an insertion within the UL38 ORF. 
For the investigation described in this thesis, a transposition reaction was carried out in 
accordance with the manufacturers' instructions. A mass of approximately 160 ng of target 
DNA was used in the reaction. After one hour, and following inactivation of the 
transposase, 1 III of the reaction mixture was diluted in 9 III of H20. The dilution was 
necessary due to the high salt concentrations in the transposition reaction mixture, which 
can result in arcing during electroporation. Thereafter, 5 III of the resulting mixture was 
used to transform DH5a cells (Section 2.2.3.3). The resulting bacteria were spread over 
four LB/agar + amp + kan plates and incubated at 37°C overnight. 
Each plate produced approximately 15-20 colonies. Each colony was picked and grown 
overnight at 37°C in 200 III ofLB + amp + kan. On the following day the resulting cultures 
were pooled, and a vacuum miniprep (Qiagen) used to obtain DNA. 
In pBJ382, the UL38 ORF is flanked by XbaI and HinclI restriction sites. Digestion of 
pBJ382 with these enzymes would normally produce fragments of 1491 bp (UL38 ORF) 
and 2678 bp (plasmid vector). However, as shown in Figure 3.3, the pooled pBJ382 
DNAs- each with a full-length transposon inserted into it (p8J382'") - will produce bands 
Pooled, digested with 
Xbal and Hinen 
(i) 
(ii) 
(iii) 
(iv) 
XbaI 
Figure 3.3: Digestion of pooled D A with Hincll and XbaI following in ertional 
mutagenesis. 
Digestion of pooled D A hould yield four bands on an agarose gel. (i) A 3817 bp fragment 
containing the transposon (black) inserted into the backbone of the plasmid (turquoise). (ii) A 
2678 bp fragment containing the backbone of the plasmid alone. (iii) A 2630 bp fragment 
containing the tran poson inserted into the UL38 ORF (red). (iv) A 1491 bp fragment 
containing the UL38 ORF alone. The de ired products of the Hincll/XbaI digest are type (iii) 
bands. 
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of 1491 bp, 2630 bp, 2678 bp, and 3817 bp. The 2630 bp band represents an insertion of 
the transposon sequence into the UL38 ORF. Therefore, the pooled DNA was digested 
with XbaI and HincII, run on I xT AE gel, and the 2630 bp band extracted. On the gel it was 
not possible to distinguish the 2630 bp band from the 2678 bp band, but products from the 
2678 bp band can be eliminated at a later stage of the experimental procedure, as described 
in the following paragraph. 
To allow expression of the insertional mutants, the pool of mutated DL38 ORFs was 
transferred to a plasmid containing suitable promoter and enhancer elements. pFBpCI was 
made by inserting a BglII-EcoRI fragment containing the HCMV promoter/enhancer from 
pCI-neo (Promega) into BamHIIEcoRI digested pFASTBAC Hta (Invitrogen) (pFBpCI 
supplied by Roger Everett). pFBpCI contains one NotI restriction site, which would prove 
a hindrance during digestion with Noll to remove the central portion of the transposon (as 
described below). The NotI site in pFBpCI was removed by digestion of the DNA with 
NotI, making the ends flush with T4 polymerase, and religation to produce pFBpCINotl •• 
The XbaIlHincII digested fragments containing the mutated UL38 ORF as described above 
were ligated into NheI/StuI digested pFBpCINOtl• (HincII is compatible with StuI, while 
NheI is compatible with Xbal). The resulting mixture was used to transform DH5a cells 
(Section 2.2.3.3). The transformed bacteria were spread over four LB/agar + amp + kan 
plates and incubated at 37°C overnight. Bacteria transformed with plasmids containing the 
2678 bp DNA described in the previous paragraph would be unable to grow on these plates 
as they do not possess the kanamycin resistance gene contained within the transposon. 
Colonies obtained from these plates were pooled and a vacuum miniprep (Qiagen) used to 
obtain DNA. This DNA comprised a pool of plasmids that would allow the expression of 
VP19C mutants under the control of the HCMV immediate-early promoter. The DNA pool 
was digested with NotI and religated, thus removing the bulk of the transposon sequence 
and leaving a set of 15 bp insertions, which introduced five additional amino acids to the 
protein. 
Following ligation of the NotI digested DNA pool, it was transformed into DH5a cells 
(Section 2.2.3.3) and the resulting bacteria were spread over four LB/agar + amp plates and 
incubated at 37°C overnight. The four plates produced a total for 48 colonies. Each colony 
was picked and grown overnight at 37°C in 2.5ml of LB + amp. On the following day, a 
vacuum miniprep was used to obtain DNA from each culture. As the vector plasmid does 
not contain any Noll restriction sites, the position of the insertion in each of the 48 
miniprep DNAs could be estimated by a series of restriction digests. The plasmid contains 
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a single NdeI restriction site 722 bp upstream of the start of the UL38 coding sequence, 
and a single XbaI restriction site 110 bp downstream of the UL38 stop codon. Hence, 
NdeIlNotI and Notl/XbaI digests of each DNA allow an estimation to be made of the 
location of the NotI restriction site, as shown in Figure 3.4. Following this estimation, 
sequencing was carried out on each of the DNAs, as described in Section 2.2.2.9, using 
sequencing primers as described in Table 3.1. Sequencing determined the precise locations 
of each of the IS bp insertions. The 48 DNAs examined produced a total of eleven 
different IS bp insertions in the UL38 open reading frame. 
VPI9C contains 465 ammo acids and therefore eleven insertional mutants equates to 
approximately one mutant for every 42 amino acids. It was decided that in order to produce 
a satisfactory analysis of the effects produced in VP 19C by the five amino acid insertions, 
more mutants were required. Furthermore, it was felt that the number of different 
insertional mutants obtained from the first attempt had been reduced by the inclusion of 
pooling steps in the experimental procedure. Thus, 5 f.ll of the original transposition 
reaction was transformed into DH5u cells, the resulting bacteria were spread over four 
LB/agar + amp + kan plates and incubated at 37°C overnight. 
The four plates produced a total of 65 colonies. To ensure that the final number of 
insertional mutants produced did not decrease as a result of DNA pooling, each colony was 
treated as a distinct entity for the remainder of the procedure. Each colony was picked and 
grown overnight at 37°C in 200 f.ll of LB + amp + kan. On the following day, DNA was 
obtained from each of the resulting cultures using the vacuum miniprep method. Each 
DNA was examined to identify whether it contained an insertion into or near the UL38 
ORF (by carrying out an XbaI/HincII digest as described previously). Of the 65 DNAs 
examined, 23 contained an insertion into or near the UL38 ORF (approximately 33%). 
Each of the 23 insertional mutants was cloned into the modified pFBpCINotl - as described 
for the pooled clones above. Digestion with NotI and subsequent religation was carried out 
to remove the central portion of the transposon. The approximate location of the insertion 
was estimated and the sequence of each DNA was obtained as described previously. From 
these 23 mutants, 19 new, unique insertions into the UL38 ORF were identified (there were 
two cases where the transposon had inserted at the same position in two separate mutants, 
and two cases where the transposon had inserted between the XbaI and HincH restriction 
sites but outwith the UL38 ORF). 
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Figure 3.4: The positions of insertions into the UL38 ORF were estimated by carrying out 
NdeIlNotI and NotIlXbaI digests on each mutant. 
A. In pUL38FbpCI, a unique NdeI site lies 722 bp upstream of the start of the UL38 ORF, 
while a unique XbaI site lies 110 bp downstream of the stop codon. Hence, NdeIlNo11 and 
NotIlXbaI digests of each DNA allow an estimation to be made of the location of the inserted 
Noll restriction site. B. Gel photograph showing results of NdeIINotl and NotIlXbaI digests. 
Band sizes on a 100 bp DNA ladder (New England Bioloabs) are shown. Clone I has a Notl 
restriction site approximately 800 bp from the Xbal site (approximately 700 bp from the 
beginning of the UL38 ORF). Clone 2 has a Notl resreiction site approximately 600 bp from 
the XbaI site (approximately 900 bp from the beginning of the UL38 ORF). Clone 3 has a 
Noll restriction site approximately 600 bp from the NdeI site (upstream of the start of the 
UL38 ORF). Clone 4 has a Noll restriction site approximately 900 bp from the Xbal site 
(approximately 600 bp from the start of the UL38 ORF). These estimations were used to 
select suitable sequencing primers for identifying the precise location of the insertion. 
Primer ID Primer S~uence Position within the UL38 ORF 
UL38 SEQ 2 5' TCGTTTAACTTCCTGGTGGC 3 ' 553-572 
UL38 SEQ 3 5' ATGTGCGTTCGTGGACCTGG 3' 867-886 
UL38 SEQ 4 5' AGTTCGCCGACAGGCTGTAC 3 ' 1184-1203 
UL38 SEQ 5 5' CACGATCCGCGTTGGGTTGG 3 ' 376-357 
UL38 SEQ 6 5' CACACGCCGCCACCAGGAAG 3 ' 580-561 
UL38 SEQ 7 5' AGGTCCACGAACGCACATGC 3 ' 884-865 
Table 3.1: Sequencing primers used in DNA sequence analysis of the UL38 insertional mutants. 
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The first two cycles of the Mutation Generation System experimental procedure had 
produced a total of 30 unique 15 bp insertions into the UL38 ORF (one mutant for every 
15.5 amino acids). In order to obtain more insertional mutants, the procedure was carried 
out for a third time. The starting plasmid for the previous two cycles (pBJ382) had been 
chosen because of the high proportion of the nucleotides of this plasmid that were 
contained within the UL38 ORF. The drawback of using pBJ382 was that following 
mutagenesis, a sub-cloning step was required to insert the mutated UL38 into pFBpCI. 
An XbaI/HincH restriction digest was carried out on pBJ382. The fragment containing the 
UL38 ORF was isolated and purified as described above. This fragment was ligated into 
NheIlStuI digested pFBpCINotl-. The resulting plasmid (pUL38FbpCI) contains a gene that 
codes for ampicillin resistance and no NotI restriction sites. It is 7420 bp in length, of 
which 1395 bp comprises the UL38 ORF. Hence, approximately 19% of insertions should 
lie within the UL38 ORF. 
A transposition reaction was carried out in accordance with the manufacturers' instructions 
and as described previously. A mass of approximately 300 ng of target DNA was used in 
the reaction. 1 ul of the reaction mixture was diluted in 9 J!l of H20 and 5 J!l of the 
resulting mixture was used to transform DH5a cells. The resulting bacteria were spread 
over four LB/agar + amp + kan plates and incubated at 37°C overnight. The four plates 
produced a total of approximately 138 colonies. Each colony was picked and grown 
overnight at 37°C in 200 J!l of LB + amp + kan. Vacuum minipreps were used to obtain 
plasmid DNA from each culture the following day. 
In pUL38FbpCI, PstI restriction sites lie 251 bp upstream and 122 bp downstream of the 
UL38 ORF. Hence, digestion with PstI will produce a fragment of 2929 bp if the 
transposon has inserted within or near to the UL38 ORF, and 1790 bp if the insertion has 
occurred elsewhere in the plasmid. A typical diagnostic gel showing the results of PsII 
digests is shown in Figure 3.5. Out of the 138 DNAs, 25 were found to contain a plasmid 
that had inserted into or near the UL38 ORF. Digestion by Noll and subsequent religation 
was carried out on each of the 25 DNAs. The approximate location of each insertion was 
estimated and the sequence of each DNA obtained as described previously. Out of the 25 
DNAs sequenced, two had insertions in identical locations to previously isolated mutants, 
and three had insertions that were outwith the UL38 ORF. The remaining 20 DNAs were 
unique insertions into the UL38 ORF. 
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Figure 3.5: PstI digests were used to identify clones with insertions lying in or near the UL38 
ORF. 
A. pUL38FbpCI contains two PstI sites, lying 251 bp upstream and 122 bp downstream of the 
UL38 ORF. Thus, clones containing insertions lying in or near the UL38 ORF could be 
identified by digestion with Pst!. B. Gel photograph showing results of Pst! digests. Band 
sizes of a I kb DNA ladder (New England Biolabs) are shown. Digestion with Pstl will 
produce a fragment of2929 bp if the transposon has inserted within or near to the UL38 ORF, 
and 1790 bp if the insertion has occurred elsewhere in the plasmid. Therefore, in clones J and 
4 the transposon has inserted within or near the UL38 ORF. In clones 2 and 3 it has inserted 
elsewhere in the plasmid. 
102 
The three cycles of mutagenesis produced 50 clonally distinct mutants of the UL38 ORF, 
as summarised in Table 3.2. The insertion (in) number given in the name of each 
insertional mutant refers to the first amino acid in sequence that is altered by the 
introduction of extra amino acids, for example in in 16, the first 15 amino acids of the 
sequence are the same as wild-type VP 19C, but the 16th is a cysteine rather than a serine. 
The insertions were distributed throughout the ORF with an average spacing of 
approximately 9 amino acids in VPI9C, and with a maximum separation of 38. Two pairs 
of insertions (in242A, in242B and in358A, in358B) were at different sites in the same 
codon. In these cases the mutant proteins differ only in the identity of the inserted amino 
acids (Table 3.2). One insertion (inS TOP) disrupted the TGA stop codon, resulting in the 
addition of five amino acids at the end of the protein. 
3.3. Complementation of insertional mutants 
To analyse the effects of the mutations on the properties of VPI9C, their ability to 
complement the growth of the HSV-l deletional mutant v.138YFP (Section 2.1.6; Thurlow 
et al., 2005) was examined. 0.5 ~g of DNA from each insertional mutant and a wild-type 
UL19 control was transfected into BHK-21 cells, which were incubated at 37°C for five 
hours before being infected with 2 pfu/cell of v.138YFP. After one hour, the unabsorbed 
input virus was neutralised by an acid wash. Incubation was continued at 3ic for 40 
hours, at which time the progeny virus was harvested and titrated on complementing 
UL38RSC cells, which express VP19C (Section 2.1.4). Figure 3.6 shows the relative yield 
obtained for each of the insertional mutants compared to that obtained with the wild-type 
control. 
Eighteen of the 50 insertional mutants had little or no effect on the ability of VPI9C to 
support virus growth, producing yields of over 80% of the wild-type VP 19C control level. 
The remaining 32 showed lower levels of complementation, with two producing yields of 
less than 10%, and 16 being completely negative for virus growth. The results shown in 
Figure 3.6 suggest that VP 19C (465 amino acids) can be divided into three broadly defined 
regions, with the majority of the severely disabling insertions (less than 10% of wild-type 
yield) occurring in the central region of the protein, between in 113 and in350. The yield 
obtained with all twelve of the insertions into the first 107 amino acids was greater than 
40% of the wild-type level- indeed, only in38 in the middle of this region - and in 106 and 
inl07 at its C-terminus gave yields of less than 80%. Similarly, all but two of the 14 
insertions into the C-terminal 107 amino acids (in390 and in463) gave complementation 
AA 
no. 
16 
23 
24 
26 
37 
51 
80 
84 
86 
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AA AA AA AA AA AA AA AA AA 
sequence no. sequence no. sequence no. sequence no. sequence 
ggCGRSGst 106 spAAASPrh 234 amCGRTMvh 328 vyAAAVYvi 390 agCGRTGqv 
ppMRPHPtt 107 prAAAPRhh 235 mvAAAMVht 329 yvMRPHVik 396 pqCGRTQfa 
ptAAAPTtr 113 rqCGRSQvi 242A phAAAPHev 330 viNAAAlks 426 19AAALGmm 
trCGRTRdt 143 hlVRPHLah 242B phCGRTHev 338 rgCGRSGle 436 clLRPHLhr 
vlLRPHLrp 182 raVRPHAgl 243 heCGRNEvm 343 alVRPHLer 438 hrMRPHRte 
IpSAAAPrg 183 agAAAAGlv 248 fgCGRIGgl 350 lrCGRIRit 439 rtDAAATer 
tpCGRTPnd 193 aaALVAAca 286 avAAAAVil 358A hgCGRNGte 449 pvAAAPVvi 
dtDAAATeq 200 daLRPHArd 289 IpVRPHPac 358B hgAAAHGte 459 rpGAAAPge 
eqVRPQQal 207 avAAAAVra 310 flLRPHLyl 365 ppVRPHPap 463 wrVRPQRac 
alMRPHLig 217 rgCGRSGtr 327 cvCGRSVyv 368 pnCGRTNrn STOP caCAAAA* 
Table 3.2: Locations and sequences of five amino acid insertions into VPI9C. 
The number denotes the last unchanged amino acid before the insertion. The five inserted amino acids 
are shown in upper case and the unchanged flanking residues in lower case. 
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Virus Titre (% of Wild-type) 
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Figure 3.6: Functional analysis of VP19C insertional mutants. (Top) Complementation of 
growth of the VP19C null mutant vA38YFP by transfected plasm ids expressing the VPI9C 
insertional mutants was carried out in BHK-21 cells. The progeny virus was titrated on 
UL38RSC cells. The results are shown as percentages of the titre obtained with the wild-type 
VPI9C control plasmid (pUL38FBpCJ). (Bottom) Scale drawing of the UL38 ORF showing 
the extent of the poorly-conserved N-terrninal sequences (Figure S.IA). 
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levels greater than 30%. In contrast, 16 of the 18 insertions giving complementation values 
of less than 10% mapped to the central region of the protein, between amino acids 113 and 
350. Out of the 24 insertions in this region, only four gave values of greater than 30%. 
3.4. Interaction of insertional mutants with VP23 and 
VP5 
In order to ensure the formation of functional capsids, and hence infectious virions, VP 19C 
must interact correctly with the other triplex protein, VP23 and with the major capsid 
protein, VP5. Since these interactions are essential, they can be assumed to have formed 
correctly in the VPI9C mutants that complemented v~38YFP. For this reason, only the 
eighteen mutants that gave less than 10% of the yield of wild-type VP 19C and were 
considered to be severely disabled were examined. 
Previous studies have shown that VP 19C is a nuclear protein. In the absence of other virus 
proteins, VP23 and VP5 are uniformly distributed throughout the cell. However, they 
become predominantly nuclear in the presence of VPI9C (Rixon el al., \996). To examine 
these interactions, BHK-21 cells were co-transfected with plasm ids expressing the VP19C 
mutants, along with either pE18, which expresses VP23 (Nicholson et al., 1994), or pE19, 
which expresses VP5 (Rixon et aI., 1996). The distributions of the proteins were 
determined by immunofluorescence (Section 2.2.4.5). Only one of the mutant VPI9Cs 
(in330) was altered in its distribution and was no longer able to locate to the nucleus, 
making it impossible to determine its effect on the distribution of the other proteins 
(Figures 3.7 and 3.8). 
The interaction between VP23 and the remaining 17 severely disabled VP19C mutants was 
examined by this assay. In a typical slide, the levels of fluorescence observed (and hence 
presumably the amounts of VP19C and VP23 transfected) varied greatly between cells. In 
general, the presence of VP 19C and VP23 in the nuclei was more easily seen in cells 
exhibiting lower levels of fluorescence. Since there was variation in the patterns of 
fluorescence, each coverslip that demonstrated convincing examples of clear-cut nuclear 
localisation of the proteins under study was scored as positive for the nuclear location of 
that protein. In those that are scored as negative, no convincing examples of nuclear 
localisation were observed. Two distinct patterns were seen (Figure 3.7). Nine mutants 
(in143, in234, in235, in327, in328, in329, in350, in390, and in463) exhibited a wild-type 
pattern, with VP19C and VP23 co-Iocalising to the nucleus. In the case of in390, the 
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Figure 3.7: Influence ofVPl9C insertional mutants on the distribution ofVP23. 
BHK-21 cells were cotransfected with pEl8 (expressing VP23) and either pUL38FBpCI 
(wild-type (WT) VPI9C), or one of the VPl9C insertional mutants as indicated. VPI9C was 
detected with the monoclonal antibody mAb02040 and visualised using FITC GAM (green). 
VP23 was detected with the antiserum rAb 186, and visualised using TRITe-conjugated GAR 
(red). 
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Figure 3.8: Influence ofVP19C insertional mutants on the distribution ofVP5. 
BHK-21 cells were cotransfected with pE19 (expressing VP5) and either pUL38FBpCI (wild-
type (WT) VPI9C), or one of the VPI9C insertional mutants as indicated. VP19C was 
detected with the monoclonal antibody mAb02040, and visualised using FITC GAM (green). 
VP5 was detected with the antiserum rAb 184, and visualised using TRITC-conjugated GAR 
(red). 
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VP19C antibody was unable to bind to the mutant protein, but VP23 was clearly 
transported to the nucleus, implying that the insertion had disrupted the antibody-binding 
site but had not interfered with the ability of VP19C to interact with VP23 or to localise to 
the nucleus. This would suggest that the binding site for the VP19C antibody is near amino 
acid 390. In the remaining eight mutants (inl13, in193, in242A, in242B, in243, in248, 
in289, and in31O), VP19C localised to the nucleus as expected but VP23 remained in the 
cytoplasm, implying that the inserted sequences had disrupted the interaction between 
VP19C and VP23. 
When the equivalent analysis was carried out for the interaction between VP19C and VP5, 
seven of the severely disabled VP19C mutants (inl13, in242A, in242B, in289, in328, 
in329, and in463) were unable to transport VP5 to the nucleus (Figure 3.8). Out of these, 
four (inl13, in242A, in242B and in289) had also failed to transport VP23 to the nucleus, 
while the other three (in328, in329 and in463) interacted successfully with VP23. The 
interaction between VP 19C and VP5 was less clear-cut than the interaction between 
VP 19C and VP23. Cells in which VP 5 had been transported to the nucleus by VP 19C were 
more difficult to identify. Even when assessing the interaction between wild-type VP19C 
and VP5, a significant fraction of the VP5 was frequently observed in the cytoplasm. 
Nevertheless, the same criteria were applied as for VP19CNP23 co-localisation, and all 
coverslips scored as positive contained clear-cut examples of nuclear localisation of VP5. 
The interactions ofVP19C mutants with VP23 and VP5 are summarised in Table 3.3. 
3.5. Insertional mutants in DNA packaging 
Mutants in143, in234, in235, in327, in350, and in390 were shown to be able to transport 
both VP23 and VP5 to the nucleus, however they were unable to support virus growth. 
Since failure to package the viral genome correctly would be lethal, each of these mutants 
was analysed further by a plasmid-based DNA packaging assay. As described in Section 
2.2.9, the presence of DNase-resistant DNA in the WT and in84 (a non-lethal insertional 
mutant) transfected samples (Figure 3.9) demonstrates that DNA packaging had taken 
place, while in each of the lethal insertional mutants tested the lack of packaged DNA 
suggests either that capsid assembly was disrupted or that the packaging mechanism was 
affected directly. 
VP 19C mutant Localises to the Takes VP23 to the Takes VP5 to the 
nucleus nucleus nucleus 
inl13 + - -
inl43 + + + 
inl93 + - + 
in234 + + + 
in235 + + + 
in242A + 
- -
in242B + - -
in243 + - + 
in248 + - + 
in289 + - -
in310 + - + 
in327 + + + 
in328 + + -
in329 + + -
in330 
- - -
in350 + + + 
in390 + + + 
in463 + + -
Table 3.3: Intracellular distribution of the severely disabled VP 19C insertional mutants. 
Total 
DNA 
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DNase-Resistant 
(Packaged) DNA 
Figure 3.9: Ability ofVP19C insertional mutants to package D A. 
BHK-21 cells were transfected with either pUL38FBpCI (wild-type VP19C), one of the 
VP19C insertional mutants, or a negative (no DNA) control as indicated. Cells were 
superinfected with vf..38YFP, and total (top) and Dnase-resistant (bottom) DNAs were 
prepared. The D As were digested with EeoR! and DpnI, and the fragments were separated 
by electrophoresis through an agarose gel. The gel was blotted, the membrane wa hybridised 
to 32P-IabeJed pATl53 D A and, after being washed, the membrane was exposed to a 
phosphoimager screen. 
CHAPTER 4 
MUTATIONAL ANALYSIS OF THE VP19C N-TERMINAL 
REGION 
105 
4. Mutational analysis of the VP19C N-terminal 
region 
4.1. The VP19C N-terminal 
Studies examining HSV-l capsid formation using a recombinant baculovirus-based model 
system had shown that the N-terminal 90 amino acids of VP19C were not absolutely 
required for capsid assembly (Spencer et al., 1998). Because these sequences were 
considered dispensable for capsid assembly, it was decided to try and map the location of 
the VP19C N-terminus by difference mapping between capsid reconstructions made using 
N-terminally truncated and wild-type VP19C. Spencer et al. (1998) infected insect cells 
with recombinant baculoviruses expressing VP5, preVP22a, and VP23 along with one of 
the mutant VPI9Cs. The three VP19C mutants that they analysed had the first 45, the first 
90, and the first 105 amino acids removed. They observed capsids in cells infected with 
each of the two shorter deletions, although the efficiency of capsid formation was lower for 
the 90 amino acid deletion. No intact capsids were seen with the 105 amino acid deletion. 
Therefore, in order to map the N-terminus of VPI9C, recombinant baculoviruses 
expressing two deletional mutants of VP19C were constructed - a deletion of the first 45 
amino acids (which was expected to produce capsids efficiently) and a deletion of the first 
63 amino acids (which was hoped to aid difference mapping by removing a larger section 
of the N-terminal region without reducing efficiency of capsid formation). 
4.2. Cloning strategy for N-terminal deletion mutants 
The nomenclature used in relation to N-terminal deletion mutants is as follows: in 
constructs with names containing '-45' or '-63', the first 45 or 63 amino acids respectively 
ofVP19C have been removed. In contructs with names containing 'NLS', the SV40 large 
T antigen nuclear localisation signal (Kalderon et aI., 1984) has been attached to the N-
terminus of VPI9C. In constructs suffixed with an asterisk (such as pUL38-63FBpCI*), 
the UL38 ORF contains a mutation at position 493 that was subsequently 'repaired' 
(Section 4.2.2). The cloning strategy for the construction of VP19C N-terminal deletion 
mutants is summarised in Figure 4.1. To make the recombinant baculoviruses, truncated 
UL38 ORFs were generated by PCR (Figure 4.1A) using the forward primers UL38-45F 
and UL38-63F, and the reverse primer UL38R (Table 4.1). pE38 (Nicholson et aI., 1994) 
was used as template DNA (Figure 4.2A). The PCR products were purified and cloned into 
~UL38R 
~~--------------~~ 
UL38-45F~ XhaI 
Xhal 
I 
A. 
UL380RF l peR Reaction 
I Ligate into + pGEM-T Easy 
UL38-45 T Easy 
4307 bp 
: 
I Digest with XbaI and PstI. + into XbaIlPstI digested pF 
Xhal 
UL38-45FB1 
6081 bp 
PstI 
Figure 4.1: Cloning strategy for VPI9C N-terminal deletion mutants. 
A. Cloning strategy for producing pUL38-45FB I. A PCR reaction was carried out using pE38 
as template DNA, UL38-45F as a forward primer, and UL38R as a reverse primer (Table 4.1). 
The PCR product was purified and cloned into pGEM-T Easy. The UL38 ORF was isolated 
by digestion with XbaI (which was introduced by UL38-45F) and PstI which is contained on 
pGEM-T Easy, downstream of the point at which the PCR product inserts. This fragment was 
ligated into XbaIIPstI digested pFASTBAC 1 to generate pUL38-45FB I. The location of the 
polyhedrin promoter (P) is shown. A similar process was carried out to produce pUL38-
63FB I"', with the exception that the UL38-45F primer was replaced with UL38-63F. 
B. UL38-45 T Easy 
4307 bp 
caRl Xbal 
pFastbac pC1 
5950 bp 
EcoRI 13040p ( pel I EC01 59000p • 
I J 1.38-45 ORF 
! Ligation 
EcoRI 
I 
UL38-45FBpCI 
7204 bp 
Vector backbone 
j aI 
Figure 4.1: Cloning strategy for VPI9C N-terrninal deletion mutants. 
B. Cloning strategy for producing pUL38-45FBpCI. An EcoRI/SpeI digest was carried out on 
pUL38-45T Easy and a 1304 bp fragment was isolated. An EcoRIIXbaI digest was carried 
out on pF ASTBAC pCI and a 5900 bp fragment was isolated. These fragments were ligated 
together to produce pUL38-45FBpCI. A similar strategy was used to produce pUL38-
63FBpCI*, except that the EcoRI/SpeI fragment was purified from pUL38-63T Easy*. 
c. 
UL38-~ 
45PCRFl 
Sail 
1 
UL380RF l peR Reaction 
I Ligate into + pGEM-T Easy 
Sall 
XbaI 
V 38R- ba 
~XbaI 
XbaI I: 
Figure 4. I: Cloning strategy for VPI 9C N-terminal deletion mutants. 
C. Cloning strategy to produce pUL38-45PCR-T Easy. A PCR reaction was carried out using 
pE38 as template DNA, UL38-45PCR FI as a forward primer, and 38R-Xba as a reverse 
primer. The PCR product was purified and cloned into pGEM-T Easy. A similar process was 
carried out to produce pUL38-63PCR-T Easy*, with the exceptions being that pE38 was 
replaced with pUL38-45T Easy, and UL38-45PCR FI was replaced with UL38-63PCR Fl. 
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Figure 4.1: Cloning strategy for VPI9C N-terminal deletion mutants. 
D. Cloning strategy to produce pUL38-45NLSFBpCI. A PCR reaction was carried out using 
pUL38-45PCR-T Easy as template DNA, UL38NLS-45PCR F3 as a forward primer, and 
38R-Xba as a reverse primer. UL38NLS-45PCR contains DNA coding for the SV40 NLS. 
The PCR product was purified and cloned into pGEM-T Easy. The location of the NLS in the 
plasmid is shown in blue. The UL38 ORF was isolated by digestion with EcoRI (which is 
contained on pGEM-T Easy, upstream of the point at which the PCR product inserts) and 
Xbal (which was introduced by 38R-Xba). This fragment was ligated into EcaRIIXbal 
digested pFBpCI to generate UL38-45NLSFBpCI. A similar process was carried out to 
produce UL38-63NLSFBpCI*, with the exceptions being that pUL38-45PCR-T Easy was 
replaced with pUL38-63PCR-T Easy*, and that following the production of UL38-
45NLSFBpCI, the plasmid was digested with SaIl and Xbal, the fragment containing the 
UL38 ORF was removed and replaced with the UL38 ORF obtained from a SalI/Xba! digest 
ofpUL38-63PCR-T Easy*. 
.. 
Sall 
af[ l?I':::bp XbaI 
J - -' I 
38-63 OR 
! 
SalI 
SaIl 
pUL3845NLSFBpCf 
7225bp 
XbaI 
SafI 5883 bp XbaI I I • 
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pUL38-63NLSFBpCI 
7165 bp 
Figure 4.1: Cloning strategy for VP 19C N-terminal deletion mutants. 
E. Cloning strategy to 'repair' pUL38-63FBpCI*. The mutation lies downstream of a Pvull 
restriction site. An EcoRI/PvulI digest was carried out on pUL38-63FBpCI* and a 324 bp 
fragment was isolated. An EcoRIlPvuII digest was carried out on pUL38-4SFBpCI and a 
6836 bp fragment was isolated. These fragments were ligated together to produce pUL38-
63FBpCI. A similar strategy was used to 'repair' pUL38-63NLSFBpCI. pUL38-
63NLSFBpCI* was digested with PvuII and KpnI and a band of 6198 bp was isolated. 
pUL38-45NLSFBpCI was also digested with Pvull and KpnI and a band of 967 bp was 
isolated. The two purified DNAs were ligated together to produce pUL38-63NLSFBpCI. 
• 
I 
' Rl Pl'lIIl 
pUL38-63NLSFBpCI 
7165 bp 
EcoRl Pvull 
pUL38-45NLSFBpCI 
7219 bp 
oRI I 6836 bp Pvull I 
• 
Start codon, 
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" caRl Pvull 
pU L38~3F BpCI 
7165 bp 
mino acids 163-465 of 
wild-type VP19C and the 
backbone of pFBpCI. 
Figure 4.1: Cloning strategy for VP 19C N-terminal deletion mutants. 
F. Cloning strategy for producing pUL38-63NLSFBpCI*. A SalI/XbaI digest was carried out 
on pUL38-63PCR-T Easy and a 1215 bp fragment was isolated. A SalI/Xbal digest was 
carried out on pUL38-45NLSFBpCI and a 5883 bp fragment was isolated. These fragments 
were ligated together to produce pUL38-63NLSFBpCI*. 
G. pUL38-45NLSFBpCI 
7219 bp 
Kprtl 
Pvull 
pUL38-63NLSFBpC'* 
7165 bp 
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J 
pvr' 6198 b! 
L38-450RF 
~ Ligation 
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rill 
Figure 4.1: Cloning strategy for VP19C N-tenninal deletion mutants. 
G. Cloning strategy for producing pUL38-63NLSFBpCI. A PvuIIlKpnI digest was carried out 
on pUL38-63NLSFBpCI* and a 6198 bp fragment was isolated. A PvuIIlKpnI digest was 
carried out on pUL38-45NLSFBpCI and a 967 bp fragment was isolated. These fragments 
were ligated together to produce pUL38-63NLSFBpCI. 
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Figure 4.2: Cloning of the UL38 N-terminal truncation. 
A. Preparative agarose gel showing products from PCRs carried out using the forward 
primers UL38-45F and UL38-63F, and the reverse primer UL38R. pE38 was used as template 
DNA. The PCR using UL38-45F as a forward primer yields a product of 1290 bp. The PCR 
using UL38-63F as a forward primer yields a product of 1239 bp. Band sizes were estimated 
using a 100 bp ladder (New England Biolabs). The sizes of the most prominent bands on the 
ladder are shown to the right of the diagram. 
B. Analytical agarose gel showing EcoRI digestion of the UL38-45F PCR products cloned 
into pGEM-T Easy. Bands of 1310 bp (insert) and 2997 bp (vector) indicate successful 
cloning (lanes 1, 3, 4, 5, 7, 8, 9, 10, and 11). Band sizes were estimated using a 100 bp ladder 
(New England Biolabs) (lane L1) and a A DNA estEll digest ladder (New England Biolabs) 
(lane L2). A reconstruction of the 100 bp ladder is shown to the left of the diagram, showing 
the sizes of the most prominent bands. Selected bands from the A DNA BstEII digest ladder 
are shown to the right of the diagram. 
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Figure 4.2: Cloning of the UL38 N-terminal truncation. 
C. Analytical agarose gel showing EcoRl digestion of the UL38-63F PCR product cloned into 
pGEM-T Easy. Bands of 1259 bp (insert) and 2997 bp (vector) indicate successful cloning 
(all numbered lanes other than lanes 9 and 13). Band sizes were estimated using a 100 bp 
ladder (New England Biolabs) (lane L1) and a A DNA EstEll digest ladder (New England 
Biolabs) (lane L2). A reconstruction of the 100 bp ladder is shown to the left of the diagram, 
showing the sizes of the most prominent bands. Selected bands from the A DNA EstEll digest 
ladder are shown to the right of the diagram. 
D. UL38 sequences were isolated from pUL38-45T Easy and pUL38-63T Easy by digestion 
with Xbal and Pstl separated in a preparative agarose gel. This digest should yield bands of 
1318 bp (insert) and 2989 bp (vector) in pUL38-45T Easy and bands of 1267 bp (insert) and 
2989 bp (vector) in pUL38-63T-Easy. In each case the smaller band was isolated and 
purified. Band sizes were estimated using a 100 bp ladder (New England Biolabs). The sizes 
of the most prominent bands on the ladder are shown to the left of the diagram. 
Figure 4.2: Cloning of the UL38 N-terminal truncation. 
E. Analytical agarose gel showing Xball Pst) digestion of UL3 8-45 cloned into pF ASTBAC I . 
This digest should yield bands of 1318 bp (insert) and 4763 bp (vector). This band pattern 
was observed in all clones examined (lanes 1-12). Band sizes were estimated using a 100 bp 
ladder (New England Biolabs) (lane LI) and a A. DNA estEll digest ladder (New England 
Biolabs) (lane L2). The sizes of the most prominent bands on the 100 bp ladder are shown to 
the left of the diagram. Selected bands from the /... DNA estEll digest ladder are shown to the 
right of the diagram. 
F. Analytical agarose gel showing XbaIlPst) digestion ofUL38-63 cloned into pFASTBACI. 
This digest should yield bands of 1267 bp (insert) and 4763 bp (vector). This band pattern 
was observed in all clones examined (lanes 1-12). Band sizes were estimated using a 100 bp 
ladder (New England Biolabs) (lane LI) and a A. DNA BstEII digest ladder (New England 
Biolabs) (lane L2). The sizes of the most prominent bands on the 100 bp ladder are shown to 
the left of the diagram. Selected bands from the /... DNA BstEII digest ladder are shown to the 
right of the diagram. 
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Figure 4.2: Cloning of the UL38 N-terminal truncation. 
G. UL38 sequences were isolated from pUL38-45T Easy and pUL38-63T Easy by digestion 
with EcaRI and SpeJ. This digest should yield bands of 1304 bp (insert) and 3003 bp (vector) 
in pUL38-45T Easy, and should yield bands of 1253 bp (vector) and 3003 bp (insert) in 
pUL38-63T Easy. Band sizes were estimated using a 100 bp ladder (New England Biolabs). 
The sizes of the most prominent bands on the ladder are shown to the right of the diagram. 
H. Preparative agarose gel showing PCR reactions were carried out using the forward primers 
UL38-45PCR FI and UL38-63PCR FI, and the reverse primer 38R-Xba. For the UL38-45 
construct, pE38 was used as template DNA. For the UL38-63 construct, pUL38-45T Easy 
was used as a template. The PCR using UL38-45 PCR FI as a forward primer should yield a 
product of 1290 bp. The PCR using UL38-63PCR FI as a forward primer should yield a 
product of 1239 bp. Band sizes were estimated using a 100 bp ladder (New England Biolabs). 
The sizes of the most prominent bands on the ladder are shown to the left of the diagram. 
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Figure 4.2: Cloning of the UL38 N-terminal truncation. 
I. Analytical agarose gel showing San/XbaI digests of the UL38-45PCR FI and UL38-63PCR 
F I products cloned into pGEM-T Easy. A SanlXbaI digest of pUL38-45PCR-T Easy should 
yield bands of 1305 bp and 3003 bp. A San/XbaI digest of pUL38-63PCR-T Easy should 
yield bands of or 1256 bp and 3003 bp. Clones with inserts in the correct orientation for 
pUL38-45PCR-T and shown in lanes I, 2, 3, and 4. Clones with inserts in the correct 
orientation for pUL38-63PCR-T are shown in lanes 7, 8, and 12). Band sizes were estimated 
using a 100 bp ladder (New England Biolabs) (shown on the outer lanes of the diagram). The 
sizes of the most prominent bands on the ladder are shown to the right of the diagram. 
J. Preparative agarose gel showing products from PCR carried out using primers UL38NLS-
45PCR F3 and 38R-Xba, with pUL38-45PCR-T Easy as template. This PCR reaction should 
yield a product of 1302 bp. Band sizes were estimated using a 100 bp ladder (New England 
Biolabs). The sizes of the most prominent bands on the ladder are shown to the left of the 
diagram. 
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Figure 4.2: Cloning of the UL38 N-terminal truncation. 
K. Analytical agarose gel showing San digestion of pUL38-4SNLS-T Easy. A Sail digest 
should yield bands of 130S bp and 301S bp if the PCR product has inserted in the correct 
orientation (lanes 2 and 4). Band sizes were estimated using a I kb ladder.L. Preparative 
agarose gel showing an EcoRIIXbaI digest of pUL38-4SNLS-T Easy. This digest yields bands 
of 1307 bp (insert) and 3013 bp (vector), as observed in both lanes shown. Band sizes were 
estimated using a 100 bp ladder (New England Biolabs). The sizes of the most prominent 
bands on the ladder are shown to the left of the diagram. 
L. Preparative gel showing an EcoRIIXbaI digest of pUL38-4SNLS-T Easy. This digest 
yields bands of 1307 bp (insert) and 3013 bp (vector), as observed in the two lanes shown. 
Band sizes were estimated using a 100 bp ladder (New England Biolabs). The sizes of the 
most prominent bands on the ladder are shown to the left of the diagram. 
M . 
3675 
2323 
1929 hn-___ .... 
EcoRlISphI digests of putative pUL38-45NLSFBpCI clones 
2000 bp 
1500 bp 
600 bp 
Figure 4.2: Cloning of the UL38 N-terrninal truncation. 
M. Analytical agarose gel showing EcoRIISphI digestion of pUL38-45NLSFBpCI to 
determine whether cloning had been successful. This digest should yield bands of 23 bp, 33 
bp, 1288 bp, and 5875 bp. Band sizes were estimated using a A DNA Hs/EII digest ladder 
(New England Biolabs) (lane LI and a 100 bp ladder (New England Biolabs) (lane L2). 
Selected bands from the A DNA HsIEII digest ladder are shown to the left of the diagram. The 
sizes of the most prominent bands on the 100 bp ladder are shown to the right of the diagram. 
Primer ID Primer Sequence 
UL38-45F 5' GTCTAGAGGATCCATATGGGCCCAGGGCTCCCCAGGGGGTC 3' 
UL38-63F 5' GTCTAGAGGATCCATATGTTGCTTGGCCTGGACGGCACAGAC 3' 
UL38R 5' GACAAGATCTCACGCGCATGCCCGCCACTCGCCGGGG 3' 
UL3845PCR FI 5' GAAGAAGAAGCGCAAGGTCGACGGCCCAGGGCTCCCCAGGGGGTCG 3' 
UL38-63 PCR FI 5' GAAGAAGAAGCGCAAGGTCGACTTGCTTGGCCTGGACGGCACAGACG 3' 
38R-Xba 5' TCTAGATCACGCGCATGCCCGCCACTCGC 3' 
UL38NLS-45PCR F3 5' CGCAATGGCTCCGAAGAAGAAGCGCAAGGTCGACGGCCCAGGGCTCCCCAGGGGGTCGG 3' 
UL38ATG 5' GACAGAATTCGCAATGAAGACCAATCCGC 3' 
UL38AA46 5' ACAGTCGACCCGTCGCGGCGAGAGATCGG 3' 
UL38AA56 5' ACAGTCGACCGGGGTCCCGACCCCCTGGG 3' 
UL38AA66 5' ACAGTCGACCCAAGCAACCACAGCGTGC 3' 
UL38AA76 5' ACAGTCGACGCCCCAGGGGGCGCGTCTG 3' 
UL38AA83 5' ACAGTCGACGTATCGTCGTTGGGGGTCAGC 3' 
UL38AA118 5' ACAGTCGACAGATCCGTCAGGATCACTTGG 3' 
UL38-24 NTERM 5' GCAATGACACGCGATACCGCGGGACAG 3' 
UL38-33 NTERM 5' GCAATGCTTCGGCGCGTCCTGCGCCCC 3' 
GFP UPSTREAM 5' GCTGATTATGATCTAGAGTCGC 3' 
UL38NspeI 5' ACTAGTTCGCAATGGCTCCGAAGAAGAAGCGCAAGG 3' 
UL38CbglII 5' AGATCTTAGATCACGCGCATGCCCGCCACTCG 3' 
-
Table 4.1: PCR primers used in cloning UL38 N-terminal mutants. 
The recognition sequences for BamHI (GGTACC), BgnI (AGATCT), Sail (GTCGAC), Xbal 
(TCT AGA), and SpeI (ACT AGT) used in cloning are singly or doubly underlined. 
106 
pGEM-T Easy (Promega) in accordance with the manufacturers' instructions. Individual 
clones were grown and screened by EcoRI digestion (Figures 4.2B and 4.2C). Single 
clones were selected and designated pUL38-45T Easy and pUL38-63T Easy (Figure 4.1A). 
For expression in insect cells, the U138 sequences were isolated from pU138-45T Easy 
and pUL38-63T Easy by digestion with XbaI and PstI (Figure 4.20) and cloned 
downstream from the polyhedrin promoter in Xball PstI digested pF ASTBAC 1 (Invitrogen) 
(Figure 4.1A). Individual clones were grown and screened by digestion with XbaI and PstI 
(Figures 4.2E and 4.2F). Single clones were selected and designated pUL38-45FBl and 
pUL38-63FB I. These plasmids were then used to generate recombinant baculoviruses 
using the FASTBAC protocol (Invitrogen). During the course of this work, 
immunolocalisation was carried out which suggested that the protein did not go to the 
nucleus efficiently in baculovirus infected SF21 cells. The work up to this point was 
carried out by David McNab. Because of the unexpected effects of these mutations on the 
behaviour ofVPI9C, it was decided to investigate the role of the N-terminal region further. 
Therefore, I carried out an investigation of their properties in mammalian cells where they 
could be examined in the context of HSV -1 infection. 
4.2.1. Nuclear Localisation of N-terminal Deletion Mutants 
For expression in mammalian cells, the U138 sequences were isolated from pUL38-45T 
Easy and pUL38-63T Easy by digestion with EcoRI and SpeI (Figure 4.2G) and cloned 
downstream from the HCMV IE 1 promoter in EcoRVXbaI digested pFBpCI (see Section 
2.1.9) to generate pUL38-45FBpCI and pUL38-63FBpCI* (Figure 4.IB). Initial 
experiments with these constructs appeared to show that neither VP19C-45 nor VP19C-63 
were efficiently localised to the nucleus. Failure to locate to the nucleus would be expected 
to interfere with capsid assembly. Therefore it was decided to insert a NLS into each of the 
mutant proteins. Consequently, the well-characterised SV40 large T antigen NLS 
(Kalderon et aI., 1984) was fused to the N-termini ofVP19C-45 and VPI9C-63. 
4.2.1.1. Construction of VP19C·NLS fusions 
Attempts to insert the SV 40 NLS in front of the VP 19C truncations were unsuccessful, so a 
two-step cloning strategy was adopted. PCR reactions were carried out (Figure 4.1 C) using 
the forward primers UL38-45PCR FI and UL38-63PCR FI and the reverse primer 38R-
Xba (Table 4.1). For the UL38-45 construct, pE38 (Nicholson et al., 1994) was used as a 
template. For the UL38-63 construct, pUL38-63T Easy (described above) was used as a 
107 
template. UL38-45PCR Fl and UL38-63PCR Fl introduce SaIl sites immediately 
upstream of amino acids 45 and 63 in the UL38 ORF. The PCR products (Figure 4.2H) 
were purified and cloned into pGEM-T Easy (Figure 4.1 C). To determine whether the PCR 
products had inserted into pGEM-T Easy in the correct orientation, the plasmids were 
digested with Sail (Figure 4.21). Single clones with inserts in the correct orientations were 
designated pUL38-45PCR-T Easy and pUL38-63PCR-T Easy* respectively. 
An oligonucleotide, UL38NLS-45PCR F3, was designed that specifies the nuclear 
localisation signal (NLS) of the SV40 large T antigen (sequence PKKKRKV (Kalderon et 
al., 1984» fused to the N-terminus of the UL38 ORF truncated at amino acid 45 (Table 
4.1). A PCR reaction was performed (Figure 4.10) using primers UL38NLS-45PCR F3 
and 38R-Xba, with pUL38-45PCR-T Easy as template (Figure 4.2J). The PCR fragment 
was purified and cloned into pGEM-T Easy to generate pUL38-45NLS-T Easy (Figure 
4.10). To determine whether the PCR products had inserted into pGEM-T Easy in the 
correct orientation, the plasmids were digested with SaIl. (Figure 4.2K). The UL38 insert 
was isolated by digestion with EcoRI and Xbal (Figure 4.2L) and ligated into EcoRIIXbal 
digested pFBpCI to generate pUL38-45NLSFBpCI (Figure 4.10). The insertions were 
identified by EcoRIISphl digestion (Figure 4.2M). The SalIlXbal fragment from pUL38-
63PCR-T Easy* was then purified and ligated into SalI/Xbal digested pUL38-
45NLSFBpCI to generate pUL38-63NLSFBpCI* (Figure 4.1 E). 
4.2.2. IRepairing' the Mutation in pUL38-63FBpC/* 
At this point the complete sequence of pUL38-63FBpCI* became available and it was 
noticed that it contained an unexpected point mutation in the UL38 ORF: the guanine that 
appears at position 493 in the wild-type ORF had been substituted for an adenine. This 
resulted in an alteration in the amino acid sequence, with a glutamine residue (GAG) being 
substituted for a lysine (AAG) (Figure 4.3). Subsequent analysis of the sequence of the 
NLS-containing UL38-63 construct (pUL38-63NLSFBpCI*) showed that it contained the 
same point mutation in the UL38 ORF. In order to ensure that any phenotypic differences 
were not due to this alteration, the UL38 ORFs in these plasmids had to be repaired. 
To construct a 'repaired' version of pUL38-63FBpCI*, pUL38-45NLSFBpCI (Section 
4.2.1.1) was digested with EcoRI and Pvull and a 6836 bp band (containing the section of 
the UL38 ORF that codes for amino acids 163-465 of wild-type VP19C and the backbone 
of the pFBpCI plasmid) was isolated. At the same time, pUL38-63FBpCI* was also 
480 490 500 
I I I 
~ 
480 490 500 510 
I I I I 
G G C C G CCC T GGGG T C G 
Figure 4.3: The mutation in pUL38-63FBpCI*, and its subsequent correction . 
Above: When pUL38-63FBpCI was sequenced, it was found to contain an unexpected point 
mutation in the UL38 ORF: the guanine at position 493 in the wild-type ORF had been 
substituted by an adenine (encircled). Below: This mutation was ' repaired ' to make pUL38-
63FBpCI. The guanine at position 493 is encircled. 
Sequencing results were produced using the Chromas program 
(www.technelysium.com.aulchromas.html). 
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digested with EcoRI and Pvull and a 324 bp band (containing the section of UL38 that 
codes for amino acids 63-162 of wild-type VP 19C) was isolated. The two purified DNAs 
were ligated together to generate pUL38-63FBpCI (Figure 4.1 F). The mutation occurs in 
amino acid 165 of the VP 19C amino acid sequence, and as pUL38-45NLSFBpCI does not 
contain this mutation, pUL38-63FBpCI should not contain it either. Similarly, to remove 
the secondary mutation in pUL38-63NLSFBpCI*, it was digested with Pvull and KpnI, 
and a band of 6198 bp was isolated. In addition, pUL38-45NLSFBpCI was also digested 
with Pvull and KpnI, and a band of 967 bp was isolated. The two purified DNAs were 
ligated together to produce pUL38-63NLSFCpCI (Figure 4.1 G). The sequence of the 
resulting DNA was determined, and was shown to contain a guanine at position 493. The 
repaired versions of pUL38-63FBpCI and pUL38-63NLSFBpCI with the correct (wild-
type) nucleotide sequences were used in all subsequent studies. 
4.2.3.Nuclear Localisation and Complementation of VP19C-
NLS Fusions 
To determine the effects of the N-terminal truncations on the behaviour of VP 19C, the 
distributions of VP19C-45 and VP19C-63 in cells transfected with pUL38-45FBpCI and 
pUL38-63FBpCI were examined. In marked contrast to the pattern seen with wild-type 
VP19C (Figures 3.7 and 3.8), neither VP19C-45 (Figure 4.4B) nor VP19C-63 (Figure 
4.4E) was specifically nuclear. These results confirm the initial finding from the 
baculovirus-infected cells (see above), and suggested that the N-terminal region of the 
protein is important for nuclear localisation. 
In contrast to VP19C-45 and VP19C-63, VP19C-45NLS (Figure 4.4C) and VP19C-63NLS 
(Figure 4.4F) both localised efficiently to the nucleus, confirming that the exogenous NLS 
functioned as expected. Furthermore, when pElS (expressing VP23) was co-transfected 
with pUL28-45FBpCI and pUL38-63FBpCI, VP19C-45NLS (Figure 4.40) and VPI9C-
63NLS (Figure 4.4G) were also able to transport VP23 to the nucleus. 
In a further attempt to analyse the effects of the N-terminal truncations on the properties of 
VP19C, their ability to complement the growth of the HSV-l deJetional mutant v~38YFP 
(Section 2.1.6; Thurlow et al., 2005) was examined. pUL38-45FBpCI, pUL38-63FBpCI, 
and pE38 (encoding wild-type VP19C) DNAs were transfected into BHK-21 cells, which 
were incubated at 3ic for five hours before being infected with 2 pfu/cell of v~38YFP. 
After one hour, the unabsorbed input virus was neutralised by an acid wash (Section 
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Figure 4.4: Roles of the VPI9C N-terminal sequences. 
(A) Complementation of growth of the VPI9C null mutant v~38YFP by transfected plasmid 
pUL38-4SFBpCI (expressing VPI9C-4S), pUL38-63FBpCI (VP19C-63), pUL38-
4SNLSFBpCI (VP19C-4SNLS), or pUL38-63NLSFBpCI (VP19C-63NLS) was carried out in 
BHK-21 cells. The progeny virus was titrated on UL38RSC cells. The error bars indicate the 
standard errors of the means. (B to G) Intracellular localisation of N-terminal mutants of 
VP 19C. BHK-2l cells were transfected singly with plasmids (B) pUL38-4SFBpCI 
(expressing VPI9C-4S) and (E) pUL38-63FBpCI (VP19C-63), or were cotransfected with (C 
and D) pUL38-4SNLSFBpCI (VP19C-4SNLS) and pE18 (VP23) or with (F and G) pUL38-
63NLSFBpCI (VP 19C-63NLS) and pE 18. VP 19C (D, C, E, and F) was detected with the 
monoclonal antibody mAb02040, and visualised using FITC-conjugated GAM (green). VP23 
(D and G) was detected with the antiserum rAb 186, and visualised using TRITC-conjugated 
GAR (red). 
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2.2.4.4). Incubation was continued at 3ic for 40 hours, at which time the progeny virus 
was harvested and titrated on complementing UL38RSC cells (Section 2.1.4). 
As shown in Figure 4.4A, the yield obtained with VP19C-45 was approximately 50 fold 
lower than for the wild-type VPl9C control, while the removal of the first 63 amino acids 
completely abolished complementation, thereby demonstrating that the N-terminal 
sequences of VP 19C are important for the production of wild-type levels of infectious 
virus. 
When the ability of pUL38-45NLSFBpCI and pUL38-63NLSFBpCI to complement the 
growth of the HSV -I deletional mutant v A3 8YFP was tested, VP 19C-45NLS was found to 
complement vA38YFP as effectively as wild type VPl9C (Figure 4.4A), thereby 
demonstrating that the reduction in growth caused by the removal of the N-terminal 45 
amino acids was primarily as a result of the defect in nuclear localisation. In contrast, no 
complementation occurred in VP19C-63NLS (Figure 4.4A), suggesting that amino acids 
45 to 63 have an additional role in the formation of infectious virus. 
4.3. Mapping the VP19C NLS 
Although VP19C is transported to the nucleus in the absence of other viral proteins, no 
NLS was identified when the complete amino acid sequence was submitted to the NLS-
prediction programs PredictNLS and PSORT II 
(http://cubic. bioc.columbia.eduipredictNLS/ and http://psort.nibb.ac.jp/form2.html 
respectively). To confirm that the N-terminal region of VPl9C did contain an NLS, 
increasing amounts of sequence from the N-terminus were fused to the green fluorescent 
protein (OFP) and the intracellular distribution of the chimeric proteins were determined. 
DNA fragments containing increasing numbers of residues from the 5' end of the VPl9C 
ORF were produced by PCR using the forward primer UL38ATG, and the reverse primers 
UL38AA46, UL38AA56, UL38AA66, UL38AA76, UL38AA83, and UL38AAl18 (Table 
4.1). The appropriate PCR products were purified and cloned into pGEM-T Easy. 
Individual colonies were grown and screened by digestion with EcoRI, which makes two 
cuts flanking the insert in pGEM-T Easy. Single clones were selected and designated 
pGEM-AA46, pGEM-AA56, pGEM-AA66, pGEM-AA76, pGEM-AA83, and pGEM-
AA118. The UL38 inserts were isolated by digestion with EcoRI and Sail (Figure 4.5) and 
ligated into EcoRI/SaII digested pEGFP-NI (Clontech) to generate p46AA-UL38-GFP, 
A. B. c. 
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Figure 4.5: Analytical agarose gels showing EcoRJISalI digests of representative pGEM-T 
Easy N-terrninal VP19C clone. 
PCR was carried out using pE38 as template D A, the forward primer UL38ATG, and 
suitable reverse primers as described in the text. The peR product were ligated into pGEM-T 
Easy. EcoRl/SafI digests were carried out on the re ulting constructs. A. Digestion ofpGEM-
AA46 with EcoRI and SalI produces a band of 146 bp. B. Dige tion of pGEM-AA83 with 
EcoRI and SalI produce a band of 257 bp. C. Digestion of pGEM-AA 118 with EcoRI and 
SafI produces a band of 362 bp. Band izes were estimated using a 100 bp ladder (New 
England Biolabs). Selected band sizes in the 100 bp ladder are indicated. 
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p56AA-UL38-GFP, p66AA-UL38-GFP, p76AA-UL38-GFP, p83AA-UL38-GFP, and 
pI18AA-UL38-GFP. All the plasmids were checked by diagnostic restriction enzyme 
digestion and DNA sequencing. 
To determine their intracellular localisation properties, BHK-21 cells were transfected with 
the individual fusion protein constructs and incubated at 37°C for 16 hours before they 
were fixed with 4% formaldehyde. The distribution of green fluorescence was visualised 
on a confocal microscope. In cells expressing GFP alone, the fluorescence was uniformly 
distributed between the cytoplasm and the nucleus (Figure 4.6A). However, fusing GFP to 
the N-terminal 118, 83, 76, 66 or 56 amino acids of VP19C converted it to a nuclear 
protein (Figures 4.6B-4.6E). In contrast, the distribution seen with the fusion containing 
the N-terminal 46 amino acids resembled the GFP control (Figure 4.6F). Thus, it was clear 
that an NLS is located within the first 56 residues of VPI9C. Examination of the amino 
acid sequence in this region revealed a high concentration of arginine residues extending 
from amino acids 25 to 57 (Figure 4.61). Since stretches of basic amino acids are 
characteristic of many NLSs (Palmeri and Malim, 1999, and references therein), amino 
acid sequences from within this region were also fused to GFP. 
To delete sequences from the N-terminus, PCR was carried out with p66AA-UL38-GFP as 
a template and using the forward primers UL38-24 NTERM and UL38-33 N-TERM and 
the reverse primer GFP UPSTREAM (Table 4.1). The resulting PCR products were cloned 
into pGEM-T Easy. Individual colonies were grown and screened by digestion with EcoRI. 
Inserts were isolated by digestion with EcoRI and Notl and ligated into EcoRIINotI 
digested p66AA-UL38-GFP to generate p24-66AA-UL38-GFP and p33-66AA-UL38-
GFP. 
In p24-66AA-UL38-GFP, nuclear localisation of GFP was observed (Figure 4.6G), 
confirming that the NLS mapped within the region comprising residues 24 to 66. However, 
the intracellular distribution of GFP that was observed for p33-66AA-UL38-GFP was 
unexpected and distinctive: producing a cytoplasmic pattern that resembled the distribution 
expected for mitochondria (Figure 4.6H). Submission of the VP19C sequence to the 
subcellular localisation site prediction program iPSORT 
(http://biocaml.org/ipsortliPSORT/#predict) identified amino acids 32 to 40 
(LLRRVLRPP) as a potential mitochondrial localisation signal. Given what is known 
about the functions of VP19C, it seems unlikely that this mitochondrial localisation signal 
is functional in the context of the intact protein, so this was not investigated further. 
(I) 24 33 46 56 66 
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HKTNPLPATPSVV1GGSTVELPPTTRDTAGQGLLRRVL~PPISRRDGPGLP~GSGPRRAASTLWLLGLDGT 
Figure 4.6: Mapping the VP19C NLS 
BHK-21 cells were transfected with plasm ids expressing the GFP protein fused in-frame to 
the N-terminal (B) 83, (C) 76, (D) 66, (E) 56, or (F) 46 amino acids of VP19C. (G and H) 
GFP is fused to amino acids 24 to 66, and 33 to 66 of VP19C. (a) GFP control. (i) N-terminal 
70 amino acids of VP19C with the positions of various truncations indicated. Arginine 
residues are underlined. 
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Although further analysis would be required to determine the precise composition of the 
VP19C NLS, the results presented here map it to an arginine-rich sequence between 
residues 24 and 56. 
4.4. Nature of the growth defect associated with 
VP19C-63NLS 
As described earlier, VP 19C-63NLS was completely unable to substitute for wild-type 
VPl9C in virus infection. To determine at what stage during infection the block on 
replication was occurring, electron microscopy was carried out. To ensure efficient 
complementation, cells were infected with recombinant baculoviruses expressing the UL38 
N-terminal deletion mutants. Although not normally active in mammalian cells, genes 
cloned into baculovirus vectors can be expressed if their expression is driven by a 
mammalian promoter. U20S cells were selected for this procedure due to their ability to be 
efficiently transduced with baculoviruses. 
bUL38FBacpCI was produced during the course of the work for this thesis, and bUL38-
45NLSFBacpCI were made by David McNab. UL38-63NLSFBacpCI was made in 
accordance with the protocol detailed in the BAC-TO-BAC Baculovirus Expression 
Systems manual (Invitrogen) and described in Section 2.2.7. As the UL38-63NLS ORF 
was already contained on a modified pF ASTBAC plasmid (pFBpCI), no further cloning 
steps were required. 
Duplicate 35 mm plates of U20S cells (one containing a glass coverslip) were incubated 
with 50 pfulcell of baculoviruses bUL38FBacpCI (expressing VPI9C), bUL38-
45NLSFBacpCI (VP19C-45NLS) and bUL38-63NLSFBacpCI (VPI9C-63NLS) for one 
hour at 37°C. The baculovirus inoculum was removed and the cells were infected with 
5pfulcell ofv!l38YFP and incubation was continued at 37°C. After 16 hours, the coverslip 
from one of the duplicate plates was removed and processed for immunofluorescence 
microscopy, while the remaining cells were used for western blotting. The second plate 
was harvested and processed for electron microscopy. Immunofluorescence (Figure 4.7) 
showed similar numbers of cells expressing the three forms of VP 19C, while western 
blotting (Figure 4.8) confirmed that all three proteins were expressed at similar levels. 
Productively infected cells are easily distinguished by the presence of characteristic 
herpesvirus capsids in their nuclei. Examination of thin sections revealed the presence of 
capsids in the nuclei of 48% of the bUL38FBacpCI and 57% of the bUL38-
WT UL38-45NLS UL38-63NLS 
Figure 4.7: Expression ofVP19C, VPI9 -45 L , and VP19C-63 L in U20S cell . 
U20 cell were transduced separately with baculoviruse UL38FBacp I (expressing 
VPI9C), UL38-45 L FBacpCl (VPI9C-45 L ), and L38-63 L FBacpCI (VPI9 -
63 L ) for one hour at 37° . All samples were al 0 infected with vL\38YFP. VP 19C wa 
detected with the monoclonal antibody mAb02040, and visualised using FITC GAM (green). 
(A) 
Figure 4.8: Effects ofVP19C N-tenninal mutations on capsid assembly. 
(A and B) 35 mm plates of U20S cells were transduced with 50 pfulcell of baculovirus 
bUL38FBacpCI (A), or bUL38-45NLSFBacpCI (B), and incubated at 20°C for one hour 
before being infected with 5 pfu/cell of v~38YFP. Infection was continued at 37°C for 16 
hours. The cells were then harvested for electron microscopy. The majority of caps ids shown 
in panels A and Bare B-capsids and are not arrowed. C-capsids are indicated by triangles. 
Scale bar = 500 nm (applicable to both micrographs shown). 

Figure 4.8: Effects ofVPI9C N-terminal mutations on capsid assembly. 
(C to E) 35 mm plates of Sf21 cells were infected with 5 pfu/cell each of baculoviruses 
AcUL19 (VP5), AcUL26.5 (preVP22a), and AcAB3.12 (VP23, VP26 and the UL26 
protease), and with 5 pfu/cell of (C) AcUL38, (D) UL38-45FBac, or (E) UL38-63FBac, and 
incubated at 28°C for 48 hours. At the appropriate times after infection, the cells were 
harvested and prepared for electron microscopy. The majority of capsids in panels C to E are 
B capsids and are not arrowed. In panel D, arrowheads indicate concentrations of incomplete 
capsids. Only incomplete capsids are present in panel E, and are not arrowed. Baculovirus 
capsids (C to E) are indicated by arrows. Scale bar = 500 nm (applicable to all micrographs 
shown). (F) Expression of VPI9C in the infected cells was confirmed by western blotting. 
Protein samples were separated on a 10% sodium dodecyl sulphate polyacrylamide gel and 
detected by enhanced chemiluminescence using mAb02040 and protein A-peroxidase. Lanes 
I and 2 show U20S cell samples corresponding to panels A and B. Lane 3 shows a samples 
from U20S cells transduced with UL38-63NLSFBacpCI and infected with vLl38YFP. Lanes 
4 to 6 show Sf21 cell samples corresponding to panels C to E. 
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45NLSFBacpCI transduced samples. As expected for VP 19C proteins that support 
productive infection, all three capsid types (DNA containing (C-capsids), intermediate (B-
capsids), and empty (A-capsids) were seen in cells expressing wild-type VP19C and 
VP19C-45NLS (Figure 4.8). In contrast, no virus-specified particles of any type were 
observed in over 100 nuclei of the bUL38-63NLSFBacpCI transduced samples. Published 
studies had reported that capsid assembly in a baculovirus model was not prevented by the 
removal of up to 90 amino acids from the N-terminus of VP19C, although it was less 
efficient than with full-length VP19C (Spencer et aI., 1998). Therefore, the failure to detect 
capsids in the bUL38-63NLSFBacpCI transduced U20S cells was unexpected. 
To investigate this further, capsid assembly was analysed using the more efficient 
baculovirus model system. Duplicate plates of Sf21 cells (one containing a glass coverslip) 
were infected separately with 5 pfu/cell of baculoviruses AcUL38 (expressing full-length 
VP19C), bUL38-45FBac (VP19C-45) or bUL38-63FBac (VP19C-63). All samples were 
also infected with 5 pfu/cell each of baculoviruses AcULl9 (VP5), AcUL26.5 (preVP22a) 
and AcAB3.12 (VP23 , VP26 and the UL26 protease) to supply the remaining capsid 
proteins. As expected, characteristic herpesvirus B capsids were readily observed in cells 
expressing wild-type VP19C (Figure 4.8A), and in lower amounts in cells expressing 
VP 19C-45 (Figure 4.8B). The reduced number of intact capsids seen with VP 19C-45 is 
probably a result of inefficient nuclear localisation due to the absence of the NLS. 
However, in cells expressing VP 19C-63, only incomplete capsid shells were seen (Figure 
4.8C-E). Once again, immunofluorescence (Figure 4.9) and western blotting (Figure 4.8F) 
confirmed that all three proteins were being expressed at similar levels, thereby 
demonstrating that the block on particle formation was a direct result of the VP 19C-63 
deletion. Incomplete capsid shells will only be made if VP 19C is present (Tatman et al., 
1994), therefore the presence of incomplete capsid shells in these cells confirms that 
VP19C-63 is being made. 
4.5. VP19C-45NLS Difference Mapping 
The original intention in making the N-terminal deletions of VP19C was to locate the 
position of the N-terminus in capsid reconstructions. The inability of the VP19C-63 
deletions to support capsid assembly meant that this could be attempted only with the 
shorter deletion. However, since VP 19C-45NLS was as effective as wild-type VP 19C in 
supporting virus growth, it was decided to construct a virus expressing this form of the 
protein and use it for capsid reconstruction. Plasmid p~38YFP, which was originally used 
WT UL38-4S UL38-63 
Figure 4.9: Expression ofYP 19C, VP 19 -45, and VP 19C-63 in f2l cell. 
Sf2l cells were cotransfected separately with baculoviruses AcUL38 (expressing fu ll- length 
VPl9 ), UL38-45Fbac (VP19C-45), or UL38-63Fbac (VPI9 -63). All ample were al 0 
infected with baculovirll e AcUL 19 (VP5) AcUL26.5 (preVP22a) and AcAB3.l2 (VP23 , 
VP26 and the UL26 protea e) to upply the remaining capsid proteins. VP 19C wa detected 
with the monoclonal antibody mAb02040, and vi uali ed 1I ing FIT GAM (green). 
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to make the UL38 minus mutant v~38YFP (Thurlow et al. 200S), contains the YFP ORF 
in place of the UL38 ORF flanked by unique NheI and BglIJ restriction enzyme sites. 
Compatible restriction enzyme sites were introduced at either end of the UL38-4SNLS 
ORF by PCR using UL38NspeI and UL38CbglIJ as primers, and pUL38-4SNLS-T Easy as 
template. The resulting PCR product was ligated into pGEM-T Easy. Colonies were 
screened for the presence of the insert and one clone was selected and designated UL38-
45NLSrescue pGEM (Figure 4.10A). A 1309 bp fragment containing the UL38-4SNLS 
ORF was isolated into the NheIlBglII digested p~38YFP. Colonies were screened for the 
presence of the insert and one clone was designated as UL38-4SNLSrescue. (Figure 
4.10B). To rescue the truncated UL38 back into virus, BHK cells were transfected with 
UL38-4SNLSrescue, incubated for five hours at 37°C and infected with 2 pfulcell of 
v~38YFP. Progeny virus was harvested and titrated on non-complementing BHK cells. 
Individual plaques were screened for the absence of YFP. One isolate (designated v38-
45NLS) was grown to high titre and used in subsequent experiments. To produce capsids 
for structural analysis, approximately Sx 108 BHK-21 cells were infected with S pfulcell of 
v38-4SNLS or HSV-l strain 17. After 16 hours at 3ic, the cells were harvested and 
capsids purified by sucrose gradient sedimentation. The B-capsid samples were used in 
subsequent studies. Analysis of the protein composition of VP 19C-4SNLS capsids 
confirmed that they contained the truncated form of VP19C (Figure 4.11 A). The purified 
capsids were then sent to Wah Chiu's laboratory at the Baylor College of Medicine, 
Houston, Texas, for electron cryomicroscopy. Electron cryomicroscopic images of the 
VP 19C-4SNLS B capsids (Figure 4.11 B) showed that they were of similar size and 
conformation to wild-type B capsids, while 3D reconstruction confirmed that they 
conformed to the classical T=16 structure of HSV-l capsids. However, when the VPI9C-
45NLS capsids and wild-type B capsids were superimposed, differences became apparent 
(Figure 4.12). Surprisingly, the most obvious differences were at the tops of the hexons, 
where additional masses appeared to be present in the wild-type capsids, and in the tops of 
pentons, where the VPI9C-4SNLS capsids appeared to contain extra mass. These 
differences were not uniform across the capsids, but formed a gradient with the greatest 
apparent excesses of wild-type capsid mass towards the centres of the faces and the 
greatest deficiencies at the vertices. This pattern can be described most simply by a change 
in the overall curvature of the VPI9C-4SNLS capsid shell to give a more angular capsid 
with flatter faces and more prominent vertices. 
To determine whether there had been any alteration in triplex appearance resulting from 
the N-terminal truncation of VPI9C, the structures of triplexes computationally isolated 
A. 
UL38NspeI~ UL380RF l peR Reaction 
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Figure 4.10: Cloning strategy for UL38-45NLSrescue. 
A. Cloning strategy to produce UL38-45NLSrescue pGEM. A PCR reaction was carried out 
using pUL38-45NLS-T Easy as template DNA, UL38NspeI as a forward primer, and 
UL38CbglII as a reverse primer. The PCR product was purified and cloned into pGEM-T 
Easy. 
B. 
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Figure 4.10: Cloning strategy for UL38-45NLSrescue. 
B. An SpeIlBgnJ digest was carried out on pUL38-45NLSrescue pGEM and a 1309 bp 
fragment was isolated. An NheIlEcoRI digest was carried out on pL\38YFP and a 6091 bp 
fragment was isolated. These fragments were ligated together to produce pUL38-
45NLSrescue. 
B. 
Figure 4.11: A. Protein composition of truncated VPI9C capsids. B-capsids purified from 
BHK-21 cells infected with wild-type HSV -I, or with vUL38-45NLS, were analysed on a 
10% SDS polyacrylamide gel. The positions of the capsid proteins are indicated on the left of 
the gel. The sizes of the major capsid protein, VP5, the triplex p-subunit, VP23, and the 
internal scaffolding proteins, VP24 and VP22a, are the same for both viruses. In contrast, 
VP19C is smaller in the vUL38-45NLS sample (denoted by *) than in wild-type capsids due 
to the removal of the N-terminal residues. The sizes of the Rainbow Marker (RM) molecular 
weight standards are indicated to the right of the gel. B. Electron cryomicroscopic image of 
vUL38-45NLS caps ids in vitreous ice. 
• ~ 
• 
< 
Figure 4.12: The UL38-45NLS capsid was reconstructed to an effective resolution of 20 A 
and used to generate difference maps with the HSV-I wild-type B-capsid reconstructed to the 
same resolution. The image is viewed along a fivefold axis of symmetry. The differences 
were not uniform across capsids. A. Additional mass seen in wild-type capsids is shown in 
red. The greatest excess of wild-type capsid mass was towards the centres of the faces. B. The 
wild-type capsid is shown as a solid red structure. The UL38-45NLS capsid is shown as a 
blue mesh. At the vertices, the blue mesh overlies the solid red structure indicating that this is 
the location of the greatest excess ofUL38-45NLS capsid mass. 
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from the VP19C-45NLS and wild-type B capsid maps were compared. There are several 
differences in the conformation of the triplexes, but the greatest change was at the top, 
where the wild-type triplex appeared to have considerable extra mass (Figure 4.13). 
A. 
B. 
Figure 4.13: 3D representations of wild-type and VPI9C-45NLS triplexes. 
A. Difference map between wild-type and VPI9C-45NLS capsid reconstruction. In this 
enlarged region from the capsid comparison, a single triplex is shown (encircled). Regions in 
which the wild-type capsid contains extra mass are shown in red. B. 3D representation of a 
wild-type triplex shown in approximately the same orientation as in A. VP 19C is shown in 
green. The two VP23s are shown in blue and white. This 8 A resolution image was supplied 
by Matthew Baker. Segmentation of triplex proteins was carried out by Wen Jiang and 
Matthew Baker. Molecular graphics images were produced using the UCSF Chimera package 
from the Computer Graphics Laboratory, University of Cali fomi a, San Francisco (Pettersen el 
al., 2004). 
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5. Mutational analysis of VP19C - Discussion 
5.1. Computational analysis of VP19C 
Members of the three subfamilies of mammalian and avian herpesviruses (Alpha, Beta and 
Gammaherpesvirinae) share a common capsid architecture and in all examples analysed to 
date, the triplex is composed of one copy of a VP 19C homologue (the a-subunit) and two 
copies of a VP23 homologue (the p-subunit) (Gibson et al., 1996; Chen et al., 1999; Yu el 
al., 2003). It is not known whether capsids from the fish and bivalve herpesviruses families 
are organised in this way, although CCV capsids contain suitably-sized candidate proteins 
with appropriate stoichiometries (Booy et al., 1996). In HSV -I and most other 
Alphaherpesvirinae, the a-subunit is considerably larger than the p-subunit (465 amino 
acids compared with 318 in HSV -1). However, in Beta and Gammaherpesvirinae, the a-
subunit is significantly smaller than HSV -1 VP 19C (Gibson et al., 1996; Nealon et aI., 
2001; O'Connor et al., 2003) and is of similar size to the p-subunit. Since the large size of 
the a-subunit in Alphaherpesvirinae appears anomalous, it seems likely that the additional 
sequences represent relatively recent evolutionary developments. Comparison of a-subunit 
sequences reveals that the N-terminal III amino acids of VPI9C are not conserved in the 
other Alphaherpesvirinae apart from HSV-2 (Figure 5.1A). This region is also highly 
divergent among different herpesvirus subfamilies. However, differences in the N-terminal 
region are not entirely responsible for the size variation among the subfamilies. An 
alignment of sequences from Alpha, Beta and Gammaherpesviruses is in broad agreement 
with earlier findings (Trus et at., 2001) and indicates that the greater size of 
Alphaherpesvirinae a-subunit proteins is largely accounted for by two internal insertions, 
each of approximately 40-50 residues (insert 1 and insert 2), as well as by extra sequences 
at the N-terminus (Figure 5.1 B). 
Predictions of secondary structure were obtained for the sequences of herpesvirus triplex 
a-subunits (Figure 5.1 C). The most striking observation was the apparent increase in 
secondary structure conservation towards the C-terminus. Perhaps indicating the 
importance of this region in the function of the protein. Also notable was the lack of any 
evidence of conservation of secondary structure in the N-terminal region of the triplex a-
subunits in Alphaherpesvirinae. Indeed, the secondary structure prediction program was 
unable to detect secondary structural elements in the VP 19C N -terminal region to any 
significant degree of likelihood, with the most N-terminal secondary structural element 
predicted being the presence of a loop structure beginning at amino acid 102. 
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Figure 5. I: Sequence comparisons of VP 19C homologues. 
The sequences of fifteen Alphaherpesviruses, nine Betaherpesviruses, and twelve 
Gammaherpesviruses (identified by a BLAST search from the VIDA database 
(http://www.biochem.ucl.ac.uklbsm!virus_databaseNIDA.html) using the HSV - I, HCMV, 
and KSHV herpesvirus triplex a-subunit sequences as input) were aligned using the 
CLUST AL W (http://www.ebi.ac.uklclustalw/) multiple sequence alignment program 
(Thompson et af., 1994). The CLUST AL W output was used as the basis for subsequent 
analyses. (a) Levels of sequence conservation among the triplex a-subunits in 
alphaherpesviruses were analysed and plotted using the JalView (http://www.jalview.org/) 
multiple sequence editor program (Clamp et at., 2004). (b) Schematic representation of the 
consensus alignment between alpha, beta, and gammaherpesvirus triplex a-subunit sequences, 
showing the locations of additional sequences (insert 1 and insert 2 comprising residues 140 
to 176 and 357 to 405 respectively in HSV-I) in the alphaherpesvirus proteins. The consensus 
sequence was calculated using the Consensus program (http://www.bork.embl-
heidelberg.de/Alignmenticonsensus.html). (c) Secondary structure predictions for triplex a-
subunits of (top) alpha, (middle) beta, and (bottom) gammaherpesviruses. Secondary structure 
predictions were carried out on each individual sequence using PredictProtein (Rost et af., 
2004) ((http://cubic.bioc.columbia.edulpredictproteinl). Structural elements present in >50% 
of examples (Figures 5A-G) were plotted relative to the alignments shown in (b) for each 
subfamily. The positions of a-helices are shown in red, ~ sheet in blue, and coil in green. 
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The nature of the triplex, as a non-symmetrical structure, occupying an icosahedrally 
symmetrical position in the capsid, is anomalous, and suggests the possibility that the 
progenitors of VP19C and VP23 arose as a result of gene duplication from a single 
trivalent ancestor. Although sequence analysis does not support this conjecture, evidence 
of structural relationships can endure in circumstances where sequence conservation is no 
longer apparent, as has been shown for the floor domain of VP5 and the capsid proteins of 
certain tailed bacteriophages (Baker et af., 2005). However, comparisons of the structures 
of VP19C and VP23 from secondary structure prediction programs (Figure 5.2A-G), and 
from currently available 3D reconstructions (Figure 5.3) provide no evidence for 
relatedness between the two proteins. Thus, either they had independent origins, or the 
adaptation needed to fulfil their differing functions is sufficient to have removed any traces 
of a common original structure. 
Trus et al., (2001) discussed the possibility of an evolutionary relationship between VP 19C 
and VP23 and were unable to rule it out, citing the alignments that they observed when 
analysing triplex a- and p-subunits using Clustal W. An attempt to carry out a similar 
alignment for VP19C and VP23 using Clustal W produced similar results (Figure 5.2Hi). 
However, the resulting alignment gave rather poor identity and similarity scores, and 
contained numerous gaps. In order to test the validity of the alignment, the VP23 amino 
acid sequence was randomly shuffled using the Sequence Manipulation Suite Shuffle 
Protein program (http://bioinformatics.org/sms2/shuffleyrotein.html) (Stothard, 2000) and 
aligned to VP19C. This produced an alignment of similar quality (Figure 5.2Hii). A 
slightly less convincing alignment was observed when VP19C was aligned with a random 
sequence of 318 amino acids (the same length as VP23) (Figure 5.2Hiii) generated using 
the Sequence Manipulation Suite Random Protein Sequence program 
(http://bioinformatics.org/sms2/randomyrotein.html)(Stothard,2000).Therefore,it 
appears questionable that Clustal W alignments alone provide evidence of an evolutionary 
relationship between such very poorly related proteins as VP 19C and VP23. 
5.2. VP19C insertional mutagenesis 
Transposon-based insertional mutagenesis is a rapid and efficient method of screening a 
protein sequence for functional domains. The manufacturers claim that the insertions occur 
randomly. However, the panel of mutants obtained included subsets of insertions that lay 
in close proximity to each other - such as six insertions between amino acids 234 and 248 
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Figure S.2A: Secondary structure predictions for alphaherpesvirus triplex a-subunits. 
Sequences were obtained from the VIDA database 
(http://www.biochem.ucl.ac.uklbsm/virus_databaselVlDA.html) and aligned using the 
CLUST AL W (http://www.ebi.ac.uklclustalw/) multiple sequence alignment program (Thompson 
et al., 1994). Secondary structure predictions were carried out on each individual sequence using 
PredictProtein (Rost et al., 2004) (http://cubic.bioc.columbia.edu/predictproteinl). The positions 
of a-helices are shown in red, p sheet in turquoise, and coil in green. Structural elements present 
in >50% of examples were calculated and plotted below the CLUST AL W alignment. The 
sequence of the triplex a-subunit for HSV - I was used to show the presence of conserved 
structural elements in the 'consensus' for secondary structure. Positions of insertions in VPI9C 
insertional mutants are shown relative to the alignment and demarcated by a letter M. Non-lethal 
insertions are shown in green. Lethal insertions are shown in red. There appears to be no 
correlation between the predicted secondary structure of a region of VP I 9C the likelihood of an 
insertion into that region being lethal. 
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Figure 5.2B: Secondary structure predictions for betaherpesvirus triplex a-subunits. 
Sequences were obtained from the VIDA database 
(http://www.biochem.ucl.ac.uklbsm/virus_databaseNIDA.html) and aligned using the 
CLUST AL W (http://www.ebi.ac.uklclustalwl) multiple sequence alignment program 
(Thompson et al., 1994). Secondary structure predictions were carried out on each individual 
sequence using PredictProtein (Rost et al., 2004) 
(http://cubic.bioc.columbia.edu/predictproteinl). The positions of a-helices are shown in red, 
~ sheet in turquoise, and coil in green. Structural elements present in >50% of examples were 
calculated and plotted below the CLUST AL W alignment. The sequence of the triplex a-
subunit for HCMV was used to show the presence of conserved structural elements in the 
'consensus' for secondary structure. 
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Figure 5.2C: Secondary structure predictions for gammaherpesvirus triplex a-subunits. 
Sequences were obtained from the VIDA database 
(http://www.biochem.ucl.ac.uk/bsm/virus_databaseNIDA.html) and aligned using the 
CLUST AL W (http://www.ebi.ac.uklclustalwl) multiple sequence alignment program 
(Thompson e/ al., 1994). Secondary structure predictions were carried out on each individual 
sequence using PredictProtein (Rost e/ al., 2004) 
(http://cubic.bioc.columbia.edu/predictprotein/). The positions of a-helices are shown in red, 
~ sheet in turquoise, and coil in green. Structural elements present in >50% of examples were 
calculated and plotted below the CLUST AL W alignment. The sequence of the triplex a-
subunit for KSHV was used to show the presence of conserved structural elements in the 
'consensus' for secondary structure. 
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Figure 5.2D: Secondary structure predictions for alphaherpesvirus triplex p-subunits . 
Sequences were obtained from the VIDA database 
(http://www.biochem.ucl.ac.uk!bsm/virus_databaseNIDA.html) and aligned using the 
CLUST AL W (http://www.ebi.ac.uklclustalwi) multiple sequence alignment program 
(Thompson et al., 1994). Secondary structure predictions were carried out on each individual 
sequence using PredictProtein (Rost et al., 2004) 
(http://cubic.bioc.columbia.edu/predictproteinl). The positions of a-helices are shown in red, 
p sheet in turquoise, and coil in green. Structural elements present in >50% of examples were 
calculated and plotted below the CLUSTAL W alignment. The sequence of the triplex p-
subunit in HSV -I was used to show the presence of conserved structural elements in the 
'consensus' for secondary structure. 
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Figure 5.2E: Secondary structure predictions for betaherpesvirus triplex p-subunits . 
Sequences were obtained from the VIDA database 
(http://www.biochem.ucl.ac.uk!bsmlvirus_databaseNIDA.html) and aligned using the 
CLUST AL W (http://www.ebi.ac.uk/clustalwl) multiple sequence alignment program 
(Thompson el al., 1994). Secondary structure predictions were carried out on each individual 
sequence using PredictProtein (Rost el al., 2004) 
(http://cubic.bioc.columbia.edu/predictprotein/). The positions of a-helices are shown in red, 
p sheet in turquoise, and coil in green. Structural elements present in >50% of examples were 
calculated and plotted below the CLUSTAL W alignment. The sequence of the triplex p-
subunit for HCMV was used to show the presence of conserved structural elements in the 
'consensus' for secondary structure. 
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Figure S.2F: Secondary structure predictions for gammaherpesvirus triplex ~-subunits . 
Sequences were obtained from the VIDA database 
(http://www.biochem.ucl.ac.uk/bsm/virus_databaseNIDA.html) and aligned using the 
CLUST AL W (http://www.ebi.ac.uk/clustalwl) multiple sequence alignment program 
(Thompson et al., 1994). Secondary structure predictions were carried out on each individual 
sequence using PredictProtein (Rost et aI., 2004) 
(http://cubic.bioc.columbia.edu/predictproteinl). The positions of a-helices are shown in red, 
13 sheet in turquoise, and coil in green. Structural elements present in >50% of examples were 
calculated and plotted below the CLUST AL W alignment. The sequence of the triplex 13-
subunit for KSHV was used to show the presence of conserved structural elements in the 
'consensus' for secondary structure. 
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Figure 5.2G: Secondary structure predictions for triplex a and p subunits of alpha. beta. and 
gammaherpesviruses. 
Consensus sequences from Figures 5.2A-F are shown. The positions of a-helices are shown in 
red, p sheet in turquoise, and coil in green. In the a-subunit alignment, the amino acids in 
insert I and insert 2 (as described in Figure 5.1) have been removed from the 
alphaherpesvirus consensus, and the remaining amino acids have been aligned from the C-
terminal. In the p-subunit alignment, amino acids have been aligned from the N-terminal. 
(Greater levels of consensus between alpha, beta, and gammaherpes were observed when 
triplex a subunits were aligned from the C-terminal, while in the case of triplex p subunits, 
greater levels of consensus were observed when alignment was carried out from the N-
terminal.) Although secondary structure predictions confirm similarities between viruses for 
each type of protein, they do not indicate an evolutionary relationship between the two 
proteins. 
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MKTNPLPATPSVWGGSTVELPPTTRDTAGQGLLRRVLRPPISRRDGPVLPRGSGPRRAAS 60 
MLADGFETDIAIPSG _________________________ ISRPDAAALQRCEG------ 29 
* 
*** * * * * 
* 
TLWLLGLDGTDAPPGALTPNDDTEQALDKILRGTMRGGAALIGSPRHHLTRQVILTDLCQ 120 
_____________________________________ RVVFLPTIRRQLTLADVAHESFV 52 
** 
PNADRAGTLLLALRHPADLPHLAHQRAPPGRQTERLGEAWGQLMEATALGSGRAESGCTR 180 
SGGVSPDTLGLLLAYRRRFPAVITRVLP------------------TRIVACPLDVGLTH 94 
* * 
** * * * * * 
AGLVSFNFLVAACAASYDARDAADAVRAHVTANYRGTRVGARLDRFSECLRAMVHTHVFP 240 
AGTVNLRNTSPVDLCNGDP-------ISLVPPVFEGQATDVRLDSLDLTLRFPVP----- 142 
* ** * * * 
*** 
HEVMRFFGGLVSWVTQDELASVTAVCAGPQEAAHTGHPGRPRSAVILPACAFVDLDAELG 300 
----- ____ LPSPLAREIVARLVARGIRDLNPSPRNPGGLPDLNVLYYNGSRLSLLADVQ 193 
* * 
* * * * * * 
LGGPGAAFLYLVLTYRQRRDQELCCVYVIKSQLPPRGLEPALERLFGRLRITNTIHGTED 360 
QLGP- ________ VNAELRSLVLNMVYSITEGTT--IILTLIPRLFALSAQDGYVNALLQ 242 
** * * ** * 
*** 
MTPPAPNRNPDFPLAGLAANPQTPRCSAGQVTNPQFADRLYRWQPDLRGRPTARTCTYAA 420 
MQSVTR-------EAAQLIHPEAPALMQDGERRLPLYEALVAWLTHAG------------ 283 
* * * 
FAELGMMPEDSPRCLHRTERFGAVTVPVVILEGVVWCPGEWRACA 465 
--QLGDTLALAP-VVRVCTFDGAAVVRSGDMAPVIRyp------- 318 
** * ** * * 
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MKTNPLPATPSVWGGSTVELPPTTRDTAGQGLLRRVLRPPISRRDGPVLPRGSGPRRAAS 60 
------------YDSLATDVLPGTLASP----------PTAGVLSSPILD----LRRLLA 34 
* * * * * ** 
TLWLLGLDGTDAPPGALTPNDDTEQALDKILRGTMRGGAALIGSPRHHLTRQVILTDLCQ 120 
NLLRLIPAMTESPGRIAILDAVPLRAPEGLIDDAALG----LG---ITFLYNEVAVGLVP 87 
* * * * * * * 
PNADRAGTLLLALRHPADLPHLAHQRAPPGRQTERLGEAWGQLMEATALGSGRAESGCTR 180 
FDAG-LDVTVVEVGEPGTRNTLGNyRISIAR-----VEFFMGLPCSSILGLDRSVLNIRR 141 
* * * * * * * ** * 
AGLVSFNFLVAACAASYDARDAADAVRAHVTANYRGTRVGARLDRFSECLRAMVHTHVFP 240 
D--------------NYRHGMVTRAVAAEVTVGELNTATPLLRQNIQASLP--VSRHRRP 185 
* ** * ** * * * * 
HEVMRFFGGLVSWVTQDELASVTAVCAGPQEAAHTGHPGRPRSAVILPACAFVDLDAELG 300 
DTPLDAILPSISVVTTLRLAAALAQQPCVQTDAPLLVPQMP------------------- 226 
* ** * * * * * 
LGGPGAAFLYLVLTYRQRRDQELCCVYVIKSQLPPRGLEPALERLFGRLRITNTIHGTED 360 
----------ATLLYDFWRD---VYPFMLLSILPQ-----------GRALCLGGVLQCAS 262 
* * ** * ** ** 
MTPPAPNRNPDFPLAGLAANPQTPRCSAGQVTNPQFADRLYRWQPDLRGRPTARTCTYAA 420 
LTVPARRSANATQLVDDRVGPPGSQRREGGVP-----------------------ALAHN 299 
* ** * * * * 
FAELGMMPEDSPRCLHRTERFGAVTVPVVILEGVVWCPGEWRACA 465 
FPQVHIRDYVDLELVFRVE-------------------------- 318 
* * * 
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MKTNPLPATPSVWGGSTVELPPTTRDTAGQGLLRRVLRPPISRRDGPVLPRGSGPRRAAS 60 
------------------------------------------------------------
TLWLLGLDGTDAPPGALTPNDDTEQALDKILRGTMRGGAALIGSPRHHLTRQVILTDLeQ 120 
_______ YDSKRPQFSYESWKRYNRDQDNYHGHRMIAWMRLWPQHSCFSDTRVILENLYS 53 
* *.... *** .... 
PNADRAGTLLLALRHPADLPHLAHQRAPPGRQTERLGEAWGQLMEATALGSGRAESGCTR 180 
----------YEHMCTEPCHGIDHyTTENAWRTYLMKEIWSRHLTACIKWG---SFTAMR 100 
'" .. 
* * * 
AGLVSFNFLVAACAASYDARDAADAVRAHVTANYRGTRVGARLDRFSECLRAMVHTHVFP 240 
HNCYCMRHHMIMDGRWYSPFRVAIAIAKHSKG----------------ySWKMANKEGIP 144 
* .. 
* 
.. .. .. 
HEVMRFFGGLVSWVTQDELASVTAVCAGPQEAAHTGHPGRPRSAVILPACAFVDLDAELG 300 
HRWIIETAKRRRWMYDWQFYHP- __ IEQPHNEGFTDINN--TRILMIRSCSKNDLDDEE- 198 
* 'It * *** * 
* 
.. .. * .. 
MTPPAPNRNPDFPLAGLAANPQTPRCSAGQVTNPQFADRLYRWQPDLRGRPTARTCTYAA 420 
IGPEACSMN---- ______ NPTR ____ TGQRQ __________ WDRDQ--EyFFWSIEYQF 288 
.. .. .. 
** 
.... 
.. 
FAELGMMPEDSPRCLHRTERFGAVTVPVVILEGVVWCPGEWRACA 465 
DMQIPFWEGDSPEGLD-----------VATHCWFQQCKKGW---- 318 
*** * * 
.. .. 
Figure S.2Hiii 
.. 
Figure 2H: VPl9CNP23 alignments do not give an indication of an evolutionary relationship 
between the two proteins. 
(i). HSV-l VPl9C and VP23 were aligned using the CLUSTAL W 
(http://www.ebi.ac.uklclustalw) multiple sequence alignment program (Thompson e/ al., 
1994). (ii). VP23 was shuffled using the Sequence Manipulation Suite Shuffle Protein 
program (http://bioinformatics.orglsms2/shuffle-protein.html) (Stothard, 2000) and aligned to 
VP 19C using CLUST AL W. (iii). A random 318 amino acid sequence was generated using 
the Sequence Manipulation Suite Random Protein Sequence program 
(http://bioinformatics.orglsms2/randomyrotein.html) (Stothard, 2000), and aligned to VPl9C 
using CLUST AL W. Conserved residues are denoted by asterisks. Similar numbers of 
conserved residues were obtained from the three alignments (66, 65, and 54 respectively). 
A. B. 
c. 
Figure 5.3: Three-dimensional reconstructions of the H V-l triplex proteins. 
A. and B. Three-dimensional reconstructions of the two copies of VP23. C. Three-
dimensional reconstruction of VP19C. The three proteins of the triplex are hown in an 
'exploded ' view. Although the imilar structural elements in the two VP23 molecules are 
evident, there appears to be little obvious similarity between VP23 and VP19C. The predicted 
positions of a-helices are shown in each reconstruction. Four a-helices ar vi ible in VP 19 , 
and they are not predicted to be in similar position to a-helices in VP23. 
Images were supplied by Matthew Baker. 
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and four insertions between amino acids 327 and 330, while no insertions occur between 
amino acids 144 and 181 (Table 3.2). The GC content of HSV-I is reported as being 
68.3% (McGeoch et at., 1988). The average GC content of amino acids 144-181 in VP 19C 
is 80.7%, while the GC contents of 234-248 and 327-330 are 60% and 41.7% respectively, 
indicating that the mutagenesis system might have a preference for less-GC-rich DNA. The 
three cycles of mutagenesis resulted in the production of 11, 19, and 20 unique insertional 
mutants of the UL38 ORF respectively (Section 3.2). As well as producing the most 
mutants, the method used for the third cycle produced mutants in the shortest time. 
Although the plasmid used in this cycle was larger, and therefore contained a smaller 
proportion of insertions in the UL38 ORF, the number of cloning steps required in the 
procedure was reduced, accounting for the faster production. 
The results of mutational analysis must be interpreted with caution, particularly when 
considering the behaviour of individual mutants. In some cases, pairs of mutants with 
contrasting properties were very close together. For example, the plasmids containing 
insertions in286 and in289 differ markedly in their ability to complement the growth of 
v~38YFP (Figure 3.6). In addition, not all functions are equally sensitive to insertion. For 
example, although in38 maps within the sequences identified as containing a nuclear 
localisation signal, the ability of this mutant to enter the nucleus was not affected (Figure 
5.4). Therefore, without detailed information on the structure of the target protein or 
specific assays to measure particular properties it is usually not possible to make other than 
a general interpretation of results. Three-dimensional structural analysis of the capsid has 
shown that the component proteins interact in different ways at distinct locations in the 
capsid (Zhou et al., 1998a). Furthermore, the reconfiguration that occurs during capsid 
maturation involves domain movements leading to changes in the patterns of interaction 
(Trus et aI., 1996; Heymann et at., 2003). This type of behaviour means that the 
importance of particular regions of a protein may vary with maturation status and location. 
This type of analysis may not be optimal for structural proteins lacking separable domains. 
Nevertheless, the distribution of severely disabling mutations across VPI9C was non-
uniform, with 16 in the central 251 residues of VPl9C but none in the N-terminal 107 
residues and only two in the C-terminal 107 residues. The most N-terminal severely 
disabled mutant, in113, occurs almost immediately after the first evidence of conservation 
between the sequences of the alphaherpesvirus a-subunits (Figure 3.6). Originally, it had 
appeared that an equivalent distinction marked that boundary of the C-terminal 107 
residues. Preliminary alignments of the sequences of VP 19C and its homologucs in 
Figure 5.4 : uclear locali ation of L38in38. 
BHK-21 cell were cotran fected with VP19C in ertionalmutant in38. VPI9C wa detected 
with the monoclonal antibody mAb02040, and i uali ed u ing FfT GAM (green). 
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Alphaherpesvirinae appeared to show a lack of conservation in amino acid sequence that 
began approximately at residue 360 in HSV -I and extended to the C-terminus, however 
closer examination of the DNA sequences revealed that the apparent lack of conservation 
had been caused by an error in the sequence of the VP 19C homologue in gallid 
herpesvirus-l provided by University College London's Virus Database 
(http://www.biochem.ucl.ac.uk!bsm!virus_databaseNIDA3NIDA.html; Mar Alba et aI., 
2001). The introduction of a single extra thymine at position 1237 in the DNA sequence of 
this gene caused a frameshift which resulted in the next amino acid (aspartic acid (GAT» 
being substituted with a STOP codon (TGA). This error resulted in the C-terminal 68 
residues of the gallid herpesvirus-I VP 19C homologue being omitted from the protein 
sequence. When the error in the protein sequence was corrected and it was aligned with the 
VP19C homologues of other Alphaherpesvirinae, there was no decrease in levels of 
sequence conservation in the C-terminal region of VP 19C compared with the middle 
region. 
Despite there being no evidence of a loss of sequence conservation in the 107 C-terminal 
residue region, its start at in358 coincides with the beginning of the second large 
alphaherpesvirus specific insert (insert 2; Figure 5.1). However, unlike the poorly 
conserved N-terminal region, insert 2 contains a severely disabling mutation, in390 (Figure 
3.6). Only one insertion (inI43) mapped within the insert I locus, and this was also 
severely disabling (Figure 3.6), indicating that both inserted sequences are functionally 
important. The distribution of severely disabling mutants suggests that VP 19C can be 
divided into three regions based on their ability to tolerate insertions, and may suggest that 
the three regions have differing roles. However, this interpretation must be treated with 
caution as the distribution of insertions is not uniform and clustering of mutations with 
similar phenotypes (such as in327-330) tends to distort the pattern. Statistical analysis by 
chi-squared analysis (Table 5.1) indicates that the N- and C-terminal regions are more 
tolerant of insertions than the middle region (in contrast to what was stated in Adamson et 
aI., 2006). 
The sensitivity to insertion of the central region suggests that it may be important for 
folding of VPI9C in a similar manner to that suggested for the central region of the major 
capsid protein, VP5, which has been proposed to act as a folding nucleus for the more 
flexible Nand C-terminal regions (Bowman et al., 2003). The large number of tolerated 
insertions in the C-terminal region is rather surprising, as deletional analysis had shown 
that removal of as few as IS amino acids from the C-terminus destroyed the ability of 
Rescuing Non-RescuinA Total 
N-Terminal Region 12 0 12 
Middle Region 8 15 23 
Total 20 15 35 
Chi-s uared= 35[(12*15)-(0*8)]2 = 13.70 
q 12 * 23 * 20 * 15 
Two rows, two columns, therefore (2-1)*(2-1) = 1 degree of freedom. 
P<O.OOI 
Difference in ability to tolerate five amino acid insertions between the N-terminal 
region and middle region ofVP19C is very highly significant. 
Rescuing Non-Rescuing Total 
Middle Region 8 15 23 
C-Terminal Region 11 2 13 
Total 19 17 36 
Chi-s uared = 36[(8 * 2) - (15 * Il)f = 8.276 
q 23 * 13 * 1 9 * 1 7 
Two rows, two columns, therefore (2-1)*(2-1) - I degree of freedom. 
O.OOI>P>O.OOOl 
Difference in ability to tolerate five amino acid insertions between the C-terminal 
region and middle region of VP 19C is highly significant. 
Table 5.1: Chi-squared tests to showing differences in the three regions of VPI9C in terms of 
ability to tolerate insertional mutagenesis. 
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VP 19C to support capsid assembly (Spencer et al., 1998). When considered alongside the 
behaviour ofin463, which completely fails to support virus growth (Figure 3.6), this seems 
to indicate that sequences very near the C-terminus of VPl9C play an essential role in 
capsid assembly. However, the viability of most of the mutants in the C-terminal region 
suggests that it has considerable structural flexibility despite the secondary structure 
predictions, which appear to show that conservation of secondary structure increases 
towards the C-terminus (Figures 5.2A-5.2C and 5.2G). Previous work has highlighted the 
structural flexibility of triplex proteins, with it being suggested that in isolation the two 
triplex proteins (VPI9C and VP23) behave like molten globules - proteins in an 
intermediate state of folding. The plasticity inherent in such a molten globule-like state 
might provide the flexibility required to attain the non-equivalent interactions observed in 
the triplex (Kirkitadze et aI., 1998). 
The 18 severely disabled mutants can be divided into four categories based on their ability 
to interact with VP5 and VP23 (Table 3.3). Five (including in242A and in242B, which are 
in the same codon) failed to transport either VP23 or VP5 to the nucleus (Figures 3.7 and 
3.8), suggesting that these interactions may have altered the overall folding of the protein. 
These insertions (at residues 113, 242, 289, and 330) are evenly spaced across the central 
region and do not appear to demarcate any obvious domain although they may lie close 
together in the folded protein. When insertional mutagenesis was carried out on the region 
of VP5 for which the crystal structure has been obtained, it was shown that lethal insertions 
were into regions of the protein that were deeply buried away from the surface, possibly 
disrupting the overall folding of the protein (Webster, 2004). This may also be the situation 
with the VP 19C insertional mutants described here, although this could not be confirmed 
without the crystal structure of VP 19C. 
Four of the mutants interact with VP5 but not VP23, while three interact with VP23 but not 
VP5 (Figures 3.7 and 3.8). The specificity of these mutants suggests that the insertions do 
not cause global misfolding of the protein but have a more localised effect. The mutants 
that failed to take VP23 to the nucleus were located N-terminal (between residues 193 and 
310) to those that failed to bind VP5 (between residues 328 and 463), suggesting that the 
regions involved are particularly important for the binding of VP23 and VP5 respectively. 
Since VP23 and VP5 are both essential for capsid assembly (Desai el aI., 1993; Tatman el 
al., 1994; Thomsen et al., 1994) it is not surprising that the mutants that fail to interact 
with one or both of them do not support virus growth. The nature of the defect in the 
remaining severely disabled mutants is unclear. Further analysis is required to determine 
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whether they support the assembly of structurally normal capsids. However, examination 
of mutants in143, in234, in235, in327, in350, and in390 in a plasmid-borne DNA 
packaging assay (Hodge and Stow, 200 I) showed that they were unable to support DNA 
packaging in v~38YFP infected cells (Figure 3.9). This suggests either that the assembly 
of the capsid shell was disrupted, presumably due to some subtle alteration in the 
interactions with VP23 or VP5, or that an interaction involving one of the other virion 
components had been affected. An interaction between VP 19C and the UL25 protein has 
been indicated from far-western blotting (Ogasawara, 2001), although it has not been 
possible to replicate this result using immunofluorescence (Valerie Preston, personal 
communication). The tegument protein present at the vertices in mature virions is in 
contact with the peri-pentonal triplexes and may also interact with VP 19C (Zhou et al., 
1999). Failure to bind tegument would be lethal but would not be expected to prevent DNA 
packaging. However, UL25 mutants show aberrant DNA packaging (McNab et aI., 1998; 
Stow, 200 I) and disruption of this interaction might result in the type of phenotype seen 
here. 
5.3. Mutational analysis of the N-terminal region of 
VP19C 
The N-terminal regions of VPI9C and its homologues in all three herpesvirus subfamilies 
are particularly poorly conserved in both length and sequence, with effectively no 
homology evident until after amino acid III of VPI9C (Figure 5.1). This raises questions 
regarding the function of this highly variable region. Part of that function was revealed by 
the deletion of 45 residues from the N-terminus of VPI9C, which removed a nuclear 
localisation signal (Section 4.2.1 and 4.2.3). That the failure of this deleted protein to 
congregate in the nucleus was entirely responsible for the 50-fold reduction in its ability to 
complement growth of a VP 19C minus mutant was demonstrated by the recovery in virus 
growth when an exogenous (SV40) nuclear localisation signal was present (Section 4.2.3). 
From this observation it is evident that correct transport of the component proteins to the 
site of capsid assembly is an important function of VPI9C. Although the precise sequence 
of the VP19C NLS has not been identified, it has been mapped to a region containing 33 
amino acids (Section 4.3, Figure 4.6). Database searching has revealed that it does not 
belong to any known classes ofNLS. Interestingly, the pattern of arginine residues seen in 
the VPI9C NLS is not present in the N-terminal sequences of any other alphaherpesvirus 
VP 19C homologue apart from that of the very closely related HSV -2 (Figure 5.5). 
Furthermore, examination of triplex a-subunit sequences from all three herpesvirus 
HSV1. 
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------------MALPERSRNTKTASRTSEMKyySAHSNR -----PYELHSLMRSIGKNI 43 
MEANQRNSKLTQTLQIPT-SNVMLMGDNRFIQIGNGLN-------MSYNSHNFR-----S 47 
MGSQPTNSHFTLNEQTLCGTNISLLGNNRFIQIGNGLH-------MTYAPGFFGNWSRDL 53 
----------------------MNLGGNRFVQIGNGMSN------IMYTDANGG-- VRWE 30 
----------------------MNLGGNRFVQIGNGMSN------IMYTDANGA-- VRWE 30 
----------------------------MSVQIGNGLL---------------------- 10 
--------------------MAAPNGSSSYIQIGNHLRMRLPAAAPPFSGVPAAAAAAAE 40 
----------------MSGLLARNGSNDKlRAPERGLSG--------FANTRTHPYLQSV 36 
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cercoHV7 
VZV 
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equidHV1. 
psedorabies 
bovineHV1. 
gallidHV1. 
VLRPPISRRDGPVLPRGSGPRRAASTLWLLGLDGTDAPPGALTPNDDTEQALDKILRGTM 95 
VLRPPIARRDGPVLLGDRAPRRTASTMWLLGIDPAESSPGTRATRDDTEQAVDKILRGAR 95 
QSDTVRRLNLGYLDGDNRRGNLAGGLELLRDATTPNASRMNITRPLDTSTSGATAMIMQS 94 
RTSVGGRINLGYMNVGDRSS--VNDLNVLWTADTLGMYKMDRTPAFKDSTAKTTAIIAQS 101 
SIKPWN--LSTDKFTNTAN------------GTLVRITPDCIVINNAHGLQIQQN---TS 90 
TIGPRFGGLNKQPIHVPPKRTE---------TASIQVTPRSIVINRMNNIQINPT---SI 1.01 
QVPPFAGFPHQ--- RGRSNAAFGLPNTLDWLPGFVHATPNSITISNMGGIQISSAGVVTA 87 
QISPPAGFPQQQRGRGRGHVAFGLPNTLDWLPGFVQATPNSITISNMGGIQISSAGVITA 90 
----------------------------------MVVAPGTLTVGSAR------------ 24 
ASAAEAGVQSVTAPAVGGARGRAPRGYNPWAGGMLHVSDATVTIQNMSGIQIVTPRQIAV 1.00 
LPRRTHQHNLLSAALGRLTTGRNFSHGLGTRPGKFFIGSGPRNPEETNNATLGKEDTRAI 96 
R-GGAALIGS-----PRHHLTRQVILTDLCQPNADRAGTLLLALRHPADLPHLAHQRAPP 149 
RAGGLTVPGA-----PRYHLTRQVTLTDLCQPNAEPAGALLLALRHPTDLPHLARHRAPP 150 
LRTDVAENITLLTGDSRATISRQVTLTDFCFPDAEMPGLIILSIRHPLDINSEALYATPA 1.54 
I RSN--SEIREWGGD- RAVITRQVTLTDFCFPDAEFPGSILLSMRHPLDINSEALYATPG 158 
D----VFRLPLEQTHITPDLIKQVSLTDLCRPDVDFLGSPVFLIRHCLDlVEDASVCTPA 1.46 
GNPQVTIRLPLNNFKSTTQLIQQVSLTDFFRPDIEHAGSIVLILRHPSDMIGEANTLTQA 1.61 
AINSDHNSWVLSNSQPSLKLTRQVTLTDFCDPTAEKPGLPIIRLRNHLDAIGSSPSSTPP 147 
AINSEQNSWMLSSFNPSLKLTRQVTLTDFCDPTAERPGLPIIRLRHHLDAIGSSPSSTPP 1.50 
----------------- ARLIRQVTLADFCEPQAERPGLVVLALRHPADLAGAAyAATPP 67 
DTPAGTAVLSPGG-QPHIRLSRQVTLTDFCDPQLERPGAPVLTLKHPADIIGLAAAAApP 1.59 
ASKPLLDVESTRTN--DVISLTQITVIDLCQPGVEESGSLMLFLKGVKDLLKILGSRPAR 1.54 
Figure 5.5: Arginine residues In the 
alphaherpesviruses. 
-teI1Tlinal regions of triplex Ct subunit of 
The sequences of eleven alphaherpesviruses were aligned using the CLU TAL W 
(http://www.ebi.ac.uk!clustalwl) multiple sequence alignment program (Thomp on et al. 
1994). The -terminal equences from this alignment are shown. Arginine re idues are 
highlighted in red. The -tem1inal region ofHSV-1 VPI9C that contain a NL shown in 
yellow. 
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subfamilies using the predictNLS program failed to identify any recognisable NLSs. 
Therefore, it is unclear whether a role in nuclear localisation represents the usual function 
of the poorly conserved alphaherpesvirus N-termini, or where NLSs, if any are present, 
might be located in the a-subunits from beta and gammaherpesviruses. 
The mitochondrial distribution of GFP that was observed for p33-66AA-UL38-GFP 
(Figure 4.6) was unexpected. Presumably the NLS, which occupies the same region, is 
dominant and the mitochondrial signal only becomes apparent after increasingly large 
deletions have rendered the NLS inactive. Such cryptic mitochondrial localisation signals 
may be common in HSV-l; iPSORT identified nine sites in the amino acid sequence of 
HSV -I VP 19C alone that fit its criteria for potential mitochondrial localisation signals. 
Regardless of how accurate these predictions might be, the nuclear localisation of VP 19C 
demonstrates that activity from any potential mitochondrial localisation signal is masked 
by the NLS. It has previously been shown that the distribution of mitochondria is altered 
by HSV -I, with mitochondria migrating to the perinuclear region of the cytoplasm 
following infection and colocalising with the gene products of UL41 and UL46 (both of 
which are tegument proteins). The reason for this migration is unclear, but it was suggested 
that the mitochondria might supply the energy required for the incorporation of tegument 
proteins into the virion (Murata et al., 2000). Previous studies have also described 
alterations in behaviour of the mitochondria during HSV-l infection (examples include 
Lund and Ziola, 1985; Lund and Ziola, 1986; Latchman, 1988; Tsurumi and Lehman, 
1990), however, there has been no previous evidence of a relationship between VP 19C and 
mitochondria. It appears likely that mitochondrial localisation signals are common in HSV-
I but in most cases are non-functional, and that the region of VP19C attached to GFP in 
p33-66AA-UL38-GFP contained one such signal that is non-functional in wild-type 
VPI9C. 
The study of nuclear localisation signals has shown that they exist in various types. The 
NLSs found in many proteins contain monopartite or bipartite sequences that are rich in 
basic residues (reviewed by Adam, 1999; reviewed by Gorlich and Kutay 1999). These 
sequences recruit importin a proteins involved in nuclear translocation. Importin a in turn 
binds importin P protein, which mediates nuclear localisation (Chook and Blobel, 200 I). A 
limited but growing list of proteins translocate to the nucleus in the absence of importin a 
binding signals, instead interacting directly with importin p proteins via arginine-rich 
motifs (Palmeri and Malim, 1999). Examples include human ribosomal proteins (Jakel and 
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Gorlich, 1998) and human immunodeficiency virus (HIV) Tat and Rev (Truant and Cullen, 
1999). 
Schaley et al. (2005) identified a NLS in the N-terminal 58 amino acids of the adenovirus 
E4-6/7 protein. Although there is no evidence of an evolutionary relationship between this 
protein and VPI9C, they contain NLSs with similar properties. Thus, both proteins have a 
relatively arginine-rich N-terminal region, neither protein contains monopartite or bipartite 
clusters of basic amino acids that might act as a NLS, and NLS prediction programs 
PredictNLS and PSORT II were unable to identify a NLS in this region of either protein. 
The authors proposed that E4-6/7 translocates to the nucleus via a direct interaction with 
importin P as decribed above. It would be interesting to test whether VP19C also interacts 
directly with importin p. 
An alternative explanation for the nuclear localisation of VP 19C can be derived from work 
carried out by Sessler and Noy (2005) in which they attempted to find a nuclear 
localisation signal in CRABP-II. CRABP-II is a cytosolic protein that moves to the nucleus 
upon binding of retinoic acid. The amino acid sequence of CRABP-II does not contain a 
recognisable NLS. The authors showed that in the presence of retinoic acid, CRABP-ll 
undergoes a conformational change, with a surface patch that is neutral in the absence of 
retinoic acid becoming positively charged following binding. This patch was mapped to 
three basic amino acids: two lysine residues at positions 20 and 30, and an arginine at 
position 29, which shift their orientation to place their side chains in an alignment similar 
to that seen with the SV40 NLS. Similarly, although no NLS is evident from the VP19C 
protein sequence, in the folded protein the arginine residues of VP 19C may lie close 
together, acting in a similar fashion to more established NLSs. Evidence of an interaction 
between VP19C and importin a would support this hypothesis. 
Since the NLS is contained within the first 56 amino acids of VP19C (Section 4.3), the 
function of the rest of the poorly conserved N-terminal region remains unclear. EM 
analysis showed that the VP19C-63 truncation was defective for capsid assembly, both in a 
baculovirus based capsid assembly model, and by complementation of v~38YFP (Section 
4.4, Figure 4.8). The incomplete capsid shells seen in baculovirus infected cells confirm 
the fluorescence results showing that the VP19C-63 protein is able to interact with VP5 
and VP23, and indicate that the defect in assembly is not a result of a general disruption to 
the protein's structure. The results presented here contrast with those of Spencer el a/. 
(1998), who showed that a mutant of VP19C (nd90), which lacks the N-terminal 90 amino 
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acids, could support capsid assembly in a baculovirus model system. The reason for this 
difference is unclear. Although apparently intact capsids were formed with nd90, their 
assembly was inefficient and the majority of structures seen resembled the incomplete 
particles shown in Figure 4.4. It is possible that slight differences in the baculovirus model 
systems used in the two studies account for the contrasting results. Alternatively, when 
exposed at the N-terminus, amino acids 63-90 may have a disruptive effect on protein 
folding or interaction that is negated when they are absent. Whatever the reason, it is clear 
that sequences between amino acids 45 and 63 are necessary for efficient capsid formation 
and further analysis will be needed to determine precisely what role they play. 
5.4. Three-dimensional reconstructions of VP19C 
Previously, VP19C was thought to extend over the top of the triplex to connect with VP5 
(Zhou et aI., 2000). Recent results have indicated that the density at the top of the triplex 
should be reassigned to VP23 (Matthew Baker, personal communication). This 
reassignment was primarily based on interpretation of mass continuity in the new map, and 
was strengthened by the striking similarity between the tops of the two VP23 subunits 
(Figure 5.6). The large size difference between VP19C and VP23 seen in HSV-l is 
primarily a property of Alphaherpesvirinae. For example, in rhesus rhadinovirus (RRV, a 
gammaherpesvirus), TRI-l (the VP19C counterpart) and TRI-2 (VP23) are approximately 
equal in size (O'Connor et aI., 2003). It seems unlikely therefore that TRI-l is large 
enough to extend over the top of the triplex to make contact with the VP5 subunit on the 
far side. Despite this, the contacts between the triplexes and capsomers are located in 
similar positions (Yu et al., 2003). Although the resolution of the RRV map is not 
sufficient to reveal the dispositions of the triplex proteins accurately, this connection is in 
the part of the triplex that is believed to be formed by the two TRI-2 molecules. 
The size ratio of VP19C to VP23 has been estimated from the cryo-EM reconstruction as 
1.2-1.3 (Matthew Baker, personal communication), which compares with a ratio of 
approximately 1.5 based on their amino acid sequences. Some of this difference may be 
accounted for by the difficulty of segmenting the triplex from the rest of the capsid. 
However, the estimated relative size of VP19C is considerably lower than expected, 
suggesting either that a significant fraction of its size has been assigned to another capsid 
component, or that some portions of VP 19C are not resolved in the icosahedral capsid 
map. Although the appearance of additional mass in the wild-type triplex when compared 
to the VPI9C-45NLS triplex (Section 4.5, Figure 4.12) would be consistent with the 
A. B. 
Figure 5.6: The similarity between the tops of the two VP23s in a triplex. 
A. Three-dimensional reconstruction of an HSV-l triplex. VP19C is hown in red. The two 
YP23s are shown in blue and yellow. B. The two VP23s shown after segmentation and 
alignment using foldhunter (Jiang et ai. , 200 I). The tops of the two VP23s both contain loop-
like and arm-like structure , although they are twisted relative to each other. The loop-lik 
structures were previously a signed to VPI9C. 
Images supplied by Matthew Baker. 
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presence of extra residues at the N-terminus of VP19C (Figure 5.1), this putative extra 
VP19C mass occupies a position that has been assigned to VP23. This, together with the 
other changes between the two sets of triplexes, suggests that deletion of the N-terminal 45 
amino acids has had a global effect on the triplex, consistent with its global effect on 
capsid structure. Because of this effect, it appears that the location of the VP19C N-
terminus cannot be identified by this approach. This was surprising given the size of the 
deletion involved. When differences relating to the cloning of the NLS are taken into 
account, wild-type VP 19C is 37 amino acids longer than VP 19C-45NLS. The addition 
mass (approximately 4 kDa) should be readily detected. For example, it represents more 
than 30% of the mass of VP26, which was mapped to the top of the hexons by difference 
imaging (Zhou et ai., 1995). The N-terminal portion of VP 19C is poorly conserved among 
Aiphaherpesvirinae (Figure 5.1), is insensitive to disruption by insertional mutagenesis 
(Figure 3.6), and contains a large proportion of disordered residues (Figure 5.7). These 
properties suggest that it may not adopt a consistent conformation and thus would not be 
resolved accurately by icosahedral reconstruction techniques. Nevertheless, the reduced 
curvature of the capsid shell in the VP19C-45NLS capsids compared with wild-type 
capsids (Figure 4.12) indicates an important role for the N-terminal region of VP 19C in 
determining capsid structure. 
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Figure 5.7: Disorder prediction for HSV-l VPl9C and VP23. 
Disorder predictions were carried out using RO (Yang el aI., 2005) 
(http://www.strubi .ox.ac.ukIRONN). Residues showing value above 0.5 are predicted to be 
disordered. The -terminal region of VP 19C contains a large proportion of di ordered 
residues. Interestingly, insert 1 and insert 2 (Figure 5.]), which comprise anlino acids 
140-176 and 357-405 in HSV-l VP19C respectively, also appear to be disordered 
regions. 
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6. Labelling VP5 with FlAsH-EDT 2 
6.1. Introduction 
Tagging proteins by fusing them with fluorescent markers can permit their behaviour 
within living cells to be examined. The most frequent markers used at present are auto-
fluorescent proteins from a variety of marine coelenterates, especially the green fluorescent 
protein (GFP) from the jellyfish Aequoria victoria. These proteins can be fused to the 
protein of interest to form a chimera that frequently retains the properties of the target 
protein. However, GFP and its variants are proteins of 25-27 kDa (238 amino acids). The 
large size of GFP (often larger than the protein of interest) can interfere with the 
distribution, function and fate of recombinant proteins. Furthermore, in most cases it can 
only be fused at the N or C terminus of the host protein (Griffin et aI., 1998; Gaietta et at., 
2002). This means that some proteins may not be amenable to analysis by this method. For 
example, GFP tagging has been carried out successfully on the smallest capsid 
protein, VP26 (Desai and Person, 1998), while attempts to tag the triplex protein VP 19C 
with GFP have been unsuccessful (Frazer Rixon, personal communication). The successful 
tagging of other HSV -I capsid proteins with GFP has not been reported. 
Griffin et at. (1998) first described labelling with FlAsH-EDT2. In this method (see also 
Figure 6.1), proteins are modified by genetically inserting a small motif (typically 6-20 
residues) containing the sequence CCXXCC (where XX represents any two amino acids). 
Intact cells expressing the protein are labelled by exposing them to a membrane-permeant 
non-fluorescent bi-arsenical compound (FlAsH-EDT2). FIAsH-EDT2 binds with high 
affinity and specificity to the tetracysteine motif and thereby becomes strongly green 
fluorescent. Toxicity and binding of the trivalent arsenic atoms to endogenous thiols are 
minimised by the simultaneous administration of micromolecular concentrations of 
antidotes such as 1,2-ethanedithiol (EDT) (Gaietta et aI., 2002). 
The earliest designs of tetracysteine sequences were intended to encourage a-helicity, 
under the assumption that the bi-arsenical dye would ideally fit into the i, i+ I, i+4, and i+5 
positions of an a-helix (Griffin et at., 1998). When sequences of this type were used, 
labelled protein had to present in high concentrations to exceed background fluorescence 
(Stroffekova et al., 2001; Adams et al., 2002). Some reduction of background fl uorescence 
was achieved by increasing the concentrations of the di-thiols EDT and British Anti-
Lewisite (BAL) in washes to remove thiol-dependent background, or by including 
a. 
-CCXXCC-dom n uor cent oomp ex 
Figure 6.1 : FIAsH-EDT2 labelling of proteins. 
Fluorescein arsenical helix binder (FlAsH) in complex with two 1,2-ethanedithiol (EDT) 
molecules (FIAsH-EDT2) forms a complex with an a-helical peptide containing the CCXXCC 
FIAsH-EDT2 recognition site. Although the structure is drawn with the i and i+ 1 thiols 
bridged by one arsenic and the i+4 and i+5 thiols bridged by the other, an alternative 
conformation, in which one arsenic links i and i+4 whi le the other links i+ 1 and i+5 , is also 
possible. 
Figure taken from Griffin et al., 2000. 
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nonfluorescent dyes (such as Disperse Blue 3 or Patent Blue V) to block hydrophobic 
binding sites (Griffin et aI., 2000). Adams et al. (2002) showed that when the helix-
breaking amino acids proline and glycine were inserted between the dicysteine pairs to 
create a hairpin, the resulting sequence substantially increased the affinity and contrast of 
FIAsH-EDT2-labelled tetracysteine fusion proteins in cells, thus allowing the concentration 
of di-thiol competitors to be increased without a loss of specific fluorescence. To date, 
most studies in which FIAsH-EDT2 labelling has been utilised have involved the 
construction of recombinant proteins containing the sequence CCPGCC (examples include 
Hoffmann et al., 2005; Martin et al., 2005; Rudner et al., 2005; Ruthel et ai., 2005). 
Various derivatives of FIAsH-EDT2 can be designed by the chemical modification of the 
original flash compound. For example, a red analogue of flash (termed ReAsH) has been 
synthesised using the red fluorophore resorufin (Gaietta et al., 2002). Using a combination 
of FlAsH-EDT2 and ReAsH, Gaietta et al. (2002) determined the mechanism by which 
connexin43 (Cx43), a subunit of gap junction channels, is added to and removed from gap 
junction plaques. By engineering the FIAsH-EDT2IReAsH binding motif into Cx43 
protein, and then alternatively labelling cells with FIAsH-EDT2 or ReAsH, different pools 
of protein could be formed over time. This partitioning between red and green fluorescence 
revealed novel characteristics of Cx43 transport, assembly into channels and turnover. This 
work demonstrates the benefits of the technique for studying protein ageing over any time 
frame. It is highly versatile compared to the technique using green-to-red shifting E5 
protein, which matures in a fixed time frame (Miyawaki e/ at., 2003). 
Labelling proteins with FIAsH-EDT2 would be particularly useful for studying the 
assembly of the HSV -I capsid. In addition to the problems regarding the tagging of HSV-I 
capsid proteins (discussed above), pulse labelling of HSV-I capsid proteins in a manner 
similar to that described by Gaietta et al. (2002) might provide an insight into the way in 
which the structures that make up the capsid, or the capsid as whole, form following the 
initiation of assembly. Therefore, the aim of the work described in this chapter was to 
examine the feasibility of using FIAsH-EDT2 to label the HSV-I major capsid protein, 
VP5. 
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6.2. Insertion of the CCPGCC motif into the UL 19 
open reading frame 
Stephen Webster produced a panel of 19 insertional mutants for ULl9; each of these 
contained a randomly inserted 12 bp oligonucleotide, which included a recognition 
sequence for BglII. The target DNA was the mammalian expression plasmid, pE 19 
(Nicholson et al., 1994), which contains the ULl9 ORF under the control of the HCMV 
major immediate-early promoter (Stow et al., 1993). The insertion of the oligonucleotide 
resulted in the incorporation of an extra four amino acids in frame with the VP5 coding 
sequence. The mutants were tested for their ability to support virus growth, capsid 
assembly, DNA packaging, and for interactions with other capsid proteins. Eleven of the 
mutants complemented growth of a VP5 null mutant virus (K5LlZ) (Webster, 2004). As 
these mutants indicated points at which the VP5 sequence was able to tolerate the insertion 
of four extra amino acids, they were considered to be suitable candidates for the insertion 
of further genetic information, namely the FlAsH-EDT2 recognition sequence. 
Insertion of FlAsH oligonucleotides was initially attempted on two of Stephen Webster's 
VP5 insertional mutants: in754 and in1235. Subsequently, following the publication of the 
3D structure of the VP5 upper domain (Bowman et a/., 2003), it was possible to identify 
the locations of some of the points of insertion in the folded protein (Figure 6.2). The 3D 
structure also showed that in two more of Stephen Webster's mutants, in844 and in848, the 
insertion of extra amino acids took place at the top of the VP5 upper domain, away from 
alpha helices. These two mutants were considered to be particularly good candidates for 
the insertion of the FlAsH sequence - both were able to complement the growth of HSV-l 
deletional mutant K5LlZ, and as the amino acids inserted would be likely to lie on the 
surface of the folded protein, the FlAsH recognition sequence should be readily accessible 
to FIAsH-EDT2. 
Insertional mutant inl235 was digested with BglII. Oligonucleotides VP5 4lC FLA-S and 
VP5 41 C FLA-A (Table 6.1) were annealed together and ligated into the sequence at the 
BglII site as described in Section 2.2.2.5. Each FlAsH oligonucleotide contains a Smal 
recognition site so its presence in the DNA sequence was confirmed by digestion with 
Smal. Digesting ULl9inl235 with SmaI produces bands of 80 bp, 340 bp. 478 bp, 662 bp. 
1057 bp, and 1355 bp, while digesting ULl 9inl 235-Flash results in the 340 bp band being 
replaced with bands of 107 bp and 257 bp (Figure 6.3). This change in band pattern 
confirmed the insertion of the FlAsH oligonucleotides; however it did not confirm the 
--....,:..~~- 754 
Figure 6.2: Positions in the VP5 upper domain at which extra amino acid were added for the 
introduction ofFIA H-EDT2 recognition sequence. 
Figures were prepared in Protein Explorer 2.45 Beta 
(http://www.umas .edulmicrobio/chime/pe/protexpllfrntdoor.htm).using coordinates from the 
RCSB Protein Databank (http://www.rcsb.org) (Berman et 01., 2000). Positions at which extra 
amino acids were added are shown in red. The amino acid 1235 is located outwith the upper 
domain ofVP5, and therefore is not shown here. 
FlAsH Fragmen ts from Fragments from UL19 Oligon ucleotides Oligollucleotide Sequence Amino Acids Smal Digest Before Smal Digest After Mutant Used Inserted Oligoll ucleotide Oligonucleotide Insertion Insertion 
- -
in754 VP5 41 C FLA-S 5 ' GATCTGTGCTGCCCCGGGTGCTGCCGA 3 ' CCPGCCEI 80,90,238,478, 80,90,238,478, VP5 41 C FLA-A 3 ' ACACGACGGGGCCCACGACGGCTCTAG 5' 662, 1057, 1367 624, 662, 7701 1 O~ 
- r-
in844 VP5 J JA FLA-S 5' GATCTGCTGCCCCGGGTGCTGCGA 3 ' CCPGCCRDL 80,90,238,478, 80,90,238,478, VP5 1] A FLA-A 3 ' ACGACGGGGCCCACGACGCTCTAG 5' _ 662, 1057, 1367 497,662,894, L 057 
-
in848 VP5 56C FLA-S 5' GATCTTGCTGCCCCGGGTGCTGCA 3 ' CCPGCCRS 80,90,238, 478, 80, 90,238,478, VP5 56C FLA-A 3 ' AACGACGGGGCCCACGACGTCTAG 5 ' 662, 1057~ 1367 609,662, 782, 1 05~ 
in1 235 VP5 41 C FLA-S 5 ' GATCTGTGCTGCCCCGGGTGCTGCCGA 3 ' CCPGCCEI 80, 340, 478,662, 80, 107, 257, 478, VP5 41 C FLA-A 3 ' ACACGACGGGGCCCACGACGGCTCTAG 5' 1057, 1355 662, 1057, 1355 
Table 6.1: Oligonuclcotides used for inseliion of the FlAsH sequence into VP5 insertion mutants. Fragments sizes from Sma! digests lhal are allered 
following insc1 ion of the flAsH oligonucleotide are shown in red. 
UL19in1235-FLASH SmaI digests 
2 3 4 
500 bp 
400bp 
300 bp 
200 bp 
100 bp 
Figure 6.3: SmaI digests were used to identify clones with containing the FlAsH 
oligonucleotide. 
Digestion of UL19in1235 produces bands of 80 bp, 340 bp, 478 bp, 662 bp, 1057 bp, and 
1355 bp.Digestion of UL19in1235-FLA H results in the 340 bp band being replaced with 
bands of 107 bp and 257 bp. Therefore, the FlAsH oligonucleotide has inserted into 
UL 19in 1235 in samples 3 and 4, but not in amples 1 and 2. 
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orientation in which the oligonucleotides had been inserted. If the oligonucleotides had 
inserted in the wrong orientation, the inserted sequence would not code for the desired 
amino acids. Insertion in the correct orientation was confirmed by sequencing. 
A similar process was carried out for the insertion of FlAsH oligonucleotides into 
ULi 9in754, ULi 9in844, and ULi 9in848, although FlAsH oligonucleotides used and the 
band pattern expected following the insertion of the oligonucleotides varied in each case 
(Table 6.1). 
Following the insertion of the FlAsH oligonucleotides into the DNA sequence, the 
reSUlting plasmids (ULI 9in754-Flash, ULi 9in844-Flash, ULi 9in848Flash, and 
ULi 9inI235-Flash) were tested for their ability to complement the growth of the HSV-l 
ULi 9 deletional mutant K5~Z. Each mutant was transfected into BHK-21 cells, which 
were incubated at 37°C for five hours before being infected with 2 pfulcell K5~Z. After 
one hour, the unabsorbed input virus was harvested and titrated on UL 19R5C cells 
(Section 2.2.4.7). Of the four flash mutants, only ULl9inl235-Flash was capable of 
complementing K5~Z (albeit at a reduced efficiency compared with ULi 9in1235) (Figure 
6.4). Therefore, of the four flash mutants, only ULi 9in 1235-Flash is a suitable candidate 
for FlAsH-EDT21abelling experiments. 
6.3. Labelling with FlAsH-EDT 2 
The ability of FIAsH-EDT2 to bind to ULi 9in1235-Flash and produce fluorescence under a 
confocal microscope was examined. BHK-21 cells on coverslips were co-transfected with 
ULi 9inI235-Flash, either alone or along with pJK2, which expresses UL26.5 (Nicholson 
et aI., 1994). 24 hours after transfection, FIAsH-EDT2 labelling was used to determine the 
cellular distribution VP5. FIAsH-EDT2 labelling was carried out in accordance with 
instructions provided by Guido Gaietta (personal communication). The cells were washed 
three times with PBS supplemented with I gllitre D+ glucose. For each coverslip, I III of 
25 mM EDT was added to 2 III of 1 , .. 1M FlAsH. This mixture was incubated at room 
temperature for ten minutes - a step that ensures that all FlAsH is in FIAsH-EDT2 form. 
200 III of PBS/glucose was then added to the tube containing FIAsH-EDT2. Cells were 
then overlaid with the resulting mixture and incubated for one hour at 37°C. Following 
incubation, cells were washed five times in PBS/glucose containing 0.5 mM British Anti-
Lewisite (BAL) and 0.1 % DMSO, before fixation with 4% formaldehyde. As a control, the 
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Figure 6.4: Abilities of VP5 mutants to complement VP5 null mutant virus with and without 
the insertion of the FlAsH oligonucleotide .. 
Complementation of growth of the VP5 null mutant K5~Z by transfected plasmids expressing 
the VP5 site-directed mutants was carried out in BHK-21 cells. The progeny virus was titrated 
on UL38RSC cells. The titres of the viruses tested are shown. 
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distribution of VP5 in cells was also determined by immunofluorescence using anti-VP5 
antiserum (Section 2.2.4.5). 
In cells transfected with ULl9in1235-Flash and UL26.5, fluorescence apparently produced 
from the binding of FlAsH-EDT2 was observed primarily in the nucleus (Figure 6.5). In the 
absence of UL26.5, fluorescence was confined to the cytoplasm (Figure 6.6). These 
observations are in accordance with the expected distributions of VP5 in the presence and 
absence of preVP22a. Furthermore, fluorescence from the anti-VP5 antibody essentially 
co-localised with the FlAsH-EDT2 fluorescence (Figures 6.5 and 6.6). Thus, it appeared 
that the FlAsH-EDT2 was selectively binding to its recognition sequence. In general, 
FlAsH-EDT2 fluorescence observed in the cytoplasm appeared brighter than that observed 
in the nucleus. This may have been due to FlAsH-EDT2 being unable to efficiently 
penetrate the nuclear membrane, or to a reduced ability of FlAsH-EDT2 to bind to 
ULl9in1235-Flash when it is complexed with preVP22a. However, in cells where VP5 
was expected to be localised to the nucleus, a background level of fluorescence was also 
visible in the cytoplasm. It has been suggested (Gaietta, personal communication) that the 
cause of this was insufficient levels of BAL during the washing stages (Section 2.2.8). 
BAL removes unbound FIAsH-EDT2 from cells, and it may be that a reduced 
concentration of BAL in the washing solution could result in this being done inadequately. 
The experiment was repeated, varying the concentrations of BAL in the washing solution 
(ranging from 0.3 mM to 1.0 mM). However, no tested concentration of BAL was able to 
alter levels of background fluorescence. Trafficking experiments carried out on the HSV-I 
capsid proteins require low levels of background fluorescence in order to identify the 
locations of the components of the capsid during assembly, therefore in the absence of 
further improvements to the levels of background fluorescence it was not felt that labelling 
with FIAsH-EDT2 was a suitable method for studying the HSV-J capsid, as discussed in 
Section 8.1. 
FlAsH-EDT2 
labelled 
VP5 antibody 
labelled 
Co-localisation of 
VP5 antibody and 
FlAsH-EDT2 
Figure 6.S: FIAsH-EDT2 labelling of cells expressing UL 19in 123S-Flash and preVP22a. 
BHK-21 cells were cotransfected with UL19in 123S-Flash and pJK2 (expressing VP22a). The 
distribution of the CCPGCC-tagged VPS was detected by FIAsH-EDT2 labelling. The 
fluorescence attributed to FIAsH-EDT2 labelling (green) was compared to that obtained by 
immunofluorescence by also labelling CCPGCC-tagged VP5 with the antiserum rAb 184 and 
visualising using TRITC-conjugated GAR (red). 
FIAsH-EDT2 
labelled 
VPS antibody 
labelled 
Figure 6.6: FIAsH-EDTz labelling of cells transfected with ULI9in 123S-Flash. 
Co-localisation 
of VPS antibody 
and FlAsH-EDT2 
BHK-21 cells were transfected with UL 19in 123S-Flash. CCPGCC-tagged VP5 was detected by FIAsH-EDT2 labelling. The fluorescence attributed to FIAsH-
EDT2 labelling (green) was compared to that obtained by immunofluorescence by also labelling CCPGCC-tagged VP5 with the antiserum rAb 184 and 
visual ising using TRITC-conjugated GAR (red). 
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7. Site-directed mutagenesis of VP5 
7.1. Introduction 
The major capsid protein interacts with VP26 at the tips of hexons (Trus et aI., 1995; Zhou 
et al., 1995), and with tegument at the tips of pentons (Zhou et al., 1999). Our 
understanding of these interactions has been aided by the resolution of the crystal structure 
of the VP5 upper domain (Figure 1.16) (Bowman et aI., 2003). Since the publication of the 
crystal structure, a combination of computational and experimental approaches has been 
used in an attempt to identify the particular amino acids involved in these interactions. 
Previously, single amino acid substitutions have been used to identify residues in VPS that 
are important for interaction with preVP22a (Walters et aI., 2003) and residues in VP26 
that are important for interaction with VP5 (Desai et al., 2003). V sing a similar approach, 
residues of VP5 that were suggested as being important for interaction with VP26 were 
examined. 
7.2. Identification of VP5 residues that might have a 
role in VP26 binding 
Superimposition of the VP5 upper domain (VPSud) crystal structure onto the 8.sA capsid 
reconstruction identified positions in the VP5ud that appeared to be in close contact with 
VP26. This identified six amino acids near the top of VPS that represented good candidates 
for involvment in the interaction (Figure 7.1): Residues 833 (aspartic acid), 834 (arginine), 
836 (tyrosine), 837 (alanine), 839 (leucine), 841 (asparagine) and 851 (glutamic acid) 
(Matthew Baker, personal communication). In order to test this hypothesis, mutagenesis of 
these amino acids was carried out, and each resulting mutant was assayed for its ability to 
interact with VP26. Each mutant produced contained a single amino acid change, with the 
candidate amino acid substituted by an alanine. Since amino acid 837 is already an alanine 
it was not mutated in this study. 
7.3. Introduction of an Mlul site into the UL 19 open 
reading frame 
peR was used to generate portions of the VLl9 ORF containing the desired mutations 
(Figure 7.2), and the resulting sequences were cloned into the full length VL 19 ORf'. The 

Figure 7.1: The VP5 upper domain. 
Top: View from above of the upper domains of two hexon VP5s bound to two VP26 
molecules (blue-grey semi-transparent). In the VP5 upper domain, acidic residues are 
coloured red, basic residues are coloured blue and uncharged residues are coloured grey. 
(Figure reproduced from Bowman et al., 2003). 
Bottom left: The right-hand VP5 upper domain from the top figure, with residues that can be 
altered by PCR mutagenesis following the construction ofpWA I shown in orange. 
Bottom right: Residues suggested by Matthew Baker (personal communication) as having a 
role in VP26 or tegument binding. Residues that were substituted for alanine in the work 
described here are shown in blue, red and magenta. Amino acids shown in blue were 
suggested as having a role in VP26 binding and substitution of alanine did not affect viability. 
When the tyrosine at position 836 was substituted for alanine (red), no infectious virus was 
produced. The histidine at position 866 (magenta) was suggested as having a role in tegument 
binding. Alanine substitutions were not successfully attempted for residues shown in yellow. 
(Bottom left and bottom right figures were prepared in Protein Explorer 2.45 Beta 
(http://www.umass.edulmicrobio/chime/pe/protexpl/fmtdoor.htm).using coordinates from the 
RCSB Protein Databank (http://www.rcsb.orglpdbl) (Berman et al., 2000). 
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Figure 7.2: PCR method for site-directed mutangenesis 
A. PCR was carried out on D A to be mutagenised. Two reaction were carried out. Each 
PCR product contained an overlapping region, in which the desired mutation was located. 
'Inner' primers contained the d ired mutation (denoted by red line ). B. PCR product from 
the two reactions contained overlapping region and de ired mutation. C. The econd round of 
PCR was calTied out, using the two products from the first PCRs as template D A and the 
'outer' primers shown in A. D. The product of the second round ofP R contained the de ired 
mutation. As suitable cloning ites flanked the mutation, th P R product could then be 
introduced into the ORF targeted for mutagenesis. 
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region of the UL 19 ORF containing all the amino acids under investigation did not contain 
many unique recognition sites for restriction enzymes. There is an NruI site 159 bp 
upstream of amino acid 833, while an FspAI site is 263 bp downstream of amino acid 8SI. 
While NruI can be obtained from most suppliers at relatively little cost, FspAI proved 
more difficult to obtain and was considerably more expensive than most currently available 
restriction enzymes. For this reason, PCR mutagenesis was carried out to introduce a 
unique restriction enzyme recognition site - an MluI site - downstream of the amino acids 
under investigation. This alteration results in the substitution of a guanine for an adenine in 
the nucleotide sequence; however, it does not alter the protein sequence, with amino acid 
882 of VPS remaining a glycine. The introduction of this MluI site in this region allowed 
mutagenesis of the UL19 ORF between the NruI site (225S bp from the start of UL 19 -
amino acid 752) and the MluI site (2646 bp from the start of UL19 - amino acid 882) as 
described below (Figure 7.1). 
Analysis carried out by Matthew Baker on the three-dimensional structure of VPS had also 
suggested that amino acid 866 (histidine) lies in very close proximity to the site of 
tegument attachment in pentons (personal communication). Since amino acid 866 lies in 
the region that can be examined by this method, the study was extended to include 
mutagenesis of this amino acid. 
Attempts to carry out mutational PCR using the Quickchange mutagenesis kit (Stratagene) 
were unsuccessful due to failure of the PCR reaction, possibly caused by the large 
difference in GC content between the vector and insert sequences (Frazer Rixon, personal 
communication). Therefore, an alternative mutagenesis method was used as illustrated in 
Figure 7.2. Frazer Rixon had previously cloned the UL 19 ORF into pF ASTBAC pC I. 
pF ASTBAC pCI (provided by Roger Everett) is a derivative of the pF ASTBAC 
baculovirus transfer vector (Invitrogen) that was modified to include the HCMV IE 
promoter for expression in mammalian cells. To introduce a unique Mlul site into the 
UL19 ORF, two separate PCR reactions were carried out. In reaction 1 the primers used 
were UL19 UO SEN2 and UL19 MLU ANTI, while in reaction 2 the primers used were 
UL19 MLU SENS and UL19 DOWN ANT (Table 7.1). UL19 MLU SENS and ULl9 
MLU ANTI are complementary oligonucleotides which when annealed result in a base 
change (G to A at position 2646 in the UL19 sequence). The expected PCR product from 
reaction I was 497 bp long, while reaction 2 was expected to produce a 218 bp product 
(Figure 7.3A). Bands of appropriate sizes were identified, extracted from 1 xT AE gel and 
purified by Sephaglas purification. A PCR reaction was then set up using a mixture of the 
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Figure 7.3: Gel photographs from cloning steps during construction of VP5 site-directed 
mutants. 
A. (Lane I) peR product obtained from reaction 1 (wild-type UL19 ORF was used as a 
template, UL 19 VO SEN2 and UL 19 MLU ANTI were used as primers. The expected peR 
product from reaction 1 was 497 bp long. (Lanes 2, 3, and 4) peR product obtained from 
reaction 2 (wild-type UL19 ORF was used as a template, VL19 MLV SENS and VL 19 
DOWN ANT were used as primers). The expected peR product from reaction 2 was 218 bp 
long. Details of primers are shown in Table 7.1. Band sizes were estimated using a 100 bp 
ladder (New England Biolabs). Selected band sizes (in numbers of base pairs) in the 100 bp 
ladder are indicated. 
B. Digestion with both Nrul and FspAI produces blunt ends, therefore the mutated section of 
the UL 19 ORF could potentially insert in either orientation. Insertion in the correct 
orientation could be confirmed by the production of bands of 1537 bp and 8580 bp from an 
MlullXbal digest (as seen in lanes 2, 3, and 5). Insertion in the incorrect orientation produces 
bands of 1795 bp and 8322 bp (as seen in lanes 1, 4, and 6). Band sizes were estimated using 
a 1 kb ladder (New England Biolabs). Selected band sizes in the I kb ladder are indicated. 
c. (Lanes 1 and 2) Digestion of pGEMT UL19Mlul with HincH should produce bands of 
either 499 bp and 3216 bp, or 265 bp and 3450 bp, depending on which orientation the peR 
fragment inserted into pGEMT Easy. Both lanes 1 and 2 show clones with inserts in the first 
orientation. (Lanes 3 and 4) In pGEMT VL19Mlul clones which produced the 499bp/3126bp 
digest pattern from HincH digestion, digestion with Pvull should produced fragments of 469 
bp, 682 bp, and 2564 bp. Band sizes were estimated using a 100 bp ladder (New England 
Biolabs). The position of the 600 bp band is indicated. 
Primer ID Primer Sequence 
UL19 UO SEN2 5' GAGCTGAATCACCTAATGCGAGACC 3' 
UL19 SDM UPSTREAM 3 5' CATACACGGCAGCGAGCACGTC 3' 
UL19 DOWN ANT 5' GCCATTTTGGATGGTATGGTCCAG 3' 
UL19 MLU SENS 5' CACAACGGACGCGTGGTAGTG 3' 
UL19 MLU ANTI 5' CACTACCACGCGTCCGTTGTG 3' 
V771 SENSE 5' GCATGTAACGCGGCGACCGCGGAC 3' 
V771 ANTI 5' GTCCGCGGTCGCCGCGTTACATGC 3' 
T773 SENSE 5' GTAACGTGGCGGCCGCGGACTTC 3' 
T773 ANTI 5' GAAGTCCGCGGCCGCCACGTTAC 3' 
D775 SENSE 5' GTGGCGACCGCGGCCTTCAACC 3' 
D775 ANTI 5' GGTTGAAGGCCGCGGTCGCCAC 3' 
D833 SENSE 5' GTTCGCTTCGCCCGCGTATACGC 3' 
D833 ANTI 5' GCGTATACGCGGGCGAAGCGAAC 3' 
R834 SENSE 5' GTTCGCTTCGACGCCGTATACGCC 3 ' 
R834 ANTI 5' GGCGTATACGGCGTCGAAGCGAAC 3' 
Y836 SENSE 5' CGACCGCGTAGCCGCCACCCTG 3' 
Y836 ANTI 5' CAGGGTGGCGGCTACGCGGTCG 3' 
L839 SENSE 5' GTATACGCCACCGCTCAGAACATGGTG 3 ' 
L839 Al~TI 5' CACCATGTTCTGAGCGGTGGCGTATAC 3 ' 
N841 SENSE 5' GCCACCCTGCAGGCCATGGTGGTC 3' 
_N841 ANTI 5' GACCACCATGGCCTGCAGGGTGGC 3 ' 
H866 SE]\TSE 5' CACCCCCTGGCCCCGGCCAATCTG 3' 
H866 ANTI 5' CAGATTGGCCGGGGCCAGGGGGTG 3' 
Table 7.1: Primers used in cloning UL19 site-directed mutants. 
Bases in which the D A sequence differ from the wild-type ORF are shown in red. 
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products of reactions 1 and 2 as template DNA, while the primers were UL19UO SEN2 
and UL19 DOWN ANT. The expected PCR product from this reaction was 695 bp long. A 
band of the appropriate size was identified, extracted from 1 xT AE gel and purified by 
Sephaglas purification. The purified band was ligated into pGEMT Easy (Promega) to 
obtain pGEMT UL19MluI. The presence of the mutated section of the UL19 ORF in 
pGEMT Easy was confirmed by digestion with EcoRI (which was expected to produce a 
band of 718 bp), HincH (either 265 bp and 3450 bp, or 499 bp and 3216 bp, depending on 
the orientation that the PCR product inserted into pGEMT Easy), and Pvull (either 358 bp, 
793 bp, and 2564 bp or 469 bp, 682 bp, and 2564 bp) (Figure 7.3C). The presence of a 
mutated section of the UL 19 ORF in the plasmid was confirmed by sequencing. 
Following sequencing, pGEMT UL19MluI and 1 C7/pC 1 were digested with NruI and 
FspAI, and bands of respectively 524 bp and 9593 bp were extracted from the two digests. 
These bands were ligated to produce pWAl, a pFASTBAC clone of ULl9 with a single 
base change that introduced a unique MluI site. As digestion with both NruI and FspAI 
produces blunt ends, the mutated section of the UL 19 ORF could potentially insert in 
either orientation. To check this, MluIlXbaI digests were carried out. Insertion in the 
correct orientation could be confirmed by the production of bands of 1537 bp and 8580 bp 
from this digest (Figure 7.3B). A clone showing the correct digestion pattern was selected 
for further use and designated pWAl. The sequence of pWAl was confirmed by DNA 
sequencing. 
7.4. Construction of site-directed mutants 
To mutate the required co dons in the UL19 ORF, two-stage PCR reactions, similar to that 
described above, were carried out using the primers described in Table 7.l. The resulting 
sequences were ligated into pGEMT Easy to produce pGEMT833, pGEMT834, 
pGEMT836, pGEMT839, pGEMT841, pGEMT851, and pGEMT866. The presence of the 
mutations in the resulting plasmids was analysed by DNA sequencing. pGEMT833, 
pGEMT834, pGEMT836, pGEMT839, pGEMT841, and pGEMT866 contained the 
expected sequences. However, pGEMT851 contained a single base insertion, which 
resulted in a frameshift. Unfortunately the time constraints of this project did not allow the 
construction of pGEMT851 to be repeated. 
Each of the pGEMT plasmids described above was digested with NruI and MluI. In each 
case this produces two fragments of 391 bp and 3324 bp. The 391 bp fragment was 
133 
isolated and purified. Digestion of p W A 1 with NruI and MluI generated two bands of 391 
bp and 9726 bp. The 9726 bp band was isolated and purified. The purified 391 bp and 
9726 bp bands were ligated together to produce pWA833, pWA834, pWA836, pWA839, 
pWA841, and pWA866. 
7.5. Identification of further VP5 residues that might 
have a role in VP26 binding 
Shortly after construction of these mutants, a refined analysis of amino acids of VP5 likely 
to be involved in the interaction with VP26 became available (Matthew Baker, personal 
communication). Bioinformatic analysis of VP26 and the VP5ud suggested that there are 
three primary regions of contact between VP5 and VP26. In VP26 the N- and C-termini 
contain high concentrations of charged amino acids, and estimates obtained from 
bioinformatic approaches suggest that the areas of VP5 in close contact with these regions 
of VP26 also contain charged residues. It appears likely that residues 834 (arginine) and 
953 (aspartic acid) are both in close proximity to the N-terminal arm of VP26, while 775 
(aspartic acid), 833 (aspartic acid), 851 (glutamic acid), 899 (histidine), and 903 (glutamic 
acid) are in close proximity to the C-terminal arm. VP5 also appears to have two loops in 
close proximity to VP26, with the positions of amino acids 771 (valine), 772 (alanine), 773 
(threonine), 841 (asparigine), 842 (methionine), 872 (alanine), 873 (asparagine), and 874 
(threonine) making them possible candidates for VP26 binding. Residues suggested for 
site-directed mutagenesis are summarised in Figure 7.1. 
As described above, construction of pWA833, pWA834, and pWA841 had already been 
carried out. Amino acids 772 and 872 were alanine, and therefore not suitable for this 
method of analysis, while amino acids 899, 903, and 953 were upstream of the MluI site 
and would therefore require an alternative cloning strategy for mutagenesis. Therefore, for 
this analysis of the interaction between VP5 and VP26, mutagenesis resulting in amino 
acid substitutions at positions 771, 773, 775, 842, 873, and 874 was attempted. Cloning 
was carried out as described above, with primers used for PCR mutagenesis as listed in 
Table 7.1. When the resulting DNAs were sequenced, many were shown to contain 
unexpected single base substitutions and/or insertions, suggesting that the extension 
temperature during the PCR might have been too low; this could have resulted in the 
incorporation of erroneous bases in the sequence. Unfortunately, there was not enough 
time to repeat the cloning; nevertheless, full-length ULl9 ORFs containing bases coding 
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for amino acid substitutions at positions 771, 773, and 775 (pWA771, pWA773, and 
pWA775 respectively) were produced. 
7.6. Analysis of site-directed mutants 
7.6.1. Complementation 
To analyse the effects of the mutations on the properties of VPS, their ability to 
complement the growth of the HSV -1 deletional mutant KS~Z (Desai et at., 1993) was 
examined. DNA from each site-directed mutant was transfected into BHK-21 cells. These 
were incubated at 37°C for five hours before being infected with 2 pfulcell ofKS~Z. After 
one hour, the unabsorbed input virus was neutralised by an acid wash. Incubation was 
continued at 3ic for 40 hours, at which time the progeny virus was harvested and titrated 
on UL19RSC (Section 2.1.4). Figure 7.4 shows the relative yield obtained with each of the 
mutant plasmids compared to that obtained with the wild-type control (pE 19). With the 
exception of p W A836, all the mutants retained the ability to support virus growth to some 
degree, with the mutants in amino acids 771-77S producing slightly higher average yields 
(66-72% of the VPS wild-type control level) than mutants in amino acids 833-866 (27-
53%). 
7.6.2. Interaction with VP19C and preVP22a 
In order to ensure the formation of functional capsids, and hence infectious virions, VPS 
must interact correctly with VP 19C and pre VP22a. The presence of either of these proteins 
is sufficient to transport VPS to the nucleus. In the absence of both proteins, VPS is 
distributed throughout the cell (Rixon et aI., 1996). Since these interactions are essential, 
they can be assumed to have formed correctly in the VPS mutants that complemented 
K5~Z. To examine these interactions in p W A836, it was co-transfected into BHK-21 cells 
along with either pE38 (Rixon et at., 1996), which expresses VPI9C, or pJK2, which 
expresses preVP22a (Nicholson et aI., 1994). The distributions of the proteins were 
determined by immunofluorescence (Section 2.2.4.S). These co-transfections demonstrated 
that the mutation in p W A836 did not affect interactions with VP 19C and pre VP22a (Figure 
7.S). 
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Figure 7.4: Abilities ofVP5 site-directed mutants to complement VP5 null mutant virus. 
Complementation of growth of the VP5 null mutant K5dZ by transfected plasmids expressing 
the VP5 site-directed mutants was carried out in BHK-21 cells. The progeny virus was titrated 
on UL38RSC cells. The results are shown as percentages of the titre obtained with the wild-
type VP5 control plasmid. 
pWA836N P19C 
co-transfection 
p W A836/pre VP22a 
co-transfection 
Figure 7.5: Influence of VP 19C and pre VP22a on the distribution of V P5 insertiona I mutant 
pWA836 . 
BHK-21 cells were cotran fected with pWA836 and either pUL38FBp [(which expres e 
wild-type VPI9C), or plK2 (wild-type preVP22a). VPI9C wa detected with the monoclonal 
antibody rnAb02040 and visuali ed u ing FITC GAM (green). preVP22a wa detected with 
the monoclonal antibod mAbMCA406 and visualised using FITC GAM (green). pWA836 
wa detected with the anti erum rAb186, and visuali ed using TRfTC-conjugated GAR (red). 
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7.6.3. DNA packaging 
As shown in Figure 7.S, both VP 19C and VP22a were able to transport the mutant form of 
VPS expressed from p W A836 to the nucleus, indicating that the mutation had not disrupted 
VPS's binding to either protein. Since successful DNA packaging depends on the presence 
of functional capsids, the ability of p W A836 to support the packaging of DNA was also 
examined in a plasmid-based packaging assay. As described in Section 2.2.9, the presence 
of DNase-resistant DNA in the WT, pWAl, and pWA77 1 transfected samples (Figure 7.6) 
demonstrates that DNA packaging had taken place, while in p W A836 the lack of packaged 
DNA suggests that either the capsid assembly or packaging mechanism were disrupted. 
7.6.4. Interaction with VP26 
The effects of the VPS mutations on the interaction between VPS and VP26 was analysed 
by immunofluorescence. VP26 does not localise specifically to the nucleus when expressed 
in the the absence of other viral proteins, but is predominantly nuclear when co-expressed 
with VP5 and preVP22a (Rixon ef al., 1996). To examine the ability of the VP5 mutants to 
interact with VP26, each mutated plasmid was co-transfected into BHK-2l cells along with 
pE3STl, which expresses a pp6S epitope tagged form of VP26 (Rixon et aI., 1996), and 
pJK2, which expresses pre VP22a (Nicholson et aI., 1994). The distributions of the proteins 
were determined by immunofluorescence (Section 2.2.4.5). VP26 was seen to be located in 
the nucleus in the presence of preVP22a and each of the VPS mutants (Figure 7.7), 
indicating that none of the single amino acid substitutions examined prevented the 
interaction between VP5 and VP26. This is discussed further in Section 8.2. 
Total 
DNA 
DNase-Resistant 
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Figure 7.6: Ability ofVP5 ite-directed mutant to package D A. 
BHK-21 cells were transfected with either pE19 (wild-type (WT) VP5), one of the VP5 site-
directed mutants, or a negative (no D A) control as indicated. Cells were uperinfected with 
K5Ll..Z, and total (top) and D ase-resi tant (bottom) D As were prepared. The D A were 
digested with EcoRI and DpnI, and the fragments were separated by electrophore is through 
an agarose gel. The gel wa blotted, the membrane wa hybridised to 32P-Iabeled pATl 53 
D A and, after being wa hed, the membrane was exposed to a pho phoimager screen. 

Figure 7.7: Influence ofVP5 site-directed mutants on the distribution ofVP26. 
BHK-21 cells were cotransfected with pE35Tl (expressing pp65 epitope tagged form of 
VP26), pJK2 (preVP22a), and either pE 19 (wild-type (WT) VP5), or one of the VP5 site-
directed mutants as indicated. VP26 was detected with the monoclonal antibody 9220 
(Capricorn Products), and visualised using FITC GAM (green). VP5 was detected with the 
antiserum rAb 184, and visualised using TRlTC-conjugated GAR (red). 
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8. Using Mutagenesis to Study VP5 - Discussion 
Alterations and additions to the sequence of the HSV-l major capsid protein have provided 
an insight into the functional organisation of the protein. Warner et al. (2001) randomly 
mutagenised the N-terminal 255 nucleotides of VP5 using error-prone peR in order to 
identify residues that were important for interactions with the scaffold proteins. (The N-
terminal region of VP5 had previously been identified as important for interaction with the 
scaffold proteins (Desai and Person, 1999; Warner et al., 2000»). Webster (2004) generated 
a panel of insertional mutants of VP5, each of which had an extra four amino acids inserted 
at a random position in the protein sequence, and examined each mutant's ability to 
support virus growth, capsid assembly, DNA packaging and to interact with other capsid 
proteins. 
8.1. Labelling VP5 with FlAsH-EDT 2 
Tetracysteine motifs were inserted into four positions in the VP5 amino acid sequence. It 
had previously been shown that at each of these positions it was possible to insert four 
extra amino acids without disrupting protein function; however, with the exception of the 
insertion at amino acid 1235, insertions of a further eight or nine amino acids (Table 6.1) 
resulted in the protein losing its ability to function normally and complement growth of a 
VP5 deleted virus (K5.1Z). Examination of the 3D structure of the VP5 upper domain 
shows that amino acids 754, 844, and 848 are all in loops that are exposed on the surface of 
the VP5 upper domain. The introduction of hydrophobic residues such as cysteine to an 
exposed region of a protein might have an affect on the protein's folding and binding 
specificities. 
When the sequence CCPGCCEI was inserted into the existing insertion (REIS) in VP5 
mutant in1235, it was still able to rescue K5.1Z (Figure 6.4). In the resulting VP5 mutant. 
ULI9inI235-Flash, a total of twelve extra amino acids had been inserted at amino acid 
1235. This observation indicates that this region of the protein is particularly tolerant of 
insertional mutagenesis; it could suggest that this region is not one that the structure and 
function of VP5 is particularly dependent on. As this region of the protein is not in the VPS 
upper domain, it is not possible to determine the location of amino acid 1235 in the folded 
protein. Baker et al. (2003) used computation analysis to predict the locations of secondary 
structural elements in the remainder of VPS, and to predict where these secondary 
structural elements would be located in the folded protein. They predicted that residues 
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1194-1374 are located in the middle domain of VP5, making up a region known as the 
VP5 helix bundle with residues from the N-terminal region of the protein. However, the 
software that they used did not identify any secondary structural elements at or near to 
amino acid 1235. None of the remaining flash mutants were able to rescue K5~Z. It 
appeared that in each of these cases, although the insertion of four extra amino acids did 
not affect the mutant protein's ability to complement growth of K5~Z, the addition of a 
further eight or nine amino acids at the same point of insertion rendered VPS non-
functional. This was particularly surprising for in 844 and in848, which are located at the 
top of the hexon and penton VPS subunits in a location that had been suggested to be more 
tolerant of insertions (Webster, 2004), and would suggest that the structure of VPS is 
poorly able to tolerate major changes. Some structural proteins are more tolerant to the 
addition of extra residues than others. For example, in hepatitis B virus (HBV), multiple 
copies of a 183 amino acid core protein form the nucleocapsid. It has been shown that 
HBV capsids can still be formed when the entire GFP sequence (238 amino acids) is 
inserted in a loop between two long a-helices between amino acids 79 and 80 of the HBV 
core protein (Kratz et aI., 1999). 
When BHK-21 cells were transfected with UL19in123S-Flash and VP22a, and then 
subsequently examined following exposure to FIAsH-EDT2 and immunofluorescence with 
a VP5 antibody, fluorescence was observed in similar positions within the nucleus (Figure 
6.S). This indicates the insertion of the tetracysteine motif does not disrupt the ability of 
VP22a to transport VPS to the nucleus, and that FlAsH-EDT2 is able to bind to the 
tetracysteine motif in ULl9inI23S-Flash with some degree of specificity. When 
transfections were carried out in the absence of VP22a, the strongest fluorescence appeared 
in the cytoplasm (Figure 6.6), as would be expected from a transfection of VPS alone. In 
general, cytoplasmic fluorescence appeared brighter than nuclear fluorescence. This might 
be due to a reduced efficiency of FIAsH-EDT2 staining in the nucleus as compared to the 
cytoplasm, or to the FIAsH-EDT2 recognition site being less accessible in VPS when 
complexed with preVP22a. 
All the cells examined contained considerable levels of background fluorescence (Figure 
6.S). Cells with bright punctate fluorescence were often observed (examples are shown in 
Figure 8.1). These would prove a particular problem for studies of labelled capsids. 
Although the removal of this was attempted by increasing the concentration of BAL during 
the washing stages of the procedure (upon advice from Guido Gaietta) (Section 6.3), no 
effective decrease was observed in the levels of background fluorescence. In fact, the 
Wild-type VP5 + 
preVP22a 
UL19in1235-Flash 
+ preVP22a 
Figure 8.1: Levels of background fluore cence often seen in cells labell d with FIA H- DT2• 
BHK-21 cells were cotran fected with UL 19in 1235-Flash and pJK2 (expre sing VP22a) and 
either pE 19 (expre sing wild-type VP5) or ULl9in1235-Fla h. FIA H-EDT2 labelling wa 
carried out. Little nuclear fluore cence can be seen in cell tran fecled with wi ld-t pe VP5 
(thus containing no CCPGCC motif), and nuclear f1uore cence can be ob en/ed in cell 
transfected with UL 19in 1235-Fla h, however background nuore cence can be ob erved in the 
cytoplasm of both cell . 
138 
levels of background fluorescence are such that the method of FIAsH-EDT2 labelling is 
currently inapplicable to studies of the HSV -I capsid without further optimisation. Several 
published studies have also reported problems with background fluorescence in FlAsH-
EDT2 labelling. Stroffekova et af. (2001) suggested that FIAsH-EDT2 might bind to 
endogenous cysteine-containing proteins, making the method not easily applicable to 
proteins that contain many endogenous cysteine residues. They further suggested that with 
the levels of background fluorescence observed, FIAsH-EDT2 labelling might only be 
applicable for labelling recombinant proteins that are expressed at a very high level. They 
also reported a variation between cell types in levels of background fluorescence, with 
higher levels of background fluorescence observed in HEK 293 cells than in HeLa-S3 
cells. In this study, BHK-21 cells were the only cell type in which labelling was attempted, 
therefore no conclusions can be drawn on the relative levels of background fluorescence 
compared to other cell types. 
Recently, attempts have been made to increase the affinity of the tetracysteine motif to 
FIAsH-EDT2 (Martin et al., 2005). If this increase could be achieved, more stringent 
dithiol washes could be used to increase the contrast between the fluorescence obtained 
from specific and nonspecific binding. These attempts have centred on the amino acids 
surrounding the tetracysteine motif, and have resulted in the identification of two 
sequences, HRWCCPGCCKTF and FLNCCPGCCMEP, that showed increased contrast 
between fluorescence obtained from specific and non-specific binding when used to 
replace previously characterised tetracysteine motifs (a twenty fold increase in contrast 
over AEAAARECCRECCARA (Griffin ef al., 1998), and a six fold increase over 
AEAAARECCPGCCARA (Adams et aI., 2002». The molecular explanation of the higher 
affinity possessed by HRWCCPGCCKTF and FLNCCPGCCMEP for FIAsH-EDT2 is 
currently unclear, but based on this recently-published information, it would be interesting 
to construct recombinant VP5 proteins containing these sequences and to examine whether 
they reduce the problems of background fluorescence that have up to now been 
experienced in the application of FIAsH-EDT2 labelling to the HSV-l capsid. 
8.2. VP5 upper domain site-directed mutagenesis 
A panel of nine VP5 mutants was constructed, each of which had an amino acid sequence 
that differed from wild-type VP5 by one amino acid (Section 7.4). These changes were at 
positions of apparent close contact between VP5 and VP26, or where bioinformatic 
analysis suggested a possible role in the binding of VP26 or, in the case of one mutant, of 
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tegument (Sections 7.2 and 7.S). Eight of the mutants were able to complement virus that 
did not contain VP5 (Section 7.6.1, Figure 7.4. The failure to complement of the VPS 
mutant with an amino acid substitution at position 836 appears to be due to a defect in its 
ability to package DNA (Section 7.6.3, Figure 7.6). Although it has been demonstrated that 
this mutant is able to interact with VPI9C and VP22a (Figure 7.S), its ability to interact 
with other HSV -I capsid proteins such as VP23 has not been examined. The phenotype of 
this mutant resembles that of some of VP 19C insertional mutants described in Section 3.4, 
in that although the overall conformation of the protein is not disrupted to the extent that it 
cannot bind its capsid partners, it is sufficiently affected to prevent it from functioning 
normally. The inability to package DNA suggests either that the assembly of the capsid 
shell was disrupted due to an alteration in the interactions with other capsid proteins, or 
that an interaction involving one of the other virion components, such as the scaffold or 
packaging proteins, had been affected. Due to lack of time, these possibilities were not 
investigated. 
Eight of the mutants contained a substitution at an amino acid that was proposed as having 
a role in VP26 binding. However, results from co-transfection of each of the mutants with 
preVP22a and VP26 demonstrated that the mutation had not affected the ability of any of 
the mutants to bind VP26 (Section 7.6.4, Figure 7.7). Several VPS amino acids have been 
suggested as having a role in VP26 binding (Matthew Baker, personal communication). 
The suggestions were based on computer-based analyses of the crystal structure of the 
upper domain of VP5; these highlighted charged and hydrophobic residues that appear to 
be in close contact with VP26. It may be the case that some, or indeed all, of the residues 
suggested have a role in VP26 binding, but that binding is not abolished by the change 
made to anyone of them. Regarding this point, it should be noted that fluorescent co-
localisation is not a quantitative technique, and there is a degree of subjectivity in the 
assessment of how effectively the two proteins interact. It should also be noted that the 
VP5 mutants that were constructed and analysed represent a subset of the amino acids that 
were suggested as having a possible role in VP26 binding. Due to time constraints it was 
not possible to construct the remaining site-directed mutants, and it is still possible that one 
of the other amino acids suggested has a central role in VP26 binding. It would be 
interesting to extend this study to VPS mutants that contain several amino acid 
substitutions, i.e. substitutions comprising a combination of the residues suggested by 
computer-based analysis. Interestingly, Stephen Webster reported that two mutants of VPS 
did show reduced interaction with VP26. These mutants contained four amino acid 
insertions at positions close to many of the mutations described in this section - at amino 
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9. Conclusions 
The work for this thesis built upon earlier work on the HSV -I capsid structure and was an 
attempt to analyse the functions and interactions of certain capsid proteins by mutational 
analysis. The potential identification of amino acids in VP5 that might be important for 
binding VP26 was made possible by the resolution of the crystal structure of the VP5 
upper domain (Bowman et al., 2003). Single amino acid substitutions were previously used 
to identify residues in VP5 that are important for interaction with preVP22a (Walters el al., 
2003) and residues in VP26 that are important for interaction with VP5 (Desai el aI., 
2003), and using information from the crystal structure of the VP5 upper domain, it was 
hoped that a similar method of analysis would identify amino acids in VP5 that are 
important for interaction with VP26. 
One-step mutagenesis using the Quickchange procedure was unsuccessful (Frazer Rixon, 
personal communication). Therefore, mutagenesis was carried out using an overlapping 
peR strategy. Unfortunately, this method was prone to unwanted further mutations in the 
DNA sequence and as the desired mutation involved changes to 1-3 nucleotides, the only 
way to determine the fidelity of the DNA product was to obtain its sequence. As a result, 
obtaining site directed mutants was time consuming and site directed mutagenesis was only 
successful for nine of the eighteen amino acids originally suggested as having a roles in 
either VP26 or tegument binding. None of these mutations prevented VP26 binding. It 
would be interesting to see if mutation of any of the remaining amino acids has an affect 
on the binding of VP26. 
The interaction between VP5 and VP26 may involve several amino acids from the two 
proteins in contact with each other, and if that is the case then it would not be surprising 
that mutation of just one amino acid did not abolish the interaction. It would be interesting 
to analyse how the mutation of several candidate amino acids simultaneously would affect 
VP26 binding, although with eighteen amino acids suggested as candidates the number of 
different possible combinations would make a complete study impractical. However, the 
candidate amino acids can be divided into subgroups with respect to regions of VP26 that 
they might interact with and obtaining VP5 mutants with all of the candidate amino acids 
in one subgroup mutated simultaneously might reveal more about the nature of the 
interaction with VP26. 
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A panel of mutants with five amino acid insertions into the VP5 upper domain is currently 
under construction (Marion McElwee, personal communication). It will be interesting to 
see whether any of these mutants have an affect on VP26 binding, and if so, where they 
map in the VP5 upper domain in relation to the amino acids suggested for mutation in the 
work described in this thesis. 
The main body of resuts in this thesis describe the mutational analysis of the single copy 
triplex protein, VPI9C. The Mutation Generation System produced a panel of 50 unique 
insertional mutants of the UL38 ORF. Using this system it was possible to show that 
VP 19C can be divided into three regions with respect to tolerating the insertion of extra 
amino acids, and highlight regions of the protein that are important for binding VP23 and 
VP5. The method allowed the rapid production of insertional mutants, and by carrying out 
the procedure three times it was possible to make alterations to the protocol described in 
the manufacturers' instructions, which resulted in more efficient generation of mutants. 
Whether these alterations would be applicable to using the system to study other proteins 
would depend largely on gene size and the number of insertional mutants desired. A 
problem encountered using the Mutation Generation System is that insertion of the 
transposon appears to occur more frequently in areas of the ORF with low GC content. 
This resulted in some regions of the protein having greater representation among the panel 
of insertional mutants than others - the region from amino acids 114-181 being particularly 
poorly represented. If the Mutation Generation System is to be used to produce more 
VP 19C mutants in the future, focusing insertional mutagenesis on regions such as that 
might prove useful. 
The analysis of insertional mutants proved a useful means of making initial assessments in 
the analysis of a protein that little was known about structurally. Although the system was 
able to give indications of regions of the protein that are important for its function, it was 
not possible to identify particular amino acids that might be important for interactions with 
VP23 and VP5. However, using the information obtained from insertional mutagenesis it 
might be possible to select regions of VP19C as targets for site-directed and deletional 
mutagenesis and gain further understanding into these interactions. Identification of amino 
acids that are important for these interactions will be aided by developing techniques such 
as site-specific cross linking, although resolution of the crystal structures of the proteins 
would provide the most useful tool in understanding these interactions. 
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The N-tenninal region of VPI9C turned out to be a particularly interesting region of the 
protein. It was poorly conserved among Alphaherpesvirinae with little evidence of 
sequence conservation in the N-tenninal 110 amino acids, and secondary structure 
prediction programs were unable to identify much (if any) secondary structure in the N-
tenninal 101 amino acids. The N-terrninal 107 amino acids were particularly tolerant of 
insertional mutagenesis, and it had previously been reported that the N-terrninal 90 amino 
acids were not absolutely required for capsid assembly (Spencer e/ al., 1998). Therefore, 
further analysis of this region was needed to gain a greater understanding of its function. 
The analysis of the sub-cellular localisation of VPI9C mutants with the first 45 and the 
first 63 amino acids deleted was an effective means of identifying that this region 
contained a nuclear localisation signal. Subsequently, fusing amino acid sequences from 
the VP19C N-tenninal region to green fluorescent protein allowed the region containing 
the nuclear localisation signal to be narrowed down to amino acids 24-55. The nuclear 
localisation signal in VP19C is unusual, and it would be interesting to characterise it 
further by identifying the amino acids within this region that are essential for nuclear 
localisation. This could be achieved by making further GFP-fusion constructs with 
mutations in individual amino acids. The eight arginines that lie between amino acids 24 
and 55 would be the most obvious starting point for such site-directed mutagenesis. It 
would also be interesting to ascertain whether VP19C's nuclear localisation involves 
interaction with either importin a or importin p. 
Analysis of N-tenninal deletional mutants suggested that amino acids 1-45 are required for 
nuclear localisation of VP 19C, and have an influence on overall capsid shape, while amino 
acids 46-63 have an as yet unidentified role in capsid fonnation. Further analysis of this 
region might be expected to provide a better understanding of the role of VP19C in 
directing capsid assembly and confonnation. 
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Herpes simplex virus type I (HSV-I) capsids have an icosahedral structure with capsomers formed by the major 
capsid protein, VP5, linked in groups of three by distinctive structures called triplexes_ Triplexes are hetero-
trimers formed by two proteins in a 1:2 stoichiometry_ The single-copy protein is called VPI9C, and the dimeric 
protein is VP23. We have carried out insertional and deletional mutagenesis on VP19C and have examined the 
elfects of the mutations on virus growth and capsid assembly. Insertional mutagenesis showed that the 
N-terminal -100 amino acids of the protein, which correspond to a region that is poorly conserved among 
herpesviruses, are insensitive to disruption and that insertions into the rest of the protein had various elfects 
on virus growth. Some, but not all, severely disabled mutants were compromised in the ability to bind VP23 or 
VP5. Analysis of deletion mutants revealed the presence of a nuclear localization signal (NLS) near the N 
terminus ofVP19C, and this was mapped to a 33-amino-acid region by fusion of specific sequences to a green 
ftuorescent protein marker. By replacing the endogenous NLS with that from the simian virus 40 large T 
antigen, we were able to show that the first 45 amino acids of VPI9C were not essential for assembly of 
functional capsids and infectious virus particles, However, removing the first 63 amino acids resulted in 
formation of aberrant capsids and prevented virus growth, suggesting that the poorly conserved N-terminal 
sequences have some as-yet-unidentified function. 
Herpesviruses particles have complex structures consisting of 
four components: envelope. tegument, capsid, and core (7, 24, 
41). The core consists of the double-stranded DNA genome, 
which is packaged into a preformed capsid within the nuclei of 
infected cells. The capsid is surrounded by a proteinaceous layer 
of variable thickness called the tegument, and the entire entity is 
enclosed by a glycoprotein-containing lipid envelope. 
The herpes simplex virus type I (HSV-l) capsid has been the 
subject of intenst: study, and its structurt: and composition are 
relatively well characterized compan:d to the other virion com-
partments (31). It consists of a protein shell, which has T = 16 
icosahedral symmt:try. Three distinctive structural clements, 
designated pen tons, hexons, and triplexes, make up the bulk of 
this shell; 150 hexons form the faces and t:dges of the icosa-
hedron, while the vertices are formed by the pen tons. The 
triplexes occupy the local threefold positions bt:tween hexons 
and between hexons and pen tons. Tht: icosahedral geomt:try of 
the capsid largely determines the number of each compont:nt, 
but the precise numbers of pentons and triplexes are uncertain. 
This is because 1 of the 12 vertict:s is bt:lit:ved to bt: tht: location 
of a portal complex through which the genome entt:rs and 
leaves the capsid (16). It seems probable that the portal re-
places 1 of the pentons, leaving 11 occupying the remaining 
icosahedral vertices. Similarly, for the triplex, there art: 320 
local threefold positions in the capsid, including S surrounding 
each vertex. However, the relationship between the triplexes 
and the portal is unknown, making it unclear whether triplexes 
are present at the five positions surrounding the portal. 
Assembly of functional capsids is thought to initiate through 
an interaction between the internal scaffolding protein and the 
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portal (17). Stepwise addition of shdl and scalfold compkxes 
then results in the formation of an unstable splH.:rical procapsid 
(14, 15). This undergoes a maturational n:coniiguration (S, 17). 
during which the scaffolding protein is proteolytically cleaved 
and removed and the DNA is packaged. The rec()l1liguratiol1 
results in altered interactions between capsid proteins and 
generates a stahk polyhedral capsid shell (14, 19, 2h). 
The HSV-I capsid shell is primarily composed of four types 
of protein. Five copies of the major capsid protein, VI'S (149 
kDa), form the pentons, and six copies form the bulk of the 
hexons (IS, 46), while six copies of VP2h (12 kDa) occupy the 
outt:r surfaces of the hexons (39, 44). The remaining two pro-
teins, VPI9C (50 kDa) and VI'23 (34 kDa), make up the 
triplexes. The triplex is a charactcristic strllctural feature of 
herpesvirus capsids and is a heterotrimer with «f3, organiza-
tion, which in HSV-I is formed by a single molecule of V1'19(' 
(a-subunit) and two copies of VP23 (f3-subunit) (i S, 29). The 
tripkx forms connections with two of the three surrounding 
capsomers through domains that have been designat.:d the 
head and tail (II), and all three triplex prot.:ins interact with 
the capsid floor (14, 43). VPI9C is required for dlicienl trans-
port of VP23 to the nude us, which is the site of capsid assem-
bly (25). It is also able to transport VI'S into the nudeus, 
although in HSV-I-infected cells this function is pn.:domi-
nantly provided by the scafl'olding protein, preVP22.1 (20), a 
transient capsid component that is required during assemhly. 
The structure of the IISV-I capsid ha~ ol.:en determined to 
-S.5 A by dectron cryomicroscopy (43). Detailed examination of 
this structure, combined with the analysis of particlcs form.:d hy 
subsets of the capsid proteins (29, 39, 44, 45), has allowed the 
boundaries of the ,'omp"nent protein molecules I,) hc de/incd 
with good precision. However, with the exception of a 6O-kDa 
domain of VI'S that forms thc tops of the hexons and pentons (2), 
the structures of the capsid proteins afe unknown at the atomic 
levd, and relatively lillie is known ahout the functional organila-
1538 ADAMSON ET AL. 
TABLE I. peR primers used in cloning UUS mutants 
Primer 
UL38-45F .......................... GTCTAGAGGATCC A TA TGGGCCCAGGGCTC 
CCCAGGGGGTC 
UL18-63F .......................... GTCTAGAGGATCCATATGTTGCTfGGCc.."TG 
UL38R 
GACGGCACAGAC 
... GACA<\GATC.TC ACGCGCA TGCCCGCCAlTC 
GCCGGGG 
UL1S-45PCR 1'1 .............. GAAGAAGAAGCGCAAGGTCGACGGCCCAGG 
GCTCCCCAGGGGGTCG------
UL18-63PCR FI ............... GAAGAAGAAGCGCAAGGTCGACTrGC1TGG 
CCTGGACGGCACAGA~ 
38R-Xha ......................... TCT AGA TCACGCGCATGCCCGCCACTCGC 
UL3Si"LS-4SPCR F3 ....... CGCAATGGCTCCGAAGAAGAAGCGCAAGGT 
CGACGGCCCAGGGCTCCCCAGGGGCiTCGG 
UL38ATG ......................... GACAGAATTCGCAA TGAAGACCAATCCGC 
UL38AA46 ................ ACAGTCGACCCGTCGCGGCGAGAGATCGG 
UL18AA56 ........................ ACAGTCGACCGGGGTCCCGACCCCCTGGG 
UL38AA66 .......... ACAGTCGACCCAAGCAACCACAGCGTGC 
UL18AA76 ........................ ACAGTCGACGCCCCAGGGGGCGCGTCTG 
UL18AA83 ................ ACAGTCGACGTATCGTCGTTGGGGGTCAGC 
UL18AAI18 .......... ACAGTCGACAGATCCGTCAGGATCACTTGG 
UL38-24l\:TERM ............ GCAATGACACGCGATACCGCGGGACAG 
UL18-33l\TERM ............ GCAATGCTTCGGCGCGTCCTGCGCCCC 
GFP UPSTREAM ....... GCTGATTATGATCTAGAGTCGC 
U The recognition se<juences for 8amHI (GGTACC), 8gll1 (AGATCT), Sail 
(GTCGAC), and Xbal (TCT AGA) used in cloning are singly or douhly underlined. 
lion of the protein sequences, In this paper, we describe mutagen-
esis of VP19C to analyze the roles of different parts of the protein 
in virus growth and capsid assembly. 
MATERIALS AND METHODS 
Plasmids. (i) VPI9C insertional mutants. pFUpCI was maot= hy imerling Q 
BgIlI-EcoRI fragment containing the human cytomegalovirus (HCMV) promot-
er/enhancer from pCI-neo (Promega) into 8amHIiEcoRI-digested pFASTI3AC 
HTa (Invitrogen). As a first step, a single :>lotI site In pFASTBAC IfTa was 
removed hy digesting the D~A v.ith Notl, making the ends flush with '1'4 poly-
merase, and religation. The UL18 open reading frame (ORF) encoding VPI9C 
was isolated from pBJ3S2 (33) hy digestion with Xhal and HinclJ and ligated into 
i"he1lStul-digested pF13pCI to produce pUUXFl3pCI, which allows expression 
of VP19C under the control of the HCMV immedi<.Jte-early (IE) promoter. 
Insertional mutants we.:re generawd using the.: mmsposon-h<.Jscd Mutation Gcn-
era[ion Sy~tem (Finnzymes). Following the in vitro Ir£lnsposition reaction, 
pUL1HFBpCI clones containing the entranceposon (MI-Kan l ) sequence in-
serted at random positions, were isolated hy ~dection Oil kanamycin (Stl f.Lg..'rnl) 
agar plates. Individual colonies were grown, and the;: po~itjon of the in~errion 
within the pUL18FBpCJ DI"A was determined hy digestion with Pstl, which 
n:k:ased a fragme;:nt of 2,91H hp if the transposon had in~erted into or ncar the 
UL1~ ORF or a fragmont of 1,790 hp if it had in>crtcd elsewhere in the plasmid. 
Plasmid Dl'\As containing insert~ within the UL3H ORF were digc~tt:d with 1'\otl 
and rdigated, This removed the hulk of the transpn~on M!yuence, leaving a 15-hp 
insertion, which introduced five addItional amino a(,;id~ inlo the prolein. The 
positions uf insertiuns were determined oy Dl\A sequencing, 
(ii) VPl9C N-terminal truncations_ Truncated UL3~ ORFs were generated hy 
peR using the forward primers UUS-4SF and UL38-63F and the roVerSe primer 
UL~~R (Tabl!! 1). Tht" PCR produch were purilied and cloned inlo pGEM-T 
Easy (Promega), Individual colonie~ were grown and ~crccned hy re~trictjon 
enzyme digestion. Clones with the inserts in the correct orie;:ntation were de~ig­
nated pUL18-4ST Easy and pUL,8-63T Easy. For expression in insect cells, the 
UL38 ~equcnce~ were isolated from pUL18-4ST Easy and pUL.1S-63T Ea~y hy 
digestion with Xhal and Psti and cloned down~tn:am from the polyheJrin pro-
moH::r in XhaI!P~tl-digested pFASTBACI (Invitrogen) to generale pUL3H-
45FBI and pUL38-63FB I. For expres.."ion in mammalian cells, the;: UI.JS sC4uence~ 
were isolated from pU13H-45T Ea~y and pUL1S-6.1r Ea,y hy digeslion with f~c()RI 
and Spel and cloned downstrC<im from the HCMV IFI promoter in EcoRJ/Xhal-
dige,wd pF13pCI to generate pULlS-45FBpCI and pULlS..o3FBpCl. 
(iii) VP19C·NLS fusions, PCRs were carried out u~ing the forward primer!'. 
Ul3S-45PCR FI and UL1S-6JPCR Fl and the rt'vt'rse primer _,,I\R-Xha (T<ihle 
I). UL3S-45PCR FI and UUX-63PCR 1'1 introduce d Sall site immediately 
upstream uf amino acid~ 45 and 63 in the UL1S ORE The peR pr()duct~ were 
J. VIKtll. 
purified and cloned into pClEM-T Ea .... y 10 gCIH.'ratl' pl1IJS-4'\PCR-T LI'Y and 
pli!..1X-63PCR-T Easy, re'pectivdy An oligollllckouJe. U .. 1~:\I.S-4W(,R !.1, 
was designed thJt spl'cifll'~ IhL' nuclear Inc:!iI/:I!HHl ~lgn;J1 (."\LS) 1)1 til(.' '\Imlan 
virus 40 (SV40) large T antigen (se4"ence, I'KKKRKVI (101 tll,eo to the :\ 
terminll .... 01 the UL1i'1 ORF truncatc:d at ilmino aciu 4.'1 (Tanlc I). A peR. \1.';1' 
performed ll.'.,ing primer~ UIJSr\LS-4:'iPCR ... .1 ami .,SR-Xha, with pl fL.1S-
45PCR-T Ea~y as tht' tcmplate. The P( 'R Ir;lgmelll wa .. pun tied and c!,)!l4 ... d !THo 
pCiEM-T I:a~y h) generate pLI_1S-4S:,\I_'i:I·I:;I~Y. 'l'lll' lil3S imcrl wa ... I:-'Illall'd 
hydigcstion with l:.coKI and Xhal and ligaled Jilin l:olRLXhal-di,!-'.e~tl:d pl'Up('1 
to generate pljI.3S-45r\LSFBpCI Tht.' Sall,Xhal fragment tWill rlJIJS-
()~PCR-T J:a~y wa:o- then {lUI dkd Jlld II,!!Jtn..l uno Sail XhaI dlgcstt'd pi:!. ~"\-
45l\L~FBpCI to generate pllI..1S-Il.1l\I.SFBpCI. 
0,,) VP19('~green f1uorcsccnl protein (GFP) rusion. D~A Iragmclll!l com'llnm}! 
im . Tl.'asing nllmher~ Ill' n;~ldlle:-. Inml the 5' c:nd Ilf the VPIlJ(' ()I{F we'n: pnldlKI.:d 
by peR using the ImwanJ prime.:r UL1,1\ATCi and the revcr:-.e pTHllCr~ L'l Jio;AA4(I, 
UUSAA51>, L:I JSAAI>I>.lJUSAA76. UIJ~AAS:1. and LIIJSAAIIS (Tahle' II The 
arpropriatl' P('R prodlKts were pUTltied and cll)Ucd IIIltl p( ;1~~1-T I':aw. Indlvldu.il 
colonies wen; grown :tnd screened hy digestion with l:CtIKI. 'rhe: l)1 JS in:-.e:r1!\ Wt'!l" 
i~olatcd hy digestion with EcoRI <ind Sail and ligated inlo Fl'ol{I''Sall-llige:-.tl'd 
pEGFP-I'\! (Clontech) to generate p46AA-UI3S-(;I-P, p5tu\A-l:13S-(iI-V, 
p66AA-LIJS-GFP, p7IlAA-LJIJS-GFI', pS3AA-UIJS-CiFI', a,,<1 rIIM!\·LlIJ~­
GFP, To dclell.! ~"'Iuencc~ from the !'\ termjnu~, PCR W;t~ c;lrned (lut Wllh p()()AA-
LJIJS-GFP Dl\:A ii' a template and ll,ing the I"rward prime", LJIJS-"4 :\TLRM 
and UI3S-JJ I\.TERM and thl.! reVerse pnmn (iI-V liPS nO~AM, The rc.,ulting 
peR produch were rlonl.!d min pCil~M-T Fa~y, and then the in!\crt, wal' i,o-
lated hy digl.!~lion With E(,;oRI ;IOU ~otl and ligated into 1~l'tlRI:1'\tlll-dlgf.:!\tl"(1 
pMAA-UUS-CiFP. 
All plJsmid!\ were checked by diagno!\tlc rc!\ITlcthl/l CIlF}'nlC dlgl.'~tllill and 
DI\'A sequencing. 
Cells. BHK-21 clone 13 celb werc grown III Cila!\gnw milllillal l',~enliill ml'-
dium (MFM) ~upplcmeJltcd with 111"; tryplO!\e phll~ph.lle hrolh and IW'; Ill'W-
horn (';alr serum, UI.J~KS(, l'elb (J6) wert: grown 10 Dulhc,,'l'o\ Ml~M ~lIrpk· 
mt:nted with 10";: fcta!ealf .,erlllll and ~Otl }l~/ml (;ellctil'lI1 (i~ 1,1\ I I 11\'llrll.1-:l'l\) at 
I:very founh pa~~, ll20S cell.-. wcrc grown III Dulhl'!,:CO\ Mf~M 'lIppk'llll'lltl'd 
with IW'f fet;d calf ~erllm. Sf2! (.'-il'otioptI'rCl (rug/penla) (l'lb were nlilllll'd III 
TCIO() medium suppk'ml'Ilh:d with '5('; klall';dt '"-'rum. 
Viruses. The JfSV-1 LJL3S-minll~ mutant vJ.3SYt·P ";1' pror,lg;lIl"d lin 
UU~RSC cells (3fl). 
RaculoviruS('s. A .. ·UI3,o{ (cxJlrl'!\~ing lull-length VPIf.)C), Ad;1 III (VP'i). ,H1d 
AcUL26.5 (pn:VP22a) havc hl'l'n dl"~njhed prC'viou!\ly (23, 33). I\cAIO 1.2 (1.'\-
prc!'.:-.ing VP2J, VP26, and thl· lJI.2fl prolca~l') wa!\ made hy c10lling ttll' OIU-!\ 
into the triple exprc~!\i()n tran!\kr pla!\mid pAc'\lH (liD BItI'l·li.'nl'C~, Ph.III1lHl-
gen) and recomhining them IIltn A .. ·PAK6 (I). Kn-OInhlll.11l1 h .. ,:u!ovlru ... c:, ex-
pressing other VPI9C prolein!\ were pJ'll(iLKed 1I!\lng the HA( '-TO-HA(' Bill'lIlo-
viru!\ Fxprc~!\lon Sy,tem (1Ilvltrogl'n) Itllltl\\lIlg (hc 1ll,1I1Uf,lclllrl'r\ PltHtl .. ·tl!. 
Hrielly. pliUX·45Flll. ptrUH-I>.1F1i1. pL!I.1~I·lip(·1. plIIJ~·4~r-:I_~IHp(·l. ,md 
pULlH-6Jl\'I.SFBpCI Wi.'re Iransfel·tl·d 11110 l'ompetcllt DI t ItiBdC 1:,w'/wr/cllltJ 
coli cdb. While colol1le' wert' 'elcctt'd {Ill X~(Jal (5-hr{)I1l{)-4-rhl{lro-.l-lI1dtJl~l-
0_n_galac((lpyrilllosidc)-cOJlt:!lfllllg agar rIOltl·~, and thC' rC'l'tllllhlll:tnl h,ll'JTlld 
[)r\A~ wc:re i~(llatC'd and trallstcrlcd inlo SF~ I ,:db. The pftl~ell\ hOlndtlvlru,i." 
were ~rcC!ncd for thl.' pn:~eIKc 01 ill~l'rh h~' PCt{ PO!\IIIVt' I',llat .. " """'ll' dl· ... 'g· 
naled U 13H-45FB;\c, lJI J,I\~tI31'Hac, LJ 1 JXFHaep( '1. l ~ 1 lS·4"i~1 ~""}'Ii;I~'r( 'I, .111.1 
UIJ~-63t\L."iFBacp('! and were ,!!.rowll 10 high Illn 
Plasmid transfection and haculo\"iru" transduction. HIIK .:ell, for IIlIlIlIllhl· 
!luori.'sn:ncc 'Were ~roWIl llil 13 mill ).!Ia~~ rO\!l'r~llp~ and tI.IJl'll·CI~'d "Itb pl.l'lI11d 
DI'\A~ uMng i.ipofc.'ctlll 1'I.lIS I C,t),!l'lI I (InVHI{}).!l'll) 'lI:l'Oldlll~ [II fhe 11\,111111.1 .. -
turer\ 1fl~lrllCllt)l1~. Attn.l h of IIlCuhalion Oil .IT'(·, the t!.Hhk':lhlll rl',I~l'lIt \'I.I!\ 
rl:placed with Irc~h (.:U!tUfC rl)C."dIUIll and IIlClIh;\lltlll \'1,1.' .. ·IHLllllUt'I! 1111,1 ILLllhl'l 
III h Iwfon: thl' cell.-. w("rr tiXl"(j lor Il11mUIiOlluoll"l'l'IIC,' 
BilK celb for vinJ' rc!'.cul' wcrt' gn l\l,ll dlrcl'll~' III ~4-\I,i.'IIII!\"'IK (l!llllie .. 1t ... lll"' 
aoJ Iran~rcrtcd wilh pl.l. ... mid I).,,\A ;I~ de'l'nhcd "hi I" .. '. AI 5 h po't1t.Ln,kcIII1I1, 
thl' relb were inle,,·ted with v~.'XYH). Alter I h ;It .17"('. IHldb..olbl-d \UU ....... ;l~ 
ina .. ·tivatr:d h~ incLJhilllng the ccll ... 111 TTI. ... -gl~,l·H1l·, pH .', ttll 4."1 ... (27). The LltillJrC 
medium was repiaec:d, and the l'ell~ WCfl' 1I11'ub;lled ftlr .1 fUilill'1 ~() h ;It ,n'·(· 
hdme helflg h,lI"Vc!\ted 11110 the medIum i1lld lro/ell.lt 7l1"(' P"Ollo 111I.ltllll1 till 
LJ USRSC eelb. 
U20S ct.' II .... Wl'rc oVl'rlaid with 511 Pf'li'rcll (1IIrdtl"d tlll SCI l'ell,) Ilf Iht' 
approprj<lte hacuillvirm and IIKuhatcd al 2U'(' ,\Itl'! I Ii, till' IIHICUlulIl ~.'" 
removed i1l1d Itll' rclh Wt'ri.' Inlc,:ti.'d With ." PH J (l'l1 III v~.lSYf·P IIKlIllotlltlll ",.1.' 
conlin lied .11 J7"C Jur Ifl h, and thl' ct'lh Wt'r,,' haIYl"ln! .11It! JlItll'l"~'nl IIlI 
ciel'twn mintl~Cllpy, 
ImmunoHuuns('cnre, '!Ian ... krlc:d BIlK "·l'lI, \","Il' 11\(.'.1 Ill! I 11 In Illt'th.lIllll .11 
20"(', w;l~hed in ph\l ... phalc-hullc.'fl·d ,alll1l.· (PitS), ;lmlllll'uh.ltl,tI fIll 111111111 111 
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PBS containing 5'7c newborn calf serum and 0.05(>-1 Tween 20 (solution A). The 
coverslips were drained, inverted onto 20 )..lJ of primary antihody, and incuhated 
at room temperature for 45 min. After three washes in solution A, the c()vt:rsiips 
were: drained and inverted onto 20 j..!l of secondary antihody for a funher 45 min. 
The coverslips wt:rc washed four times in solution A and twice in lkionizt:d water 
before being mounted in Mowiol4-88 (Harco) plus 2.SCk DABCO (Sigma) and 
examined on a Zeiss LS\1 510 confocal microscope. 
Western blot analysis. Proteins separated by eicctrophoresis on ltV"f sodium 
dodecyl sulfate-polyacrylamide gc:ls were transferred rn Hyhond i-:CL nitf()cci· 
lulose membranes and analyzed using the enhanced-chemilumim:sc!.!nce method 
(Amersham). Antibody diluliom ami mt:mbrant: wa~he~ wen: I.:arricd oul ill 
PBS-T (PBS containing D.osr" [volivol) Tween 20 [Sigma]). Before addition of 
the first antibody, the membrane was blocked in PBS-T containing 5'".( milk 
powder. Protein A-peroxida", (Sigma) was diluted 1:1,000 in PBS-To 
Antibodies. Mouse monoclonal antihody mAh02040. raised agallist purified 
VP19C, wa~ diluted l:l,Olll) in solution A (immunolluores(.:cnl..oc) or I1BS-T 
(Western blotting). Rabbit antisera rAbl84 and rAb1S6, against purified VPS 
and VP23, respectively, were diluted I: I ,000 in solution A. Secondary antibodies, 
goat anti-mouse (C;A~) fluorescein lsothiocyanate (FlTC) conjugate and goat 
anti-rabbit (GAR) tetramcthyl rhodamine isothiocyanate (TRITe) conjugate 
(Sigma), were diluted 1:100 in solution A. 
Electron microscopy. Cdls were harvested and pelle ted in embc;dding capsulc~ 
(T AAB). The cell pellets were fixed with 2.5'':; glutaraldehyde and I ric osmium 
tetroxide, de hydra led through a graded alcohol senes, and c:rnbedded in Epnn 
812 resin (TAAB). Thin sections were cut using a LEICA ULTRACUT E, 
stained with uranyl acetale and lead citrate. and examined on a JEOL ](lOS 
electron microscope. 
RESULTS 
Generation and analysis of insertional mutants in VP19C. 
Fifty cJonally distinct mutants containing 5-amino-acid inser-
tions in the UL38 ORF were generatt:d hy transposon-based 
insertional mutagenesis into pUL38FhpCI, which expresses 
VPl9C from the HCMV IE promoter. The insertions were 
distributed throughout the ORF with an average spacing of -9 
amino acids and a maximum separation of 38. Two pairs of 
insertions (in242A-in242B and in358A-in358B) were at differ-
ent sites in the same codon. In these cases, the mutant proteins 
differed only in the identities of the inserted amino acids (Ta-
ble 2). One insertion (inSTOP) disrupted the TGA stop codon, 
resulting in the addition of 5 amino acids at the end of the 
protein. 
To analY-Le the effects of the mutations on the properties of 
VPI9C, their abilities to complement growth of the HSV-I UU8 
deletion mutant v~38YFP (36) were examined. DNA of each 
insertional mutant was transfected into BHK cells. which were 
incubated at 37°C for 5 h bdore being infected with 2 PFU/cell of 
v638YFP. After 1 h, tht: unabsorbed input virus was neutralized 
by an acid wash. Incubation wa, continued at 37°C for 40 h, at 
which timt: tht: progeny virus was harveste;:d and titrated on 
UL18RSC rabbit skin cells expressing VPI9C. Figure I shows the 
relative yield obtained for each of the insertional mutants com-
pared to that obtained with the wild-type control. 
Eighteen of the 50 insertional mutants had little or no effect 
on the ability of VPI9C to support virus growth, producing 
yields of ovt:r 80% of the wild-type VPI9C control level. The 
remaining 32 showed lower levels of complementation, with 
twO producing yields of < 10% and 16 being compktely nega-
tive for virus growth. The results shown in Fig. 1 suggest that 
VP 19C can he divided into three hroadly defined regions, with 
the majority of the severely disabling insertions « JO% of 
wild-type yield) occurring in the central region of the protein, 
between inl13 and in350. The yields obtaint:d with all 12 of the 
insertions into the first 107 amino acids were >40% of the 
llSV-I TRIPLEX pR()TEI~ VpI'JC 
TABLE 2. Locations and sequences 01 live amino amI 
in,crtion, into VpI'IC 
AA no." 
16 ......................... ...................... . ..... gg('(;RSGq 
23 ....................... ...................... . ............... ppMRPIIPtt 
24 ......................... .... ptAAApTtr 
26 ....................................... ....................... .trC·(iRTRdt 
37 ....................................... ................................. ..vILRPIIl.rp 
51............. ............................... .......................... ..lpSAAAPrg 
80 .............. ............................................................... ..tp('(;RTPnd 
84 ........... .............................................................. ..<It DAAA TC4 
86 ........................................ ..................... ................... .c'lVRPQOal 
102 ....................................... . ........................................ aIMRpIILi~ 
IOn ..................................................................................... ,pAAASPrh 
107.................................... ...... ........... ..prAAAPRhh 
113 ....................................................................................... r'lCGRSOvi 
143 ....................................................................................... hIVRpI I[.ah 
IK2 ....................................................................................... raVRp[IAgI 
183 ........................................................................ . ...... agAAAAGI\ 
1'13 ....................................................................................... ,laALVAA,a 
200 ....................................................................................... daLRPIIArd 
207 ............................................................. . ......... avAAAAVra 
217 ....................................................................................... rgCGRSGtr 
234 ....................................................................................... amC·C;RTM'h 
235 ..................................................................................... mvAAAMVhl 
242A ................................................................................. phAAAPI Icv 
242B ................................................... . .. phCGRTlkv 
243 ............................................................. . ... heCGR~hm 
24S ............ , .......................................................................... fgC·CjRIGgI 
2S6 ....................................................................................... :lvAAAAVil 
2S9 ................................................. ..................... . ....... lpVRPIIP", 
310.. .............. ........ .................. . .......... flLRPHLvl 
327 ....................................................... . .... cv(·(iRSYyv 
32S .................................... . .............. vyAAA VYvI 
329.... ...................................... .}~'.\1RpIIVik 
330 .................. . .................. vi:\AAAlb 
3JS..... ................................................ . ............. r~CC;RS(jk 
343.............. ................... . .............. aIVRPIIl..,r 
350 ........................................................................ . ........ lrCGRIRit 
358A ........................................................................... . .... hgCC; R~(Jtc 
35SB ..................................... . .......... hgAAAIICllc 
365 .................................. ...................... .ppVRpIIP"p 
30S...................................... . .. pnC·C;RT!'\rn 
3'10............................... ..agC·C;RTC;4v 
3% ....................... ....... pqC·(; RTOfa 
426 ........................... ·· ... lgAAALeimm 
430..................... . ....... clI.RPlll.hr 
43H .............. ..................... .............................. . .......... hrMRI'IIRlc 
43'1............... .................... . .......... rtDAAATcr 
44'1 ......................... . ....... pvAAAPVvt 
45'1....... ....................... . ....... rp(iAAApgc 
463.............. . .......................................................... wrVRI'ORac· 
STOP..... . .................... . .......... ,"('AAAA 
" AA, amino a,,;jd. Inc numhcr JClhlle~ Ihe lit ... , lll1ch.Hl~CJ .Ul11110 .Il'ld hclol~' 
the in~I:fIJOn. 
/' Tht' live ins(.'rled ;'Imino ;1I..·ld~ arc ~h{Jwn In urrwn·<lM·, .tIld lh(.· Undl.lJl)I.cd 
nanking n:sidul'~ aft· ill lilWt'rca~c 
wild-type lewl. with only in3S in the middle of this region and 
in 106 and in 107 at its C tnminus giving' HWi,. Similarly. all 
hut 2 (in390 and in4(3) of the 14 ins<.:rtions into the ('-terminal 
J07 amino acids gav.: complementation lev<:ls of ;"30";. In 
contrast. 16 orthe 18 insertions thaI gave complcm<.:ntatioll values 
of <. lory,. l11app<.:d in the central region of th.: protein hdween 
amino acids I U and 350. and of the 24 insertions in this r.:gion. 
only 4 gave values of >3(J':? 
Interaction of capsid proteins. In order to ensure the fort11a-
tion of functional capsids and hence infeclious virions. VI'I 'Ie 
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FIG. I. Functional analysis of VPI9C insertional mutants. (Top) Complem~ntation of growth of th~ VPI'IC-minu, mulanl v.l.1SYFP h~ 
Iransfeeted plasm ids expressing Ihe VPI9C insertional mutants was earri~d olll in BHK celb. Th~ prog~n)' viru, wa, lilral~d on t.:L.1SRSC cclb. 
The results are shown as percentages of the titer obtained with the wild-type VPl9C control pla,mid. (Bottom) Scale drawing of Ih~ UUS ORF 
showing the extent of the poorly conserved N-terminal sequences (Fig. 7a). 
must interact correctly with the other triplex protein, VP23, and 
with the major capsid protein, VP5. Since these interactions are 
essential, they can be assumed to have fonned correctly in those 
VP19C mutants that complemented vt.38YFP. Therdore, only 
the 18 mutants that gave less than 10% of the yield of wild-type 
VPl9C and were considered to be severely disabled were exam-
ined. Previous studies have shown that VPl9C is a nuclear pro-
tein. VP23 and VP5, when expressed in the absence of other virus 
proteins, are unifonnly distributed throughout the cell but be-
come predominantly nuclear in the presence of VPI9C (25). 
Furthermore, immunotluorescence analysis ofvt.38YFP-infected 
BHK cells revealed that VP23 remained distributed throughout 
the cell (data not shown), demonstrating that its nuclear localiza-
tion was entirely dependent on the presence of VPI9C. 
To examine these interactions, BHK cells were cotrans-
fected with plasmids expn:ssing the VPI9C mutants and with 
pEl8 (expressing VP23) (20) or with pE19 (VP5) (25), and the 
distributions of the proteins were determined by immunofluo-
rescence. One of the mutant VP19Cs (in330) was no longer 
able to locate to the nucleus, making it impossible to determine 
its effect on the distribution of the other proteins (Fig. 2 and 3). 
When the interaction between VP23 and the remaining 17 
severely disabled VP19C mutants was examined in this assay, 
twO distinct patterns were seen (Fig. 2). Nine mutants (inI43, 
in234, in235, in327, in328, in329, in350, in390, and in463) ex-
hibited a wild-type pattern, with VP19C and VP23 colocalizing 
to the nucleus. In the case of in390, the VPI9C antibody was 
unable to bind to the mutant protein. However, VP23 was 
clearly transported to the nuc!t:us, implying that the insertion 
had disrupted the antibody-binding site but had not interfered 
with the ability of VI' 19C to interact with VP23 or to localizc 
to the nuclcus. In the rcmaining eight mutants (inl 13, inl'l3, 
in242A in2428, in243, in24S, in2WJ. and in31O), VI'I 'Ie local-
ized to the nuc!t:us as expccted but VP23 n:maincd in thc 
cytoplasm, implying that the inscrted sequenccs had disrupted 
the interaclion between VI' ILJC and VP23. 
Scven severely disabled VPI9C mutants (in 113, in242A. 
in24213, in2SLJ, in32H, in32LJ, and in4(3) were unahle to trans-
port VP5 to the nucleus (Fig. 3). Of these, four (in 113, in242A. 
in24213. and in2S9) also failed to transport VP23 to the Illl-
cleus, while the other three (in328, in329, and in4(3) inter-
acted successfully with VP23. The results of thc VP23 and VP5 
analyses arc summarized in Table 3. 
Role of the VPI9C N terminus_ Studies examining lISV-1 
capsid lilrmation using a re("omhinant-haculoviruscs-bascd model 
system, had shown that the .'II-terminal <J{) amino acids of VPJ'IC 
wen; not absolutely rcquired lilr capsid assembly (30). The results 
of the complementation analysis (Fig. I) arc consistent with this 
conclusion, ,IS all of the insertions into the :-.l-terminal \07 codllns 
of the UL18 ORF wen: ahle to support virus growth. To investi-
gate the roles of these N-tenninal sequences further, plasmids 
pUl3S-45FHpCl and pULl8-63FBpCI, expre,,-,ing VPllJC pro-
teins lacking the N-h;rminal 45 (VP/C)('-45) ami fl3 (VP}CJ('-
(3) amino acids, respectively, were constructed and tested for 
the ability to compkment growth of vt.3HYFI'. As shown in 
Fig. 4a, the yield obtained with VI'I 1)('-45 was approximatdy 
50-fold lower than for the Vl'llJC-WT control. while removal 
of the first 63 amino acids complekly abolished ,omplemcn-
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FIG. 2. Influence of VPl9C insertional mutants on the distribution of VP23. BHK cells were cotransfected wilh pEl (expressing VP23) and 
either pUL3 FBpCI (wild.type [Wf] VP19C) or one of the VP19C insertional mutants as indicated. VPI9 wa detected with the monoclonal 
antibody mAb02040 and visualized u ing FITC GAM (green). VP23 was detected with the anti erum rAb] 6 and vbualized m,ing TRITC· 
conjugated GAR (red). 
tation, thereby demon trating that the -terminal sequences of 
VP19C are important for production of wild-type level of 
infectiou virus. 
To determine the effects of the -terminal truncation on 
the behavior of VP19C, the di tributions of VP19C-45 and 
VP19C-63 in transfected cells were examined. In marked con-
trast to the pattern een with VP19C-WT (Fig. 2 and 3), nei-
ther VPI9C-45 (Fig. 4b) nor VP19C-63 (Fig. 4e) was specifi-
cally nuclcar. These re ult suggested that these sequences 
contain an LS. Since the nucleu is the site of cap id assem-
bly, the smaller amount of the mutant VP19C entering thi 
compartment could account for the reduction in virus yield 
seen in the complementation as ay. To determine whether this 
was the ca e, the SV40 large T antigen LS (10) wa fused to 
the -termini of VP19C-45 and VP19C-63. The re ulting pro-
teins, VP19C-45NLS (Fig. 4c) and VP19C-631 LS (Fig. 4f), 
both localized eUicicntly to thc nucleus, and in addition, hoth 
transported VP23 (Fig. 4d and g) and VP5 (not shown) to the 
nucleus, confirming that the exogenous NLS wa functioning as 
expected. When the abilitie of the e constructs to support 
virus growth were tested, VP19C-45 LS was found to comple-
ment v~38YFP as effectively a VP19C-WT (Fig. 4a), thereby 
demonstrating that the reduction in growth cau ed by the re-
moval of the -terminal 45 amino acids was primarily a re ult 
of the defect in nuclear localization. In contra t, no comple-
mentation occurred with VP19C-63 LS (Fig. 4a), uggesting 
that amino acids 45 to 63 have an additional role in the for-
mation of infectious viru . 
Mapping the VP19C L. Although VP19C i tran ported 
to the nudeu in the absence of other viral proteins, no LS 
was identified when the complete amino acid equence was 
submitted to the LS predicti n program (http://cubic.bioc 
.columbia.edu/predict LS/ and http://port.nibb.ac.jp/form2 
.html). To confirm that the -terminal region of VPl9C did 
contain an LS, increasing amounts of equence from the 
terminu were fu ed to the GFP, and the intracellular di tri-
butions of the chimeric protein were determined. In cell 
expressing GFP alone, the fluorescence was uniformly distrib-
uted between the cytoplasm and the nucleu (Fig. 5a). lIow-
ever, fusing GFP to the -terminal 118 (not shown), 83, 76, 66, 
or 56 amino acid of VPl9C convened it to a nuclea r protein 
(Fig. 5b to e). 1n contrast, the di tribution een with the 
N-terminal 46 amino acids resembled the GFP control (Fig. 
5f). Thu , it is clear that the NLS is located within the first 56 
residue of VPI9C. Examination of the amino acid equence in 
this region revealed a high concentrati n of arginine residues 
extending from amino acids 2 to 57 (Fig. 5i). ince tretche 
of basic amino acids are characteristi of many s, thc 
entire arginine-rich equence from amino acids 24 to 66 was 
fused to GFP. This also re lilted in nuclear localuation of G FP 
(Fig. 5g), confirming that the L.';; mapped in this region. In an 
attempt to define the LS more precisely, amino acids 3 to 66 
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FIG. 3. Influence of VP19C insertional mutants on the distribution of VP5. BHK cells were cotransfected with pE19 (expressing VP5) and 
either pUL38FBpCI (wild-type [WT] VPI 9C) or one of the VPl9C insertional mutants as indicated. VPl9C was detected with the monoclonal 
antibody mAb02040 and visualized u ing FITC GAM (green). VP5 wa detected with the anlis~rum rAbl 84 and visualized u ing TRITC-
conjugated GAR (red). 
were also fused to GFP. However, the resulting chimera 
showed an unexpected and di tinctive cytoplasmic pattern that 
resembled the distribution expected [or mitochondria (Fig. 
5h). Submission of the VP19C equence to the subcellular 
TABLE 3. Intracellular distribution of severely disabled 
VPI9C insertional mutanls 
VP1 9C Localizes 
mutant to nucleus~ 
in113 + 
in143 + 
in193 + 
in234 + 
in235 + 
in242A + 
in242B + 
in243 + 
in248 + 
in289 T 
in310 + 
in327 + 
in328 + 
in329 + 
in330 
in350 + 
in390 + 
in463 + 
a + . yes; -, no. 
Takes VP23 
ro nuclcu~ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Takes VPS 
co nucl eu ~a 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
localization site prediction program iPSORT (hllp://biocaml 
.orglip ort/iP ORT/#pledict) identified amino acids 32 to 40 
(LLRRVLRPP) as a potential mitochondrial localization sig· 
na l. Given what i known about the properties and functions of 
VP19C, it seems unlikely that this mitochondria l localization 
signal is functiona l in the context of the intact protein . Pre-
sumably, the LS, which occupies the same region, i domi-
nant and the mitochondrial signal becomes apparent only after 
the increasingly large deletion have rendered the LS inac-
tive. Although further analysis is required to determine the 
pn::cise composition of the VP19C NLS, the rc ults pre ented 
here map it unambiguously to an arginine-rich sequence be-
tween residues 24 and 56. 
ature of the growth defect associated with VP19 -63 LS. 
To determine at what tage during infection the block on 
replication due to deletion of the -terminal 63 amino acids 
was occurring, duplicate 35-mm plates of U20S cells (one 
containing a glass cover lip) were incubated with 50 PFU/cell 
of baculoviruses, UL38FBacpCJ (expr sing VP19C). UL3 -
45 LSFBacpCJ (VP19 -45 LS), and UL3 -63 LSFBacp I 
(VP19C-63NLS), for 1 h at 37°C. The baculovirus inoculum 
was removed, the cells were infected with 5 PFU/cell of 
v.:l38YFP, and incubation was continued at 37°C. After 16 h, 
the coverslip from one of the duplicate plate was removed and 
processed for immunofluorescence microscopy, while the re-
maining cells were used [or Western blotting. The , e ond pla te 
VOL. 0,2006 
(a) 
r-
-
-
-
r-
o -VP I9C \ PI 9C-45 \ ·P I 9(A.~ HI 9C-&J \ PI 9C-6J , 
FIG. 4. Role of the VPl9C ·terminal sequences. (a) Comple. 
mentation of growth of the VPl9C-minus mutant v.138YFP by trans-
fected plasmid pUL38·45FBpCI (expre sing VPI9C-45), pUL38-
63FBpCI (VP19C-63), pUL38-45NLSFBpCI (VPI9C-45NLS), or 
pUL38-63 LSFBpCI (VPI9C·63 'LS) was carried out in BITK cells. 
The progeny viru was titrated on UL38R C ce lls. The error bars 
indicate the standard error of the mean. (b to g) Intracellular local· 
ization of -terminal mutant of VPI9C. BITK cells were rransfected 
singly with plasm ids (b) pUL38-45FBpCI (expres ing VPI9C·45) and 
(e) pUL38-63FBpCl (VPI9C-63) or were corransfectcd with (c and d) 
pUL38-45NLSFBpCI (VPI9C-45NLS) and pEl8 (VP23) or with (f 
and g) pUL38-63NLSFBpCI (VPI9C-63NLS) and pEl. VP19 (b, c, 
e and f) was detected with the monoclonal antibody mAb02040 and 
visualized using FITC-conjugated GAM (green). VP23 (d and g) was 
detected with the antiserum rAbl 6 and visualized using TRITC-
conjugated GAR (red). 
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was harve ted and proce sed for electron micro copy. Immu-
nofluorescence showed imilar numbers of cell expressing the 
three forms of VP19C (data not shown), and We tern blotting 
(Fig. 6f) confirmed that all three proteins were expre sed at 
imilar levels. Examination of thin section revealed the presence 
of capsid in the nuclei of 48% of the UL38FBacpCI-Lransduced 
and 57% of the UL3 -45 LSFBacpCI-transduced samples. As 
expected for VPl9C proteins that support productive infection, 
both D A-containing and empty capsids were seen in ceUs ex-
pressing wild-type VPl9C (Fig. 6a) and VP19C-45 LS (Fig. 6b). 
In contra t, no capsid-like particle of any type were seen in 
over 100 nuclei of the UL38-63NLSFBacpCI-tran duced sam-
pi . Published studies had reported that capsid a embly in a 
baculoviru model was not prevented by the removal of up to 90 
amino acid from the terminus of VPI9C, although it was less 
efficient than with full-length VP19C (30). Therefore, the failure 
to detect cap ids in the UL38-63 LSFBacpCI-transduced U20 
cells was unexpected. To investigate this further, cap id assem-
bly wa analyzed u ing the much more efficient baculovirus 
model sy tern. Duplicate plates of Sf21 cell (one containing a 
cover lip) were infected separately with 5 PFU/cell of baculo-
viru AcUL38 (expressing full-length VP19C), UL38-45FBac 
(VP19C-45), or UL38-63FBac (VP19C-63). All sample were 
also infected with 5 PFUIcell each of baculoviruses A ULl9 
(VP5), AcUL26.5 (preVP22a), and AcAB3.12 (VP23, VP26, 
and the UL26 protease) to supply the remaining cap id pro-
tein . As expected, characteri tic herpesviru B cap id were 
readily observed in cell expre ing wild-type VP19C (Fig. 6c) 
and in smaller amounts in cells expressing VP19C-45 (Fig. 6d). 
The reduced number of intact cap ids seen with VP19C-45 is 
probably a result of inefficient nuclear localization due to the 
absence of the LS. However, in cells expressing VP19 -63, 
only incomplete capsid shells were seen (Fig. 6e). Once again, 
immunofluore cence (data not shown) and Western blotting 
(Fig. 6f) confirmed that all three proteins were being expre ed 
at similar levels, thereby demonstrating that the block on par-
ticle formation wa a direct re ult of the VP19 -63 deletion. 
10 
Members of the three ubfamilie of mammalian and avian 
herpesviruse (Alpha-, Beta-, and Gammaherpesvin"dae) share a 
common capsid architecture, and in all examples analy-~ed to 
date, the triplex is composed of one copy of a VPl9 hom I gue 
(the a- ubunit) and twO copies of a VP23 homologue (the 13- ub-
unit) (3,6,40). In H V-I and mo t other aIphaherpesviru cs, the 
a-subunit is considerably larger than the f3-subunit. However, in 
beta- and gammaherpe virllces, the a-subunit is significantly 
smaller than VP19C (6, 13, 21) and i of a size imilar to that 
of the f3-sllbunit. Therefore, it eems likely that the additional 
sequence in th alphaherpe viru VP19C homologues repre-
sent relatively recent evolutionary development. omparison 
of CI-subunit equence reveal that the -terminal 111 amino 
acids of VP19 are not conerved in the other alphahcrpcsvi-
ru es (Fig. 7a). However, difIcrences in the -terminal region 
are not entirely responsible for the ize variation among the 
different herpe virus ubfamilies. An alignment of sequence 
from alpha-, beLa-, and gammaherpesviruses il, in broad agree-
ment with earlier findings (38) and indicate that the greater siz 
of the alphaherpesviru protein is largely accountcd for by two 
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FIG. 5. Mapping the VPl9C NLS. BHK cells were transfeeted with plasmids expre sing the GFP protein fused in frame to the N-terminal 3 
(b), 76 (e), 66 (d), 56 (e), or 46 (f) amino acids of VP19C. (g and h) GFP is fused to amino acids 24 to 66 and 33 to 66 of VP 19C. (a) GFP control. 
(i) -terminal 70 amino acids of VPl9C with the positions of various truncal ions indicated. Arginine residue are underlined. 
internal in ertion ,each of - 40 to 50 re idue (in ert 1 and in ert 
2), as well as by extra equence at the , terminus (Fig. 7b). 
Transposon-based insertional mutagenesis is a rapid and effi-
cient method of screening a protein sequence for functional do-
main. However, the re ults of mutational analy is must be inter-
preted with caution, particularly when considering the behavior of 
individual mutants. In some cases, pairs of mutants with contrast-
ing properties may be very close together. Thu , the pia mid 
containing insertions in286 and in289 dilIer markedly in their 
abilities to complement growth of vll.3 YFP. In addition, not all 
functions are equally ensitive to insertion. For example, although 
i n38 maps within the sequences identified a containing a nuclear 
localization signal, the ability of this mutant to enter the nucleus 
was not affected (data not shown). Therefore, without detailed 
information on the structure of the target protein or specific 
assays to measure particular propenies, it i usually not po ible 
to make other than a general interpretation of results. Three-
dimen ional structural analysis of the capsid has shown that the 
component proteins interact in different ways at distinct locations 
in the capsid (42). Furthermore, the reconfiguration that occurs 
during capsid maturation involves domain movements leading to 
changes in the patterns of interaction ( ,37). Thi type of behav-
ior means that the importance of particular regions of a protein 
may vary with maturation status and location. evenheless, the 
distribution of severely disabling mutations across VP19 was 
nonuniform, with 16 in the central region of VP19C but none in 
the N-terminal 107 residues and only 2 in the C-terminal 107 
residues. The most -terminal severely disabled mutant, in113, 
occurs almost immediately after the first evidence of conservation 
between the sequences of the alpha herpesvirus n- ubunits (Fig. 
7a) . There is no equivalent distinction marking the boundary of 
the -terminal 107 residue , although interestingly, its start at 
in35 coincides with the beginning of the second large insert 
unique to alphaherpesviruse (insert 2) (Fig. 7b). However, unlike 
the poorly con erved -terminal region, in ert 2 contains a e-
verely disabling mutation, in390. Only one insertion (in 143) 
mapped within the insert 1 locus, and it was also severely dis-
abling, indicating that this inserted sequence i functionally im-
portant. The distribution of severely di abled mutant ugge IS 
that VP19C can be divided into three regions based on the ability 
to tolerated insertions and may suggest that the three regions 
have differing roles. However, this interpretation must be treated 
with caution, as the distribution of insertion is not uniform and 
clustering of mutations wilh similar phenotypes, such as in327 to 
-330, tends to di tor! the pattern. Stati tical analy i by chi- 'quare 
analysi indicates that, although the -temlinal region is more 
tolerant of in ertions, the perceived difference between the cen-
tral and C-terminal regions i marginal. 
The sen itivity to in ertion of the central region uggests that 
it may be important for folding of VP 19 in a manner similar 
to that ugge ted for the central region (VPSud) of the major 
capsid protein, VP5, which ha been proposed to act a a 
folding nucleu for the more nexible N- and -terminal region 
(2). The large number of tolerated insertions in the C-terminal 
region i rather urpri ing, as deletional analy is had hown 
that removal of as few as 15 amino acids from the C terminu 
destroyed the ability of VP19 to uppOrt capsid a ' cmbly 
(30). When considered al ngside the behavior of in463, which 
completely fails to support viru growth, thi. eem to indicate 
that equences very near the C terminu of VP19 play e sen-
tial roles in capsid assembly. H wever, the viability of mo I of 
the mulant ill the C-terminal region suggests that it has con-
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FIG. 6. Effects of VP19C N·terminal mutations on capsid assembly. (a and b) Thirty·live·millimeter plate of U20S cells were Lran duced with 
50 PFU/cell of baculoviru UL38FBacpCI (a) or UL3 .45NLSFBacpCI (b) and incubated at 20·C for I h before being infected with 5 PFU/cell 
of vD.38YFP. Infection was continued at 37"C for 16 h. (c to e) Thirty·nve· millimeter plates of f21 cells were infected with 5 PFU/cell each of 
baculoviruses AcULl9, AcUL26.5, and AcAB3.12 and with 5 PFU/cell of AcUL38 (c), UL38-45FBac (d), or UL38-63FBac (e) and incubated at 
28°C for 48 h. At the appropriate times after infection, the cell were harve ted and prepared for electron micro copy. The majority of capsid> in 
panels a to dare B capsids and are unlabeled. In panels a and b, the C (DNA·containing) capsid, an! indicated by triangle. In panel d, 
concentration of incomplete capsid are indicated with arrowheads. Only incomplete caps ids are present in panel e, and they are not labeled. 
Baculovirus capsids (e to e) are indicated by arrows. cale bar = 500 nm. (f) Expression of VI'19C In the infected cells was confirmed hy Western 
blotting. Protein samples were separated on a 10% sodium dodecyl sulfatc·polyacrylamide gel and detected by enhanced chemiluminescence using 
mAb02040 and protein A·peroxidase. Lanes I and 2 how U20S cell sample corresponding (0 panels a and b. Lane 3 shows a sample from U20 
cells transduced with UL38-63NLSFBacpCI and infected with v.:l.3 YFP. Lanes 4 to 6 how f21 cell ;,amples corresponding (0 pane\<' c to e. 
siderable structural flexibility de pite the secondary·structure 
prediction , which appear to how that conservation of econd-
ary structure increase toward the C terminu (Fig. 7c). 
It is dimeult to discern any pattern in the interaction prop· 
ertie of the everely di abled insertional mutants. The 1 
severely disabled mutant can be divided into four categories 
based on thc ability to interact with VP5 and VP23 (Table 3). 
Five (including in242A and in242B, which are in the ame 
codon) failed to transport either VP23 or VP5 to the nucleu , 
suggcst ing that the 'e in ertions may have altered the overall 
folding of Ihe protein. The e in ertions (residue 113,242,2 9, 
and 330) are cvenly spread across the central region and do not 
appear to demarcate any obvious domain, although they may 
lie clo e together in the folded protein. Four of the mutants 
interact with VP5 but not with VP23, while in three, thi 
pattern is reversed. The . pecificity of thc e mutant ugge ts 
that the insertions do nOI cause global mi'folding of the pro-
tein but have a more localized effect. The mutants th t failed 
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FlO. 7. Sequence comparison of VP19C homologues. We u ed the CLUSTAL W (http://www.ebi.ac.uk/clustalwl) multiple sequence alignment 
program (34) to align the triplex ,,-subunit equences of 15 alphaherpesviru es, 9 betaherpesviruses, and 12 gammaherpesviru es identified by a 
BLAST search from the VIDA database (http://www.biochem.ucl.ac.ukJbsm/virus_database/VlDA.html) using the HSV-I, IICMV, and Kaposi's 
sarcoma-associated herpesvirus triplex ,,-subunit sequences as input. The CLUSTAL W output was used a the ba is for subsequent analyses. (a) 
Levels of sequence conservation among the triplex ,,- ubunits in alphaherpesviruse were analyzed and plotted using the JalView (http://www 
.jalview.orgl) multiple equence editor program (4). (b) Schematic representation of the consensus alignment between alpha-, beta- and gamma-
herpesvirus triplex ,,-subunit sequences, showing the locations of additional sequences (insert 1 and insen 2 comprising residues 140 to 176 and 
357 to 405, respectively, in HSV-I) in the alphaherpesviru proteins. The consensus sequence was calculated using the program Con ensus 
(http://www.bork.embl-heidelberg.de/Alignment/conensu.html). (c) econdary-structure prediction for triplex ,,-subunits of alpha- (top), beta-
(middle), and gammaherpesviruses (bottom). Secondary- tructure predictions were carried out on each individual sequence using PredictProtein 
(28) (http://cubic.bioc.columbia.edu/predictproteinl). Structural elements present in > 50% of examples were plotted relative to the alignments 
shown in Fig. 7b for each subfamily. The positions of ",-helices are shown in red, ~-sheet in blue, and coil in green. 
to take VP23 to the nucleus were located terminal (between 
residues 193 and 310) to those that failed to bind VP5 (be-
tween 328 and 463), sugge ting that the region involved are 
particularly important for binding of VP23 and VP5, respec-
tively. Since VP23 and VP5 are both es ential for cap id a -
sembly (5, 33, 35), it is not surprising that the mutants which 
fail to interact with one or both of them do not upport viru 
growth. The nature of the defect in the remaining everely 
disabled mutants i unclear. Further analy i is required to 
determinc whether they upport the a sembly of structurally 
normal capsid. However, examination of mutants in143, 
in234, in235, in327, in350, and in390 in a plasmid-based DNA-
packaging assay (9) howed that they were unable to upport 
o A packaging in vl138YFP-infected cell (data not hown). 
Th is suggest either that a embly of the cap id hell was dis-
rupted, pre umably due to orne subtle alteration in the inter-
actions with VP23 or VP5, or that an interaction involving one 
of the other virion components had been affected. VP19C has 
been reported to interact with the UL25 protein (22). The 
tegument protein present at the vertices in mature virion is in 
contact with the peripentonal triplexes and may al 0 interact 
with VP19C (41). Failure to bind tegument wou ld be lethal but 
would not be expected to prevent DNA packaging, However, 
UL25 mutants show aberrant D A packaging (12, 32), and 
disruption of this interaction might result in the type of phe-
notype seen here. 
The -terminal regions of all three herpesvirus ubfamilies 
are particularly poorly conserved in both length and scquence, 
with effectively no homology evident until after amino acid 111 
of VP19C (Fig. 7a). This raises question regarding the fune-
tion of thi highly variable region. Part of that function was 
revealed by the deletion of 45 residues from the terminus of 
VP19C, which removed a nuclear localization ignal. That the 
failure of this deleted protein to concentrate in the nucleu was 
entirely re pon ible for the 50-fold reduction in it ability to 
complement growth of a VP19C-minu mutant wa demon-
strated by the recovery in viru growth when an exogenou 
(SV40) nuclear localization signal wa pre ent. From this ob-
servation, it is evident that correct transport of the component 
proteins to the ite of capsid assembly is an important function 
of VP19C. Although the precise equence of the VP19C LS 
has not been identified, it has been mapped to a region con-
ta ining 33 amino acid , and database searching has revealed 
that it does not belong to any of the known cia ses of LS. 
Interestingly, the pattern of arginine residues een in the 
VP19C LS is not present in the N-terminal sequence of any 
other alphaherpe virus VP19C homologue, apart from that of 
the very clo ely related HSV-2. Furthermore, examination of 
triplex ",-subunit equence. from all three herpesviru subfam-
ilie using the predict LS program failed to identify any rec-
ognizable L s. Therefore, it is unclear whether a role in 
nuclear localization represents the usual function of the poorly 
con erved alphaherpesvirus termini or when: LS, if any 
are present, might be located in the ex- ubunit from beta- and 
gammaherpesviru c . 
ince the functional NLS is contained within the fir t 56 
amino acid of VPI9C, the function of the rest of the poorly 
con erved -terminal region remain unclear. lectron micro-
copic analysi failed to identify capsid formation by the 
VP19C-63 truncation, either in a baculovirus-ba 'cd capsid a '-
VOL. 80, 2006 
sembly model or by complementation of vtl.38YFP. The in-
complete capsid shells seen in baculovirus-infected cells con-
firm the fluorescence results showing that the VP19C-63 
protein is able to interact with VP5 and VP23 and indicate that 
the defect in assembly is not a result of a general disruption of 
the protein's structure. The results presented here contrast 
with those of Spencer t:t a!. (3D), who showed that a mutant of 
VP19C (nd90) lacking the :--I·tcrminal 90 amino acids could 
support capsid assembly in a baculovirus model system. The 
reason for this difference is unclt:ar. Although apparently in-
tact capsids were formed with nd90, their assembly was ineffi-
cient, and the majority of structures seen resembled the in-
complete particles shown in Fig. 5e. It is possible that slight 
differences in the baculovirus model systems used in the two 
studies account for the contrasting results. Alternatively, when 
exposed at the :--I terminus, amino acids 63 to 90 may have a 
disruptive effect on protein folding or interaction that is ne-
gated when they are absent. Whatever the reason, it is clear 
that sequences betwet:n residues 45 and 63 arc nect:ssary for 
efficient capsid formation, and further analysis will be needed 
to determine precisely what rolt:s they play. 
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